Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:56 ||| DT
B  ||| S:56 E:58 ||| NNP
em  ||| S:58 E:70 ||| VBD
1  ||| S:70 E:72 ||| CD
-  ||| S:72 E:83 ||| :
i  ||| S:83 E:85 ||| FW
nteracting  ||| S:85 E:96 ||| FW
proteins  ||| S:96 E:105 ||| FW
Boi1  ||| S:105 E:110 ||| FW
and  ||| S:110 E:122 ||| CC
Boi2  ||| S:122 E:127 ||| NNP
were  ||| S:127 E:132 ||| VBD
identified  ||| S:132 E:143 ||| VBN
from  ||| S:143 E:148 ||| IN
screens  ||| S:148 E:156 ||| NNS
for  ||| S:156 E:160 ||| IN
proteins  ||| S:160 E:169 ||| NNS
that  ||| S:169 E:174 ||| WDT
display  ||| S:174 E:190 ||| VBP
two-hybrid  ||| S:190 E:201 ||| JJ
interaction  ||| S:201 E:213 ||| NN
with  ||| S:213 E:218 ||| IN
the  ||| S:218 E:231 ||| DT
b  ||| S:231 E:233 ||| FW
ud-  ||| S:233 E:246 ||| FW
em  ||| S:246 E:249 ||| FW
ergence  ||| S:249 E:257 ||| FW
protein  ||| S:257 E:265 ||| FW
Bem1  ||| S:265 E:270 ||| FW
[  ||| S:270 E:272 ||| -LRB-
1  ||| S:272 E:274 ||| CD
2  ||| S:274 E:276 ||| CD
]  ||| S:276 E:278 ||| -RRB-
,  ||| S:278 E:288 ||| ,
a  ||| S:288 E:290 ||| DT
protein  ||| S:290 E:298 ||| NN
that  ||| S:298 E:303 ||| WDT
is  ||| S:303 E:306 ||| VBZ
important  ||| S:306 E:316 ||| JJ
for  ||| S:316 E:320 ||| IN
the  ||| S:320 E:324 ||| DT
initiation  ||| S:324 E:335 ||| NN
of  ||| S:335 E:338 ||| IN
budding  ||| S:338 E:354 ||| VBG
and  ||| S:354 E:358 ||| CC
that  ||| S:358 E:363 ||| WDT
contains  ||| S:363 E:372 ||| VBZ
two  ||| S:372 E:376 ||| CD
SH3  ||| S:376 E:380 ||| CD
domains ||| S:380 E:387 ||| NNS
.  ||| S:387 E:389 ||| .
Boi1  ||| S:389 E:394 ||| NNP
and  ||| S:394 E:398 ||| CC
Boi2  ||| S:398 E:403 ||| NNP
are  ||| S:403 E:415 ||| VBP
similar  ||| S:415 E:423 ||| JJ
in  ||| S:423 E:426 ||| IN
sequence  ||| S:426 E:435 ||| NN
to  ||| S:435 E:438 ||| TO
one  ||| S:438 E:442 ||| CD
another ||| S:442 E:449 ||| DT
.  ||| S:449 E:451 ||| .
Each  ||| S:451 E:456 ||| DT
contains  ||| S:456 E:465 ||| VBZ
an  ||| S:465 E:468 ||| DT
SH3  ||| S:468 E:480 ||| JJ
domain ||| S:480 E:486 ||| NN
;  ||| S:486 E:488 ||| :
a  ||| S:488 E:490 ||| DT
SAM  ||| S:490 E:494 ||| NNP
( ||| S:494 E:495 ||| -LRB-
sterile  ||| S:495 E:503 ||| FW
alpha  ||| S:503 E:509 ||| FW
motif ||| S:509 E:514 ||| FW
)  ||| S:514 E:516 ||| -RRB-
domain ||| S:516 E:522 ||| NN
;  ||| S:522 E:524 ||| :
a  ||| S:524 E:526 ||| DT
proline-rich  ||| S:526 E:547 ||| JJ
region ||| S:547 E:553 ||| NN
,  ||| S:553 E:555 ||| ,
which  ||| S:555 E:561 ||| WDT
mediates  ||| S:561 E:570 ||| VBP
binding  ||| S:570 E:578 ||| VBG
to  ||| S:578 E:581 ||| TO
the  ||| S:581 E:585 ||| DT
second  ||| S:585 E:592 ||| JJ
SH3  ||| S:592 E:596 ||| CD
domain  ||| S:596 E:603 ||| NN
of  ||| S:603 E:614 ||| IN
Bem1 ||| S:614 E:618 ||| CD
;  ||| S:618 E:620 ||| :
and  ||| S:620 E:624 ||| CC
a  ||| S:624 E:626 ||| DT
PH  ||| S:626 E:629 ||| NNP
domain  ||| S:629 E:636 ||| NN
[  ||| S:636 E:638 ||| -LRB-
1  ||| S:638 E:640 ||| CD
2  ||| S:640 E:642 ||| CD
3  ||| S:642 E:644 ||| CD
]  ||| S:644 E:646 ||| -RRB-
.  ||| S:646 E:648 ||| .
Figure  ||| S:648 E:655 ||| NN
1shows  ||| S:655 E:662 ||| VBZ
the  ||| S:662 E:674 ||| DT
relative  ||| S:674 E:683 ||| JJ
positions  ||| S:683 E:693 ||| NNS
of  ||| S:693 E:696 ||| IN
these  ||| S:696 E:702 ||| DT
sequence  ||| S:702 E:711 ||| JJ
features  ||| S:711 E:720 ||| NNS
in  ||| S:720 E:723 ||| IN
Boi1 ||| S:723 E:727 ||| CD
.  ||| S:727 E:737 ||| .
Deletion  ||| S:737 E:746 ||| NNP
of  ||| S:746 E:749 ||| IN
either  ||| S:749 E:765 ||| DT
BOI1  ||| S:765 E:770 ||| NNP
or  ||| S:770 E:782 ||| CC
BOI2  ||| S:782 E:787 ||| NNP
alone  ||| S:787 E:793 ||| RB
has  ||| S:793 E:797 ||| VBZ
little  ||| S:797 E:804 ||| JJ
effect  ||| S:804 E:811 ||| NN
on  ||| S:811 E:822 ||| IN
growth ||| S:822 E:828 ||| NN
.  ||| S:828 E:830 ||| .
However ||| S:830 E:837 ||| RB
,  ||| S:837 E:839 ||| ,
deletion  ||| S:839 E:848 ||| NN
of  ||| S:848 E:851 ||| IN
both  ||| S:851 E:856 ||| DT
genes  ||| S:856 E:862 ||| NNS
together  ||| S:862 E:871 ||| RB
is  ||| S:871 E:874 ||| VBZ
lethal  ||| S:874 E:889 ||| JJ
( ||| S:889 E:890 ||| -LRB-
at  ||| S:890 E:893 ||| IN
least  ||| S:893 E:899 ||| JJS
in  ||| S:899 E:902 ||| IN
some  ||| S:902 E:907 ||| DT
strains ||| S:907 E:914 ||| NNS
) ||| S:914 E:915 ||| -RRB-
,  ||| S:915 E:917 ||| ,
suggesting  ||| S:917 E:928 ||| VBG
that  ||| S:928 E:933 ||| IN
Boi1  ||| S:933 E:938 ||| NNP
and  ||| S:938 E:942 ||| CC
Boi2  ||| S:942 E:955 ||| RB
perform  ||| S:955 E:963 ||| VB
at  ||| S:963 E:966 ||| IN
least  ||| S:966 E:972 ||| JJS
one  ||| S:972 E:976 ||| CD
important ||| S:976 E:985 ||| JJ
,  ||| S:985 E:987 ||| ,
shared  ||| S:987 E:994 ||| VBN
function  ||| S:994 E:1003 ||| NN
[  ||| S:1003 E:1005 ||| -LRB-
1  ||| S:1005 E:1007 ||| CD
2  ||| S:1007 E:1009 ||| CD
]  ||| S:1009 E:1019 ||| -RRB-
.  ||| S:1019 E:1029 ||| .
The  ||| S:1029 E:1033 ||| DT
functions  ||| S:1033 E:1043 ||| NNS
of  ||| S:1043 E:1046 ||| IN
Boi1 ||| S:1046 E:1050 ||| NNP
/ ||| S:1050 E:1051 ||| NNP
Boi2  ||| S:1051 E:1056 ||| NNP
appear  ||| S:1056 E:1063 ||| VBP
to  ||| S:1063 E:1066 ||| TO
be  ||| S:1066 E:1069 ||| VB
linked  ||| S:1069 E:1076 ||| VBN
to  ||| S:1076 E:1079 ||| TO
those  ||| S:1079 E:1093 ||| DT
of  ||| S:1093 E:1096 ||| IN
Cdc42  ||| S:1096 E:1102 ||| NNP
and  ||| S:1102 E:1106 ||| CC
Rho3 ||| S:1106 E:1110 ||| NNP
,  ||| S:1110 E:1112 ||| ,
which  ||| S:1112 E:1118 ||| WDT
are  ||| S:1118 E:1122 ||| VBP
Rho-type  ||| S:1122 E:1131 ||| JJ
GTPases  ||| S:1131 E:1139 ||| NN
that  ||| S:1139 E:1144 ||| WDT
are  ||| S:1144 E:1156 ||| VBP
important  ||| S:1156 E:1166 ||| JJ
for  ||| S:1166 E:1170 ||| IN
polarized  ||| S:1170 E:1180 ||| JJ
cell  ||| S:1180 E:1185 ||| NN
growth  ||| S:1185 E:1192 ||| NN
[  ||| S:1192 E:1194 ||| -LRB-
4  ||| S:1194 E:1196 ||| CD
5  ||| S:1196 E:1198 ||| CD
6  ||| S:1198 E:1200 ||| CD
7  ||| S:1200 E:1202 ||| CD
8  ||| S:1202 E:1204 ||| CD
9  ||| S:1204 E:1206 ||| CD
]  ||| S:1206 E:1208 ||| -RRB-
.  ||| S:1208 E:1210 ||| .
Boi1  ||| S:1210 E:1223 ||| NNP
and  ||| S:1223 E:1227 ||| CC
Boi2  ||| S:1227 E:1232 ||| CD
display  ||| S:1232 E:1240 ||| NN
two-hybrid  ||| S:1240 E:1251 ||| JJ
interactions  ||| S:1251 E:1264 ||| NNS
with  ||| S:1264 E:1269 ||| IN
both  ||| S:1269 E:1282 ||| DT
wild-type  ||| S:1282 E:1292 ||| JJ
and  ||| S:1292 E:1296 ||| CC
mutationally  ||| S:1296 E:1309 ||| JJ
activated  ||| S:1309 E:1319 ||| JJ
Cdc42  ||| S:1319 E:1325 ||| NN
but  ||| S:1325 E:1329 ||| CC
not  ||| S:1329 E:1333 ||| RB
with  ||| S:1333 E:1338 ||| IN
a  ||| S:1338 E:1348 ||| DT
mutant  ||| S:1348 E:1355 ||| JJ
version  ||| S:1355 E:1363 ||| NN
of  ||| S:1363 E:1366 ||| IN
Cdc42  ||| S:1366 E:1372 ||| NNP
that  ||| S:1372 E:1377 ||| WDT
is  ||| S:1377 E:1380 ||| VBZ
predicted  ||| S:1380 E:1390 ||| VBN
to  ||| S:1390 E:1393 ||| TO
be  ||| S:1393 E:1396 ||| VB
impaired  ||| S:1396 E:1405 ||| VBN
in  ||| S:1405 E:1416 ||| IN
the  ||| S:1416 E:1420 ||| DT
ability  ||| S:1420 E:1428 ||| NN
to  ||| S:1428 E:1431 ||| TO
bind  ||| S:1431 E:1436 ||| VB
nucleotide ||| S:1436 E:1446 ||| NNS
,  ||| S:1446 E:1448 ||| ,
suggesting  ||| S:1448 E:1459 ||| VBG
that  ||| S:1459 E:1464 ||| IN
Boi1  ||| S:1464 E:1469 ||| NNP
and  ||| S:1469 E:1481 ||| CC
Boi2  ||| S:1481 E:1486 ||| NNP
may  ||| S:1486 E:1490 ||| MD
associate  ||| S:1490 E:1500 ||| VB
with  ||| S:1500 E:1505 ||| IN
the  ||| S:1505 E:1509 ||| DT
GTP-bound  ||| S:1509 E:1519 ||| JJ
( ||| S:1519 E:1520 ||| -LRB-
"active ||| S:1520 E:1527 ||| NNP
" ||| S:1527 E:1528 ||| ''
)  ||| S:1528 E:1530 ||| -RRB-
form  ||| S:1530 E:1535 ||| NN
of  ||| S:1535 E:1546 ||| IN
Cdc42  ||| S:1546 E:1552 ||| NNP
[  ||| S:1552 E:1554 ||| -LRB-
1  ||| S:1554 E:1556 ||| LS
]  ||| S:1556 E:1558 ||| -RRB-
.  ||| S:1558 E:1560 ||| .
Further  ||| S:1560 E:1568 ||| JJ
evidence  ||| S:1568 E:1577 ||| NN
that  ||| S:1577 E:1582 ||| IN
some  ||| S:1582 E:1587 ||| DT
function  ||| S:1587 E:1596 ||| NN
of  ||| S:1596 E:1599 ||| IN
Boi1  ||| S:1599 E:1612 ||| NNP
is  ||| S:1612 E:1615 ||| VBZ
linked  ||| S:1615 E:1622 ||| VBN
to  ||| S:1622 E:1625 ||| TO
that  ||| S:1625 E:1630 ||| DT
of  ||| S:1630 E:1633 ||| IN
Cdc42  ||| S:1633 E:1639 ||| NNP
is  ||| S:1639 E:1642 ||| VBZ
that  ||| S:1642 E:1647 ||| DT
overexpression  ||| S:1647 E:1662 ||| NN
of  ||| S:1662 E:1665 ||| IN
Boi1  ||| S:1665 E:1678 ||| CD
inhibits  ||| S:1678 E:1687 ||| CD
bud  ||| S:1687 E:1691 ||| JJ
emergence  ||| S:1691 E:1701 ||| NN
and  ||| S:1701 E:1705 ||| CC
that  ||| S:1705 E:1710 ||| IN
this  ||| S:1710 E:1715 ||| DT
inhibition  ||| S:1715 E:1726 ||| NN
can  ||| S:1726 E:1730 ||| MD
be  ||| S:1730 E:1741 ||| VB
suppressed  ||| S:1741 E:1752 ||| VBN
by  ||| S:1752 E:1755 ||| IN
overexpression  ||| S:1755 E:1770 ||| NN
of  ||| S:1770 E:1773 ||| IN
Cdc42  ||| S:1773 E:1779 ||| NNP
[  ||| S:1779 E:1781 ||| -LRB-
1  ||| S:1781 E:1783 ||| CD
2  ||| S:1783 E:1785 ||| CD
]  ||| S:1785 E:1787 ||| -RRB-
.  ||| S:1787 E:1798 ||| .
RHO3  ||| S:1798 E:1803 ||| NNP
can  ||| S:1803 E:1807 ||| MD
serve  ||| S:1807 E:1813 ||| VB
as  ||| S:1813 E:1816 ||| IN
a  ||| S:1816 E:1818 ||| DT
multicopy  ||| S:1818 E:1836 ||| JJ
suppressor  ||| S:1836 E:1847 ||| NN
of  ||| S:1847 E:1850 ||| IN
the  ||| S:1850 E:1854 ||| DT
lethality  ||| S:1854 E:1864 ||| NN
caused  ||| S:1864 E:1871 ||| VBN
by  ||| S:1871 E:1874 ||| IN
deletion  ||| S:1874 E:1883 ||| NN
of  ||| S:1883 E:1895 ||| IN
BOI1  ||| S:1895 E:1900 ||| NNP
and  ||| S:1900 E:1913 ||| CC
BOI2  ||| S:1913 E:1918 ||| NNP
[  ||| S:1918 E:1920 ||| -LRB-
1  ||| S:1920 E:1922 ||| CD
2  ||| S:1922 E:1924 ||| CD
]  ||| S:1924 E:1926 ||| -RRB-
.  ||| S:1926 E:1928 ||| .
These  ||| S:1928 E:1934 ||| DT
findings  ||| S:1934 E:1943 ||| NNS
are  ||| S:1943 E:1955 ||| VBP
consistent  ||| S:1955 E:1966 ||| JJ
with  ||| S:1966 E:1971 ||| IN
the  ||| S:1971 E:1975 ||| DT
possibilities  ||| S:1975 E:1989 ||| NNS
that  ||| S:1989 E:1994 ||| IN
Boi1  ||| S:1994 E:1999 ||| NNP
and  ||| S:1999 E:2003 ||| CC
Boi2  ||| S:2003 E:2008 ||| NNP
are  ||| S:2008 E:2020 ||| VBP
targets  ||| S:2020 E:2028 ||| NNS
of  ||| S:2028 E:2031 ||| IN
Cdc42  ||| S:2031 E:2037 ||| CD
that  ||| S:2037 E:2042 ||| IN
promote  ||| S:2042 E:2050 ||| JJ
cell  ||| S:2050 E:2055 ||| NN
growth  ||| S:2055 E:2062 ||| NN
in  ||| S:2062 E:2065 ||| IN
a  ||| S:2065 E:2067 ||| DT
manner  ||| S:2067 E:2074 ||| NN
that  ||| S:2074 E:2087 ||| WDT
is  ||| S:2087 E:2090 ||| VBZ
regulated  ||| S:2090 E:2100 ||| VBN
by  ||| S:2100 E:2103 ||| IN
Rho3 ||| S:2103 E:2107 ||| CD
.  ||| S:2107 E:2117 ||| .
Support  ||| S:2117 E:2125 ||| NN
for  ||| S:2125 E:2129 ||| IN
the  ||| S:2129 E:2133 ||| DT
view  ||| S:2133 E:2138 ||| NN
that  ||| S:2138 E:2143 ||| IN
Boi1  ||| S:2143 E:2148 ||| NNP
and  ||| S:2148 E:2152 ||| CC
Boi2  ||| S:2152 E:2157 ||| NNP
are  ||| S:2157 E:2161 ||| VBP
involved  ||| S:2161 E:2170 ||| VBN
in  ||| S:2170 E:2181 ||| IN
polarized  ||| S:2181 E:2191 ||| JJ
growth  ||| S:2191 E:2198 ||| NN
comes  ||| S:2198 E:2204 ||| VBZ
from  ||| S:2204 E:2209 ||| IN
the  ||| S:2209 E:2213 ||| DT
analysis  ||| S:2213 E:2222 ||| NN
of  ||| S:2222 E:2225 ||| IN
fission  ||| S:2225 E:2233 ||| JJ
yeast  ||| S:2233 E:2247 ||| NN
Pob1 ||| S:2247 E:2251 ||| NN
,  ||| S:2251 E:2253 ||| ,
which  ||| S:2253 E:2259 ||| WDT
is  ||| S:2259 E:2262 ||| VBZ
a  ||| S:2262 E:2264 ||| DT
homolog  ||| S:2264 E:2272 ||| NN
of  ||| S:2272 E:2275 ||| IN
Boi1  ||| S:2275 E:2280 ||| NNP
and  ||| S:2280 E:2284 ||| CC
Boi2 ||| S:2284 E:2288 ||| NNP
.  ||| S:2288 E:2290 ||| .
In  ||| S:2290 E:2293 ||| IN
particular ||| S:2293 E:2303 ||| JJ
,  ||| S:2303 E:2313 ||| ,
in  ||| S:2313 E:2325 ||| IN
S.  ||| S:2325 E:2328 ||| NNP
pombe  ||| S:2328 E:2334 ||| NN
cells ||| S:2334 E:2339 ||| NNS
,  ||| S:2339 E:2341 ||| ,
Pob1  ||| S:2341 E:2346 ||| NNP
is  ||| S:2346 E:2349 ||| VBZ
localized  ||| S:2349 E:2359 ||| VBN
to  ||| S:2359 E:2370 ||| TO
sites  ||| S:2370 E:2376 ||| NNS
of  ||| S:2376 E:2379 ||| IN
polarized  ||| S:2379 E:2389 ||| JJ
growth ||| S:2389 E:2395 ||| NN
,  ||| S:2395 E:2397 ||| ,
loss  ||| S:2397 E:2402 ||| NN
of  ||| S:2402 E:2405 ||| IN
Pob1  ||| S:2405 E:2410 ||| CD
function  ||| S:2410 E:2419 ||| NN
leads  ||| S:2419 E:2425 ||| VBZ
to  ||| S:2425 E:2428 ||| TO
a  ||| S:2428 E:2438 ||| DT
loss  ||| S:2438 E:2443 ||| NN
of  ||| S:2443 E:2446 ||| IN
polarized  ||| S:2446 E:2456 ||| JJ
growth ||| S:2456 E:2462 ||| NN
,  ||| S:2462 E:2464 ||| ,
and  ||| S:2464 E:2468 ||| CC
overexpression  ||| S:2468 E:2483 ||| NN
of  ||| S:2483 E:2486 ||| IN
Pob1  ||| S:2486 E:2491 ||| CD
causes  ||| S:2491 E:2506 ||| NNS
cell  ||| S:2506 E:2511 ||| NN
growth  ||| S:2511 E:2518 ||| NN
to  ||| S:2518 E:2521 ||| TO
become  ||| S:2521 E:2528 ||| VB
depolarized  ||| S:2528 E:2540 ||| NNS
[  ||| S:2540 E:2542 ||| -LRB-
10  ||| S:2542 E:2545 ||| CD
]  ||| S:2545 E:2547 ||| -RRB-
.  ||| S:2547 E:2557 ||| .
The  ||| S:2557 E:2561 ||| DT
PH  ||| S:2561 E:2564 ||| NNP
domain  ||| S:2564 E:2571 ||| NN
appears  ||| S:2571 E:2579 ||| VBZ
to  ||| S:2579 E:2582 ||| TO
be  ||| S:2582 E:2585 ||| VB
a  ||| S:2585 E:2587 ||| DT
critical  ||| S:2587 E:2596 ||| JJ
feature  ||| S:2596 E:2604 ||| NN
of  ||| S:2604 E:2607 ||| IN
Boi1 ||| S:2607 E:2611 ||| CD
:  ||| S:2611 E:2621 ||| :
mutations  ||| S:2621 E:2631 ||| NNS
in  ||| S:2631 E:2634 ||| IN
this  ||| S:2634 E:2639 ||| DT
domain  ||| S:2639 E:2646 ||| NN
destroy  ||| S:2646 E:2654 ||| VBD
Boi1  ||| S:2654 E:2659 ||| CD
function ||| S:2659 E:2667 ||| NN
,  ||| S:2667 E:2669 ||| ,
and  ||| S:2669 E:2673 ||| CC
Boi1-PH  ||| S:2673 E:2689 ||| NNP
( ||| S:2689 E:2690 ||| -LRB-
see  ||| S:2690 E:2694 ||| VB
Fig.  ||| S:2694 E:2699 ||| CD
1 ||| S:2699 E:2700 ||| CD
)  ||| S:2700 E:2702 ||| -RRB-
can  ||| S:2702 E:2706 ||| MD
substitute  ||| S:2706 E:2717 ||| VB
in  ||| S:2717 E:2720 ||| IN
function  ||| S:2720 E:2729 ||| NN
for  ||| S:2729 E:2733 ||| IN
Boi1  ||| S:2733 E:2738 ||| NNP
and  ||| S:2738 E:2742 ||| CC
Boi2  ||| S:2742 E:2747 ||| NNP
[  ||| S:2747 E:2757 ||| -LRB-
1  ||| S:2757 E:2759 ||| LS
]  ||| S:2759 E:2761 ||| -RRB-
.  ||| S:2761 E:2763 ||| .
In  ||| S:2763 E:2766 ||| IN
addition ||| S:2766 E:2774 ||| NN
,  ||| S:2774 E:2776 ||| ,
Boi1-PH  ||| S:2776 E:2784 ||| NNP
contains  ||| S:2784 E:2793 ||| VBZ
the  ||| S:2793 E:2797 ||| DT
region  ||| S:2797 E:2804 ||| NN
of  ||| S:2804 E:2807 ||| IN
Boi1  ||| S:2807 E:2812 ||| CD
that  ||| S:2812 E:2825 ||| IN
displays  ||| S:2825 E:2834 ||| NNS
the  ||| S:2834 E:2838 ||| DT
two-hybrid  ||| S:2838 E:2849 ||| JJ
interaction  ||| S:2849 E:2861 ||| NN
with  ||| S:2861 E:2866 ||| IN
Cdc42 ||| S:2866 E:2871 ||| NNP
,  ||| S:2871 E:2873 ||| ,
raising  ||| S:2873 E:2881 ||| VBG
the  ||| S:2881 E:2893 ||| DT
possibility  ||| S:2893 E:2905 ||| NN
that  ||| S:2905 E:2910 ||| IN
the  ||| S:2910 E:2914 ||| DT
PH  ||| S:2914 E:2917 ||| NNP
domain ||| S:2917 E:2923 ||| NN
,  ||| S:2923 E:2925 ||| ,
itself ||| S:2925 E:2931 ||| PRP
,  ||| S:2931 E:2933 ||| ,
mediates  ||| S:2933 E:2942 ||| NN
or  ||| S:2942 E:2953 ||| CC
regulates  ||| S:2953 E:2963 ||| VBZ
the  ||| S:2963 E:2967 ||| DT
association  ||| S:2967 E:2979 ||| NN
with  ||| S:2979 E:2984 ||| IN
Cdc42  ||| S:2984 E:2990 ||| NNP
[  ||| S:2990 E:2992 ||| -LRB-
1  ||| S:2992 E:2994 ||| LS
]  ||| S:2994 E:2996 ||| -RRB-
.  ||| S:2996 E:3006 ||| .
A  ||| S:3006 E:3008 ||| DT
generally  ||| S:3008 E:3018 ||| RB
shared  ||| S:3018 E:3025 ||| VBN
feature  ||| S:3025 E:3033 ||| NN
of  ||| S:3033 E:3036 ||| IN
PH  ||| S:3036 E:3039 ||| NNP
domains  ||| S:3039 E:3047 ||| NN
is  ||| S:3047 E:3050 ||| VBZ
the  ||| S:3050 E:3054 ||| DT
ability  ||| S:3054 E:3070 ||| NN
to  ||| S:3070 E:3073 ||| TO
bind  ||| S:3073 E:3078 ||| VB
acidic  ||| S:3078 E:3085 ||| JJ
phospholipids ||| S:3085 E:3098 ||| NN
,  ||| S:3098 E:3100 ||| ,
usually  ||| S:3100 E:3108 ||| RB
one  ||| S:3108 E:3112 ||| CD
or  ||| S:3112 E:3115 ||| CC
more  ||| S:3115 E:3120 ||| RBR
derived  ||| S:3120 E:3136 ||| VBN
from  ||| S:3136 E:3141 ||| IN
PI  ||| S:3141 E:3144 ||| NNP
( ||| S:3144 E:3145 ||| -LRB-
phosphatidylinositol ||| S:3145 E:3165 ||| LS
)  ||| S:3165 E:3167 ||| -RRB-
and ||| S:3167 E:3170 ||| CC
,  ||| S:3170 E:3172 ||| ,
in  ||| S:3172 E:3175 ||| IN
some  ||| S:3175 E:3180 ||| DT
cases ||| S:3180 E:3185 ||| NNS
,  ||| S:3185 E:3187 ||| ,
also  ||| S:3187 E:3192 ||| RB
PS  ||| S:3192 E:3203 ||| NNP
[  ||| S:3203 E:3205 ||| -LRB-
11  ||| S:3205 E:3208 ||| CD
12  ||| S:3208 E:3211 ||| CD
]  ||| S:3211 E:3213 ||| -RRB-
.  ||| S:3213 E:3215 ||| .
In  ||| S:3215 E:3218 ||| IN
some  ||| S:3218 E:3223 ||| DT
proteins ||| S:3223 E:3231 ||| NNS
,  ||| S:3231 E:3233 ||| ,
the  ||| S:3233 E:3237 ||| DT
main  ||| S:3237 E:3242 ||| JJ
role  ||| S:3242 E:3247 ||| NN
of  ||| S:3247 E:3250 ||| IN
the  ||| S:3250 E:3254 ||| DT
binding  ||| S:3254 E:3270 ||| NN
of  ||| S:3270 E:3273 ||| IN
PH  ||| S:3273 E:3276 ||| NNP
domains  ||| S:3276 E:3284 ||| VBD
to  ||| S:3284 E:3287 ||| TO
phospholipids  ||| S:3287 E:3301 ||| NNS
may  ||| S:3301 E:3305 ||| MD
simply  ||| S:3305 E:3312 ||| RB
be  ||| S:3312 E:3315 ||| VB
to  ||| S:3315 E:3318 ||| TO
promote  ||| S:3318 E:3334 ||| VB
association  ||| S:3334 E:3346 ||| NN
with  ||| S:3346 E:3351 ||| IN
membrane  ||| S:3351 E:3360 ||| NNS
( ||| S:3360 E:3361 ||| -LRB-
i.e. ||| S:3361 E:3365 ||| FW
,  ||| S:3365 E:3367 ||| ,
to  ||| S:3367 E:3370 ||| TO
serve  ||| S:3370 E:3376 ||| VB
as  ||| S:3376 E:3379 ||| IN
a  ||| S:3379 E:3389 ||| DT
membrane-localization  ||| S:3389 E:3411 ||| JJ
tag ||| S:3411 E:3414 ||| NN
)  ||| S:3414 E:3416 ||| -RRB-
[  ||| S:3416 E:3418 ||| -LRB-
13  ||| S:3418 E:3421 ||| CD
14  ||| S:3421 E:3424 ||| CD
]  ||| S:3424 E:3426 ||| -RRB-
.  ||| S:3426 E:3428 ||| .
In  ||| S:3428 E:3431 ||| IN
other  ||| S:3431 E:3437 ||| JJ
proteins ||| S:3437 E:3445 ||| NNS
,  ||| S:3445 E:3455 ||| ,
the  ||| S:3455 E:3459 ||| DT
binding  ||| S:3459 E:3467 ||| NN
of  ||| S:3467 E:3470 ||| IN
PH  ||| S:3470 E:3473 ||| NNP
domains  ||| S:3473 E:3481 ||| VBD
to  ||| S:3481 E:3484 ||| TO
phospholipids  ||| S:3484 E:3498 ||| NN
appears  ||| S:3498 E:3506 ||| VBZ
to  ||| S:3506 E:3509 ||| TO
be  ||| S:3509 E:3520 ||| VB
important  ||| S:3520 E:3530 ||| JJ
for  ||| S:3530 E:3534 ||| IN
allosteric  ||| S:3534 E:3545 ||| NN
or  ||| S:3545 E:3548 ||| CC
other  ||| S:3548 E:3554 ||| JJ
types  ||| S:3554 E:3560 ||| NNS
of  ||| S:3560 E:3563 ||| IN
regulation  ||| S:3563 E:3574 ||| NN
[  ||| S:3574 E:3576 ||| -LRB-
15  ||| S:3576 E:3587 ||| CD
16  ||| S:3587 E:3590 ||| CD
]  ||| S:3590 E:3592 ||| -RRB-
.  ||| S:3592 E:3602 ||| .
Given  ||| S:3602 E:3608 ||| VBN
that  ||| S:3608 E:3613 ||| IN
1 ||| S:3613 E:3614 ||| CD
)  ||| S:3614 E:3616 ||| -RRB-
Boi1  ||| S:3616 E:3621 ||| NNP
and  ||| S:3621 E:3625 ||| CC
Boi2  ||| S:3625 E:3630 ||| NNP
are  ||| S:3630 E:3634 ||| VBP
important  ||| S:3634 E:3644 ||| JJ
proteins  ||| S:3644 E:3653 ||| NNS
whose  ||| S:3653 E:3667 ||| WP$
functions  ||| S:3667 E:3677 ||| NNS
appear  ||| S:3677 E:3684 ||| VBP
to  ||| S:3684 E:3687 ||| TO
be  ||| S:3687 E:3690 ||| VB
linked  ||| S:3690 E:3697 ||| VBN
to  ||| S:3697 E:3700 ||| TO
those  ||| S:3700 E:3706 ||| DT
of  ||| S:3706 E:3709 ||| IN
Cdc42  ||| S:3709 E:3715 ||| NNP
and  ||| S:3715 E:3719 ||| CC
Rho3 ||| S:3719 E:3723 ||| NNP
,  ||| S:3723 E:3733 ||| ,
2 ||| S:3733 E:3734 ||| LS
)  ||| S:3734 E:3736 ||| -RRB-
the  ||| S:3736 E:3740 ||| DT
PH  ||| S:3740 E:3743 ||| NNP
domain  ||| S:3743 E:3750 ||| NN
appears  ||| S:3750 E:3758 ||| VBZ
to  ||| S:3758 E:3761 ||| TO
be  ||| S:3761 E:3764 ||| VB
of  ||| S:3764 E:3767 ||| IN
particular  ||| S:3767 E:3778 ||| JJ
importance  ||| S:3778 E:3789 ||| NN
for  ||| S:3789 E:3801 ||| IN
Boi1  ||| S:3801 E:3806 ||| CD
function ||| S:3806 E:3814 ||| NN
,  ||| S:3814 E:3816 ||| ,
and  ||| S:3816 E:3820 ||| CC
3 ||| S:3820 E:3821 ||| LS
)  ||| S:3821 E:3823 ||| -RRB-
a  ||| S:3823 E:3825 ||| DT
general  ||| S:3825 E:3833 ||| JJ
role  ||| S:3833 E:3838 ||| NN
of  ||| S:3838 E:3841 ||| IN
PH  ||| S:3841 E:3844 ||| NNP
domains  ||| S:3844 E:3852 ||| NN
may  ||| S:3852 E:3856 ||| MD
be  ||| S:3856 E:3867 ||| VB
to  ||| S:3867 E:3870 ||| TO
bind  ||| S:3870 E:3875 ||| VB
acidic  ||| S:3875 E:3882 ||| JJ
phospholipids ||| S:3882 E:3895 ||| NN
,  ||| S:3895 E:3897 ||| ,
we  ||| S:3897 E:3900 ||| PRP
wanted  ||| S:3900 E:3907 ||| VBD
to  ||| S:3907 E:3910 ||| TO
know  ||| S:3910 E:3915 ||| VB
whether  ||| S:3915 E:3923 ||| IN
the  ||| S:3923 E:3935 ||| DT
PH  ||| S:3935 E:3938 ||| NNP
domain  ||| S:3938 E:3945 ||| NN
of  ||| S:3945 E:3948 ||| IN
Boi1  ||| S:3948 E:3953 ||| FW
binds  ||| S:3953 E:3959 ||| FW
acidic  ||| S:3959 E:3966 ||| FW
phospholipids  ||| S:3966 E:3980 ||| FW
and ||| S:3980 E:3983 ||| CC
,  ||| S:3983 E:3985 ||| ,
if  ||| S:3985 E:3988 ||| IN
it  ||| S:3988 E:3999 ||| PRP
does ||| S:3999 E:4003 ||| VBZ
,  ||| S:4003 E:4005 ||| ,
whether  ||| S:4005 E:4013 ||| IN
this  ||| S:4013 E:4018 ||| DT
binding  ||| S:4018 E:4026 ||| NN
is  ||| S:4026 E:4029 ||| VBZ
important  ||| S:4029 E:4039 ||| JJ
for  ||| S:4039 E:4043 ||| IN
the  ||| S:4043 E:4047 ||| DT
function  ||| S:4047 E:4064 ||| NN
and  ||| S:4064 E:4068 ||| CC
proper  ||| S:4068 E:4075 ||| JJ
localization  ||| S:4075 E:4088 ||| NN
of  ||| S:4088 E:4091 ||| IN
Boi1 ||| S:4091 E:4095 ||| CD
.  ||| S:4095 E:4097 ||| .
In  ||| S:4097 E:4100 ||| IN
the  ||| S:4100 E:4104 ||| DT
current  ||| S:4104 E:4112 ||| JJ
study ||| S:4112 E:4117 ||| NN
,  ||| S:4117 E:4119 ||| ,
we  ||| S:4119 E:4130 ||| PRP
investigate  ||| S:4130 E:4142 ||| VB
these  ||| S:4142 E:4148 ||| DT
issues  ||| S:4148 E:4155 ||| NNS
as  ||| S:4155 E:4158 ||| IN
a  ||| S:4158 E:4160 ||| DT
first  ||| S:4160 E:4166 ||| JJ
step  ||| S:4166 E:4171 ||| NN
toward  ||| S:4171 E:4178 ||| IN
eludicating  ||| S:4178 E:4198 ||| JJ
roles  ||| S:4198 E:4204 ||| NNS
of  ||| S:4204 E:4207 ||| IN
Boi1 ||| S:4207 E:4211 ||| NNP
's  ||| S:4211 E:4214 ||| POS
PH  ||| S:4214 E:4217 ||| NNP
domain ||| S:4217 E:4223 ||| NN
.  ||| S:4223 E:4247 ||| .
Results  ||| S:4247 E:4274 ||| NNP
Binding  ||| S:4274 E:4282 ||| NNP
of  ||| S:4282 E:4285 ||| IN
Boi1-PH  ||| S:4285 E:4293 ||| CD
to  ||| S:4293 E:4296 ||| TO
phospholipids  ||| S:4296 E:4320 ||| VB
In  ||| S:4320 E:4323 ||| IN
all  ||| S:4323 E:4327 ||| DT
binding  ||| S:4327 E:4335 ||| JJ
analyses  ||| S:4335 E:4344 ||| NNS
reported  ||| S:4344 E:4353 ||| VBD
in  ||| S:4353 E:4356 ||| IN
this  ||| S:4356 E:4361 ||| DT
study ||| S:4361 E:4366 ||| NN
,  ||| S:4366 E:4368 ||| ,
we  ||| S:4368 E:4381 ||| PRP
used  ||| S:4381 E:4386 ||| VBD
Boi1-PH  ||| S:4386 E:4394 ||| CD
( ||| S:4394 E:4395 ||| -LRB-
see  ||| S:4395 E:4399 ||| VB
Fig.  ||| S:4399 E:4404 ||| CD
1 ||| S:4404 E:4405 ||| CD
)  ||| S:4405 E:4407 ||| -RRB-
rather  ||| S:4407 E:4414 ||| RB
than  ||| S:4414 E:4419 ||| IN
full-length  ||| S:4419 E:4431 ||| JJ
Boi1 ||| S:4431 E:4435 ||| NN
,  ||| S:4435 E:4447 ||| ,
because  ||| S:4447 E:4455 ||| IN
we  ||| S:4455 E:4458 ||| PRP
wanted  ||| S:4458 E:4465 ||| VBD
to  ||| S:4465 E:4468 ||| TO
focus  ||| S:4468 E:4474 ||| VB
on  ||| S:4474 E:4477 ||| IN
interactions  ||| S:4477 E:4490 ||| JJ
mediated  ||| S:4490 E:4499 ||| NN
by  ||| S:4499 E:4512 ||| IN
the  ||| S:4512 E:4516 ||| DT
PH  ||| S:4516 E:4519 ||| NNP
domain ||| S:4519 E:4525 ||| NN
.  ||| S:4525 E:4527 ||| .
Also ||| S:4527 E:4531 ||| RB
,  ||| S:4531 E:4533 ||| ,
we  ||| S:4533 E:4536 ||| PRP
needed  ||| S:4536 E:4543 ||| VBD
to  ||| S:4543 E:4546 ||| TO
have  ||| S:4546 E:4551 ||| VB
a  ||| S:4551 E:4553 ||| DT
soluble  ||| S:4553 E:4561 ||| JJ
pool  ||| S:4561 E:4566 ||| NN
of  ||| S:4566 E:4579 ||| IN
protein  ||| S:4579 E:4587 ||| NN
for  ||| S:4587 E:4591 ||| IN
vesicle  ||| S:4591 E:4599 ||| JJ
co-sedimentation  ||| S:4599 E:4616 ||| JJ
studies ||| S:4616 E:4623 ||| NNS
,  ||| S:4623 E:4625 ||| ,
and  ||| S:4625 E:4629 ||| CC
while  ||| S:4629 E:4645 ||| IN
most  ||| S:4645 E:4650 ||| JJS
of  ||| S:4650 E:4653 ||| IN
the  ||| S:4653 E:4657 ||| DT
Boi1-PH  ||| S:4657 E:4665 ||| NNP
was  ||| S:4665 E:4669 ||| VBD
soluble  ||| S:4669 E:4677 ||| JJ
( ||| S:4677 E:4678 ||| -LRB-
at  ||| S:4678 E:4681 ||| IN
least  ||| S:4681 E:4687 ||| JJS
when  ||| S:4687 E:4702 ||| WRB
overexpressed ||| S:4702 E:4715 ||| NNS
) ||| S:4715 E:4716 ||| -RRB-
,  ||| S:4716 E:4718 ||| ,
virtually  ||| S:4718 E:4728 ||| RB
none  ||| S:4728 E:4733 ||| NN
of  ||| S:4733 E:4736 ||| IN
the  ||| S:4736 E:4740 ||| DT
full-length  ||| S:4740 E:4752 ||| JJ
Boi1  ||| S:4752 E:4767 ||| NN
was  ||| S:4767 E:4771 ||| VBD
soluble  ||| S:4771 E:4779 ||| JJ
( ||| S:4779 E:4780 ||| -LRB-
whether  ||| S:4780 E:4788 ||| IN
or  ||| S:4788 E:4791 ||| CC
not  ||| S:4791 E:4795 ||| RB
overexpressed ||| S:4795 E:4808 ||| CD
) ||| S:4808 E:4809 ||| -RRB-
.  ||| S:4809 E:4821 ||| .
Fortuitously ||| S:4821 E:4833 ||| NNP
,  ||| S:4833 E:4835 ||| ,
we  ||| S:4835 E:4838 ||| PRP
discovered  ||| S:4838 E:4849 ||| VBD
that  ||| S:4849 E:4854 ||| IN
Boi1-PH  ||| S:4854 E:4862 ||| NNP
can  ||| S:4862 E:4866 ||| MD
be  ||| S:4866 E:4879 ||| VB
proteolyzed  ||| S:4879 E:4891 ||| VBN
in  ||| S:4891 E:4894 ||| IN
yeast  ||| S:4894 E:4900 ||| NN
extracts  ||| S:4900 E:4909 ||| NN
in  ||| S:4909 E:4912 ||| IN
a  ||| S:4912 E:4914 ||| DT
manner  ||| S:4914 E:4921 ||| NN
that  ||| S:4921 E:4926 ||| WDT
is  ||| S:4926 E:4939 ||| VBZ
stimulated  ||| S:4939 E:4950 ||| VBN
by  ||| S:4950 E:4953 ||| IN
PIP  ||| S:4953 E:4968 ||| NNP
2  ||| S:4968 E:4970 ||| CD
.  ||| S:4970 E:4972 ||| .
Figure  ||| S:4972 E:4979 ||| NN
2Ashows  ||| S:4979 E:4987 ||| VBZ
an  ||| S:4987 E:4990 ||| DT
example  ||| S:4990 E:4998 ||| NN
of  ||| S:4998 E:5001 ||| IN
this  ||| S:5001 E:5016 ||| DT
phenomenon ||| S:5016 E:5026 ||| NN
;  ||| S:5026 E:5028 ||| :
whereas  ||| S:5028 E:5036 ||| IN
most  ||| S:5036 E:5041 ||| JJS
of  ||| S:5041 E:5044 ||| IN
the  ||| S:5044 E:5048 ||| DT
anti-Boi1  ||| S:5048 E:5068 ||| CD
immunoreactivity  ||| S:5068 E:5085 ||| NNS
was  ||| S:5085 E:5089 ||| VBD
present  ||| S:5089 E:5097 ||| JJ
in  ||| S:5097 E:5100 ||| IN
a  ||| S:5100 E:5102 ||| DT
single  ||| S:5102 E:5109 ||| JJ
band  ||| S:5109 E:5114 ||| NN
when  ||| S:5114 E:5129 ||| WRB
Boi1-PH  ||| S:5129 E:5137 ||| NNP
was  ||| S:5137 E:5141 ||| VBD
incubated  ||| S:5141 E:5151 ||| VBN
with  ||| S:5151 E:5156 ||| IN
control  ||| S:5156 E:5164 ||| NN
PS  ||| S:5164 E:5167 ||| NNP
vesicles  ||| S:5167 E:5176 ||| NN
that  ||| S:5176 E:5191 ||| WDT
lacked  ||| S:5191 E:5198 ||| VBD
PIP  ||| S:5198 E:5213 ||| NNP
2  ||| S:5213 E:5215 ||| CD
,  ||| S:5215 E:5217 ||| ,
almost  ||| S:5217 E:5224 ||| RB
all  ||| S:5224 E:5228 ||| RB
of  ||| S:5228 E:5231 ||| IN
the  ||| S:5231 E:5235 ||| DT
anti-Boi1  ||| S:5235 E:5255 ||| CD
immunoreactivity  ||| S:5255 E:5272 ||| NNS
was  ||| S:5272 E:5276 ||| VBD
present  ||| S:5276 E:5284 ||| JJ
in  ||| S:5284 E:5287 ||| IN
faster-migrating  ||| S:5287 E:5304 ||| JJ
bands  ||| S:5304 E:5320 ||| NNS
when  ||| S:5320 E:5325 ||| WRB
Boi1-PH  ||| S:5325 E:5333 ||| NNP
was  ||| S:5333 E:5337 ||| VBD
incubated  ||| S:5337 E:5347 ||| VBN
with  ||| S:5347 E:5352 ||| IN
PS  ||| S:5352 E:5355 ||| NNP
vesicles  ||| S:5355 E:5364 ||| NN
that  ||| S:5364 E:5379 ||| WDT
contained  ||| S:5379 E:5389 ||| VBD
PIP  ||| S:5389 E:5404 ||| NNP
2  ||| S:5404 E:5406 ||| CD
( ||| S:5406 E:5407 ||| -LRB-
lanes  ||| S:5407 E:5413 ||| CD
1  ||| S:5413 E:5415 ||| CD
and  ||| S:5415 E:5419 ||| CC
5 ||| S:5419 E:5420 ||| CD
) ||| S:5420 E:5421 ||| -RRB-
.  ||| S:5421 E:5423 ||| .
( ||| S:5423 E:5424 ||| -LRB-
In  ||| S:5424 E:5427 ||| IN
this  ||| S:5427 E:5432 ||| DT
and  ||| S:5432 E:5436 ||| CC
all  ||| S:5436 E:5450 ||| DT
subsequent  ||| S:5450 E:5461 ||| JJ
experiments  ||| S:5461 E:5473 ||| NNS
that  ||| S:5473 E:5478 ||| WDT
use  ||| S:5478 E:5482 ||| VBP
PIP  ||| S:5482 E:5497 ||| NNP
2  ||| S:5497 E:5499 ||| CD
/ ||| S:5499 E:5500 ||| CD
PS  ||| S:5500 E:5503 ||| NNP
mixed  ||| S:5503 E:5509 ||| JJ
vesicles ||| S:5509 E:5517 ||| NN
,  ||| S:5517 E:5519 ||| ,
the  ||| S:5519 E:5523 ||| DT
mass  ||| S:5523 E:5528 ||| JJ
ratio  ||| S:5528 E:5544 ||| NN
of  ||| S:5544 E:5547 ||| IN
PIP  ||| S:5547 E:5562 ||| NNP
2  ||| S:5562 E:5564 ||| CD
: ||| S:5564 E:5565 ||| :
PS  ||| S:5565 E:5568 ||| NNP
was  ||| S:5568 E:5572 ||| VBD
1 ||| S:5572 E:5573 ||| CD
: ||| S:5573 E:5574 ||| :
20 ||| S:5574 E:5576 ||| CD
. ||| S:5576 E:5577 ||| .
)  ||| S:5577 E:5579 ||| -RRB-
Less  ||| S:5579 E:5584 ||| RBR
total  ||| S:5584 E:5590 ||| JJ
anti-Boi1  ||| S:5590 E:5610 ||| CD
immunoreactivity  ||| S:5610 E:5627 ||| NNS
was  ||| S:5627 E:5631 ||| VBD
recovered  ||| S:5631 E:5641 ||| VBN
when  ||| S:5641 E:5646 ||| WRB
Boi1-PH  ||| S:5646 E:5654 ||| NNP
was  ||| S:5654 E:5658 ||| VBD
incubated  ||| S:5658 E:5678 ||| VBN
with  ||| S:5678 E:5683 ||| IN
PIP  ||| S:5683 E:5698 ||| NNP
2  ||| S:5698 E:5700 ||| CD
/ ||| S:5700 E:5701 ||| CD
PS  ||| S:5701 E:5704 ||| NNP
mixed  ||| S:5704 E:5710 ||| JJ
vesicles  ||| S:5710 E:5719 ||| NN
than  ||| S:5719 E:5724 ||| IN
when  ||| S:5724 E:5739 ||| WRB
incubated  ||| S:5739 E:5749 ||| NNS
with  ||| S:5749 E:5754 ||| IN
vesicles  ||| S:5754 E:5763 ||| NNS
containing  ||| S:5763 E:5774 ||| VBG
only  ||| S:5774 E:5779 ||| JJ
PS  ||| S:5779 E:5782 ||| NNP
( ||| S:5782 E:5783 ||| -LRB-
lanes  ||| S:5783 E:5789 ||| CD
1  ||| S:5789 E:5791 ||| CD
and  ||| S:5791 E:5805 ||| CC
5 ||| S:5805 E:5806 ||| CD
) ||| S:5806 E:5807 ||| -RRB-
,  ||| S:5807 E:5809 ||| ,
suggesting  ||| S:5809 E:5820 ||| VBG
that  ||| S:5820 E:5825 ||| IN
the  ||| S:5825 E:5829 ||| DT
faster-migrating  ||| S:5829 E:5846 ||| JJ
species  ||| S:5846 E:5864 ||| NNS
represent  ||| S:5864 E:5874 ||| VBP
degradation  ||| S:5874 E:5886 ||| JJ
products  ||| S:5886 E:5895 ||| NNS
of  ||| S:5895 E:5898 ||| IN
Boi1-PH ||| S:5898 E:5905 ||| CD
.  ||| S:5905 E:5907 ||| .
Consistent  ||| S:5907 E:5928 ||| JJ
with  ||| S:5928 E:5933 ||| IN
this  ||| S:5933 E:5938 ||| DT
view ||| S:5938 E:5942 ||| NN
,  ||| S:5942 E:5944 ||| ,
although  ||| S:5944 E:5953 ||| IN
Boi1-PH  ||| S:5953 E:5961 ||| NNP
remained  ||| S:5961 E:5970 ||| VBD
stable  ||| S:5970 E:5977 ||| JJ
when  ||| S:5977 E:5992 ||| WRB
incubated  ||| S:5992 E:6002 ||| NNS
for  ||| S:6002 E:6006 ||| IN
longer  ||| S:6006 E:6013 ||| JJR
intervals  ||| S:6013 E:6023 ||| NNS
with  ||| S:6023 E:6028 ||| IN
vesicles  ||| S:6028 E:6037 ||| NNS
that  ||| S:6037 E:6052 ||| WDT
contained  ||| S:6052 E:6062 ||| VBD
only  ||| S:6062 E:6067 ||| RB
PS ||| S:6067 E:6069 ||| NNP
,  ||| S:6069 E:6071 ||| ,
the  ||| S:6071 E:6075 ||| DT
anti-Boi1  ||| S:6075 E:6085 ||| CD
immunoreactive  ||| S:6085 E:6100 ||| CD
bands  ||| S:6100 E:6116 ||| NNS
became  ||| S:6116 E:6123 ||| VBD
fainter  ||| S:6123 E:6131 ||| JJ
and  ||| S:6131 E:6135 ||| CC
then  ||| S:6135 E:6140 ||| RB
disappeared  ||| S:6140 E:6152 ||| VBD
altogether  ||| S:6152 E:6163 ||| RB
when  ||| S:6163 E:6178 ||| WRB
incubated  ||| S:6178 E:6188 ||| NNS
for  ||| S:6188 E:6192 ||| IN
longer  ||| S:6192 E:6199 ||| JJR
intervals  ||| S:6199 E:6209 ||| NNS
with  ||| S:6209 E:6214 ||| IN
PIP  ||| S:6214 E:6229 ||| NNP
2  ||| S:6229 E:6231 ||| CD
/ ||| S:6231 E:6232 ||| CD
PS  ||| S:6232 E:6235 ||| NNP
mixed  ||| S:6235 E:6241 ||| JJ
vesicles  ||| S:6241 E:6250 ||| NNS
( ||| S:6250 E:6251 ||| -LRB-
data  ||| S:6251 E:6256 ||| NNS
not  ||| S:6256 E:6270 ||| RB
shown ||| S:6270 E:6275 ||| VBN
) ||| S:6275 E:6276 ||| -RRB-
.  ||| S:6276 E:6288 ||| .
The  ||| S:6288 E:6292 ||| DT
finding  ||| S:6292 E:6300 ||| NN
that  ||| S:6300 E:6305 ||| IN
PIP  ||| S:6305 E:6320 ||| NNP
2  ||| S:6320 E:6322 ||| CD
can  ||| S:6322 E:6326 ||| MD
stimulate  ||| S:6326 E:6336 ||| VB
degradation  ||| S:6336 E:6348 ||| VBN
of  ||| S:6348 E:6351 ||| IN
Boi1-PH  ||| S:6351 E:6369 ||| NNP
suggests  ||| S:6369 E:6378 ||| VBZ
that  ||| S:6378 E:6383 ||| IN
PIP  ||| S:6383 E:6398 ||| NNP
2  ||| S:6398 E:6400 ||| CD
may  ||| S:6400 E:6404 ||| MD
bind  ||| S:6404 E:6409 ||| VB
to  ||| S:6409 E:6412 ||| TO
Boi1-PH  ||| S:6412 E:6420 ||| CD
in  ||| S:6420 E:6423 ||| IN
a  ||| S:6423 E:6425 ||| DT
manner  ||| S:6425 E:6432 ||| NN
that  ||| S:6432 E:6447 ||| IN
results  ||| S:6447 E:6455 ||| NNS
in  ||| S:6455 E:6458 ||| IN
the  ||| S:6458 E:6462 ||| DT
exposure  ||| S:6462 E:6471 ||| NN
of  ||| S:6471 E:6474 ||| IN
a  ||| S:6474 E:6476 ||| DT
protease-sensitive  ||| S:6476 E:6495 ||| JJ
site ||| S:6495 E:6499 ||| NN
.  ||| S:6499 E:6501 ||| .
We  ||| S:6501 E:6514 ||| PRP
do  ||| S:6514 E:6517 ||| VBP
not  ||| S:6517 E:6521 ||| RB
know  ||| S:6521 E:6526 ||| VB
the  ||| S:6526 E:6530 ||| DT
identity  ||| S:6530 E:6539 ||| NN
of  ||| S:6539 E:6542 ||| IN
the  ||| S:6542 E:6546 ||| DT
relevant  ||| S:6546 E:6555 ||| JJ
protease ||| S:6555 E:6563 ||| NN
.  ||| S:6563 E:6575 ||| .
However ||| S:6575 E:6582 ||| RB
,  ||| S:6582 E:6584 ||| ,
we  ||| S:6584 E:6587 ||| PRP
found  ||| S:6587 E:6593 ||| VBD
that  ||| S:6593 E:6598 ||| IN
the  ||| S:6598 E:6602 ||| DT
PIP  ||| S:6602 E:6617 ||| NNP
2  ||| S:6617 E:6619 ||| CD
-stimulated  ||| S:6619 E:6631 ||| JJ
proteolysis  ||| S:6631 E:6643 ||| NN
of  ||| S:6643 E:6646 ||| IN
Boi1-PH  ||| S:6646 E:6664 ||| NNP
is  ||| S:6664 E:6667 ||| VBZ
strongly  ||| S:6667 E:6676 ||| RB
enhanced  ||| S:6676 E:6685 ||| VBN
by  ||| S:6685 E:6688 ||| IN
Ca  ||| S:6688 E:6691 ||| NNP
++and  ||| S:6691 E:6697 ||| NNP
is  ||| S:6697 E:6700 ||| VBZ
inhibited  ||| S:6700 E:6710 ||| VBN
by  ||| S:6710 E:6713 ||| IN
EGTA  ||| S:6713 E:6728 ||| NNP
( ||| S:6728 E:6729 ||| -LRB-
data  ||| S:6729 E:6734 ||| NNS
not  ||| S:6734 E:6738 ||| RB
shown ||| S:6738 E:6743 ||| VBN
) ||| S:6743 E:6744 ||| -RRB-
,  ||| S:6744 E:6746 ||| ,
suggesting  ||| S:6746 E:6757 ||| VBG
that  ||| S:6757 E:6762 ||| IN
this  ||| S:6762 E:6767 ||| DT
protease  ||| S:6767 E:6776 ||| NN
may  ||| S:6776 E:6790 ||| MD
require  ||| S:6790 E:6798 ||| VB
Ca  ||| S:6798 E:6801 ||| NNP
++for  ||| S:6801 E:6807 ||| NNP
activity ||| S:6807 E:6815 ||| NN
.  ||| S:6815 E:6827 ||| .
Next ||| S:6827 E:6831 ||| JJ
,  ||| S:6831 E:6833 ||| ,
we  ||| S:6833 E:6836 ||| PRP
asked  ||| S:6836 E:6842 ||| VBD
whether  ||| S:6842 E:6850 ||| IN
proteolysis  ||| S:6850 E:6862 ||| NN
of  ||| S:6862 E:6865 ||| IN
Boi1-PH  ||| S:6865 E:6873 ||| NNP
could  ||| S:6873 E:6889 ||| MD
also  ||| S:6889 E:6894 ||| RB
be  ||| S:6894 E:6897 ||| VB
stimulated  ||| S:6897 E:6908 ||| VBN
by  ||| S:6908 E:6911 ||| IN
other  ||| S:6911 E:6917 ||| JJ
inositol-based  ||| S:6917 E:6932 ||| JJ
phospholipids ||| S:6932 E:6945 ||| NN
.  ||| S:6945 E:6957 ||| .
PI  ||| S:6957 E:6960 ||| NN
and  ||| S:6960 E:6964 ||| CC
PI3P  ||| S:6964 E:6969 ||| NNP
( ||| S:6969 E:6970 ||| -LRB-
phosphatidylinositol-3-phosphate ||| S:6970 E:7002 ||| NNP
) ||| S:7002 E:7003 ||| -RRB-
,  ||| S:7003 E:7005 ||| ,
presented  ||| S:7005 E:7025 ||| VBN
in  ||| S:7025 E:7028 ||| IN
PS-based  ||| S:7028 E:7037 ||| JJ
vesicles ||| S:7037 E:7045 ||| NN
,  ||| S:7045 E:7047 ||| ,
appeared  ||| S:7047 E:7056 ||| VBD
to  ||| S:7056 E:7059 ||| TO
stimulate  ||| S:7059 E:7069 ||| VB
slightly  ||| S:7069 E:7078 ||| RB
the  ||| S:7078 E:7092 ||| DT
proteolysis  ||| S:7092 E:7104 ||| NN
of  ||| S:7104 E:7107 ||| IN
Boi1-PH ||| S:7107 E:7114 ||| NNP
,  ||| S:7114 E:7116 ||| ,
but  ||| S:7116 E:7120 ||| CC
did  ||| S:7120 E:7124 ||| VBD
so  ||| S:7124 E:7127 ||| RB
to  ||| S:7127 E:7130 ||| TO
a  ||| S:7130 E:7132 ||| DT
much  ||| S:7132 E:7137 ||| RB
lesser  ||| S:7137 E:7154 ||| JJR
extent  ||| S:7154 E:7161 ||| NN
than  ||| S:7161 E:7166 ||| IN
did  ||| S:7166 E:7170 ||| VBD
PIP  ||| S:7170 E:7185 ||| NNP
2  ||| S:7185 E:7187 ||| CD
( ||| S:7187 E:7188 ||| -LRB-
Fig.  ||| S:7188 E:7193 ||| NNP
2A ||| S:7193 E:7195 ||| NNP
,  ||| S:7195 E:7197 ||| ,
lanes  ||| S:7197 E:7203 ||| JJ
1-3  ||| S:7203 E:7207 ||| NN
and  ||| S:7207 E:7211 ||| CC
5 ||| S:7211 E:7212 ||| CD
) ||| S:7212 E:7213 ||| -RRB-
.  ||| S:7213 E:7215 ||| .
In  ||| S:7215 E:7228 ||| IN
contrast ||| S:7228 E:7236 ||| NN
,  ||| S:7236 E:7238 ||| ,
PI4P  ||| S:7238 E:7243 ||| NNP
( ||| S:7243 E:7244 ||| -LRB-
phosphatidylinositol-4-phosphate ||| S:7244 E:7276 ||| NNP
) ||| S:7276 E:7277 ||| -RRB-
/ ||| S:7277 E:7278 ||| NNP
PS  ||| S:7278 E:7291 ||| NNP
vesicles  ||| S:7291 E:7300 ||| VBD
stimulated  ||| S:7300 E:7311 ||| VBN
substantial  ||| S:7311 E:7323 ||| JJ
proteolysis  ||| S:7323 E:7335 ||| NN
of  ||| S:7335 E:7338 ||| IN
Boi1-PH ||| S:7338 E:7345 ||| NNP
,  ||| S:7345 E:7357 ||| ,
although  ||| S:7357 E:7366 ||| IN
to  ||| S:7366 E:7369 ||| TO
a  ||| S:7369 E:7371 ||| DT
lesser  ||| S:7371 E:7378 ||| JJR
extent  ||| S:7378 E:7385 ||| NN
than  ||| S:7385 E:7390 ||| IN
did  ||| S:7390 E:7394 ||| VBD
PIP  ||| S:7394 E:7409 ||| NNP
2  ||| S:7409 E:7411 ||| CD
/ ||| S:7411 E:7412 ||| CD
PS  ||| S:7412 E:7415 ||| NNP
vesicles  ||| S:7415 E:7424 ||| NNS
( ||| S:7424 E:7425 ||| -LRB-
Fig.  ||| S:7425 E:7430 ||| NNP
2A ||| S:7430 E:7432 ||| NNP
,  ||| S:7432 E:7434 ||| ,
lanes  ||| S:7434 E:7440 ||| CD
4  ||| S:7440 E:7442 ||| CD
and  ||| S:7442 E:7456 ||| CC
5 ||| S:7456 E:7457 ||| CD
) ||| S:7457 E:7458 ||| -RRB-
.  ||| S:7458 E:7460 ||| .
These  ||| S:7460 E:7466 ||| DT
findings  ||| S:7466 E:7475 ||| NNS
indicate  ||| S:7475 E:7484 ||| VBP
that  ||| S:7484 E:7489 ||| IN
different  ||| S:7489 E:7509 ||| JJ
phosphatidylinositides  ||| S:7509 E:7532 ||| NN
can  ||| S:7532 E:7536 ||| MD
stimulate  ||| S:7536 E:7546 ||| VB
proteolysis  ||| S:7546 E:7558 ||| VBN
of  ||| S:7558 E:7571 ||| IN
Boi1-PH  ||| S:7571 E:7579 ||| NNP
but  ||| S:7579 E:7583 ||| CC
differ  ||| S:7583 E:7590 ||| VBP
greatly  ||| S:7590 E:7598 ||| RB
in  ||| S:7598 E:7601 ||| IN
their  ||| S:7601 E:7607 ||| PRP$
abilities  ||| S:7607 E:7617 ||| NNS
to  ||| S:7617 E:7620 ||| TO
do  ||| S:7620 E:7633 ||| VB
so ||| S:7633 E:7635 ||| RB
.  ||| S:7635 E:7647 ||| .
To  ||| S:7647 E:7650 ||| TO
investigate  ||| S:7650 E:7662 ||| VB
whether  ||| S:7662 E:7670 ||| IN
the  ||| S:7670 E:7674 ||| DT
nature  ||| S:7674 E:7681 ||| NN
of  ||| S:7681 E:7684 ||| IN
the  ||| S:7684 E:7688 ||| DT
bulk  ||| S:7688 E:7693 ||| JJ
lipid  ||| S:7693 E:7699 ||| NN
in  ||| S:7699 E:7712 ||| IN
the  ||| S:7712 E:7716 ||| DT
vesicles  ||| S:7716 E:7725 ||| NN
affects  ||| S:7725 E:7733 ||| VBZ
the  ||| S:7733 E:7737 ||| DT
ability  ||| S:7737 E:7745 ||| NN
of  ||| S:7745 E:7758 ||| IN
phosphatidylinositides  ||| S:7758 E:7781 ||| VBG
to  ||| S:7781 E:7784 ||| TO
stimulate  ||| S:7784 E:7794 ||| VB
proteolysis  ||| S:7794 E:7806 ||| VBN
of  ||| S:7806 E:7819 ||| IN
Boi1-PH ||| S:7819 E:7826 ||| NNP
,  ||| S:7826 E:7828 ||| ,
we  ||| S:7828 E:7831 ||| PRP
repeated  ||| S:7831 E:7840 ||| VBD
this  ||| S:7840 E:7845 ||| DT
analysis  ||| S:7845 E:7854 ||| NN
using  ||| S:7854 E:7860 ||| VBG
the  ||| S:7860 E:7864 ||| DT
neutral  ||| S:7864 E:7882 ||| JJ
phospholipid  ||| S:7882 E:7895 ||| JJ
PC  ||| S:7895 E:7898 ||| NN
( ||| S:7898 E:7899 ||| -LRB-
phosphatidylcholine ||| S:7899 E:7918 ||| LS
)  ||| S:7918 E:7920 ||| -RRB-
instead  ||| S:7920 E:7928 ||| RB
of  ||| S:7928 E:7931 ||| IN
PS ||| S:7931 E:7933 ||| NNP
.  ||| S:7933 E:7945 ||| .
Using  ||| S:7945 E:7951 ||| VBG
reaction  ||| S:7951 E:7960 ||| NN
conditions  ||| S:7960 E:7971 ||| NNS
that  ||| S:7971 E:7976 ||| WDT
were  ||| S:7976 E:7981 ||| VBD
otherwise  ||| S:7981 E:7991 ||| RB
the  ||| S:7991 E:7995 ||| DT
same  ||| S:7995 E:8000 ||| JJ
as  ||| S:8000 E:8013 ||| IN
those  ||| S:8013 E:8019 ||| DT
used  ||| S:8019 E:8024 ||| VBN
when  ||| S:8024 E:8029 ||| WRB
PS  ||| S:8029 E:8032 ||| NNP
was  ||| S:8032 E:8036 ||| VBD
the  ||| S:8036 E:8040 ||| DT
bulk  ||| S:8040 E:8045 ||| JJ
lipid ||| S:8045 E:8050 ||| NN
,  ||| S:8050 E:8052 ||| ,
no  ||| S:8052 E:8055 ||| DT
proteolysis  ||| S:8055 E:8067 ||| NN
of  ||| S:8067 E:8080 ||| IN
Boi1-PH  ||| S:8080 E:8088 ||| NNP
was  ||| S:8088 E:8092 ||| VBD
detected  ||| S:8092 E:8101 ||| VBN
in  ||| S:8101 E:8104 ||| IN
the  ||| S:8104 E:8108 ||| DT
presence  ||| S:8108 E:8117 ||| NN
of  ||| S:8117 E:8120 ||| IN
any  ||| S:8120 E:8124 ||| DT
of  ||| S:8124 E:8127 ||| IN
the  ||| S:8127 E:8141 ||| DT
phosphatidylinositides  ||| S:8141 E:8164 ||| NN
except  ||| S:8164 E:8171 ||| IN
PIP  ||| S:8171 E:8186 ||| NNP
2  ||| S:8186 E:8188 ||| CD
,  ||| S:8188 E:8190 ||| ,
which  ||| S:8190 E:8196 ||| WDT
stimulated  ||| S:8196 E:8207 ||| VBP
only  ||| S:8207 E:8212 ||| RB
a  ||| S:8212 E:8214 ||| DT
small  ||| S:8214 E:8230 ||| JJ
amount  ||| S:8230 E:8237 ||| NN
of  ||| S:8237 E:8240 ||| IN
proteolysis  ||| S:8240 E:8252 ||| NNS
( ||| S:8252 E:8253 ||| -LRB-
Fig.  ||| S:8253 E:8258 ||| NNP
2B ||| S:8258 E:8260 ||| NNP
) ||| S:8260 E:8261 ||| -RRB-
.  ||| S:8261 E:8263 ||| .
Thus ||| S:8263 E:8267 ||| RB
,  ||| S:8267 E:8269 ||| ,
PS  ||| S:8269 E:8272 ||| NNP
is  ||| S:8272 E:8275 ||| VBZ
much  ||| S:8275 E:8280 ||| RB
more  ||| S:8280 E:8295 ||| RBR
effective  ||| S:8295 E:8305 ||| JJ
than  ||| S:8305 E:8310 ||| IN
PC  ||| S:8310 E:8313 ||| NN
at  ||| S:8313 E:8316 ||| IN
facilitating  ||| S:8316 E:8329 ||| VBG
the  ||| S:8329 E:8333 ||| DT
ability  ||| S:8333 E:8341 ||| NN
of  ||| S:8341 E:8354 ||| IN
phosphatidylinositides  ||| S:8354 E:8377 ||| VBG
to  ||| S:8377 E:8380 ||| TO
stimulate  ||| S:8380 E:8390 ||| VB
proteolysis  ||| S:8390 E:8402 ||| VBN
of  ||| S:8402 E:8415 ||| IN
Boi1-PH ||| S:8415 E:8422 ||| CD
.  ||| S:8422 E:8434 ||| .
To  ||| S:8434 E:8437 ||| TO
investigate  ||| S:8437 E:8449 ||| VB
further  ||| S:8449 E:8457 ||| RBR
whether  ||| S:8457 E:8465 ||| IN
Boi1-PH  ||| S:8465 E:8473 ||| CD
binds  ||| S:8473 E:8479 ||| JJ
PIP  ||| S:8479 E:8494 ||| NNP
2  ||| S:8494 E:8496 ||| CD
,  ||| S:8496 E:8498 ||| ,
we  ||| S:8498 E:8501 ||| PRP
used  ||| S:8501 E:8506 ||| VBD
a  ||| S:8506 E:8508 ||| DT
vesicle  ||| S:8508 E:8516 ||| JJ
co-sedimentation  ||| S:8516 E:8543 ||| JJ
assay ||| S:8543 E:8548 ||| NN
.  ||| S:8548 E:8550 ||| .
In  ||| S:8550 E:8553 ||| IN
this  ||| S:8553 E:8558 ||| DT
analysis ||| S:8558 E:8566 ||| NN
,  ||| S:8566 E:8568 ||| ,
we  ||| S:8568 E:8571 ||| PRP
asked  ||| S:8571 E:8577 ||| VBD
whether  ||| S:8577 E:8585 ||| IN
an  ||| S:8585 E:8588 ||| DT
otherwise  ||| S:8588 E:8608 ||| RB
soluble  ||| S:8608 E:8616 ||| JJ
fraction  ||| S:8616 E:8625 ||| NN
of  ||| S:8625 E:8628 ||| IN
Boi1-PH ||| S:8628 E:8635 ||| NNP
,  ||| S:8635 E:8637 ||| ,
after  ||| S:8637 E:8643 ||| IN
being  ||| S:8643 E:8649 ||| VBG
incubated  ||| S:8649 E:8659 ||| NN
with  ||| S:8659 E:8674 ||| IN
PIP  ||| S:8674 E:8689 ||| NNP
2  ||| S:8689 E:8691 ||| CD
-bearing  ||| S:8691 E:8700 ||| JJ
vesicles ||| S:8700 E:8708 ||| NN
,  ||| S:8708 E:8710 ||| ,
would  ||| S:8710 E:8716 ||| MD
now  ||| S:8716 E:8730 ||| RB
sediment  ||| S:8730 E:8739 ||| VBN
in  ||| S:8739 E:8742 ||| IN
conditions  ||| S:8742 E:8753 ||| NNS
( ||| S:8753 E:8754 ||| -LRB-
436,000  ||| S:8754 E:8762 ||| CD
×  ||| S:8762 E:8764 ||| CD
g  ||| S:8764 E:8766 ||| NN
for  ||| S:8766 E:8770 ||| IN
1  ||| S:8770 E:8772 ||| CD
hr ||| S:8772 E:8774 ||| CD
)  ||| S:8774 E:8776 ||| -RRB-
that  ||| S:8776 E:8781 ||| WDT
cause  ||| S:8781 E:8797 ||| VBP
vesicles  ||| S:8797 E:8806 ||| VBN
to  ||| S:8806 E:8809 ||| TO
pellet ||| S:8809 E:8815 ||| VB
.  ||| S:8815 E:8817 ||| .
( ||| S:8817 E:8818 ||| -LRB-
To  ||| S:8818 E:8821 ||| TO
inhibit  ||| S:8821 E:8829 ||| VB
the  ||| S:8829 E:8833 ||| DT
proteolysis  ||| S:8833 E:8845 ||| NN
of  ||| S:8845 E:8858 ||| IN
Boi1-PH ||| S:8858 E:8865 ||| NNP
,  ||| S:8865 E:8867 ||| ,
we  ||| S:8867 E:8870 ||| PRP
performed  ||| S:8870 E:8880 ||| VBD
this  ||| S:8880 E:8885 ||| DT
analysis  ||| S:8885 E:8894 ||| NN
in  ||| S:8894 E:8897 ||| IN
buffer  ||| S:8897 E:8904 ||| NN
that  ||| S:8904 E:8909 ||| WDT
lacks  ||| S:8909 E:8925 ||| VBZ
Ca  ||| S:8925 E:8928 ||| JJ
++but  ||| S:8928 E:8934 ||| NN
that  ||| S:8934 E:8939 ||| WDT
contains  ||| S:8939 E:8948 ||| VBZ
EGTA  ||| S:8948 E:8953 ||| NNP
and  ||| S:8953 E:8957 ||| CC
two  ||| S:8957 E:8961 ||| CD
other  ||| S:8961 E:8967 ||| JJ
protease  ||| S:8967 E:8986 ||| JJ
inhibitors  ||| S:8986 E:8997 ||| NN
that  ||| S:8997 E:9002 ||| WDT
were  ||| S:9002 E:9007 ||| VBD
not  ||| S:9007 E:9011 ||| RB
present  ||| S:9011 E:9019 ||| VB
in  ||| S:9019 E:9022 ||| IN
the  ||| S:9022 E:9026 ||| DT
proteolysis  ||| S:9026 E:9048 ||| JJ
assay ||| S:9048 E:9053 ||| NN
. ||| S:9053 E:9054 ||| .
)  ||| S:9054 E:9056 ||| -RRB-
First ||| S:9056 E:9061 ||| NNP
,  ||| S:9061 E:9063 ||| ,
we  ||| S:9063 E:9066 ||| PRP
asked  ||| S:9066 E:9072 ||| VBD
whether  ||| S:9072 E:9080 ||| IN
Boi1-PH  ||| S:9080 E:9088 ||| NNP
could  ||| S:9088 E:9094 ||| MD
pellet  ||| S:9094 E:9101 ||| VB
with  ||| S:9101 E:9116 ||| IN
vesicles  ||| S:9116 E:9125 ||| NNS
that  ||| S:9125 E:9130 ||| WDT
lacked  ||| S:9130 E:9137 ||| VBD
PIP  ||| S:9137 E:9152 ||| NNP
2  ||| S:9152 E:9154 ||| CD
.  ||| S:9154 E:9156 ||| .
We  ||| S:9156 E:9159 ||| PRP
did  ||| S:9159 E:9163 ||| VBD
not  ||| S:9163 E:9167 ||| RB
detect  ||| S:9167 E:9174 ||| VB
any  ||| S:9174 E:9178 ||| DT
pelleting  ||| S:9178 E:9188 ||| NN
of  ||| S:9188 E:9201 ||| IN
Boi1-PH  ||| S:9201 E:9209 ||| CD
with  ||| S:9209 E:9214 ||| IN
PC  ||| S:9214 E:9217 ||| NN
vesicles  ||| S:9217 E:9226 ||| NNS
( ||| S:9226 E:9227 ||| -LRB-
data  ||| S:9227 E:9232 ||| NNS
not  ||| S:9232 E:9236 ||| RB
shown ||| S:9236 E:9241 ||| VBN
) ||| S:9241 E:9242 ||| -RRB-
,  ||| S:9242 E:9244 ||| ,
but  ||| S:9244 E:9248 ||| CC
found  ||| S:9248 E:9254 ||| VBD
that  ||| S:9254 E:9269 ||| IN
Boi1-PH  ||| S:9269 E:9277 ||| NNP
could  ||| S:9277 E:9283 ||| MD
pellet  ||| S:9283 E:9290 ||| VB
with  ||| S:9290 E:9295 ||| IN
vesicles  ||| S:9295 E:9304 ||| VBG
composed  ||| S:9304 E:9313 ||| VBN
of  ||| S:9313 E:9316 ||| IN
PS  ||| S:9316 E:9319 ||| NNP
( ||| S:9319 E:9320 ||| -LRB-
Fig.  ||| S:9320 E:9335 ||| CD
3 ||| S:9335 E:9336 ||| CD
,  ||| S:9336 E:9338 ||| ,
top  ||| S:9338 E:9342 ||| JJ
panel ||| S:9342 E:9347 ||| NN
) ||| S:9347 E:9348 ||| -RRB-
,  ||| S:9348 E:9350 ||| ,
suggesting  ||| S:9350 E:9361 ||| VBG
that  ||| S:9361 E:9366 ||| IN
Boi1-PH  ||| S:9366 E:9374 ||| NNP
can  ||| S:9374 E:9378 ||| MD
bind  ||| S:9378 E:9383 ||| VB
PS ||| S:9383 E:9385 ||| NNP
.  ||| S:9385 E:9397 ||| .
Next ||| S:9397 E:9401 ||| JJ
,  ||| S:9401 E:9403 ||| ,
we  ||| S:9403 E:9406 ||| PRP
asked  ||| S:9406 E:9412 ||| VBD
whether  ||| S:9412 E:9420 ||| IN
the  ||| S:9420 E:9424 ||| DT
inclusion  ||| S:9424 E:9434 ||| NN
of  ||| S:9434 E:9437 ||| IN
PIP  ||| S:9437 E:9452 ||| NNP
2  ||| S:9452 E:9454 ||| CD
in  ||| S:9454 E:9457 ||| IN
the  ||| S:9457 E:9461 ||| DT
PS  ||| S:9461 E:9464 ||| NNP
vesicles  ||| S:9464 E:9473 ||| VBD
affected  ||| S:9473 E:9482 ||| VBN
the  ||| S:9482 E:9496 ||| DT
ability  ||| S:9496 E:9504 ||| NN
of  ||| S:9504 E:9507 ||| IN
Boi1-PH  ||| S:9507 E:9515 ||| CD
to  ||| S:9515 E:9518 ||| TO
pellet ||| S:9518 E:9524 ||| VB
.  ||| S:9524 E:9526 ||| .
In  ||| S:9526 E:9529 ||| IN
the  ||| S:9529 E:9533 ||| DT
starting  ||| S:9533 E:9542 ||| VBG
buffer  ||| S:9542 E:9559 ||| NN
conditions  ||| S:9559 E:9570 ||| NNS
( ||| S:9570 E:9571 ||| -LRB-
phosphate-buffered  ||| S:9571 E:9590 ||| JJ
saline  ||| S:9590 E:9597 ||| NN
without  ||| S:9597 E:9605 ||| IN
additional  ||| S:9605 E:9626 ||| JJ
salt ||| S:9626 E:9630 ||| NN
) ||| S:9630 E:9631 ||| -RRB-
,  ||| S:9631 E:9633 ||| ,
a  ||| S:9633 E:9635 ||| DT
larger  ||| S:9635 E:9642 ||| JJR
percentage  ||| S:9642 E:9653 ||| NN
of  ||| S:9653 E:9656 ||| IN
Boi1-PH  ||| S:9656 E:9664 ||| CD
pelleted  ||| S:9664 E:9673 ||| NN
when  ||| S:9673 E:9678 ||| WRB
the  ||| S:9678 E:9692 ||| DT
vesicles  ||| S:9692 E:9701 ||| NN
contained  ||| S:9701 E:9711 ||| VBD
PIP  ||| S:9711 E:9726 ||| NNP
2  ||| S:9726 E:9728 ||| CD
( ||| S:9728 E:9729 ||| -LRB-
Fig.  ||| S:9729 E:9734 ||| CD
3 ||| S:9734 E:9735 ||| CD
,  ||| S:9735 E:9737 ||| ,
lanes  ||| S:9737 E:9743 ||| CD
1  ||| S:9743 E:9745 ||| CD
and  ||| S:9745 E:9749 ||| CC
2 ||| S:9749 E:9750 ||| LS
) ||| S:9750 E:9751 ||| -RRB-
.  ||| S:9751 E:9753 ||| .
However ||| S:9753 E:9760 ||| RB
,  ||| S:9760 E:9772 ||| ,
most  ||| S:9772 E:9777 ||| JJS
of  ||| S:9777 E:9780 ||| IN
the  ||| S:9780 E:9784 ||| DT
Boi1-PH  ||| S:9784 E:9792 ||| JJ
pelleted  ||| S:9792 E:9801 ||| NN
whether  ||| S:9801 E:9809 ||| IN
or  ||| S:9809 E:9812 ||| CC
not  ||| S:9812 E:9816 ||| RB
PIP  ||| S:9816 E:9831 ||| NNP
2  ||| S:9831 E:9833 ||| CD
was  ||| S:9833 E:9837 ||| VBD
present ||| S:9837 E:9844 ||| JJ
.  ||| S:9844 E:9846 ||| .
So ||| S:9846 E:9848 ||| RB
,  ||| S:9848 E:9850 ||| ,
to  ||| S:9850 E:9853 ||| TO
try  ||| S:9853 E:9857 ||| VB
to  ||| S:9857 E:9870 ||| TO
accentuate  ||| S:9870 E:9881 ||| VB
the  ||| S:9881 E:9885 ||| DT
effects  ||| S:9885 E:9893 ||| NNS
of  ||| S:9893 E:9896 ||| IN
PIP  ||| S:9896 E:9911 ||| NNP
2  ||| S:9911 E:9913 ||| CD
on  ||| S:9913 E:9916 ||| IN
Boi1-PH ||| S:9916 E:9923 ||| NNP
's  ||| S:9923 E:9926 ||| POS
co-sedimentation  ||| S:9926 E:9943 ||| JJ
with  ||| S:9943 E:9958 ||| IN
vesicles ||| S:9958 E:9966 ||| NN
,  ||| S:9966 E:9968 ||| ,
we  ||| S:9968 E:9971 ||| PRP
repeated  ||| S:9971 E:9980 ||| VBD
this  ||| S:9980 E:9985 ||| DT
analysis  ||| S:9985 E:9994 ||| NN
using  ||| S:9994 E:10000 ||| VBG
buffer  ||| S:10000 E:10007 ||| NN
that  ||| S:10007 E:10022 ||| WDT
contained  ||| S:10022 E:10032 ||| VBD
additional  ||| S:10032 E:10043 ||| JJ
concentrations  ||| S:10043 E:10058 ||| NNS
of  ||| S:10058 E:10061 ||| IN
KCl ||| S:10061 E:10064 ||| JJ
.  ||| S:10064 E:10066 ||| .
In  ||| S:10066 E:10069 ||| IN
the  ||| S:10069 E:10083 ||| DT
presence  ||| S:10083 E:10092 ||| NN
of  ||| S:10092 E:10095 ||| IN
50 ||| S:10095 E:10097 ||| CD
,  ||| S:10097 E:10099 ||| ,
100 ||| S:10099 E:10102 ||| CD
,  ||| S:10102 E:10104 ||| ,
and  ||| S:10104 E:10108 ||| CC
200  ||| S:10108 E:10112 ||| CD
mM  ||| S:10112 E:10115 ||| JJ
additional  ||| S:10115 E:10126 ||| JJ
KCl ||| S:10126 E:10129 ||| NN
,  ||| S:10129 E:10131 ||| ,
the  ||| S:10131 E:10135 ||| DT
ratio  ||| S:10135 E:10151 ||| NN
of  ||| S:10151 E:10154 ||| IN
Boi1-PH  ||| S:10154 E:10162 ||| CD
that  ||| S:10162 E:10167 ||| IN
pelleted  ||| S:10167 E:10176 ||| NN
with  ||| S:10176 E:10181 ||| IN
respect  ||| S:10181 E:10189 ||| NN
to  ||| S:10189 E:10192 ||| TO
that  ||| S:10192 E:10197 ||| IN
which  ||| S:10197 E:10213 ||| WDT
stayed  ||| S:10213 E:10220 ||| VBD
in  ||| S:10220 E:10223 ||| IN
the  ||| S:10223 E:10227 ||| DT
supernatant  ||| S:10227 E:10239 ||| NN
was  ||| S:10239 E:10243 ||| VBD
greater  ||| S:10243 E:10251 ||| JJR
when  ||| S:10251 E:10256 ||| WRB
using  ||| S:10256 E:10262 ||| VBG
vesicles  ||| S:10262 E:10281 ||| NNS
that  ||| S:10281 E:10286 ||| WDT
contained  ||| S:10286 E:10296 ||| VBD
PIP  ||| S:10296 E:10311 ||| NNP
2  ||| S:10311 E:10313 ||| CD
( ||| S:10313 E:10314 ||| -LRB-
Fig.  ||| S:10314 E:10319 ||| CD
3 ||| S:10319 E:10320 ||| CD
,  ||| S:10320 E:10322 ||| ,
lanes  ||| S:10322 E:10328 ||| CD
3-8 ||| S:10328 E:10331 ||| CD
) ||| S:10331 E:10332 ||| -RRB-
,  ||| S:10332 E:10334 ||| ,
suggesting  ||| S:10334 E:10345 ||| VBG
that  ||| S:10345 E:10360 ||| IN
Boi1-PH  ||| S:10360 E:10368 ||| NNP
has  ||| S:10368 E:10372 ||| VBZ
a  ||| S:10372 E:10374 ||| DT
higher  ||| S:10374 E:10381 ||| JJR
affinity  ||| S:10381 E:10390 ||| NN
for  ||| S:10390 E:10394 ||| IN
PIP  ||| S:10394 E:10409 ||| NNP
2  ||| S:10409 E:10411 ||| CD
than  ||| S:10411 E:10416 ||| IN
for  ||| S:10416 E:10420 ||| IN
PS ||| S:10420 E:10422 ||| NNP
.  ||| S:10422 E:10434 ||| .
In  ||| S:10434 E:10437 ||| IN
similar  ||| S:10437 E:10445 ||| JJ
experiments  ||| S:10445 E:10457 ||| NNS
using  ||| S:10457 E:10463 ||| VBG
mixed  ||| S:10463 E:10469 ||| JJ
PIP  ||| S:10469 E:10484 ||| NNP
2  ||| S:10484 E:10486 ||| CD
/ ||| S:10486 E:10487 ||| CD
PC  ||| S:10487 E:10490 ||| NN
vesicles ||| S:10490 E:10498 ||| NN
,  ||| S:10498 E:10500 ||| ,
all  ||| S:10500 E:10504 ||| DT
of  ||| S:10504 E:10507 ||| IN
the  ||| S:10507 E:10511 ||| DT
Boi1-PH  ||| S:10511 E:10529 ||| NNP
stayed  ||| S:10529 E:10536 ||| VBD
in  ||| S:10536 E:10539 ||| IN
the  ||| S:10539 E:10543 ||| DT
soluble  ||| S:10543 E:10551 ||| JJ
fraction  ||| S:10551 E:10560 ||| NN
( ||| S:10560 E:10561 ||| -LRB-
data  ||| S:10561 E:10566 ||| NNS
not  ||| S:10566 E:10570 ||| RB
shown ||| S:10570 E:10575 ||| VBN
) ||| S:10575 E:10576 ||| -RRB-
,  ||| S:10576 E:10588 ||| ,
supporting  ||| S:10588 E:10599 ||| VBG
the  ||| S:10599 E:10603 ||| DT
views  ||| S:10603 E:10609 ||| NNS
that  ||| S:10609 E:10614 ||| IN
the  ||| S:10614 E:10618 ||| DT
composition  ||| S:10618 E:10630 ||| NN
of  ||| S:10630 E:10633 ||| IN
the  ||| S:10633 E:10637 ||| DT
lipid  ||| S:10637 E:10653 ||| JJ
bilayer  ||| S:10653 E:10661 ||| NN
affects  ||| S:10661 E:10669 ||| VBZ
the  ||| S:10669 E:10673 ||| DT
ability  ||| S:10673 E:10681 ||| NN
of  ||| S:10681 E:10684 ||| IN
Boi1-PH  ||| S:10684 E:10692 ||| CD
to  ||| S:10692 E:10695 ||| TO
bind  ||| S:10695 E:10700 ||| VB
PIP  ||| S:10700 E:10715 ||| NNP
2  ||| S:10715 E:10717 ||| CD
and  ||| S:10717 E:10721 ||| CC
that  ||| S:10721 E:10726 ||| IN
PS  ||| S:10726 E:10729 ||| NNP
promotes  ||| S:10729 E:10738 ||| VBZ
this  ||| S:10738 E:10753 ||| DT
association ||| S:10753 E:10764 ||| NN
.  ||| S:10764 E:10794 ||| .
Mutant  ||| S:10794 E:10801 ||| JJ
versions  ||| S:10801 E:10810 ||| NNS
of  ||| S:10810 E:10813 ||| IN
Boi1-PH  ||| S:10813 E:10821 ||| NNP
that  ||| S:10821 E:10826 ||| WDT
are  ||| S:10826 E:10830 ||| VBP
impaired  ||| S:10830 E:10839 ||| VBN
in  ||| S:10839 E:10842 ||| IN
the  ||| S:10842 E:10856 ||| DT
ability  ||| S:10856 E:10864 ||| NN
to  ||| S:10864 E:10867 ||| TO
bind  ||| S:10867 E:10872 ||| VB
PIP  ||| S:10872 E:10876 ||| NNP
2  ||| S:10876 E:10888 ||| CD
To  ||| S:10888 E:10891 ||| TO
investigate  ||| S:10891 E:10903 ||| VB
whether  ||| S:10903 E:10911 ||| IN
binding  ||| S:10911 E:10919 ||| VBG
to  ||| S:10919 E:10922 ||| TO
PIP  ||| S:10922 E:10937 ||| NNP
2  ||| S:10937 E:10939 ||| CD
may  ||| S:10939 E:10943 ||| MD
be  ||| S:10943 E:10946 ||| VB
important  ||| S:10946 E:10956 ||| JJ
for  ||| S:10956 E:10960 ||| IN
Boi1  ||| S:10960 E:10965 ||| CD
function ||| S:10965 E:10973 ||| NN
,  ||| S:10973 E:10985 ||| ,
we  ||| S:10985 E:10988 ||| PRP
sought  ||| S:10988 E:10995 ||| VBD
to  ||| S:10995 E:10998 ||| TO
make  ||| S:10998 E:11003 ||| VB
mutant  ||| S:11003 E:11010 ||| JJ
versions  ||| S:11010 E:11019 ||| NNS
of  ||| S:11019 E:11022 ||| IN
Boi1-PH  ||| S:11022 E:11030 ||| NNP
that  ||| S:11030 E:11035 ||| WDT
are  ||| S:11035 E:11049 ||| VBP
defective  ||| S:11049 E:11059 ||| JJ
in  ||| S:11059 E:11062 ||| IN
the  ||| S:11062 E:11066 ||| DT
ability  ||| S:11066 E:11074 ||| NN
to  ||| S:11074 E:11077 ||| TO
bind  ||| S:11077 E:11082 ||| VB
PIP  ||| S:11082 E:11097 ||| NNP
2  ||| S:11097 E:11099 ||| CD
.  ||| S:11099 E:11101 ||| .
As  ||| S:11101 E:11104 ||| IN
a  ||| S:11104 E:11106 ||| DT
guide  ||| S:11106 E:11112 ||| NN
for  ||| S:11112 E:11116 ||| IN
designing  ||| S:11116 E:11126 ||| VBG
such  ||| S:11126 E:11141 ||| JJ
mutants ||| S:11141 E:11148 ||| NN
,  ||| S:11148 E:11150 ||| ,
we  ||| S:11150 E:11153 ||| PRP
used  ||| S:11153 E:11158 ||| VBD
information  ||| S:11158 E:11170 ||| NN
about  ||| S:11170 E:11176 ||| IN
one  ||| S:11176 E:11180 ||| CD
of  ||| S:11180 E:11183 ||| IN
the  ||| S:11183 E:11187 ||| DT
PH  ||| S:11187 E:11190 ||| NNP
domains  ||| S:11190 E:11208 ||| NN
from  ||| S:11208 E:11213 ||| IN
pleckstrin ||| S:11213 E:11223 ||| NN
.  ||| S:11223 E:11225 ||| .
Figure  ||| S:11225 E:11232 ||| NN
4shows  ||| S:11232 E:11239 ||| VBZ
those  ||| S:11239 E:11245 ||| DT
positions  ||| S:11245 E:11255 ||| NNS
in  ||| S:11255 E:11258 ||| IN
the  ||| S:11258 E:11272 ||| DT
N-terminal  ||| S:11272 E:11283 ||| JJ
PH  ||| S:11283 E:11286 ||| NNP
domain  ||| S:11286 E:11293 ||| NN
of  ||| S:11293 E:11296 ||| IN
pleckstrin  ||| S:11296 E:11307 ||| NNS
that  ||| S:11307 E:11312 ||| WDT
have  ||| S:11312 E:11317 ||| VBP
been  ||| S:11317 E:11332 ||| VBN
implicated ||| S:11332 E:11342 ||| VBN
,  ||| S:11342 E:11344 ||| ,
based  ||| S:11344 E:11350 ||| VBN
on  ||| S:11350 E:11353 ||| IN
NMR  ||| S:11353 E:11357 ||| NNP
analysis ||| S:11357 E:11365 ||| NN
,  ||| S:11365 E:11367 ||| ,
to  ||| S:11367 E:11370 ||| TO
contact  ||| S:11370 E:11378 ||| VB
PIP  ||| S:11378 E:11393 ||| NNP
2  ||| S:11393 E:11395 ||| CD
[  ||| S:11395 E:11397 ||| -LRB-
17  ||| S:11397 E:11400 ||| CD
]  ||| S:11400 E:11402 ||| -RRB-
.  ||| S:11402 E:11404 ||| .
Boi1 ||| S:11404 E:11408 ||| NNP
's  ||| S:11408 E:11411 ||| POS
PH  ||| S:11411 E:11414 ||| NNP
domain  ||| S:11414 E:11421 ||| NN
has  ||| S:11421 E:11435 ||| VBZ
identical  ||| S:11435 E:11445 ||| JJ
or  ||| S:11445 E:11448 ||| CC
similar  ||| S:11448 E:11456 ||| JJ
amino  ||| S:11456 E:11462 ||| JJ
acids  ||| S:11462 E:11468 ||| NNS
at  ||| S:11468 E:11471 ||| IN
most  ||| S:11471 E:11476 ||| JJS
of  ||| S:11476 E:11479 ||| IN
the  ||| S:11479 E:11483 ||| DT
analogous  ||| S:11483 E:11503 ||| JJ
positions  ||| S:11503 E:11513 ||| NNS
( ||| S:11513 E:11514 ||| -LRB-
Fig.  ||| S:11514 E:11519 ||| CD
4 ||| S:11519 E:11520 ||| CD
) ||| S:11520 E:11521 ||| -RRB-
.  ||| S:11521 E:11533 ||| .
To  ||| S:11533 E:11536 ||| TO
obtain  ||| S:11536 E:11543 ||| VB
mutant  ||| S:11543 E:11550 ||| JJ
versions  ||| S:11550 E:11559 ||| NNS
of  ||| S:11559 E:11562 ||| IN
Boi1  ||| S:11562 E:11567 ||| NNP
that  ||| S:11567 E:11572 ||| WDT
might  ||| S:11572 E:11578 ||| MD
be  ||| S:11578 E:11591 ||| VB
defective  ||| S:11591 E:11601 ||| JJ
in  ||| S:11601 E:11604 ||| IN
the  ||| S:11604 E:11608 ||| DT
ability  ||| S:11608 E:11616 ||| NN
to  ||| S:11616 E:11619 ||| TO
bind  ||| S:11619 E:11624 ||| VB
PIP  ||| S:11624 E:11639 ||| NNP
2  ||| S:11639 E:11641 ||| CD
,  ||| S:11641 E:11643 ||| ,
we  ||| S:11643 E:11646 ||| PRP
created  ||| S:11646 E:11654 ||| VBD
three  ||| S:11654 E:11660 ||| CD
sets  ||| S:11660 E:11665 ||| NNS
of  ||| S:11665 E:11668 ||| IN
mutations  ||| S:11668 E:11688 ||| NNS
that  ||| S:11688 E:11693 ||| WDT
resulted  ||| S:11693 E:11702 ||| VBD
in  ||| S:11702 E:11705 ||| IN
amino-acid  ||| S:11705 E:11716 ||| JJ
subsitutions  ||| S:11716 E:11729 ||| NN
at  ||| S:11729 E:11732 ||| IN
some  ||| S:11732 E:11737 ||| DT
of  ||| S:11737 E:11740 ||| IN
those  ||| S:11740 E:11756 ||| DT
positions ||| S:11756 E:11765 ||| NNS
.  ||| S:11765 E:11767 ||| .
We  ||| S:11767 E:11770 ||| PRP
call  ||| S:11770 E:11775 ||| VBP
these  ||| S:11775 E:11781 ||| DT
sets  ||| S:11781 E:11786 ||| NNS
of  ||| S:11786 E:11789 ||| IN
substitutions  ||| S:11789 E:11803 ||| FW
"KK ||| S:11803 E:11806 ||| FW
"  ||| S:11806 E:11818 ||| ''
( ||| S:11818 E:11819 ||| -LRB-
K785E  ||| S:11819 E:11825 ||| NNP
and  ||| S:11825 E:11829 ||| CC
K786A ||| S:11829 E:11834 ||| CD
) ||| S:11834 E:11835 ||| -RRB-
,  ||| S:11835 E:11837 ||| ,
"TK ||| S:11837 E:11840 ||| NNP
"  ||| S:11840 E:11842 ||| ''
( ||| S:11842 E:11843 ||| -LRB-
T793A  ||| S:11843 E:11849 ||| NNP
and  ||| S:11849 E:11853 ||| CC
K795E ||| S:11853 E:11858 ||| CD
) ||| S:11858 E:11859 ||| -RRB-
,  ||| S:11859 E:11861 ||| ,
and  ||| S:11861 E:11865 ||| CC
"KKTK ||| S:11865 E:11870 ||| NNP
"  ||| S:11870 E:11882 ||| ''
( ||| S:11882 E:11883 ||| -LRB-
K785E ||| S:11883 E:11888 ||| NNP
,  ||| S:11888 E:11890 ||| ,
K786A ||| S:11890 E:11895 ||| NNP
,  ||| S:11895 E:11897 ||| ,
T793A ||| S:11897 E:11902 ||| NNP
,  ||| S:11902 E:11904 ||| ,
and  ||| S:11904 E:11908 ||| CC
K795E ||| S:11908 E:11913 ||| NNP
;  ||| S:11913 E:11915 ||| :
a  ||| S:11915 E:11917 ||| DT
combination  ||| S:11917 E:11929 ||| NN
of  ||| S:11929 E:11932 ||| IN
the  ||| S:11932 E:11936 ||| DT
KK  ||| S:11936 E:11949 ||| NNP
and  ||| S:11949 E:11953 ||| CC
TK  ||| S:11953 E:11956 ||| NNP
sets ||| S:11956 E:11960 ||| NNS
)  ||| S:11960 E:11962 ||| -RRB-
( ||| S:11962 E:11963 ||| -LRB-
Fig.  ||| S:11963 E:11968 ||| CD
4 ||| S:11968 E:11969 ||| CD
) ||| S:11969 E:11970 ||| -RRB-
.  ||| S:11970 E:11982 ||| .
To  ||| S:11982 E:11985 ||| TO
investigate  ||| S:11985 E:11997 ||| VB
whether  ||| S:11997 E:12005 ||| IN
these  ||| S:12005 E:12011 ||| DT
substitutions  ||| S:12011 E:12025 ||| NNS
affect  ||| S:12025 E:12032 ||| VBP
the  ||| S:12032 E:12046 ||| DT
ability  ||| S:12046 E:12054 ||| NN
of  ||| S:12054 E:12057 ||| IN
Boi1-PH  ||| S:12057 E:12065 ||| CD
to  ||| S:12065 E:12068 ||| TO
bind  ||| S:12068 E:12073 ||| VB
PIP  ||| S:12073 E:12088 ||| NNP
2  ||| S:12088 E:12090 ||| CD
,  ||| S:12090 E:12092 ||| ,
we  ||| S:12092 E:12095 ||| PRP
first  ||| S:12095 E:12101 ||| RB
used  ||| S:12101 E:12106 ||| VBN
the  ||| S:12106 E:12110 ||| DT
proteolysis  ||| S:12110 E:12132 ||| JJ
assay ||| S:12132 E:12137 ||| NN
.  ||| S:12137 E:12139 ||| .
We  ||| S:12139 E:12142 ||| PRP
found  ||| S:12142 E:12148 ||| VBD
that ||| S:12148 E:12152 ||| IN
,  ||| S:12152 E:12154 ||| ,
in  ||| S:12154 E:12157 ||| IN
conditions  ||| S:12157 E:12168 ||| NNS
in  ||| S:12168 E:12171 ||| IN
which  ||| S:12171 E:12177 ||| WDT
PIP  ||| S:12177 E:12192 ||| NNP
2  ||| S:12192 E:12194 ||| CD
stimulated  ||| S:12194 E:12205 ||| JJ
proteolysis  ||| S:12205 E:12217 ||| NN
of  ||| S:12217 E:12220 ||| IN
most  ||| S:12220 E:12225 ||| JJS
of  ||| S:12225 E:12238 ||| IN
the  ||| S:12238 E:12242 ||| DT
wild-type  ||| S:12242 E:12252 ||| JJ
Boi1-PH ||| S:12252 E:12259 ||| NN
,  ||| S:12259 E:12261 ||| ,
PIP  ||| S:12261 E:12276 ||| NNP
2  ||| S:12276 E:12278 ||| CD
did  ||| S:12278 E:12282 ||| VBD
not  ||| S:12282 E:12286 ||| RB
stimulate  ||| S:12286 E:12296 ||| VB
the  ||| S:12296 E:12300 ||| DT
proteolysis  ||| S:12300 E:12312 ||| NN
of  ||| S:12312 E:12325 ||| IN
the  ||| S:12325 E:12329 ||| DT
TK ||| S:12329 E:12331 ||| NNP
,  ||| S:12331 E:12333 ||| ,
KK ||| S:12333 E:12335 ||| NNP
,  ||| S:12335 E:12337 ||| ,
and  ||| S:12337 E:12341 ||| CC
KKTK  ||| S:12341 E:12346 ||| NNP
versions  ||| S:12346 E:12355 ||| NNS
of  ||| S:12355 E:12358 ||| IN
Boi1-PH  ||| S:12358 E:12366 ||| NNP
( ||| S:12366 E:12367 ||| -LRB-
Fig.  ||| S:12367 E:12372 ||| NNP
5A ||| S:12372 E:12374 ||| NNP
,  ||| S:12374 E:12376 ||| ,
lanes  ||| S:12376 E:12392 ||| CD
3 ||| S:12392 E:12393 ||| CD
,  ||| S:12393 E:12395 ||| ,
6 ||| S:12395 E:12396 ||| CD
,  ||| S:12396 E:12398 ||| ,
9 ||| S:12398 E:12399 ||| CD
,  ||| S:12399 E:12401 ||| ,
and  ||| S:12401 E:12405 ||| CC
12 ||| S:12405 E:12407 ||| CD
) ||| S:12407 E:12408 ||| -RRB-
,  ||| S:12408 E:12410 ||| ,
suggesting  ||| S:12410 E:12421 ||| VBG
that  ||| S:12421 E:12426 ||| IN
all  ||| S:12426 E:12430 ||| DT
three  ||| S:12430 E:12436 ||| CD
sets  ||| S:12436 E:12441 ||| NNS
of  ||| S:12441 E:12454 ||| IN
substitutions  ||| S:12454 E:12468 ||| NNS
may  ||| S:12468 E:12472 ||| MD
disrupt  ||| S:12472 E:12480 ||| VB
binding  ||| S:12480 E:12488 ||| VBG
to  ||| S:12488 E:12491 ||| TO
PIP  ||| S:12491 E:12506 ||| NNP
2  ||| S:12506 E:12508 ||| CD
and ||| S:12508 E:12511 ||| CC
/ ||| S:12511 E:12512 ||| NNP
or  ||| S:12512 E:12515 ||| CC
PS ||| S:12515 E:12517 ||| NNP
.  ||| S:12517 E:12529 ||| .
To  ||| S:12529 E:12532 ||| TO
investigate  ||| S:12532 E:12544 ||| VB
further  ||| S:12544 E:12552 ||| RBR
whether  ||| S:12552 E:12560 ||| IN
the  ||| S:12560 E:12564 ||| DT
three  ||| S:12564 E:12570 ||| CD
sets  ||| S:12570 E:12575 ||| NNS
of  ||| S:12575 E:12588 ||| IN
substitutions  ||| S:12588 E:12602 ||| NNS
affect  ||| S:12602 E:12609 ||| VBP
the  ||| S:12609 E:12613 ||| DT
ability  ||| S:12613 E:12621 ||| NN
of  ||| S:12621 E:12624 ||| IN
Boi1-PH  ||| S:12624 E:12632 ||| CD
to  ||| S:12632 E:12635 ||| TO
bind  ||| S:12635 E:12640 ||| VB
these  ||| S:12640 E:12656 ||| DT
lipids ||| S:12656 E:12662 ||| NN
,  ||| S:12662 E:12664 ||| ,
we  ||| S:12664 E:12667 ||| PRP
used  ||| S:12667 E:12672 ||| VBD
the  ||| S:12672 E:12676 ||| DT
vesicle  ||| S:12676 E:12684 ||| JJ
co-sedimentation  ||| S:12684 E:12701 ||| JJ
assay ||| S:12701 E:12706 ||| NN
.  ||| S:12706 E:12708 ||| .
In  ||| S:12708 E:12721 ||| IN
the  ||| S:12721 E:12725 ||| DT
presence  ||| S:12725 E:12734 ||| NN
of  ||| S:12734 E:12737 ||| IN
vesicles  ||| S:12737 E:12746 ||| VBG
composed  ||| S:12746 E:12755 ||| VBN
of  ||| S:12755 E:12758 ||| IN
only  ||| S:12758 E:12763 ||| JJ
PS ||| S:12763 E:12765 ||| NNP
,  ||| S:12765 E:12767 ||| ,
an  ||| S:12767 E:12780 ||| DT
appreciable  ||| S:12780 E:12792 ||| JJ
amount  ||| S:12792 E:12799 ||| NN
of  ||| S:12799 E:12802 ||| IN
Boi1-PH ||| S:12802 E:12809 ||| NNP
( ||| S:12809 E:12810 ||| -LRB-
KK ||| S:12810 E:12812 ||| NNP
)  ||| S:12812 E:12814 ||| -RRB-
pelleted  ||| S:12814 E:12823 ||| NNS
( ||| S:12823 E:12824 ||| -LRB-
Fig.  ||| S:12824 E:12829 ||| NNP
5B ||| S:12829 E:12831 ||| NNP
,  ||| S:12831 E:12843 ||| ,
second  ||| S:12843 E:12850 ||| JJ
panel ||| S:12850 E:12855 ||| NN
,  ||| S:12855 E:12857 ||| ,
lanes  ||| S:12857 E:12863 ||| CD
3  ||| S:12863 E:12865 ||| CD
and  ||| S:12865 E:12869 ||| CC
4 ||| S:12869 E:12870 ||| LS
) ||| S:12870 E:12871 ||| -RRB-
.  ||| S:12871 E:12873 ||| .
However ||| S:12873 E:12880 ||| RB
,  ||| S:12880 E:12882 ||| ,
the  ||| S:12882 E:12886 ||| DT
percentage  ||| S:12886 E:12897 ||| NN
of  ||| S:12897 E:12910 ||| IN
Boi1-PH ||| S:12910 E:12917 ||| NNP
( ||| S:12917 E:12918 ||| -LRB-
KK ||| S:12918 E:12920 ||| NNP
)  ||| S:12920 E:12922 ||| -RRB-
that  ||| S:12922 E:12927 ||| IN
pelleted  ||| S:12927 E:12936 ||| NN
was  ||| S:12936 E:12940 ||| VBD
less  ||| S:12940 E:12945 ||| JJR
than  ||| S:12945 E:12950 ||| IN
that  ||| S:12950 E:12955 ||| DT
for  ||| S:12955 E:12969 ||| IN
wild-type  ||| S:12969 E:12979 ||| NNP
Boi1-PH  ||| S:12979 E:12987 ||| NNP
( ||| S:12987 E:12988 ||| -LRB-
Fig.  ||| S:12988 E:12993 ||| NNP
5B ||| S:12993 E:12995 ||| NNP
,  ||| S:12995 E:12997 ||| ,
top  ||| S:12997 E:13001 ||| JJ
and  ||| S:13001 E:13005 ||| CC
second  ||| S:13005 E:13012 ||| JJ
panels ||| S:13012 E:13018 ||| NNS
,  ||| S:13018 E:13020 ||| ,
lanes  ||| S:13020 E:13036 ||| CD
3  ||| S:13036 E:13038 ||| CD
and  ||| S:13038 E:13042 ||| CC
4 ||| S:13042 E:13043 ||| LS
) ||| S:13043 E:13044 ||| -RRB-
,  ||| S:13044 E:13046 ||| ,
suggesting  ||| S:13046 E:13057 ||| VBG
that  ||| S:13057 E:13062 ||| IN
the  ||| S:13062 E:13066 ||| DT
KK  ||| S:13066 E:13069 ||| NNP
substitutions  ||| S:13069 E:13083 ||| RB
reduce  ||| S:13083 E:13100 ||| VB
somewhat  ||| S:13100 E:13109 ||| RB
the  ||| S:13109 E:13113 ||| DT
binding  ||| S:13113 E:13121 ||| JJ
affinity  ||| S:13121 E:13130 ||| NN
for  ||| S:13130 E:13134 ||| IN
PS ||| S:13134 E:13136 ||| NNP
.  ||| S:13136 E:13138 ||| .
The  ||| S:13138 E:13142 ||| DT
TK  ||| S:13142 E:13155 ||| NNP
substitutions  ||| S:13155 E:13169 ||| NN
had  ||| S:13169 E:13173 ||| VBD
a  ||| S:13173 E:13175 ||| DT
more  ||| S:13175 E:13180 ||| RBR
obvious  ||| S:13180 E:13188 ||| JJ
effect ||| S:13188 E:13194 ||| NN
:  ||| S:13194 E:13196 ||| :
no  ||| S:13196 E:13199 ||| DT
Boi1-PH ||| S:13199 E:13206 ||| NNP
( ||| S:13206 E:13207 ||| -LRB-
TK ||| S:13207 E:13209 ||| NNP
)  ||| S:13209 E:13221 ||| -RRB-
was  ||| S:13221 E:13225 ||| VBD
seen  ||| S:13225 E:13230 ||| VBN
to  ||| S:13230 E:13233 ||| TO
pellet  ||| S:13233 E:13240 ||| VB
with  ||| S:13240 E:13245 ||| IN
PS  ||| S:13245 E:13248 ||| NNP
vesicles  ||| S:13248 E:13257 ||| NNS
( ||| S:13257 E:13258 ||| -LRB-
Fig.  ||| S:13258 E:13263 ||| NNP
5B ||| S:13263 E:13265 ||| NNP
,  ||| S:13265 E:13267 ||| ,
third  ||| S:13267 E:13283 ||| JJ
panel ||| S:13283 E:13288 ||| NN
,  ||| S:13288 E:13290 ||| ,
lanes  ||| S:13290 E:13296 ||| CD
3  ||| S:13296 E:13298 ||| CD
and  ||| S:13298 E:13302 ||| CC
4 ||| S:13302 E:13303 ||| LS
) ||| S:13303 E:13304 ||| -RRB-
,  ||| S:13304 E:13306 ||| ,
suggesting  ||| S:13306 E:13317 ||| VBG
that  ||| S:13317 E:13322 ||| IN
the  ||| S:13322 E:13326 ||| DT
TK  ||| S:13326 E:13339 ||| NNP
substitutions  ||| S:13339 E:13353 ||| VBD
impaired  ||| S:13353 E:13362 ||| VBN
binding  ||| S:13362 E:13370 ||| VBG
to  ||| S:13370 E:13373 ||| TO
PS  ||| S:13373 E:13376 ||| NNP
to  ||| S:13376 E:13379 ||| TO
a  ||| S:13379 E:13381 ||| DT
greater  ||| S:13381 E:13389 ||| JJR
extent  ||| S:13389 E:13406 ||| NN
than  ||| S:13406 E:13411 ||| IN
did  ||| S:13411 E:13415 ||| VBD
the  ||| S:13415 E:13419 ||| DT
KK  ||| S:13419 E:13422 ||| NNP
substitutions ||| S:13422 E:13435 ||| NN
.  ||| S:13435 E:13437 ||| .
As  ||| S:13437 E:13440 ||| RB
expected ||| S:13440 E:13448 ||| VBN
,  ||| S:13448 E:13450 ||| ,
given  ||| S:13450 E:13456 ||| VBN
that  ||| S:13456 E:13471 ||| IN
the  ||| S:13471 E:13475 ||| DT
TK  ||| S:13475 E:13478 ||| NNP
substitutions  ||| S:13478 E:13492 ||| NN
were  ||| S:13492 E:13497 ||| VBD
sufficient  ||| S:13497 E:13508 ||| JJ
to  ||| S:13508 E:13511 ||| TO
severely  ||| S:13511 E:13520 ||| RB
affect  ||| S:13520 E:13537 ||| VB
pelleting  ||| S:13537 E:13547 ||| VBN
with  ||| S:13547 E:13552 ||| IN
PS  ||| S:13552 E:13555 ||| NNP
vesicles ||| S:13555 E:13563 ||| NN
,  ||| S:13563 E:13565 ||| ,
none  ||| S:13565 E:13570 ||| NN
of  ||| S:13570 E:13573 ||| IN
the  ||| S:13573 E:13577 ||| DT
Boi1-PH ||| S:13577 E:13584 ||| NNP
( ||| S:13584 E:13585 ||| -LRB-
KKTK ||| S:13585 E:13589 ||| NNP
)  ||| S:13589 E:13591 ||| -RRB-
was  ||| S:13591 E:13605 ||| VBD
seen  ||| S:13605 E:13610 ||| VBN
to  ||| S:13610 E:13613 ||| TO
co-sediment  ||| S:13613 E:13625 ||| JJ
with  ||| S:13625 E:13630 ||| IN
PS  ||| S:13630 E:13633 ||| NNP
vesicles  ||| S:13633 E:13642 ||| NNS
( ||| S:13642 E:13643 ||| -LRB-
Fig.  ||| S:13643 E:13648 ||| NNP
5B ||| S:13648 E:13650 ||| NNP
,  ||| S:13650 E:13652 ||| ,
bottom  ||| S:13652 E:13669 ||| JJ
panel ||| S:13669 E:13674 ||| NN
,  ||| S:13674 E:13676 ||| ,
lanes  ||| S:13676 E:13682 ||| CD
3  ||| S:13682 E:13684 ||| CD
and  ||| S:13684 E:13688 ||| CC
4 ||| S:13688 E:13689 ||| LS
) ||| S:13689 E:13690 ||| -RRB-
.  ||| S:13690 E:13702 ||| .
Whereas  ||| S:13702 E:13710 ||| IN
inclusion  ||| S:13710 E:13720 ||| NN
of  ||| S:13720 E:13723 ||| IN
PIP  ||| S:13723 E:13738 ||| NNP
2  ||| S:13738 E:13740 ||| CD
in  ||| S:13740 E:13743 ||| IN
the  ||| S:13743 E:13747 ||| DT
vesicles  ||| S:13747 E:13756 ||| NN
increased  ||| S:13756 E:13766 ||| VBD
the  ||| S:13766 E:13770 ||| DT
amount  ||| S:13770 E:13787 ||| NN
of  ||| S:13787 E:13790 ||| IN
wild-type  ||| S:13790 E:13800 ||| JJ
Boi1-PH  ||| S:13800 E:13808 ||| NN
that  ||| S:13808 E:13813 ||| IN
co-sedimented ||| S:13813 E:13826 ||| NNP
,  ||| S:13826 E:13828 ||| ,
PIP  ||| S:13828 E:13843 ||| NNP
2  ||| S:13843 E:13845 ||| CD
did  ||| S:13845 E:13849 ||| VBD
not  ||| S:13849 E:13853 ||| RB
have  ||| S:13853 E:13858 ||| VB
an  ||| S:13858 E:13861 ||| DT
obvious  ||| S:13861 E:13869 ||| JJ
effect  ||| S:13869 E:13876 ||| NN
on  ||| S:13876 E:13889 ||| IN
the  ||| S:13889 E:13893 ||| DT
co-sedimentation  ||| S:13893 E:13910 ||| JJ
behavior  ||| S:13910 E:13919 ||| NN
of  ||| S:13919 E:13922 ||| IN
Boi1-PH ||| S:13922 E:13929 ||| NNP
( ||| S:13929 E:13930 ||| -LRB-
KK ||| S:13930 E:13932 ||| NNP
)  ||| S:13932 E:13934 ||| -RRB-
( ||| S:13934 E:13935 ||| -LRB-
Fig.  ||| S:13935 E:13940 ||| NNP
5B ||| S:13940 E:13942 ||| NNP
,  ||| S:13942 E:13954 ||| ,
top  ||| S:13954 E:13958 ||| JJ
and  ||| S:13958 E:13962 ||| CC
second  ||| S:13962 E:13969 ||| JJ
panels ||| S:13969 E:13975 ||| NNS
,  ||| S:13975 E:13977 ||| ,
lanes  ||| S:13977 E:13983 ||| CD
3-6 ||| S:13983 E:13986 ||| CD
) ||| S:13986 E:13987 ||| -RRB-
,  ||| S:13987 E:13989 ||| ,
suggesting  ||| S:13989 E:14000 ||| VBG
that  ||| S:14000 E:14005 ||| IN
the  ||| S:14005 E:14009 ||| DT
KK  ||| S:14009 E:14022 ||| NNP
substitutions  ||| S:14022 E:14036 ||| FW
impair  ||| S:14036 E:14043 ||| FW
binding  ||| S:14043 E:14051 ||| FW
to  ||| S:14051 E:14054 ||| TO
PIP  ||| S:14054 E:14069 ||| NNP
2  ||| S:14069 E:14071 ||| CD
.  ||| S:14071 E:14073 ||| .
In  ||| S:14073 E:14076 ||| IN
contrast ||| S:14076 E:14084 ||| NN
,  ||| S:14084 E:14086 ||| ,
the  ||| S:14086 E:14090 ||| DT
TK  ||| S:14090 E:14093 ||| NNP
mutant  ||| S:14093 E:14100 ||| JJ
version  ||| S:14100 E:14118 ||| NN
of  ||| S:14118 E:14121 ||| IN
Boi1-PH  ||| S:14121 E:14129 ||| NNP
appeared  ||| S:14129 E:14138 ||| VBD
to  ||| S:14138 E:14141 ||| TO
retain  ||| S:14141 E:14148 ||| VB
a  ||| S:14148 E:14150 ||| DT
slight  ||| S:14150 E:14157 ||| JJ
ability  ||| S:14157 E:14165 ||| NN
to  ||| S:14165 E:14168 ||| TO
pellet  ||| S:14168 E:14185 ||| VB
with  ||| S:14185 E:14190 ||| IN
PIP  ||| S:14190 E:14205 ||| NNP
2  ||| S:14205 E:14207 ||| CD
/ ||| S:14207 E:14208 ||| CD
PS  ||| S:14208 E:14211 ||| NNP
vesicles  ||| S:14211 E:14220 ||| NNS
( ||| S:14220 E:14221 ||| -LRB-
Fig.  ||| S:14221 E:14226 ||| NNP
5B ||| S:14226 E:14228 ||| NNP
,  ||| S:14228 E:14230 ||| ,
third  ||| S:14230 E:14236 ||| JJ
panel ||| S:14236 E:14241 ||| NN
,  ||| S:14241 E:14253 ||| ,
lanes  ||| S:14253 E:14259 ||| CD
3-6 ||| S:14259 E:14262 ||| CD
) ||| S:14262 E:14263 ||| -RRB-
.  ||| S:14263 E:14275 ||| .
None  ||| S:14275 E:14280 ||| NN
of  ||| S:14280 E:14283 ||| IN
the  ||| S:14283 E:14287 ||| DT
Boi1-PH ||| S:14287 E:14294 ||| NNP
( ||| S:14294 E:14295 ||| -LRB-
KKTK ||| S:14295 E:14299 ||| NNP
)  ||| S:14299 E:14301 ||| -RRB-
was  ||| S:14301 E:14305 ||| VBD
detected  ||| S:14305 E:14314 ||| VBN
in  ||| S:14314 E:14317 ||| IN
the  ||| S:14317 E:14321 ||| DT
pellet  ||| S:14321 E:14338 ||| JJ
fraction  ||| S:14338 E:14347 ||| NN
even  ||| S:14347 E:14352 ||| RB
when  ||| S:14352 E:14357 ||| WRB
using  ||| S:14357 E:14363 ||| VBG
vesicles  ||| S:14363 E:14372 ||| NNS
that  ||| S:14372 E:14377 ||| WDT
contained  ||| S:14377 E:14387 ||| VBD
PIP  ||| S:14387 E:14402 ||| NNP
2  ||| S:14402 E:14404 ||| CD
( ||| S:14404 E:14405 ||| -LRB-
Fig.  ||| S:14405 E:14410 ||| NNP
5A ||| S:14410 E:14412 ||| NNP
,  ||| S:14412 E:14414 ||| ,
bottom  ||| S:14414 E:14421 ||| JJ
panel ||| S:14421 E:14426 ||| NN
,  ||| S:14426 E:14428 ||| ,
lanes  ||| S:14428 E:14434 ||| CD
5  ||| S:14434 E:14436 ||| CD
and  ||| S:14436 E:14450 ||| CC
6 ||| S:14450 E:14451 ||| CD
) ||| S:14451 E:14452 ||| -RRB-
,  ||| S:14452 E:14454 ||| ,
consistent  ||| S:14454 E:14465 ||| JJ
with  ||| S:14465 E:14470 ||| IN
the  ||| S:14470 E:14474 ||| DT
view  ||| S:14474 E:14479 ||| NN
that  ||| S:14479 E:14484 ||| IN
the  ||| S:14484 E:14488 ||| DT
KKTK  ||| S:14488 E:14493 ||| NNP
mutant  ||| S:14493 E:14500 ||| NN
is  ||| S:14500 E:14503 ||| VBZ
more  ||| S:14503 E:14518 ||| RBR
severely  ||| S:14518 E:14527 ||| RB
impaired  ||| S:14527 E:14536 ||| VBN
in  ||| S:14536 E:14539 ||| IN
the  ||| S:14539 E:14543 ||| DT
ability  ||| S:14543 E:14551 ||| NN
to  ||| S:14551 E:14554 ||| TO
bind  ||| S:14554 E:14559 ||| VB
PIP  ||| S:14559 E:14574 ||| NNP
2  ||| S:14574 E:14576 ||| CD
than  ||| S:14576 E:14581 ||| IN
are  ||| S:14581 E:14585 ||| VBP
the  ||| S:14585 E:14589 ||| DT
KK  ||| S:14589 E:14592 ||| NNP
and  ||| S:14592 E:14596 ||| CC
TK  ||| S:14596 E:14599 ||| NNP
mutants ||| S:14599 E:14606 ||| NN
.  ||| S:14606 E:14636 ||| .
Exploring  ||| S:14636 E:14646 ||| VBG
the  ||| S:14646 E:14650 ||| DT
significance  ||| S:14650 E:14663 ||| NN
of  ||| S:14663 E:14666 ||| IN
binding  ||| S:14666 E:14674 ||| VBG
to  ||| S:14674 E:14687 ||| TO
phospholipids  ||| S:14687 E:14711 ||| VB
To  ||| S:14711 E:14714 ||| TO
investigate  ||| S:14714 E:14726 ||| VB
whether  ||| S:14726 E:14734 ||| IN
binding  ||| S:14734 E:14742 ||| VBG
to  ||| S:14742 E:14745 ||| TO
phospholipid  ||| S:14745 E:14758 ||| NNS
may  ||| S:14758 E:14762 ||| MD
be  ||| S:14762 E:14775 ||| VB
important  ||| S:14775 E:14785 ||| JJ
for  ||| S:14785 E:14789 ||| IN
Boi1  ||| S:14789 E:14794 ||| CD
function ||| S:14794 E:14802 ||| NN
,  ||| S:14802 E:14804 ||| ,
we  ||| S:14804 E:14807 ||| PRP
used  ||| S:14807 E:14812 ||| VBD
a  ||| S:14812 E:14814 ||| DT
red ||| S:14814 E:14817 ||| JJ
/ ||| S:14817 E:14818 ||| CD
white ||| S:14818 E:14823 ||| NN
,  ||| S:14823 E:14835 ||| ,
colony-sectoring  ||| S:14835 E:14852 ||| JJ
assay  ||| S:14852 E:14858 ||| NN
to  ||| S:14858 E:14861 ||| TO
test  ||| S:14861 E:14866 ||| VB
whether  ||| S:14866 E:14874 ||| IN
the  ||| S:14874 E:14878 ||| DT
KK ||| S:14878 E:14880 ||| NNP
,  ||| S:14880 E:14882 ||| ,
TK ||| S:14882 E:14884 ||| NNP
,  ||| S:14884 E:14886 ||| ,
and  ||| S:14886 E:14900 ||| CC
KKTK  ||| S:14900 E:14905 ||| NNP
mutant  ||| S:14905 E:14912 ||| JJ
versions  ||| S:14912 E:14921 ||| NNS
of  ||| S:14921 E:14924 ||| IN
Boi1  ||| S:14924 E:14929 ||| NNP
could  ||| S:14929 E:14935 ||| MD
substitute  ||| S:14935 E:14946 ||| VB
in  ||| S:14946 E:14949 ||| IN
function  ||| S:14949 E:14968 ||| NN
for  ||| S:14968 E:14972 ||| IN
wild-type  ||| S:14972 E:14993 ||| NNP
BOI1  ||| S:14993 E:14998 ||| NNP
and  ||| S:14998 E:15013 ||| CC
BOI2  ||| S:15013 E:15018 ||| NNP
.  ||| S:15018 E:15020 ||| .
For  ||| S:15020 E:15024 ||| IN
this  ||| S:15024 E:15029 ||| DT
analysis ||| S:15029 E:15037 ||| NN
,  ||| S:15037 E:15039 ||| ,
we  ||| S:15039 E:15042 ||| PRP
used  ||| S:15042 E:15057 ||| VBD
strain  ||| S:15057 E:15064 ||| CD
PY967 ||| S:15064 E:15069 ||| CD
,  ||| S:15069 E:15071 ||| ,
which  ||| S:15071 E:15077 ||| WDT
lacks  ||| S:15077 E:15083 ||| VBZ
the  ||| S:15083 E:15087 ||| DT
genomic  ||| S:15087 E:15095 ||| JJ
copies  ||| S:15095 E:15102 ||| NNS
of  ||| S:15102 E:15116 ||| IN
BOI1  ||| S:15116 E:15121 ||| NNP
and  ||| S:15121 E:15136 ||| CC
BOI2  ||| S:15136 E:15141 ||| NNP
and  ||| S:15141 E:15145 ||| CC
which  ||| S:15145 E:15151 ||| WDT
is  ||| S:15151 E:15154 ||| VBZ
kept  ||| S:15154 E:15159 ||| VBN
alive  ||| S:15159 E:15165 ||| JJ
by  ||| S:15165 E:15179 ||| IN
BOI1  ||| S:15179 E:15184 ||| FW
-bearing  ||| S:15184 E:15193 ||| FW
plasmid  ||| S:15193 E:15201 ||| FW
pPB799.  ||| S:15201 E:15219 ||| FW
pPB799  ||| S:15219 E:15226 ||| NNP
also  ||| S:15226 E:15231 ||| RB
contains  ||| S:15231 E:15240 ||| VBZ
the  ||| S:15240 E:15255 ||| DT
ADE3  ||| S:15255 E:15260 ||| JJ
color  ||| S:15260 E:15266 ||| NN
marker ||| S:15266 E:15272 ||| NN
.  ||| S:15272 E:15274 ||| .
Cells  ||| S:15274 E:15280 ||| NNS
that  ||| S:15280 E:15285 ||| WDT
have  ||| S:15285 E:15300 ||| VBP
this  ||| S:15300 E:15305 ||| DT
plasmid  ||| S:15305 E:15313 ||| NNS
are  ||| S:15313 E:15317 ||| VBP
red ||| S:15317 E:15320 ||| JJ
,  ||| S:15320 E:15322 ||| ,
while  ||| S:15322 E:15328 ||| IN
those  ||| S:15328 E:15334 ||| DT
that  ||| S:15334 E:15339 ||| WDT
fail  ||| S:15339 E:15344 ||| VBP
to  ||| S:15344 E:15347 ||| TO
inherit  ||| S:15347 E:15355 ||| VB
it  ||| S:15355 E:15368 ||| PRP
are  ||| S:15368 E:15372 ||| VBP
white ||| S:15372 E:15377 ||| JJ
.  ||| S:15377 E:15379 ||| .
PY967  ||| S:15379 E:15385 ||| NNP
cells  ||| S:15385 E:15391 ||| NNS
form  ||| S:15391 E:15396 ||| VBP
thoroughly  ||| S:15396 E:15407 ||| RB
red  ||| S:15407 E:15411 ||| JJ
colonies  ||| S:15411 E:15430 ||| NNS
( ||| S:15430 E:15431 ||| -LRB-
lacking  ||| S:15431 E:15439 ||| VBG
white  ||| S:15439 E:15445 ||| JJ
sectors ||| S:15445 E:15452 ||| NNS
) ||| S:15452 E:15453 ||| -RRB-
,  ||| S:15453 E:15455 ||| ,
because  ||| S:15455 E:15463 ||| IN
cells  ||| S:15463 E:15469 ||| NNS
that  ||| S:15469 E:15474 ||| WDT
fail  ||| S:15474 E:15479 ||| VBP
to  ||| S:15479 E:15492 ||| TO
inherit  ||| S:15492 E:15500 ||| VB
the  ||| S:15500 E:15504 ||| DT
plasmid  ||| S:15504 E:15512 ||| JJ
lack  ||| S:15512 E:15528 ||| NN
BOI1  ||| S:15528 E:15533 ||| NN
and  ||| S:15533 E:15537 ||| CC
so  ||| S:15537 E:15540 ||| RB
do  ||| S:15540 E:15543 ||| VBP
not  ||| S:15543 E:15547 ||| RB
propagate ||| S:15547 E:15556 ||| VBN
.  ||| S:15556 E:15568 ||| .
However ||| S:15568 E:15575 ||| RB
,  ||| S:15575 E:15577 ||| ,
when  ||| S:15577 E:15582 ||| WRB
transformed  ||| S:15582 E:15594 ||| VBN
with  ||| S:15594 E:15599 ||| IN
a  ||| S:15599 E:15601 ||| DT
second  ||| S:15601 E:15608 ||| JJ
plasmid  ||| S:15608 E:15616 ||| NN
that  ||| S:15616 E:15621 ||| WDT
can  ||| S:15621 E:15635 ||| MD
substitute  ||| S:15635 E:15646 ||| VB
in  ||| S:15646 E:15649 ||| IN
function  ||| S:15649 E:15658 ||| NN
for  ||| S:15658 E:15673 ||| IN
BOI1  ||| S:15673 E:15678 ||| NNP
,  ||| S:15678 E:15680 ||| ,
PY967  ||| S:15680 E:15686 ||| CD
cells  ||| S:15686 E:15692 ||| NNS
that  ||| S:15692 E:15697 ||| WDT
fail  ||| S:15697 E:15702 ||| VBP
to  ||| S:15702 E:15715 ||| TO
inherit  ||| S:15715 E:15723 ||| VB
pPB799  ||| S:15723 E:15730 ||| RB
are  ||| S:15730 E:15734 ||| VBP
still  ||| S:15734 E:15740 ||| RB
viable  ||| S:15740 E:15747 ||| JJ
and  ||| S:15747 E:15751 ||| CC
so  ||| S:15751 E:15754 ||| RB
give  ||| S:15754 E:15759 ||| VB
rise  ||| S:15759 E:15764 ||| NN
to  ||| S:15764 E:15767 ||| TO
white  ||| S:15767 E:15783 ||| JJ
sectors ||| S:15783 E:15790 ||| NNS
.  ||| S:15790 E:15802 ||| .
To  ||| S:15802 E:15805 ||| TO
test  ||| S:15805 E:15810 ||| VB
the  ||| S:15810 E:15814 ||| DT
different  ||| S:15814 E:15824 ||| JJ
versions  ||| S:15824 E:15833 ||| NNS
of  ||| S:15833 E:15847 ||| IN
BOI1  ||| S:15847 E:15852 ||| CD
for  ||| S:15852 E:15856 ||| IN
function ||| S:15856 E:15864 ||| NN
,  ||| S:15864 E:15866 ||| ,
we  ||| S:15866 E:15869 ||| PRP
introduced  ||| S:15869 E:15890 ||| VBD
them  ||| S:15890 E:15895 ||| PRP
on  ||| S:15895 E:15898 ||| IN
plasmids  ||| S:15898 E:15907 ||| NN
into  ||| S:15907 E:15912 ||| IN
strain  ||| S:15912 E:15919 ||| NN
PY967 ||| S:15919 E:15924 ||| NN
,  ||| S:15924 E:15926 ||| ,
at  ||| S:15926 E:15929 ||| IN
both  ||| S:15929 E:15934 ||| DT
23  ||| S:15934 E:15937 ||| CD
and  ||| S:15937 E:15941 ||| CC
30°C ||| S:15941 E:15945 ||| NNP
,  ||| S:15945 E:15957 ||| ,
and  ||| S:15957 E:15961 ||| CC
then  ||| S:15961 E:15966 ||| RB
scored  ||| S:15966 E:15973 ||| VBD
the  ||| S:15973 E:15977 ||| DT
degree  ||| S:15977 E:15984 ||| NN
of  ||| S:15984 E:15987 ||| IN
sectoring  ||| S:15987 E:15997 ||| NN
of  ||| S:15997 E:16000 ||| IN
the  ||| S:16000 E:16004 ||| DT
resultant  ||| S:16004 E:16024 ||| JJ
transformant  ||| S:16024 E:16037 ||| JJ
colonies ||| S:16037 E:16045 ||| NNS
.  ||| S:16045 E:16047 ||| .
For  ||| S:16047 E:16051 ||| IN
each  ||| S:16051 E:16056 ||| DT
plasmid  ||| S:16056 E:16064 ||| JJ
tested ||| S:16064 E:16070 ||| NN
,  ||| S:16070 E:16082 ||| ,
approximately  ||| S:16082 E:16096 ||| RB
200  ||| S:16096 E:16100 ||| CD
colonies  ||| S:16100 E:16109 ||| NNS
from  ||| S:16109 E:16114 ||| IN
each  ||| S:16114 E:16119 ||| DT
transformation  ||| S:16119 E:16134 ||| NN
plate  ||| S:16134 E:16150 ||| NN
were  ||| S:16150 E:16155 ||| VBD
analyzed  ||| S:16155 E:16164 ||| VBN
at  ||| S:16164 E:16167 ||| IN
each  ||| S:16167 E:16172 ||| DT
temperature ||| S:16172 E:16183 ||| NN
.  ||| S:16183 E:16185 ||| .
As  ||| S:16185 E:16188 ||| IN
negative  ||| S:16188 E:16197 ||| JJ
and  ||| S:16197 E:16211 ||| CC
positive  ||| S:16211 E:16220 ||| JJ
controls  ||| S:16220 E:16229 ||| NNS
for  ||| S:16229 E:16233 ||| IN
sectoring ||| S:16233 E:16242 ||| NN
,  ||| S:16242 E:16244 ||| ,
we  ||| S:16244 E:16247 ||| PRP
used  ||| S:16247 E:16252 ||| VBD
an  ||| S:16252 E:16255 ||| DT
empty  ||| S:16255 E:16261 ||| JJ
plasmid  ||| S:16261 E:16279 ||| NN
and  ||| S:16279 E:16283 ||| CC
one  ||| S:16283 E:16287 ||| CD
that  ||| S:16287 E:16292 ||| WDT
contains  ||| S:16292 E:16301 ||| VBZ
wild-type  ||| S:16301 E:16322 ||| JJ
BOI1  ||| S:16322 E:16327 ||| NN
,  ||| S:16327 E:16329 ||| ,
respectively ||| S:16329 E:16341 ||| RB
.  ||| S:16341 E:16343 ||| .
As  ||| S:16343 E:16346 ||| RB
indicated  ||| S:16346 E:16366 ||| VBN
in  ||| S:16366 E:16369 ||| IN
Figure  ||| S:16369 E:16376 ||| NNP
6 ||| S:16376 E:16377 ||| CD
,  ||| S:16377 E:16379 ||| ,
the  ||| S:16379 E:16383 ||| DT
empty  ||| S:16383 E:16389 ||| JJ
plasmid  ||| S:16389 E:16397 ||| NNS
( ||| S:16397 E:16398 ||| -LRB-
- ||| S:16398 E:16399 ||| NNP
)  ||| S:16399 E:16401 ||| -RRB-
gave  ||| S:16401 E:16406 ||| VBD
no  ||| S:16406 E:16409 ||| DT
sectoring  ||| S:16409 E:16429 ||| JJ
colonies ||| S:16429 E:16437 ||| NNS
,  ||| S:16437 E:16439 ||| ,
indicating  ||| S:16439 E:16450 ||| VBG
that  ||| S:16450 E:16455 ||| IN
the  ||| S:16455 E:16459 ||| DT
level  ||| S:16459 E:16465 ||| NN
of  ||| S:16465 E:16468 ||| IN
background  ||| S:16468 E:16489 ||| NN
sectoring  ||| S:16489 E:16499 ||| NN
in  ||| S:16499 E:16502 ||| IN
this  ||| S:16502 E:16507 ||| DT
assay  ||| S:16507 E:16513 ||| NN
is  ||| S:16513 E:16516 ||| VBZ
low ||| S:16516 E:16519 ||| JJ
.  ||| S:16519 E:16521 ||| .
The  ||| S:16521 E:16525 ||| DT
plasmid  ||| S:16525 E:16533 ||| NN
that  ||| S:16533 E:16538 ||| WDT
contains  ||| S:16538 E:16557 ||| VBZ
wild-type  ||| S:16557 E:16578 ||| JJ
BOI1  ||| S:16578 E:16583 ||| NN
gave  ||| S:16583 E:16588 ||| VBD
a  ||| S:16588 E:16590 ||| DT
range  ||| S:16590 E:16596 ||| NN
of  ||| S:16596 E:16599 ||| IN
sectoring  ||| S:16599 E:16619 ||| JJ
abilities ||| S:16619 E:16628 ||| NNS
,  ||| S:16628 E:16630 ||| ,
with  ||| S:16630 E:16635 ||| IN
71  ||| S:16635 E:16638 ||| CD
and  ||| S:16638 E:16642 ||| CC
79 ||| S:16642 E:16644 ||| CD
%  ||| S:16644 E:16646 ||| NN
of  ||| S:16646 E:16649 ||| IN
the  ||| S:16649 E:16653 ||| DT
colonies  ||| S:16653 E:16662 ||| NN
showing  ||| S:16662 E:16670 ||| VBG
a  ||| S:16670 E:16682 ||| DT
moderate  ||| S:16682 E:16691 ||| JJ
or  ||| S:16691 E:16694 ||| CC
heavy  ||| S:16694 E:16700 ||| JJ
degree  ||| S:16700 E:16707 ||| NN
of  ||| S:16707 E:16710 ||| IN
sectoring  ||| S:16710 E:16720 ||| NN
at  ||| S:16720 E:16723 ||| IN
23  ||| S:16723 E:16726 ||| CD
and  ||| S:16726 E:16730 ||| CC
30°C ||| S:16730 E:16734 ||| NNP
,  ||| S:16734 E:16746 ||| ,
respectively  ||| S:16746 E:16759 ||| RB
( ||| S:16759 E:16760 ||| -LRB-
Fig.  ||| S:16760 E:16765 ||| CD
6 ||| S:16765 E:16766 ||| CD
) ||| S:16766 E:16767 ||| -RRB-
.  ||| S:16767 E:16779 ||| .
At  ||| S:16779 E:16782 ||| IN
both  ||| S:16782 E:16787 ||| DT
temperatures ||| S:16787 E:16799 ||| NNS
,  ||| S:16799 E:16801 ||| ,
the  ||| S:16801 E:16805 ||| DT
TK  ||| S:16805 E:16808 ||| NNP
mutant  ||| S:16808 E:16815 ||| JJ
version  ||| S:16815 E:16823 ||| NN
of  ||| S:16823 E:16826 ||| IN
Boi1  ||| S:16826 E:16841 ||| NNP
allowed  ||| S:16841 E:16849 ||| VBD
a  ||| S:16849 E:16851 ||| DT
substantial  ||| S:16851 E:16863 ||| JJ
fraction  ||| S:16863 E:16872 ||| NN
of  ||| S:16872 E:16875 ||| IN
colonies  ||| S:16875 E:16884 ||| NNS
to  ||| S:16884 E:16887 ||| TO
show  ||| S:16887 E:16892 ||| VB
either  ||| S:16892 E:16909 ||| DT
moderate  ||| S:16909 E:16918 ||| JJ
or  ||| S:16918 E:16921 ||| CC
heavy  ||| S:16921 E:16927 ||| JJ
sectoring  ||| S:16927 E:16937 ||| NNS
( ||| S:16937 E:16938 ||| -LRB-
Fig.  ||| S:16938 E:16943 ||| CD
6 ||| S:16943 E:16944 ||| CD
) ||| S:16944 E:16945 ||| -RRB-
,  ||| S:16945 E:16947 ||| ,
suggesting  ||| S:16947 E:16958 ||| VBG
that  ||| S:16958 E:16963 ||| IN
the  ||| S:16963 E:16977 ||| DT
TK  ||| S:16977 E:16980 ||| NNP
mutant  ||| S:16980 E:16987 ||| NN
is  ||| S:16987 E:16990 ||| VBZ
able  ||| S:16990 E:16995 ||| JJ
to  ||| S:16995 E:16998 ||| TO
provide  ||| S:16998 E:17006 ||| VB
whatever  ||| S:17006 E:17015 ||| JJ
vital  ||| S:17015 E:17021 ||| JJ
function  ||| S:17021 E:17040 ||| NN
normally  ||| S:17040 E:17049 ||| RB
is  ||| S:17049 E:17052 ||| VBZ
provided  ||| S:17052 E:17061 ||| VBN
by  ||| S:17061 E:17064 ||| IN
Boi1 ||| S:17064 E:17068 ||| CD
/ ||| S:17068 E:17069 ||| CD
Boi2 ||| S:17069 E:17073 ||| CD
.  ||| S:17073 E:17075 ||| .
However ||| S:17075 E:17082 ||| RB
,  ||| S:17082 E:17084 ||| ,
this  ||| S:17084 E:17089 ||| DT
version  ||| S:17089 E:17107 ||| NN
of  ||| S:17107 E:17110 ||| IN
Boi1  ||| S:17110 E:17115 ||| NNP
appeared  ||| S:17115 E:17124 ||| VBD
to  ||| S:17124 E:17127 ||| TO
function  ||| S:17127 E:17136 ||| VB
less  ||| S:17136 E:17141 ||| RBR
efficiently  ||| S:17141 E:17153 ||| RB
than  ||| S:17153 E:17158 ||| IN
did  ||| S:17158 E:17172 ||| VBD
wild-type  ||| S:17172 E:17182 ||| JJ
Boi1 ||| S:17182 E:17186 ||| NN
:  ||| S:17186 E:17188 ||| :
at  ||| S:17188 E:17191 ||| IN
23°C ||| S:17191 E:17195 ||| NNP
,  ||| S:17195 E:17197 ||| ,
the  ||| S:17197 E:17201 ||| DT
percentage  ||| S:17201 E:17212 ||| NN
of  ||| S:17212 E:17215 ||| IN
colonies  ||| S:17215 E:17224 ||| NNS
that  ||| S:17224 E:17239 ||| WDT
showed  ||| S:17239 E:17246 ||| VBD
either  ||| S:17246 E:17253 ||| DT
moderate  ||| S:17253 E:17262 ||| JJ
or  ||| S:17262 E:17265 ||| CC
heavy  ||| S:17265 E:17271 ||| JJ
sectoring  ||| S:17271 E:17281 ||| NN
with  ||| S:17281 E:17286 ||| IN
Boi1 ||| S:17286 E:17290 ||| NNP
( ||| S:17290 E:17291 ||| -LRB-
TK ||| S:17291 E:17293 ||| NNP
)  ||| S:17293 E:17305 ||| -RRB-
was  ||| S:17305 E:17309 ||| VBD
only  ||| S:17309 E:17314 ||| RB
29 ||| S:17314 E:17316 ||| CD
% ||| S:17316 E:17317 ||| NN
,  ||| S:17317 E:17319 ||| ,
and ||| S:17319 E:17322 ||| CC
,  ||| S:17322 E:17324 ||| ,
at  ||| S:17324 E:17327 ||| IN
30°C ||| S:17327 E:17331 ||| NNP
,  ||| S:17331 E:17333 ||| ,
the  ||| S:17333 E:17337 ||| DT
percentage  ||| S:17337 E:17348 ||| NN
of  ||| S:17348 E:17351 ||| IN
colonies  ||| S:17351 E:17370 ||| NNS
that  ||| S:17370 E:17375 ||| WDT
showed  ||| S:17375 E:17382 ||| VBD
moderate  ||| S:17382 E:17391 ||| JJ
or  ||| S:17391 E:17394 ||| CC
heavy  ||| S:17394 E:17400 ||| JJ
sectoring  ||| S:17400 E:17410 ||| NN
with  ||| S:17410 E:17415 ||| IN
Boi1 ||| S:17415 E:17419 ||| NNP
( ||| S:17419 E:17420 ||| -LRB-
TK ||| S:17420 E:17422 ||| NNP
)  ||| S:17422 E:17424 ||| -RRB-
was  ||| S:17424 E:17438 ||| VBD
only  ||| S:17438 E:17443 ||| RB
10 ||| S:17443 E:17445 ||| CD
% ||| S:17445 E:17446 ||| NN
.  ||| S:17446 E:17458 ||| .
At  ||| S:17458 E:17461 ||| IN
each  ||| S:17461 E:17466 ||| DT
temperature ||| S:17466 E:17477 ||| NN
,  ||| S:17477 E:17479 ||| ,
almost  ||| S:17479 E:17486 ||| RB
every  ||| S:17486 E:17492 ||| DT
one  ||| S:17492 E:17496 ||| NN
of  ||| S:17496 E:17499 ||| IN
the  ||| S:17499 E:17503 ||| DT
colonies  ||| S:17503 E:17522 ||| NN
of  ||| S:17522 E:17525 ||| IN
cells  ||| S:17525 E:17531 ||| NNS
that  ||| S:17531 E:17536 ||| WDT
contained  ||| S:17536 E:17546 ||| VBD
either  ||| S:17546 E:17553 ||| RB
the  ||| S:17553 E:17557 ||| DT
KK  ||| S:17557 E:17560 ||| NNP
or  ||| S:17560 E:17563 ||| CC
KKTK  ||| S:17563 E:17568 ||| NNP
mutant  ||| S:17568 E:17585 ||| JJ
versions  ||| S:17585 E:17594 ||| NNS
of  ||| S:17594 E:17597 ||| IN
Boi1  ||| S:17597 E:17602 ||| NNP
showed  ||| S:17602 E:17609 ||| VBD
no  ||| S:17609 E:17612 ||| DT
sectoring  ||| S:17612 E:17622 ||| NN
( ||| S:17622 E:17623 ||| -LRB-
Fig.  ||| S:17623 E:17628 ||| CD
6 ||| S:17628 E:17629 ||| CD
) ||| S:17629 E:17630 ||| -RRB-
,  ||| S:17630 E:17632 ||| ,
suggesting  ||| S:17632 E:17653 ||| VBG
that  ||| S:17653 E:17658 ||| IN
these  ||| S:17658 E:17664 ||| DT
mutant  ||| S:17664 E:17671 ||| JJ
versions  ||| S:17671 E:17680 ||| NNS
of  ||| S:17680 E:17683 ||| IN
Boi1  ||| S:17683 E:17688 ||| RB
provide  ||| S:17688 E:17696 ||| VB
little  ||| S:17696 E:17703 ||| JJ
or  ||| S:17703 E:17706 ||| CC
no  ||| S:17706 E:17719 ||| DT
function ||| S:17719 E:17727 ||| NN
.  ||| S:17727 E:17739 ||| .
To  ||| S:17739 E:17742 ||| TO
investigate  ||| S:17742 E:17754 ||| VB
whether  ||| S:17754 E:17762 ||| IN
the  ||| S:17762 E:17766 ||| DT
diminished  ||| S:17766 E:17777 ||| JJ
amount  ||| S:17777 E:17784 ||| NN
of  ||| S:17784 E:17797 ||| IN
sectoring  ||| S:17797 E:17807 ||| VBG
allowed  ||| S:17807 E:17815 ||| VBN
by  ||| S:17815 E:17818 ||| IN
the  ||| S:17818 E:17822 ||| DT
different  ||| S:17822 E:17832 ||| JJ
mutant  ||| S:17832 E:17839 ||| JJ
versions  ||| S:17839 E:17848 ||| NNS
of  ||| S:17848 E:17861 ||| IN
Boi1  ||| S:17861 E:17866 ||| NNP
might  ||| S:17866 E:17872 ||| MD
be  ||| S:17872 E:17875 ||| VB
due  ||| S:17875 E:17879 ||| JJ
to  ||| S:17879 E:17882 ||| TO
effects  ||| S:17882 E:17890 ||| NNS
of  ||| S:17890 E:17893 ||| IN
the  ||| S:17893 E:17897 ||| DT
amino-acid  ||| S:17897 E:17918 ||| JJ
substitutions  ||| S:17918 E:17932 ||| NN
on  ||| S:17932 E:17935 ||| IN
the  ||| S:17935 E:17939 ||| DT
concentration  ||| S:17939 E:17953 ||| NN
of  ||| S:17953 E:17956 ||| IN
Boi1  ||| S:17956 E:17961 ||| NNP
( ||| S:17961 E:17962 ||| -LRB-
e.g. ||| S:17962 E:17966 ||| NNP
,  ||| S:17966 E:17968 ||| ,
by  ||| S:17968 E:17981 ||| IN
decreasing  ||| S:17981 E:17992 ||| VBG
the  ||| S:17992 E:17996 ||| DT
stability  ||| S:17996 E:18006 ||| NN
of  ||| S:18006 E:18009 ||| IN
Boi1 ||| S:18009 E:18013 ||| CD
) ||| S:18013 E:18014 ||| -RRB-
,  ||| S:18014 E:18016 ||| ,
we  ||| S:18016 E:18019 ||| PRP
used  ||| S:18019 E:18024 ||| VBD
immunoblotting  ||| S:18024 E:18049 ||| VBN
to  ||| S:18049 E:18052 ||| TO
compare  ||| S:18052 E:18060 ||| VB
the  ||| S:18060 E:18064 ||| DT
concentrations  ||| S:18064 E:18079 ||| NNS
of  ||| S:18079 E:18082 ||| IN
the  ||| S:18082 E:18086 ||| DT
mutant  ||| S:18086 E:18093 ||| JJ
proteins  ||| S:18093 E:18102 ||| NNS
to  ||| S:18102 E:18115 ||| TO
that  ||| S:18115 E:18120 ||| DT
of  ||| S:18120 E:18123 ||| IN
wild-type  ||| S:18123 E:18133 ||| JJ
Boi1 ||| S:18133 E:18137 ||| NN
.  ||| S:18137 E:18139 ||| .
This  ||| S:18139 E:18144 ||| DT
analysis  ||| S:18144 E:18153 ||| NN
was  ||| S:18153 E:18157 ||| VBD
done  ||| S:18157 E:18162 ||| VBN
using  ||| S:18162 E:18168 ||| VBG
a  ||| S:18168 E:18180 ||| DT
genomically  ||| S:18180 E:18203 ||| JJ
boi1  ||| S:18203 E:18208 ||| CD
BOI2  ||| S:18208 E:18213 ||| CD
strain ||| S:18213 E:18219 ||| NN
,  ||| S:18219 E:18221 ||| ,
so  ||| S:18221 E:18224 ||| RB
that  ||| S:18224 E:18229 ||| IN
the  ||| S:18229 E:18233 ||| DT
only  ||| S:18233 E:18248 ||| JJ
version  ||| S:18248 E:18256 ||| NN
of  ||| S:18256 E:18259 ||| IN
Boi1  ||| S:18259 E:18264 ||| CD
present  ||| S:18264 E:18272 ||| NN
was  ||| S:18272 E:18276 ||| VBD
the  ||| S:18276 E:18280 ||| DT
one  ||| S:18280 E:18284 ||| NN
expressed  ||| S:18284 E:18294 ||| VBD
from  ||| S:18294 E:18299 ||| IN
a  ||| S:18299 E:18311 ||| DT
plasmid ||| S:18311 E:18318 ||| NN
.  ||| S:18318 E:18320 ||| .
As  ||| S:18320 E:18323 ||| RB
shown  ||| S:18323 E:18329 ||| VBN
in  ||| S:18329 E:18332 ||| IN
Figure  ||| S:18332 E:18339 ||| NN
7A ||| S:18339 E:18341 ||| NN
,  ||| S:18341 E:18343 ||| ,
each  ||| S:18343 E:18348 ||| DT
of  ||| S:18348 E:18351 ||| IN
the  ||| S:18351 E:18355 ||| DT
mutant  ||| S:18355 E:18372 ||| JJ
versions  ||| S:18372 E:18381 ||| NNS
of  ||| S:18381 E:18384 ||| IN
Boi1  ||| S:18384 E:18389 ||| NNP
is  ||| S:18389 E:18392 ||| VBZ
present  ||| S:18392 E:18400 ||| JJ
at  ||| S:18400 E:18403 ||| IN
a  ||| S:18403 E:18405 ||| DT
concentration  ||| S:18405 E:18419 ||| NN
similar  ||| S:18419 E:18427 ||| JJ
to  ||| S:18427 E:18440 ||| TO
or  ||| S:18440 E:18443 ||| CC
higher  ||| S:18443 E:18450 ||| JJR
than  ||| S:18450 E:18455 ||| IN
that  ||| S:18455 E:18460 ||| DT
of  ||| S:18460 E:18463 ||| IN
wild-type  ||| S:18463 E:18473 ||| NNP
Boi1 ||| S:18473 E:18477 ||| NNP
,  ||| S:18477 E:18479 ||| ,
suggesting  ||| S:18479 E:18490 ||| VBG
that  ||| S:18490 E:18505 ||| IN
the  ||| S:18505 E:18509 ||| DT
reduced  ||| S:18509 E:18517 ||| JJ
functions  ||| S:18517 E:18527 ||| NNS
of  ||| S:18527 E:18530 ||| IN
the  ||| S:18530 E:18534 ||| DT
mutant  ||| S:18534 E:18541 ||| JJ
versions  ||| S:18541 E:18550 ||| NNS
of  ||| S:18550 E:18553 ||| IN
Boi1  ||| S:18553 E:18558 ||| NNP
are  ||| S:18558 E:18572 ||| VBP
not  ||| S:18572 E:18576 ||| RB
likely  ||| S:18576 E:18583 ||| JJ
to  ||| S:18583 E:18586 ||| TO
be  ||| S:18586 E:18589 ||| VB
due  ||| S:18589 E:18593 ||| JJ
to  ||| S:18593 E:18596 ||| TO
effects  ||| S:18596 E:18604 ||| NNS
on  ||| S:18604 E:18607 ||| IN
their  ||| S:18607 E:18623 ||| PRP$
concentrations ||| S:18623 E:18637 ||| NNS
.  ||| S:18637 E:18649 ||| .
One  ||| S:18649 E:18653 ||| CD
potential  ||| S:18653 E:18663 ||| JJ
role  ||| S:18663 E:18668 ||| NN
of  ||| S:18668 E:18671 ||| IN
the  ||| S:18671 E:18675 ||| DT
binding  ||| S:18675 E:18683 ||| NN
of  ||| S:18683 E:18686 ||| IN
Boi1  ||| S:18686 E:18691 ||| CD
to  ||| S:18691 E:18704 ||| TO
phospholipid  ||| S:18704 E:18717 ||| NN
is  ||| S:18717 E:18720 ||| VBZ
simply  ||| S:18720 E:18727 ||| RB
to  ||| S:18727 E:18730 ||| TO
target  ||| S:18730 E:18737 ||| VB
Boi1  ||| S:18737 E:18742 ||| CD
to  ||| S:18742 E:18745 ||| TO
the  ||| S:18745 E:18749 ||| DT
plasma  ||| S:18749 E:18766 ||| JJ
membrane ||| S:18766 E:18774 ||| NN
.  ||| S:18774 E:18776 ||| .
If  ||| S:18776 E:18779 ||| IN
this  ||| S:18779 E:18784 ||| DT
were  ||| S:18784 E:18789 ||| VBD
the  ||| S:18789 E:18793 ||| DT
only  ||| S:18793 E:18798 ||| JJ
role  ||| S:18798 E:18803 ||| NN
for  ||| S:18803 E:18807 ||| IN
such  ||| S:18807 E:18812 ||| JJ
binding ||| S:18812 E:18819 ||| NN
,  ||| S:18819 E:18831 ||| ,
then  ||| S:18831 E:18836 ||| RB
attachment  ||| S:18836 E:18847 ||| VBN
to  ||| S:18847 E:18850 ||| TO
a  ||| S:18850 E:18852 ||| DT
membrane-localization  ||| S:18852 E:18874 ||| JJ
tag  ||| S:18874 E:18878 ||| NN
might  ||| S:18878 E:18884 ||| MD
be  ||| S:18884 E:18897 ||| VB
able  ||| S:18897 E:18902 ||| JJ
to  ||| S:18902 E:18905 ||| TO
restore  ||| S:18905 E:18913 ||| VB
function  ||| S:18913 E:18922 ||| NN
to  ||| S:18922 E:18925 ||| TO
versions  ||| S:18925 E:18934 ||| NNS
of  ||| S:18934 E:18937 ||| IN
Boi1  ||| S:18937 E:18942 ||| NNP
that  ||| S:18942 E:18947 ||| WDT
are  ||| S:18947 E:18961 ||| VBP
impaired  ||| S:18961 E:18970 ||| VBN
in  ||| S:18970 E:18973 ||| IN
the  ||| S:18973 E:18977 ||| DT
ability  ||| S:18977 E:18985 ||| NN
to  ||| S:18985 E:18988 ||| TO
bind  ||| S:18988 E:18993 ||| VB
phospholipid ||| S:18993 E:19005 ||| NNS
.  ||| S:19005 E:19007 ||| .
One  ||| S:19007 E:19011 ||| CD
type  ||| S:19011 E:19016 ||| NN
of  ||| S:19016 E:19029 ||| IN
membrane-localization  ||| S:19029 E:19051 ||| JJ
tag  ||| S:19051 E:19055 ||| NN
is  ||| S:19055 E:19058 ||| VBZ
the  ||| S:19058 E:19062 ||| DT
myristoyl  ||| S:19062 E:19072 ||| JJ
group ||| S:19072 E:19077 ||| NN
,  ||| S:19077 E:19079 ||| ,
which  ||| S:19079 E:19095 ||| WDT
is  ||| S:19095 E:19098 ||| VBZ
attached  ||| S:19098 E:19107 ||| VBN
to  ||| S:19107 E:19110 ||| TO
the  ||| S:19110 E:19114 ||| DT
glycine  ||| S:19114 E:19122 ||| JJ
residue  ||| S:19122 E:19130 ||| NN
of  ||| S:19130 E:19133 ||| IN
proteins ||| S:19133 E:19141 ||| NNS
,  ||| S:19141 E:19143 ||| ,
such  ||| S:19143 E:19148 ||| JJ
as  ||| S:19148 E:19162 ||| IN
S.  ||| S:19162 E:19165 ||| NNP
cerevisiae  ||| S:19165 E:19176 ||| FW
Gpa1  ||| S:19176 E:19181 ||| FW
( ||| S:19181 E:19182 ||| -LRB-
the  ||| S:19182 E:19186 ||| DT
α  ||| S:19186 E:19188 ||| JJ
subunit  ||| S:19188 E:19206 ||| NN
of  ||| S:19206 E:19209 ||| IN
the  ||| S:19209 E:19213 ||| DT
pheromone-responsive  ||| S:19213 E:19234 ||| JJ
G  ||| S:19234 E:19236 ||| NNP
protein ||| S:19236 E:19243 ||| NN
)  ||| S:19243 E:19245 ||| -RRB-
[  ||| S:19245 E:19247 ||| -LRB-
18  ||| S:19247 E:19250 ||| CD
]  ||| S:19250 E:19252 ||| -RRB-
,  ||| S:19252 E:19254 ||| ,
that  ||| S:19254 E:19269 ||| WDT
contain  ||| S:19269 E:19277 ||| VBP
at  ||| S:19277 E:19280 ||| IN
their  ||| S:19280 E:19286 ||| PRP$
N-termini  ||| S:19286 E:19296 ||| JJ
the  ||| S:19296 E:19300 ||| DT
sequence  ||| S:19300 E:19309 ||| JJ
MGXXXS ||| S:19309 E:19315 ||| NNP
/ ||| S:19315 E:19316 ||| NNP
T  ||| S:19316 E:19318 ||| NNP
( ||| S:19318 E:19319 ||| -LRB-
where  ||| S:19319 E:19335 ||| WRB
"X ||| S:19335 E:19337 ||| NNP
"  ||| S:19337 E:19339 ||| ``
can  ||| S:19339 E:19343 ||| MD
be  ||| S:19343 E:19346 ||| VB
any  ||| S:19346 E:19350 ||| DT
amino  ||| S:19350 E:19356 ||| JJ
acid ||| S:19356 E:19360 ||| NN
)  ||| S:19360 E:19362 ||| -RRB-
[  ||| S:19362 E:19364 ||| -LRB-
19  ||| S:19364 E:19367 ||| CD
]  ||| S:19367 E:19369 ||| -RRB-
.  ||| S:19369 E:19371 ||| .
Thus ||| S:19371 E:19375 ||| RB
,  ||| S:19375 E:19377 ||| ,
we  ||| S:19377 E:19380 ||| PRP
investigated  ||| S:19380 E:19403 ||| VBD
whether  ||| S:19403 E:19411 ||| IN
fusion  ||| S:19411 E:19418 ||| NN
to  ||| S:19418 E:19421 ||| TO
the  ||| S:19421 E:19425 ||| DT
sequence  ||| S:19425 E:19434 ||| JJ
MGCTVS ||| S:19434 E:19440 ||| NNP
,  ||| S:19440 E:19442 ||| ,
which  ||| S:19442 E:19448 ||| WDT
is  ||| S:19448 E:19451 ||| VBZ
present  ||| S:19451 E:19469 ||| JJ
at  ||| S:19469 E:19472 ||| IN
the  ||| S:19472 E:19476 ||| DT
N-terminus  ||| S:19476 E:19487 ||| JJ
of  ||| S:19487 E:19490 ||| IN
Gpa1  ||| S:19490 E:19495 ||| NNP
and  ||| S:19495 E:19499 ||| CC
which  ||| S:19499 E:19505 ||| WDT
we  ||| S:19505 E:19508 ||| PRP
will  ||| S:19508 E:19513 ||| MD
henceforth  ||| S:19513 E:19534 ||| VB
refer  ||| S:19534 E:19540 ||| VBN
to  ||| S:19540 E:19543 ||| TO
as  ||| S:19543 E:19546 ||| IN
"Myr ||| S:19546 E:19550 ||| NNP
" ||| S:19550 E:19551 ||| ''
,  ||| S:19551 E:19553 ||| ,
could  ||| S:19553 E:19559 ||| MD
restore  ||| S:19559 E:19567 ||| VB
function  ||| S:19567 E:19576 ||| NN
to  ||| S:19576 E:19579 ||| TO
the  ||| S:19579 E:19583 ||| DT
mutant  ||| S:19583 E:19600 ||| JJ
versions  ||| S:19600 E:19609 ||| NNS
of  ||| S:19609 E:19612 ||| IN
Boi1  ||| S:19612 E:19617 ||| NNP
that  ||| S:19617 E:19622 ||| WDT
are  ||| S:19622 E:19626 ||| VBP
impaired  ||| S:19626 E:19635 ||| VBN
in  ||| S:19635 E:19638 ||| IN
the  ||| S:19638 E:19642 ||| DT
ability  ||| S:19642 E:19650 ||| NN
to  ||| S:19650 E:19653 ||| TO
bind  ||| S:19653 E:19668 ||| VB
phospholipid ||| S:19668 E:19680 ||| NNS
.  ||| S:19680 E:19692 ||| .
At  ||| S:19692 E:19695 ||| IN
the  ||| S:19695 E:19699 ||| DT
time  ||| S:19699 E:19704 ||| NN
that  ||| S:19704 E:19709 ||| IN
we  ||| S:19709 E:19712 ||| PRP
initiated  ||| S:19712 E:19722 ||| VBD
this  ||| S:19722 E:19727 ||| DT
analysis ||| S:19727 E:19735 ||| NN
,  ||| S:19735 E:19737 ||| ,
the  ||| S:19737 E:19741 ||| DT
only  ||| S:19741 E:19756 ||| JJ
lipid-binding-impaired  ||| S:19756 E:19779 ||| JJ
version  ||| S:19779 E:19787 ||| NN
of  ||| S:19787 E:19790 ||| IN
Boi1  ||| S:19790 E:19795 ||| CD
that  ||| S:19795 E:19800 ||| IN
we  ||| S:19800 E:19803 ||| PRP
had  ||| S:19803 E:19817 ||| VBD
generated  ||| S:19817 E:19827 ||| VBN
so  ||| S:19827 E:19830 ||| RB
far  ||| S:19830 E:19834 ||| RB
was  ||| S:19834 E:19838 ||| VBD
the  ||| S:19838 E:19842 ||| DT
KK  ||| S:19842 E:19845 ||| NNP
mutant ||| S:19845 E:19851 ||| NN
.  ||| S:19851 E:19853 ||| .
In  ||| S:19853 E:19856 ||| IN
preliminary  ||| S:19856 E:19878 ||| JJ
analyses ||| S:19878 E:19886 ||| NNS
,  ||| S:19886 E:19888 ||| ,
we  ||| S:19888 E:19891 ||| PRP
found  ||| S:19891 E:19897 ||| VBD
that  ||| S:19897 E:19902 ||| IN
Myr  ||| S:19902 E:19906 ||| NNP
did  ||| S:19906 E:19910 ||| VBD
not  ||| S:19910 E:19914 ||| RB
improve  ||| S:19914 E:19922 ||| VB
the  ||| S:19922 E:19926 ||| DT
ability  ||| S:19926 E:19944 ||| NN
of  ||| S:19944 E:19947 ||| IN
full-length  ||| S:19947 E:19959 ||| JJ
Boi1 ||| S:19959 E:19963 ||| NNP
( ||| S:19963 E:19964 ||| -LRB-
KK ||| S:19964 E:19966 ||| NNP
)  ||| S:19966 E:19968 ||| -RRB-
to  ||| S:19968 E:19971 ||| TO
promote  ||| S:19971 E:19979 ||| VB
sectoring ||| S:19979 E:19988 ||| NNS
,  ||| S:19988 E:19990 ||| ,
but  ||| S:19990 E:19994 ||| CC
that  ||| S:19994 E:19999 ||| IN
it  ||| S:19999 E:20012 ||| PRP
did  ||| S:20012 E:20016 ||| VBD
improve  ||| S:20016 E:20024 ||| VB
the  ||| S:20024 E:20028 ||| DT
ability  ||| S:20028 E:20036 ||| NN
of  ||| S:20036 E:20039 ||| IN
the  ||| S:20039 E:20043 ||| DT
KK  ||| S:20043 E:20046 ||| NNP
version  ||| S:20046 E:20054 ||| NN
of  ||| S:20054 E:20057 ||| IN
Boi1-PH  ||| S:20057 E:20065 ||| CD
to  ||| S:20065 E:20078 ||| TO
promote  ||| S:20078 E:20086 ||| VB
sectoring  ||| S:20086 E:20096 ||| NNS
( ||| S:20096 E:20097 ||| -LRB-
data  ||| S:20097 E:20102 ||| NNS
not  ||| S:20102 E:20106 ||| RB
shown ||| S:20106 E:20111 ||| VBN
) ||| S:20111 E:20112 ||| -RRB-
.  ||| S:20112 E:20114 ||| .
Therefore ||| S:20114 E:20123 ||| RB
,  ||| S:20123 E:20125 ||| ,
in  ||| S:20125 E:20138 ||| IN
subsequent  ||| S:20138 E:20149 ||| JJ
tests  ||| S:20149 E:20155 ||| NNS
to  ||| S:20155 E:20158 ||| TO
ask  ||| S:20158 E:20162 ||| VB
whether  ||| S:20162 E:20170 ||| IN
Myr  ||| S:20170 E:20174 ||| NNP
could  ||| S:20174 E:20180 ||| MD
restore  ||| S:20180 E:20198 ||| VB
function  ||| S:20198 E:20207 ||| NN
to  ||| S:20207 E:20210 ||| TO
mutant  ||| S:20210 E:20217 ||| VB
versions  ||| S:20217 E:20226 ||| NNS
of  ||| S:20226 E:20229 ||| IN
Boi1  ||| S:20229 E:20234 ||| NNP
that  ||| S:20234 E:20239 ||| WDT
are  ||| S:20239 E:20243 ||| VBP
impaired  ||| S:20243 E:20252 ||| VBN
in  ||| S:20252 E:20265 ||| IN
the  ||| S:20265 E:20269 ||| DT
ability  ||| S:20269 E:20277 ||| NN
to  ||| S:20277 E:20280 ||| TO
bind  ||| S:20280 E:20285 ||| VB
lipid ||| S:20285 E:20290 ||| NN
,  ||| S:20290 E:20292 ||| ,
we  ||| S:20292 E:20295 ||| PRP
used  ||| S:20295 E:20300 ||| VBD
specifically  ||| S:20300 E:20313 ||| RB
the  ||| S:20313 E:20327 ||| DT
Boi1-PH  ||| S:20327 E:20335 ||| JJ
segment  ||| S:20335 E:20343 ||| NN
of  ||| S:20343 E:20346 ||| IN
Boi1  ||| S:20346 E:20351 ||| NNP
rather  ||| S:20351 E:20358 ||| RB
than  ||| S:20358 E:20363 ||| IN
full-length  ||| S:20363 E:20375 ||| JJ
Boi1 ||| S:20375 E:20379 ||| NN
.  ||| S:20379 E:20391 ||| .
First ||| S:20391 E:20396 ||| NNP
,  ||| S:20396 E:20398 ||| ,
we  ||| S:20398 E:20401 ||| PRP
checked  ||| S:20401 E:20409 ||| VBD
to  ||| S:20409 E:20412 ||| TO
see  ||| S:20412 E:20416 ||| VB
whether  ||| S:20416 E:20424 ||| IN
Myr  ||| S:20424 E:20428 ||| NNP
had  ||| S:20428 E:20432 ||| VBD
any  ||| S:20432 E:20446 ||| DT
inhibitory  ||| S:20446 E:20457 ||| JJ
effects  ||| S:20457 E:20465 ||| NNS
on  ||| S:20465 E:20468 ||| IN
the  ||| S:20468 E:20472 ||| DT
function  ||| S:20472 E:20481 ||| NN
of  ||| S:20481 E:20484 ||| IN
wild-type  ||| S:20484 E:20494 ||| JJ
Boi1-PH ||| S:20494 E:20501 ||| NN
.  ||| S:20501 E:20513 ||| .
Myr-Boi1 ||| S:20513 E:20521 ||| NNP
( ||| S:20521 E:20522 ||| -LRB-
PH ||| S:20522 E:20524 ||| NNP
)  ||| S:20524 E:20526 ||| -RRB-
allowed  ||| S:20526 E:20534 ||| VBD
a  ||| S:20534 E:20536 ||| DT
degree  ||| S:20536 E:20543 ||| NN
of  ||| S:20543 E:20546 ||| IN
sectoring  ||| S:20546 E:20556 ||| JJ
similar  ||| S:20556 E:20564 ||| JJ
to  ||| S:20564 E:20577 ||| TO
that  ||| S:20577 E:20582 ||| DT
for  ||| S:20582 E:20586 ||| IN
Boi1-PH  ||| S:20586 E:20594 ||| CD
without  ||| S:20594 E:20602 ||| IN
the  ||| S:20602 E:20606 ||| DT
tag  ||| S:20606 E:20610 ||| NN
( ||| S:20610 E:20611 ||| -LRB-
Fig.  ||| S:20611 E:20616 ||| CD
6 ||| S:20616 E:20617 ||| CD
) ||| S:20617 E:20618 ||| -RRB-
,  ||| S:20618 E:20620 ||| ,
suggesting  ||| S:20620 E:20641 ||| VBG
that  ||| S:20641 E:20646 ||| IN
Myr  ||| S:20646 E:20650 ||| NNP
does  ||| S:20650 E:20655 ||| VBZ
not  ||| S:20655 E:20659 ||| RB
impair  ||| S:20659 E:20666 ||| VB
the  ||| S:20666 E:20670 ||| DT
function  ||| S:20670 E:20679 ||| NN
of  ||| S:20679 E:20682 ||| IN
Boi1-PH ||| S:20682 E:20689 ||| CD
.  ||| S:20689 E:20701 ||| .
Next ||| S:20701 E:20705 ||| JJ
,  ||| S:20705 E:20707 ||| ,
we  ||| S:20707 E:20710 ||| PRP
asked  ||| S:20710 E:20716 ||| VBD
whether  ||| S:20716 E:20724 ||| IN
Myr  ||| S:20724 E:20728 ||| NNP
could  ||| S:20728 E:20734 ||| MD
improve  ||| S:20734 E:20742 ||| VB
the  ||| S:20742 E:20746 ||| DT
ability  ||| S:20746 E:20764 ||| NN
of  ||| S:20764 E:20767 ||| IN
the  ||| S:20767 E:20771 ||| DT
different  ||| S:20771 E:20781 ||| JJ
mutant  ||| S:20781 E:20788 ||| JJ
versions  ||| S:20788 E:20797 ||| NNS
of  ||| S:20797 E:20800 ||| IN
Boi1-PH  ||| S:20800 E:20808 ||| CD
to  ||| S:20808 E:20811 ||| TO
function ||| S:20811 E:20819 ||| VB
.  ||| S:20819 E:20831 ||| .
At  ||| S:20831 E:20834 ||| IN
23°C ||| S:20834 E:20838 ||| NNP
,  ||| S:20838 E:20840 ||| ,
25 ||| S:20840 E:20842 ||| CD
%  ||| S:20842 E:20844 ||| NN
of  ||| S:20844 E:20847 ||| IN
colonies  ||| S:20847 E:20856 ||| FW
containing  ||| S:20856 E:20867 ||| FW
Boi1-PH ||| S:20867 E:20874 ||| FW
( ||| S:20874 E:20875 ||| -LRB-
TK ||| S:20875 E:20877 ||| NNP
)  ||| S:20877 E:20879 ||| -RRB-
without  ||| S:20879 E:20897 ||| IN
the  ||| S:20897 E:20901 ||| DT
tag  ||| S:20901 E:20905 ||| NN
showed  ||| S:20905 E:20912 ||| VBD
moderate  ||| S:20912 E:20921 ||| JJ
or  ||| S:20921 E:20924 ||| CC
heavy  ||| S:20924 E:20930 ||| JJ
sectoring ||| S:20930 E:20939 ||| NN
.  ||| S:20939 E:20941 ||| .
This  ||| S:20941 E:20946 ||| DT
value  ||| S:20946 E:20962 ||| NN
rose  ||| S:20962 E:20967 ||| VBD
to  ||| S:20967 E:20970 ||| TO
81 ||| S:20970 E:20972 ||| CD
%  ||| S:20972 E:20974 ||| NN
when  ||| S:20974 E:20979 ||| WRB
using  ||| S:20979 E:20985 ||| VBG
the  ||| S:20985 E:20989 ||| DT
Myr-tagged  ||| S:20989 E:21000 ||| JJ
version  ||| S:21000 E:21008 ||| NN
of  ||| S:21008 E:21021 ||| IN
Boi1-PH ||| S:21021 E:21028 ||| NNP
( ||| S:21028 E:21029 ||| -LRB-
TK ||| S:21029 E:21031 ||| NNP
)  ||| S:21031 E:21033 ||| -RRB-
( ||| S:21033 E:21034 ||| -LRB-
Fig.  ||| S:21034 E:21039 ||| CD
6 ||| S:21039 E:21040 ||| CD
) ||| S:21040 E:21041 ||| -RRB-
,  ||| S:21041 E:21043 ||| ,
suggesting  ||| S:21043 E:21054 ||| VBG
that  ||| S:21054 E:21059 ||| IN
Myr  ||| S:21059 E:21063 ||| NNP
improves  ||| S:21063 E:21072 ||| VBZ
the  ||| S:21072 E:21086 ||| DT
ability  ||| S:21086 E:21094 ||| NN
of  ||| S:21094 E:21097 ||| IN
the  ||| S:21097 E:21101 ||| DT
TK  ||| S:21101 E:21104 ||| NNP
mutant  ||| S:21104 E:21111 ||| JJ
version  ||| S:21111 E:21119 ||| NN
of  ||| S:21119 E:21122 ||| IN
Boi1-PH  ||| S:21122 E:21130 ||| CD
to  ||| S:21130 E:21133 ||| TO
function ||| S:21133 E:21141 ||| VB
.  ||| S:21141 E:21153 ||| .
At  ||| S:21153 E:21156 ||| IN
30°C ||| S:21156 E:21160 ||| NNP
,  ||| S:21160 E:21162 ||| ,
the  ||| S:21162 E:21166 ||| DT
effect  ||| S:21166 E:21173 ||| NN
of  ||| S:21173 E:21176 ||| IN
Myr  ||| S:21176 E:21180 ||| NNP
was  ||| S:21180 E:21184 ||| VBD
even  ||| S:21184 E:21189 ||| RB
more  ||| S:21189 E:21194 ||| RBR
striking ||| S:21194 E:21202 ||| JJ
:  ||| S:21202 E:21214 ||| :
without  ||| S:21214 E:21222 ||| IN
the  ||| S:21222 E:21226 ||| DT
tag ||| S:21226 E:21229 ||| NN
,  ||| S:21229 E:21231 ||| ,
only  ||| S:21231 E:21236 ||| RB
1 ||| S:21236 E:21237 ||| CD
%  ||| S:21237 E:21239 ||| NN
of  ||| S:21239 E:21242 ||| IN
the  ||| S:21242 E:21246 ||| DT
Boi1-PH ||| S:21246 E:21253 ||| NNP
( ||| S:21253 E:21254 ||| -LRB-
TK ||| S:21254 E:21256 ||| NNP
)  ||| S:21256 E:21258 ||| -RRB-
colonies  ||| S:21258 E:21277 ||| NNS
showed  ||| S:21277 E:21284 ||| VBD
any  ||| S:21284 E:21288 ||| DT
degree  ||| S:21288 E:21295 ||| NN
of  ||| S:21295 E:21298 ||| IN
sectoring ||| S:21298 E:21307 ||| NNS
;  ||| S:21307 E:21309 ||| :
however ||| S:21309 E:21316 ||| RB
,  ||| S:21316 E:21318 ||| ,
with  ||| S:21318 E:21323 ||| IN
the  ||| S:21323 E:21327 ||| DT
tag ||| S:21327 E:21330 ||| NN
,  ||| S:21330 E:21342 ||| ,
90 ||| S:21342 E:21344 ||| CD
%  ||| S:21344 E:21346 ||| NN
of  ||| S:21346 E:21349 ||| IN
the  ||| S:21349 E:21353 ||| DT
colonies  ||| S:21353 E:21362 ||| NN
showed  ||| S:21362 E:21369 ||| VBD
moderate  ||| S:21369 E:21378 ||| JJ
or  ||| S:21378 E:21381 ||| CC
heavy  ||| S:21381 E:21387 ||| JJ
sectoring  ||| S:21387 E:21407 ||| NNS
( ||| S:21407 E:21408 ||| -LRB-
Fig.  ||| S:21408 E:21413 ||| CD
6 ||| S:21413 E:21414 ||| CD
) ||| S:21414 E:21415 ||| -RRB-
.  ||| S:21415 E:21427 ||| .
Myr  ||| S:21427 E:21431 ||| NNP
also  ||| S:21431 E:21436 ||| RB
greatly  ||| S:21436 E:21444 ||| RB
improved  ||| S:21444 E:21453 ||| VBN
the  ||| S:21453 E:21457 ||| DT
ability  ||| S:21457 E:21465 ||| NN
of  ||| S:21465 E:21468 ||| IN
the  ||| S:21468 E:21472 ||| DT
KK  ||| S:21472 E:21475 ||| NNP
mutant  ||| S:21475 E:21492 ||| JJ
version  ||| S:21492 E:21500 ||| NN
of  ||| S:21500 E:21503 ||| IN
Boi1-PH  ||| S:21503 E:21511 ||| CD
to  ||| S:21511 E:21514 ||| TO
cause  ||| S:21514 E:21520 ||| VB
sectoring ||| S:21520 E:21529 ||| NNS
:  ||| S:21529 E:21531 ||| :
Myr-Boi1-PH ||| S:21531 E:21542 ||| CD
( ||| S:21542 E:21543 ||| -LRB-
KK ||| S:21543 E:21545 ||| NNP
)  ||| S:21545 E:21557 ||| -RRB-
allowed  ||| S:21557 E:21565 ||| VBD
59 ||| S:21565 E:21567 ||| CD
%  ||| S:21567 E:21569 ||| NN
moderate  ||| S:21569 E:21578 ||| JJ
or  ||| S:21578 E:21581 ||| CC
heavy  ||| S:21581 E:21587 ||| JJ
sectoring  ||| S:21587 E:21597 ||| NN
at  ||| S:21597 E:21600 ||| IN
23°C  ||| S:21600 E:21605 ||| NNP
and  ||| S:21605 E:21619 ||| CC
allowed  ||| S:21619 E:21627 ||| VBD
28 ||| S:21627 E:21629 ||| CD
%  ||| S:21629 E:21631 ||| NN
moderate  ||| S:21631 E:21640 ||| JJ
or  ||| S:21640 E:21643 ||| CC
heavy  ||| S:21643 E:21649 ||| JJ
sectoring  ||| S:21649 E:21659 ||| NN
at  ||| S:21659 E:21662 ||| IN
30°C ||| S:21662 E:21666 ||| NNP
,  ||| S:21666 E:21668 ||| ,
compared  ||| S:21668 E:21687 ||| VBN
to  ||| S:21687 E:21690 ||| TO
there  ||| S:21690 E:21696 ||| RB
being  ||| S:21696 E:21702 ||| VBG
no  ||| S:21702 E:21705 ||| DT
sectoring  ||| S:21705 E:21715 ||| NN
at  ||| S:21715 E:21718 ||| IN
either  ||| S:21718 E:21725 ||| DT
temperature  ||| S:21725 E:21737 ||| NN
without  ||| S:21737 E:21755 ||| IN
Myr  ||| S:21755 E:21759 ||| NNP
( ||| S:21759 E:21760 ||| -LRB-
Fig.  ||| S:21760 E:21765 ||| CD
6 ||| S:21765 E:21766 ||| CD
) ||| S:21766 E:21767 ||| -RRB-
.  ||| S:21767 E:21769 ||| .
At  ||| S:21769 E:21772 ||| IN
23°C ||| S:21772 E:21776 ||| NNP
,  ||| S:21776 E:21778 ||| ,
Myr  ||| S:21778 E:21782 ||| NNP
also  ||| S:21782 E:21787 ||| RB
improved  ||| S:21787 E:21796 ||| VBN
the  ||| S:21796 E:21800 ||| DT
function  ||| S:21800 E:21809 ||| NN
of  ||| S:21809 E:21822 ||| IN
the  ||| S:21822 E:21826 ||| DT
KKTK  ||| S:21826 E:21831 ||| NNP
( ||| S:21831 E:21832 ||| -LRB-
the  ||| S:21832 E:21836 ||| DT
most  ||| S:21836 E:21841 ||| RBS
severe ||| S:21841 E:21847 ||| JJ
)  ||| S:21847 E:21849 ||| -RRB-
mutant  ||| S:21849 E:21856 ||| JJ
version  ||| S:21856 E:21864 ||| NN
of  ||| S:21864 E:21867 ||| IN
Boi1-PH ||| S:21867 E:21874 ||| CD
:  ||| S:21874 E:21876 ||| :
at  ||| S:21876 E:21889 ||| IN
this  ||| S:21889 E:21894 ||| DT
temperature ||| S:21894 E:21905 ||| NN
,  ||| S:21905 E:21907 ||| ,
whereas  ||| S:21907 E:21915 ||| IN
Boi1-PH ||| S:21915 E:21922 ||| NNP
( ||| S:21922 E:21923 ||| -LRB-
KKTK ||| S:21923 E:21927 ||| NNP
)  ||| S:21927 E:21929 ||| -RRB-
without  ||| S:21929 E:21937 ||| IN
Myr  ||| S:21937 E:21941 ||| NNP
did  ||| S:21941 E:21955 ||| VBD
not  ||| S:21955 E:21959 ||| RB
allow  ||| S:21959 E:21965 ||| VB
any  ||| S:21965 E:21969 ||| DT
sectoring ||| S:21969 E:21978 ||| NN
,  ||| S:21978 E:21980 ||| ,
Myr-Boi1-PH ||| S:21980 E:21991 ||| NNP
( ||| S:21991 E:21992 ||| -LRB-
KKTK ||| S:21992 E:21996 ||| NNP
)  ||| S:21996 E:21998 ||| -RRB-
allowed  ||| S:21998 E:22006 ||| VBD
17 ||| S:22006 E:22008 ||| CD
%  ||| S:22008 E:22010 ||| NN
of  ||| S:22010 E:22023 ||| IN
the  ||| S:22023 E:22027 ||| DT
colonies  ||| S:22027 E:22036 ||| NN
to  ||| S:22036 E:22039 ||| TO
show  ||| S:22039 E:22044 ||| VB
moderate  ||| S:22044 E:22053 ||| JJ
or  ||| S:22053 E:22056 ||| CC
heavy  ||| S:22056 E:22062 ||| JJ
sectoring  ||| S:22062 E:22072 ||| NNS
( ||| S:22072 E:22073 ||| -LRB-
Fig.  ||| S:22073 E:22088 ||| CD
6 ||| S:22088 E:22089 ||| CD
) ||| S:22089 E:22090 ||| -RRB-
.  ||| S:22090 E:22092 ||| .
In  ||| S:22092 E:22095 ||| IN
constrast ||| S:22095 E:22104 ||| NN
,  ||| S:22104 E:22106 ||| ,
when  ||| S:22106 E:22111 ||| WRB
tested  ||| S:22111 E:22118 ||| VBN
at  ||| S:22118 E:22121 ||| IN
30°C ||| S:22121 E:22125 ||| NNP
,  ||| S:22125 E:22127 ||| ,
Myr  ||| S:22127 E:22131 ||| NNP
did  ||| S:22131 E:22135 ||| VBD
not  ||| S:22135 E:22139 ||| RB
affect  ||| S:22139 E:22156 ||| VB
significantly  ||| S:22156 E:22170 ||| RB
the  ||| S:22170 E:22174 ||| DT
amount  ||| S:22174 E:22181 ||| NN
of  ||| S:22181 E:22184 ||| IN
sectoring  ||| S:22184 E:22194 ||| VBG
allowed  ||| S:22194 E:22202 ||| VBN
by  ||| S:22202 E:22215 ||| IN
Boi1-PH ||| S:22215 E:22222 ||| NNP
( ||| S:22222 E:22223 ||| -LRB-
KKTK ||| S:22223 E:22227 ||| NNP
) ||| S:22227 E:22228 ||| -RRB-
:  ||| S:22228 E:22230 ||| :
98 ||| S:22230 E:22232 ||| CD
%  ||| S:22232 E:22234 ||| NN
of  ||| S:22234 E:22237 ||| IN
the  ||| S:22237 E:22241 ||| DT
colonies  ||| S:22241 E:22250 ||| NN
of  ||| S:22250 E:22253 ||| IN
cells  ||| S:22253 E:22259 ||| NNS
containing  ||| S:22259 E:22280 ||| VBG
Myr-Boi1-PH ||| S:22280 E:22291 ||| NNP
( ||| S:22291 E:22292 ||| -LRB-
KKTK ||| S:22292 E:22296 ||| NNP
)  ||| S:22296 E:22298 ||| -RRB-
were  ||| S:22298 E:22303 ||| VBD
non-sectoring  ||| S:22303 E:22317 ||| JJ
at  ||| S:22317 E:22320 ||| IN
this  ||| S:22320 E:22325 ||| DT
temperature  ||| S:22325 E:22347 ||| NN
( ||| S:22347 E:22348 ||| -LRB-
Fig.  ||| S:22348 E:22353 ||| CD
6 ||| S:22353 E:22354 ||| CD
) ||| S:22354 E:22355 ||| -RRB-
.  ||| S:22355 E:22367 ||| .
It  ||| S:22367 E:22370 ||| PRP
is  ||| S:22370 E:22373 ||| VBZ
unlikely  ||| S:22373 E:22382 ||| JJ
that  ||| S:22382 E:22387 ||| IN
the  ||| S:22387 E:22391 ||| DT
mechanism  ||| S:22391 E:22401 ||| NN
by  ||| S:22401 E:22404 ||| IN
which  ||| S:22404 E:22410 ||| WDT
Myr  ||| S:22410 E:22424 ||| NNP
improves  ||| S:22424 E:22433 ||| VBZ
the  ||| S:22433 E:22437 ||| DT
function  ||| S:22437 E:22446 ||| NN
of  ||| S:22446 E:22449 ||| IN
the  ||| S:22449 E:22453 ||| DT
different  ||| S:22453 E:22463 ||| JJ
mutant  ||| S:22463 E:22470 ||| JJ
versions  ||| S:22470 E:22479 ||| NNS
of  ||| S:22479 E:22492 ||| IN
Boi1-PH  ||| S:22492 E:22500 ||| NNP
is  ||| S:22500 E:22503 ||| VBZ
by  ||| S:22503 E:22506 ||| IN
increasing  ||| S:22506 E:22517 ||| VBG
their  ||| S:22517 E:22523 ||| PRP$
stability ||| S:22523 E:22532 ||| NN
,  ||| S:22532 E:22534 ||| ,
because  ||| S:22534 E:22542 ||| IN
the  ||| S:22542 E:22556 ||| DT
presence  ||| S:22556 E:22565 ||| NN
of  ||| S:22565 E:22568 ||| IN
Myr  ||| S:22568 E:22572 ||| NNP
did  ||| S:22572 E:22576 ||| VBD
not  ||| S:22576 E:22580 ||| RB
have  ||| S:22580 E:22585 ||| VB
an  ||| S:22585 E:22588 ||| DT
obvious  ||| S:22588 E:22596 ||| JJ
effect  ||| S:22596 E:22603 ||| NN
on  ||| S:22603 E:22606 ||| IN
the  ||| S:22606 E:22620 ||| DT
relative  ||| S:22620 E:22629 ||| JJ
concentrations  ||| S:22629 E:22644 ||| NNS
of  ||| S:22644 E:22647 ||| IN
the  ||| S:22647 E:22651 ||| DT
different  ||| S:22651 E:22661 ||| JJ
versions  ||| S:22661 E:22670 ||| NNS
of  ||| S:22670 E:22683 ||| IN
Boi1-PH  ||| S:22683 E:22691 ||| NNP
( ||| S:22691 E:22692 ||| -LRB-
Fig.  ||| S:22692 E:22697 ||| NNP
7B ||| S:22697 E:22699 ||| NNP
) ||| S:22699 E:22700 ||| -RRB-
.  ||| S:22700 E:22730 ||| .
Localization  ||| S:22730 E:22743 ||| NNP
of  ||| S:22743 E:22746 ||| IN
wild-type  ||| S:22746 E:22756 ||| JJ
and  ||| S:22756 E:22760 ||| CC
mutant  ||| S:22760 E:22767 ||| JJ
versions  ||| S:22767 E:22776 ||| NNS
of  ||| S:22776 E:22789 ||| IN
Boi1  ||| S:22789 E:22794 ||| NNP
and  ||| S:22794 E:22798 ||| CC
Boi2  ||| S:22798 E:22813 ||| CD
To  ||| S:22813 E:22816 ||| TO
investigate  ||| S:22816 E:22828 ||| VB
whether  ||| S:22828 E:22836 ||| IN
binding  ||| S:22836 E:22844 ||| VBG
to  ||| S:22844 E:22847 ||| TO
phospholipid  ||| S:22847 E:22860 ||| NNS
may  ||| S:22860 E:22864 ||| MD
be  ||| S:22864 E:22877 ||| VB
important  ||| S:22877 E:22887 ||| JJ
for  ||| S:22887 E:22891 ||| IN
proper  ||| S:22891 E:22898 ||| JJ
localization  ||| S:22898 E:22911 ||| NN
of  ||| S:22911 E:22914 ||| IN
Boi1 ||| S:22914 E:22918 ||| NNP
,  ||| S:22918 E:22920 ||| ,
we  ||| S:22920 E:22923 ||| PRP
used  ||| S:22923 E:22928 ||| VBD
GFP  ||| S:22928 E:22942 ||| NNP
( ||| S:22942 E:22943 ||| -LRB-
green  ||| S:22943 E:22949 ||| JJ
fluorescent  ||| S:22949 E:22961 ||| JJ
protein ||| S:22961 E:22968 ||| NN
)  ||| S:22968 E:22970 ||| -RRB-
fusions  ||| S:22970 E:22978 ||| NN
to  ||| S:22978 E:22981 ||| TO
identify  ||| S:22981 E:22990 ||| VB
first  ||| S:22990 E:22996 ||| RB
the  ||| S:22996 E:23010 ||| DT
patterns  ||| S:23010 E:23019 ||| NNS
of  ||| S:23019 E:23022 ||| IN
localization  ||| S:23022 E:23035 ||| NN
of  ||| S:23035 E:23038 ||| IN
wild-type  ||| S:23038 E:23048 ||| NNP
Boi1  ||| S:23048 E:23053 ||| NNP
and  ||| S:23053 E:23057 ||| CC
Boi2  ||| S:23057 E:23062 ||| NNP
and  ||| S:23062 E:23076 ||| CC
then  ||| S:23076 E:23081 ||| RB
those  ||| S:23081 E:23087 ||| DT
of  ||| S:23087 E:23090 ||| IN
the  ||| S:23090 E:23094 ||| DT
mutant  ||| S:23094 E:23101 ||| JJ
versions  ||| S:23101 E:23110 ||| NNS
of  ||| S:23110 E:23113 ||| IN
Boi1  ||| S:23113 E:23118 ||| NNP
that  ||| S:23118 E:23123 ||| WDT
are  ||| S:23123 E:23137 ||| VBP
impaired  ||| S:23137 E:23146 ||| VBN
in  ||| S:23146 E:23149 ||| IN
the  ||| S:23149 E:23153 ||| DT
ability  ||| S:23153 E:23161 ||| NN
to  ||| S:23161 E:23164 ||| TO
bind  ||| S:23164 E:23169 ||| VB
phospholipid ||| S:23169 E:23181 ||| NNS
.  ||| S:23181 E:23183 ||| .
The  ||| S:23183 E:23197 ||| DT
micrographs  ||| S:23197 E:23209 ||| NN
in  ||| S:23209 E:23212 ||| IN
Figure  ||| S:23212 E:23219 ||| NNP
8show  ||| S:23219 E:23225 ||| NNP
examples  ||| S:23225 E:23234 ||| NNS
of  ||| S:23234 E:23237 ||| IN
the  ||| S:23237 E:23241 ||| DT
different  ||| S:23241 E:23261 ||| JJ
patterns  ||| S:23261 E:23270 ||| NNS
of  ||| S:23270 E:23273 ||| IN
localization  ||| S:23273 E:23286 ||| NN
observed  ||| S:23286 E:23295 ||| VBD
for  ||| S:23295 E:23299 ||| IN
wild-type  ||| S:23299 E:23309 ||| JJ
Boi1-GFP ||| S:23309 E:23317 ||| NN
.  ||| S:23317 E:23329 ||| .
In  ||| S:23329 E:23332 ||| IN
unbudded  ||| S:23332 E:23341 ||| JJ
cells ||| S:23341 E:23346 ||| NNS
,  ||| S:23346 E:23348 ||| ,
Boi1-GFP  ||| S:23348 E:23357 ||| NNP
was  ||| S:23357 E:23361 ||| VBD
seen  ||| S:23361 E:23366 ||| VBN
to  ||| S:23366 E:23369 ||| TO
be  ||| S:23369 E:23372 ||| VB
concentrated  ||| S:23372 E:23395 ||| VBN
in  ||| S:23395 E:23398 ||| IN
a  ||| S:23398 E:23400 ||| DT
single  ||| S:23400 E:23407 ||| JJ
spot  ||| S:23407 E:23412 ||| NN
at  ||| S:23412 E:23415 ||| IN
the  ||| S:23415 E:23419 ||| DT
cell  ||| S:23419 E:23424 ||| NN
cortex  ||| S:23424 E:23431 ||| NNS
( ||| S:23431 E:23432 ||| -LRB-
"polar ||| S:23432 E:23438 ||| NNP
"  ||| S:23438 E:23440 ||| ''
pattern ||| S:23440 E:23447 ||| NN
)  ||| S:23447 E:23449 ||| -RRB-
in  ||| S:23449 E:23462 ||| IN
70 ||| S:23462 E:23464 ||| CD
%  ||| S:23464 E:23466 ||| NN
of  ||| S:23466 E:23469 ||| IN
the  ||| S:23469 E:23473 ||| DT
cells  ||| S:23473 E:23479 ||| NNS
( ||| S:23479 E:23480 ||| -LRB-
Fig.  ||| S:23480 E:23485 ||| NNP
8A ||| S:23485 E:23487 ||| NNP
) ||| S:23487 E:23488 ||| -RRB-
.  ||| S:23488 E:23490 ||| .
In  ||| S:23490 E:23493 ||| IN
small-budded  ||| S:23493 E:23506 ||| JJ
cells ||| S:23506 E:23511 ||| NNS
,  ||| S:23511 E:23523 ||| ,
Boi1-GFP  ||| S:23523 E:23532 ||| NNP
was  ||| S:23532 E:23536 ||| VBD
concentrated  ||| S:23536 E:23549 ||| VBN
in  ||| S:23549 E:23552 ||| IN
the  ||| S:23552 E:23556 ||| DT
bud  ||| S:23556 E:23560 ||| NN
in  ||| S:23560 E:23563 ||| IN
89 ||| S:23563 E:23565 ||| CD
%  ||| S:23565 E:23567 ||| NN
of  ||| S:23567 E:23570 ||| IN
the  ||| S:23570 E:23574 ||| DT
cells  ||| S:23574 E:23590 ||| NNS
( ||| S:23590 E:23591 ||| -LRB-
Fig.  ||| S:23591 E:23596 ||| NNP
8B ||| S:23596 E:23598 ||| NNP
) ||| S:23598 E:23599 ||| -RRB-
.  ||| S:23599 E:23601 ||| .
In  ||| S:23601 E:23604 ||| IN
cells  ||| S:23604 E:23610 ||| NNS
containing  ||| S:23610 E:23621 ||| VBG
large  ||| S:23621 E:23627 ||| JJ
buds ||| S:23627 E:23631 ||| NNS
,  ||| S:23631 E:23633 ||| ,
Boi1-GFP  ||| S:23633 E:23642 ||| NNP
was  ||| S:23642 E:23656 ||| VBD
concentrated  ||| S:23656 E:23669 ||| VBN
in  ||| S:23669 E:23672 ||| IN
the  ||| S:23672 E:23676 ||| DT
bud  ||| S:23676 E:23680 ||| NN
in  ||| S:23680 E:23683 ||| IN
50 ||| S:23683 E:23685 ||| CD
%  ||| S:23685 E:23687 ||| NN
of  ||| S:23687 E:23690 ||| IN
the  ||| S:23690 E:23694 ||| DT
cells  ||| S:23694 E:23700 ||| NNS
and  ||| S:23700 E:23704 ||| CC
was  ||| S:23704 E:23718 ||| VBD
concentrated  ||| S:23718 E:23731 ||| VBN
at  ||| S:23731 E:23734 ||| IN
the  ||| S:23734 E:23738 ||| DT
neck  ||| S:23738 E:23743 ||| NN
in  ||| S:23743 E:23746 ||| IN
31 ||| S:23746 E:23748 ||| CD
%  ||| S:23748 E:23750 ||| NN
of  ||| S:23750 E:23753 ||| IN
the  ||| S:23753 E:23757 ||| DT
cells  ||| S:23757 E:23763 ||| NNS
( ||| S:23763 E:23764 ||| -LRB-
Fig.  ||| S:23764 E:23769 ||| NNP
8C ||| S:23769 E:23771 ||| NNP
) ||| S:23771 E:23772 ||| -RRB-
.  ||| S:23772 E:23784 ||| .
Boi2-GFP  ||| S:23784 E:23793 ||| NNP
showed  ||| S:23793 E:23800 ||| VBD
distributions  ||| S:23800 E:23814 ||| NNS
of  ||| S:23814 E:23817 ||| IN
localization  ||| S:23817 E:23830 ||| JJ
patterns  ||| S:23830 E:23849 ||| NNS
generally  ||| S:23849 E:23859 ||| RB
similar  ||| S:23859 E:23867 ||| JJ
to  ||| S:23867 E:23870 ||| TO
those  ||| S:23870 E:23876 ||| DT
for  ||| S:23876 E:23880 ||| IN
Boi1-GFP  ||| S:23880 E:23889 ||| NNP
( ||| S:23889 E:23890 ||| -LRB-
Fig.  ||| S:23890 E:23895 ||| NNP
8A ||| S:23895 E:23897 ||| NNP
, ||| S:23897 E:23898 ||| ,
8B ||| S:23898 E:23900 ||| NNP
, ||| S:23900 E:23901 ||| ,
8C ||| S:23901 E:23903 ||| CD
) ||| S:23903 E:23904 ||| -RRB-
.  ||| S:23904 E:23916 ||| .
Thus ||| S:23916 E:23920 ||| RB
,  ||| S:23920 E:23922 ||| ,
Boi1-GFP  ||| S:23922 E:23931 ||| NNP
and  ||| S:23931 E:23935 ||| CC
Boi2-GFP  ||| S:23935 E:23944 ||| NNP
both  ||| S:23944 E:23949 ||| CC
appear  ||| S:23949 E:23956 ||| VB
to  ||| S:23956 E:23959 ||| TO
be  ||| S:23959 E:23962 ||| VB
localized  ||| S:23962 E:23982 ||| VBN
to  ||| S:23982 E:23985 ||| TO
sites  ||| S:23985 E:23991 ||| NNS
of  ||| S:23991 E:23994 ||| IN
polarized  ||| S:23994 E:24004 ||| JJ
growth  ||| S:24004 E:24011 ||| NN
throughout  ||| S:24011 E:24022 ||| IN
the  ||| S:24022 E:24026 ||| DT
cell  ||| S:24026 E:24041 ||| NN
cycle ||| S:24041 E:24046 ||| NN
.  ||| S:24046 E:24058 ||| .
The  ||| S:24058 E:24062 ||| DT
KK ||| S:24062 E:24064 ||| NNP
,  ||| S:24064 E:24066 ||| ,
TK ||| S:24066 E:24068 ||| NNP
,  ||| S:24068 E:24070 ||| ,
and  ||| S:24070 E:24074 ||| CC
KKTK  ||| S:24074 E:24079 ||| NNP
versions  ||| S:24079 E:24088 ||| NNS
of  ||| S:24088 E:24091 ||| IN
Boi1-GFP  ||| S:24091 E:24100 ||| CD
all  ||| S:24100 E:24104 ||| DT
showed  ||| S:24104 E:24111 ||| VBD
a  ||| S:24111 E:24123 ||| DT
polar  ||| S:24123 E:24129 ||| JJ
pattern  ||| S:24129 E:24137 ||| NN
of  ||| S:24137 E:24140 ||| IN
localization  ||| S:24140 E:24153 ||| NN
in  ||| S:24153 E:24156 ||| IN
approximately  ||| S:24156 E:24170 ||| JJ
half  ||| S:24170 E:24175 ||| NN
of  ||| S:24175 E:24188 ||| IN
the  ||| S:24188 E:24192 ||| DT
unbudded  ||| S:24192 E:24201 ||| JJ
cells  ||| S:24201 E:24207 ||| NNS
( ||| S:24207 E:24208 ||| -LRB-
Fig.  ||| S:24208 E:24213 ||| NNP
8A ||| S:24213 E:24215 ||| NNP
) ||| S:24215 E:24216 ||| -RRB-
,  ||| S:24216 E:24218 ||| ,
suggesting  ||| S:24218 E:24229 ||| VBG
that  ||| S:24229 E:24234 ||| IN
binding  ||| S:24234 E:24242 ||| VBG
to  ||| S:24242 E:24255 ||| TO
phospholipid  ||| S:24255 E:24268 ||| NN
is  ||| S:24268 E:24271 ||| VBZ
not  ||| S:24271 E:24275 ||| RB
critical  ||| S:24275 E:24284 ||| JJ
for  ||| S:24284 E:24288 ||| IN
this  ||| S:24288 E:24293 ||| DT
pattern  ||| S:24293 E:24301 ||| NN
of  ||| S:24301 E:24314 ||| IN
localization ||| S:24314 E:24326 ||| NN
.  ||| S:24326 E:24328 ||| .
In  ||| S:24328 E:24331 ||| IN
small-budded  ||| S:24331 E:24344 ||| JJ
cells ||| S:24344 E:24349 ||| NNS
,  ||| S:24349 E:24351 ||| ,
the  ||| S:24351 E:24355 ||| DT
KK ||| S:24355 E:24357 ||| NNP
,  ||| S:24357 E:24359 ||| ,
TK ||| S:24359 E:24361 ||| NNP
,  ||| S:24361 E:24363 ||| ,
and  ||| S:24363 E:24367 ||| CC
KKTK  ||| S:24367 E:24382 ||| NNP
mutant  ||| S:24382 E:24389 ||| JJ
proteins  ||| S:24389 E:24398 ||| NNS
showed  ||| S:24398 E:24405 ||| VBD
localization  ||| S:24405 E:24418 ||| VBN
to  ||| S:24418 E:24421 ||| TO
the  ||| S:24421 E:24425 ||| DT
bud  ||| S:24425 E:24429 ||| NN
in  ||| S:24429 E:24432 ||| IN
only  ||| S:24432 E:24447 ||| RB
18 ||| S:24447 E:24449 ||| CD
,  ||| S:24449 E:24451 ||| ,
21 ||| S:24451 E:24453 ||| CD
,  ||| S:24453 E:24455 ||| ,
and  ||| S:24455 E:24459 ||| CC
27 ||| S:24459 E:24461 ||| CD
%  ||| S:24461 E:24463 ||| NN
of  ||| S:24463 E:24466 ||| IN
the  ||| S:24466 E:24470 ||| DT
cells ||| S:24470 E:24475 ||| NNS
,  ||| S:24475 E:24477 ||| ,
respectively  ||| S:24477 E:24490 ||| RB
( ||| S:24490 E:24491 ||| -LRB-
compared  ||| S:24491 E:24500 ||| VBN
to  ||| S:24500 E:24513 ||| TO
in  ||| S:24513 E:24516 ||| IN
89 ||| S:24516 E:24518 ||| CD
%  ||| S:24518 E:24520 ||| NN
of  ||| S:24520 E:24523 ||| IN
the  ||| S:24523 E:24527 ||| DT
cells  ||| S:24527 E:24533 ||| NNS
for  ||| S:24533 E:24537 ||| IN
wild-type  ||| S:24537 E:24547 ||| JJ
Boi1-GFP ||| S:24547 E:24555 ||| CD
)  ||| S:24555 E:24557 ||| -RRB-
( ||| S:24557 E:24558 ||| -LRB-
Fig.  ||| S:24558 E:24563 ||| NNP
8B ||| S:24563 E:24565 ||| NNP
) ||| S:24565 E:24566 ||| -RRB-
.  ||| S:24566 E:24578 ||| .
Thus ||| S:24578 E:24582 ||| RB
,  ||| S:24582 E:24584 ||| ,
although  ||| S:24584 E:24593 ||| IN
the  ||| S:24593 E:24597 ||| DT
KK ||| S:24597 E:24599 ||| NNP
,  ||| S:24599 E:24601 ||| ,
TK ||| S:24601 E:24603 ||| NNP
,  ||| S:24603 E:24605 ||| ,
and  ||| S:24605 E:24609 ||| CC
KKTK  ||| S:24609 E:24614 ||| NNP
mutant  ||| S:24614 E:24621 ||| JJ
proteins  ||| S:24621 E:24630 ||| NNS
all  ||| S:24630 E:24644 ||| RB
were  ||| S:24644 E:24649 ||| VBD
able  ||| S:24649 E:24654 ||| JJ
to  ||| S:24654 E:24657 ||| TO
localize  ||| S:24657 E:24666 ||| VB
to  ||| S:24666 E:24669 ||| TO
the  ||| S:24669 E:24673 ||| DT
bud  ||| S:24673 E:24677 ||| NN
in  ||| S:24677 E:24680 ||| IN
small-budded  ||| S:24680 E:24693 ||| JJ
cells ||| S:24693 E:24698 ||| NNS
,  ||| S:24698 E:24710 ||| ,
they  ||| S:24710 E:24715 ||| PRP
were  ||| S:24715 E:24720 ||| VBD
localized  ||| S:24720 E:24730 ||| VBN
and ||| S:24730 E:24733 ||| CC
/ ||| S:24733 E:24734 ||| NNP
or  ||| S:24734 E:24737 ||| CC
retained  ||| S:24737 E:24746 ||| VBD
there  ||| S:24746 E:24752 ||| RB
less  ||| S:24752 E:24767 ||| RBR
efficiently  ||| S:24767 E:24779 ||| RB
than  ||| S:24779 E:24784 ||| IN
was  ||| S:24784 E:24788 ||| VBD
wild-type  ||| S:24788 E:24798 ||| JJ
Boi1-GFP ||| S:24798 E:24806 ||| NN
.  ||| S:24806 E:24818 ||| .
A  ||| S:24818 E:24820 ||| DT
more  ||| S:24820 E:24825 ||| RBR
striking  ||| S:24825 E:24834 ||| JJ
effect  ||| S:24834 E:24841 ||| NN
of  ||| S:24841 E:24844 ||| IN
the  ||| S:24844 E:24848 ||| DT
KK ||| S:24848 E:24850 ||| NNP
,  ||| S:24850 E:24852 ||| ,
TK ||| S:24852 E:24854 ||| NNP
,  ||| S:24854 E:24856 ||| ,
and  ||| S:24856 E:24860 ||| CC
KKTK  ||| S:24860 E:24875 ||| NNP
substitutions  ||| S:24875 E:24889 ||| NN
on  ||| S:24889 E:24892 ||| IN
the  ||| S:24892 E:24896 ||| DT
localization  ||| S:24896 E:24909 ||| NN
of  ||| S:24909 E:24912 ||| IN
Boi1-GFP  ||| S:24912 E:24921 ||| NNP
was  ||| S:24921 E:24925 ||| VBD
seen  ||| S:24925 E:24930 ||| VBN
in  ||| S:24930 E:24943 ||| IN
cells  ||| S:24943 E:24949 ||| NNS
that  ||| S:24949 E:24954 ||| WDT
contained  ||| S:24954 E:24964 ||| VBD
large  ||| S:24964 E:24970 ||| JJ
buds ||| S:24970 E:24974 ||| NNS
:  ||| S:24974 E:24976 ||| :
Boi1-TK-GFP  ||| S:24976 E:24988 ||| NNP
was  ||| S:24988 E:25002 ||| VBD
concentrated  ||| S:25002 E:25015 ||| VBN
in  ||| S:25015 E:25018 ||| IN
the  ||| S:25018 E:25022 ||| DT
bud  ||| S:25022 E:25026 ||| NN
in  ||| S:25026 E:25029 ||| IN
only  ||| S:25029 E:25034 ||| RB
4 ||| S:25034 E:25035 ||| CD
%  ||| S:25035 E:25037 ||| NN
of  ||| S:25037 E:25040 ||| IN
large-budded  ||| S:25040 E:25053 ||| JJ
cells ||| S:25053 E:25058 ||| NNS
,  ||| S:25058 E:25070 ||| ,
and  ||| S:25070 E:25074 ||| CC
Boi1-KK-GFP  ||| S:25074 E:25086 ||| NNP
and  ||| S:25086 E:25090 ||| CC
Boi1-KKTK-GFP  ||| S:25090 E:25104 ||| NNP
were  ||| S:25104 E:25109 ||| VBD
concentrated  ||| S:25109 E:25122 ||| VBN
in  ||| S:25122 E:25135 ||| IN
the  ||| S:25135 E:25139 ||| DT
bud  ||| S:25139 E:25143 ||| NN
in  ||| S:25143 E:25146 ||| IN
less  ||| S:25146 E:25151 ||| JJR
than  ||| S:25151 E:25156 ||| IN
1 ||| S:25156 E:25157 ||| CD
%  ||| S:25157 E:25159 ||| NN
of  ||| S:25159 E:25162 ||| IN
such  ||| S:25162 E:25167 ||| JJ
cells  ||| S:25167 E:25173 ||| NNS
( ||| S:25173 E:25174 ||| -LRB-
Fig.  ||| S:25174 E:25179 ||| NNP
8C ||| S:25179 E:25181 ||| NNP
) ||| S:25181 E:25182 ||| -RRB-
.  ||| S:25182 E:25184 ||| .
None  ||| S:25184 E:25189 ||| NN
of  ||| S:25189 E:25202 ||| IN
the  ||| S:25202 E:25206 ||| DT
sets  ||| S:25206 E:25211 ||| NNS
of  ||| S:25211 E:25214 ||| IN
substitutions  ||| S:25214 E:25228 ||| NN
had  ||| S:25228 E:25232 ||| VBD
an  ||| S:25232 E:25235 ||| DT
obvious  ||| S:25235 E:25243 ||| JJ
effect  ||| S:25243 E:25250 ||| NN
on  ||| S:25250 E:25263 ||| IN
localization  ||| S:25263 E:25276 ||| VBG
to  ||| S:25276 E:25279 ||| TO
the  ||| S:25279 E:25283 ||| DT
neck ||| S:25283 E:25287 ||| NN
,  ||| S:25287 E:25289 ||| ,
however  ||| S:25289 E:25297 ||| RB
( ||| S:25297 E:25298 ||| -LRB-
Fig.  ||| S:25298 E:25303 ||| NNP
8C ||| S:25303 E:25305 ||| NNP
) ||| S:25305 E:25306 ||| -RRB-
.  ||| S:25306 E:25308 ||| .
These  ||| S:25308 E:25324 ||| DT
findings  ||| S:25324 E:25333 ||| NNS
suggest  ||| S:25333 E:25341 ||| VBP
that ||| S:25341 E:25345 ||| RB
,  ||| S:25345 E:25347 ||| ,
in  ||| S:25347 E:25350 ||| IN
large-budded  ||| S:25350 E:25363 ||| JJ
cells ||| S:25363 E:25368 ||| NNS
,  ||| S:25368 E:25370 ||| ,
binding  ||| S:25370 E:25378 ||| VBG
to  ||| S:25378 E:25391 ||| TO
phospholipid  ||| S:25391 E:25404 ||| NNS
may  ||| S:25404 E:25408 ||| MD
be  ||| S:25408 E:25411 ||| VB
important  ||| S:25411 E:25421 ||| JJ
for  ||| S:25421 E:25425 ||| IN
the  ||| S:25425 E:25429 ||| DT
localization  ||| S:25429 E:25442 ||| NN
of  ||| S:25442 E:25455 ||| IN
Boi1  ||| S:25455 E:25460 ||| CD
to  ||| S:25460 E:25463 ||| TO
the  ||| S:25463 E:25467 ||| DT
bud  ||| S:25467 E:25471 ||| NN
but  ||| S:25471 E:25475 ||| CC
not  ||| S:25475 E:25479 ||| RB
for  ||| S:25479 E:25483 ||| IN
localization  ||| S:25483 E:25496 ||| VBG
to  ||| S:25496 E:25499 ||| TO
the  ||| S:25499 E:25503 ||| DT
neck ||| S:25503 E:25507 ||| NN
.  ||| S:25507 E:25519 ||| .
Although  ||| S:25519 E:25528 ||| IN
our  ||| S:25528 E:25532 ||| PRP$
studies  ||| S:25532 E:25540 ||| NNS
focus  ||| S:25540 E:25546 ||| VBP
on  ||| S:25546 E:25549 ||| IN
roles  ||| S:25549 E:25555 ||| NNS
of  ||| S:25555 E:25558 ||| IN
Boi1 ||| S:25558 E:25562 ||| NNP
's  ||| S:25562 E:25565 ||| POS
PH  ||| S:25565 E:25578 ||| NNP
domain ||| S:25578 E:25584 ||| NN
,  ||| S:25584 E:25586 ||| ,
we  ||| S:25586 E:25589 ||| PRP
were  ||| S:25589 E:25594 ||| VBD
also  ||| S:25594 E:25599 ||| RB
curious  ||| S:25599 E:25607 ||| JJ
to  ||| S:25607 E:25610 ||| TO
know  ||| S:25610 E:25615 ||| VB
which  ||| S:25615 E:25621 ||| WDT
other  ||| S:25621 E:25627 ||| JJ
portions  ||| S:25627 E:25646 ||| NNS
of  ||| S:25646 E:25649 ||| IN
Boi1  ||| S:25649 E:25654 ||| NNP
contribute  ||| S:25654 E:25665 ||| VBP
to  ||| S:25665 E:25668 ||| TO
its  ||| S:25668 E:25672 ||| PRP$
proper  ||| S:25672 E:25679 ||| JJ
patterns  ||| S:25679 E:25688 ||| NNS
of  ||| S:25688 E:25701 ||| IN
localization ||| S:25701 E:25713 ||| NN
.  ||| S:25713 E:25715 ||| .
In  ||| S:25715 E:25718 ||| IN
particular ||| S:25718 E:25728 ||| JJ
,  ||| S:25728 E:25730 ||| ,
we  ||| S:25730 E:25733 ||| PRP
wished  ||| S:25733 E:25740 ||| VBD
to  ||| S:25740 E:25743 ||| TO
know  ||| S:25743 E:25748 ||| VB
whether  ||| S:25748 E:25766 ||| IN
either  ||| S:25766 E:25773 ||| RB
the  ||| S:25773 E:25777 ||| DT
SH3  ||| S:25777 E:25781 ||| JJ
domain  ||| S:25781 E:25788 ||| NN
or  ||| S:25788 E:25791 ||| CC
the  ||| S:25791 E:25795 ||| DT
proline-rich  ||| S:25795 E:25808 ||| JJ
( ||| S:25808 E:25809 ||| -LRB-
Bem1-binding ||| S:25809 E:25821 ||| NNP
)  ||| S:25821 E:25833 ||| -RRB-
region  ||| S:25833 E:25840 ||| NN
of  ||| S:25840 E:25843 ||| IN
Boi1  ||| S:25843 E:25848 ||| NNP
is  ||| S:25848 E:25851 ||| VBZ
important  ||| S:25851 E:25861 ||| JJ
for  ||| S:25861 E:25865 ||| IN
any  ||| S:25865 E:25869 ||| DT
pattern  ||| S:25869 E:25877 ||| NN
of  ||| S:25877 E:25890 ||| IN
localization ||| S:25890 E:25902 ||| NN
.  ||| S:25902 E:25904 ||| .
To  ||| S:25904 E:25907 ||| TO
address  ||| S:25907 E:25915 ||| VB
this  ||| S:25915 E:25920 ||| DT
issue ||| S:25920 E:25925 ||| NN
,  ||| S:25925 E:25927 ||| ,
we  ||| S:25927 E:25930 ||| PRP
used  ||| S:25930 E:25935 ||| VBD
the  ||| S:25935 E:25949 ||| DT
following  ||| S:25949 E:25959 ||| JJ
mutant  ||| S:25959 E:25966 ||| JJ
versions  ||| S:25966 E:25975 ||| NNS
of  ||| S:25975 E:25978 ||| IN
Boi1 ||| S:25978 E:25982 ||| CD
:  ||| S:25982 E:25984 ||| :
the  ||| S:25984 E:25988 ||| DT
"S ||| S:25988 E:25990 ||| NN
"  ||| S:25990 E:25992 ||| ''
mutant ||| S:25992 E:25998 ||| NN
,  ||| S:25998 E:26000 ||| ,
which  ||| S:26000 E:26016 ||| WDT
contains  ||| S:26016 E:26025 ||| VBZ
a  ||| S:26025 E:26027 ||| DT
Lys  ||| S:26027 E:26031 ||| JJ
residue  ||| S:26031 E:26039 ||| NN
in  ||| S:26039 E:26042 ||| IN
place  ||| S:26042 E:26048 ||| NN
of  ||| S:26048 E:26051 ||| IN
a  ||| S:26051 E:26053 ||| DT
Trp  ||| S:26053 E:26057 ||| JJ
residue  ||| S:26057 E:26065 ||| NN
at  ||| S:26065 E:26068 ||| IN
a  ||| S:26068 E:26080 ||| DT
highly  ||| S:26080 E:26087 ||| RB
conserved  ||| S:26087 E:26097 ||| JJ
position  ||| S:26097 E:26106 ||| NN
in  ||| S:26106 E:26109 ||| IN
the  ||| S:26109 E:26113 ||| DT
SH3  ||| S:26113 E:26117 ||| JJ
domain ||| S:26117 E:26123 ||| NN
;  ||| S:26123 E:26125 ||| :
the  ||| S:26125 E:26129 ||| DT
"P ||| S:26129 E:26131 ||| NN
"  ||| S:26131 E:26143 ||| ''
mutant ||| S:26143 E:26149 ||| NN
,  ||| S:26149 E:26151 ||| ,
in  ||| S:26151 E:26154 ||| IN
which  ||| S:26154 E:26160 ||| WDT
seven  ||| S:26160 E:26166 ||| CD
of  ||| S:26166 E:26169 ||| IN
the  ||| S:26169 E:26173 ||| DT
nine  ||| S:26173 E:26178 ||| CD
Pro  ||| S:26178 E:26182 ||| FW
residues  ||| S:26182 E:26191 ||| FW
in  ||| S:26191 E:26194 ||| IN
the  ||| S:26194 E:26208 ||| DT
Pro-rich  ||| S:26208 E:26217 ||| JJ
region  ||| S:26217 E:26224 ||| NN
are  ||| S:26224 E:26228 ||| VBP
replaced  ||| S:26228 E:26237 ||| VBN
with  ||| S:26237 E:26242 ||| IN
Ala  ||| S:26242 E:26246 ||| NNP
residues  ||| S:26246 E:26255 ||| NNS
( ||| S:26255 E:26256 ||| -LRB-
a  ||| S:26256 E:26258 ||| DT
version  ||| S:26258 E:26276 ||| NN
of  ||| S:26276 E:26279 ||| IN
Boi1  ||| S:26279 E:26284 ||| NNP
that  ||| S:26284 E:26289 ||| WDT
does  ||| S:26289 E:26294 ||| VBZ
not  ||| S:26294 E:26298 ||| RB
bind  ||| S:26298 E:26303 ||| CD
Bem1 ||| S:26303 E:26307 ||| CD
) ||| S:26307 E:26308 ||| -RRB-
;  ||| S:26308 E:26310 ||| :
and  ||| S:26310 E:26314 ||| CC
the  ||| S:26314 E:26318 ||| DT
"SP ||| S:26318 E:26321 ||| NN
"  ||| S:26321 E:26323 ||| ''
mutant ||| S:26323 E:26329 ||| NN
,  ||| S:26329 E:26341 ||| ,
which  ||| S:26341 E:26347 ||| WDT
contains  ||| S:26347 E:26356 ||| VBZ
both  ||| S:26356 E:26361 ||| PDT
the  ||| S:26361 E:26365 ||| DT
"S ||| S:26365 E:26367 ||| NN
"  ||| S:26367 E:26369 ||| ''
and  ||| S:26369 E:26373 ||| CC
"P ||| S:26373 E:26375 ||| NNP
"  ||| S:26375 E:26377 ||| ''
changes  ||| S:26377 E:26385 ||| NNS
[  ||| S:26385 E:26387 ||| -LRB-
1  ||| S:26387 E:26389 ||| LS
]  ||| S:26389 E:26391 ||| -RRB-
.  ||| S:26391 E:26403 ||| .
The  ||| S:26403 E:26407 ||| DT
most  ||| S:26407 E:26412 ||| RBS
striking  ||| S:26412 E:26421 ||| JJ
effect  ||| S:26421 E:26428 ||| NN
of  ||| S:26428 E:26431 ||| IN
the  ||| S:26431 E:26435 ||| DT
SH3-domain  ||| S:26435 E:26446 ||| JJ
mutation  ||| S:26446 E:26465 ||| NN
was  ||| S:26465 E:26469 ||| VBD
on  ||| S:26469 E:26472 ||| IN
the  ||| S:26472 E:26476 ||| DT
localization  ||| S:26476 E:26489 ||| NN
of  ||| S:26489 E:26492 ||| IN
Boi1-GFP  ||| S:26492 E:26501 ||| CD
to  ||| S:26501 E:26504 ||| TO
necks ||| S:26504 E:26509 ||| NNS
:  ||| S:26509 E:26511 ||| :
we  ||| S:26511 E:26514 ||| PRP
never  ||| S:26514 E:26530 ||| RB
saw  ||| S:26530 E:26534 ||| VBD
Boi1-S-GFP  ||| S:26534 E:26545 ||| CD
localized  ||| S:26545 E:26555 ||| NN
to  ||| S:26555 E:26558 ||| TO
necks  ||| S:26558 E:26564 ||| NNS
( ||| S:26564 E:26565 ||| -LRB-
Fig.  ||| S:26565 E:26570 ||| NNP
8C ||| S:26570 E:26572 ||| NNP
) ||| S:26572 E:26573 ||| -RRB-
,  ||| S:26573 E:26575 ||| ,
suggesting  ||| S:26575 E:26596 ||| VBG
that  ||| S:26596 E:26601 ||| IN
the  ||| S:26601 E:26605 ||| DT
SH3  ||| S:26605 E:26609 ||| JJ
domain  ||| S:26609 E:26616 ||| NN
is  ||| S:26616 E:26619 ||| VBZ
required  ||| S:26619 E:26628 ||| VBN
for  ||| S:26628 E:26632 ||| IN
such  ||| S:26632 E:26637 ||| JJ
localization ||| S:26637 E:26649 ||| NN
.  ||| S:26649 E:26651 ||| .
In  ||| S:26651 E:26664 ||| IN
constrast ||| S:26664 E:26673 ||| NN
,  ||| S:26673 E:26675 ||| ,
the  ||| S:26675 E:26679 ||| DT
SH3-domain  ||| S:26679 E:26690 ||| JJ
mutation  ||| S:26690 E:26699 ||| NN
had  ||| S:26699 E:26703 ||| VBD
no  ||| S:26703 E:26706 ||| DT
obvious  ||| S:26706 E:26714 ||| JJ
effect  ||| S:26714 E:26731 ||| NN
on  ||| S:26731 E:26734 ||| IN
the  ||| S:26734 E:26738 ||| DT
localization  ||| S:26738 E:26751 ||| NN
of  ||| S:26751 E:26754 ||| IN
Boi1-GFP  ||| S:26754 E:26763 ||| CD
to  ||| S:26763 E:26766 ||| TO
the  ||| S:26766 E:26770 ||| DT
bud  ||| S:26770 E:26774 ||| NN
in  ||| S:26774 E:26777 ||| IN
either  ||| S:26777 E:26794 ||| DT
small-  ||| S:26794 E:26801 ||| JJ
or  ||| S:26801 E:26804 ||| CC
large-budded  ||| S:26804 E:26817 ||| JJ
cells  ||| S:26817 E:26823 ||| NNS
( ||| S:26823 E:26824 ||| -LRB-
Figs.  ||| S:26824 E:26830 ||| CD
8Band  ||| S:26830 E:26836 ||| CD
8C ||| S:26836 E:26838 ||| CD
) ||| S:26838 E:26839 ||| -RRB-
.  ||| S:26839 E:26841 ||| .
However ||| S:26841 E:26848 ||| RB
,  ||| S:26848 E:26860 ||| ,
this  ||| S:26860 E:26865 ||| DT
mutation  ||| S:26865 E:26874 ||| NN
increased  ||| S:26874 E:26884 ||| VBD
the  ||| S:26884 E:26888 ||| DT
frequency  ||| S:26888 E:26898 ||| NN
of  ||| S:26898 E:26901 ||| IN
localization  ||| S:26901 E:26914 ||| VBG
to  ||| S:26914 E:26927 ||| TO
the  ||| S:26927 E:26931 ||| DT
periphery  ||| S:26931 E:26941 ||| NN
of  ||| S:26941 E:26944 ||| IN
large-budded  ||| S:26944 E:26957 ||| JJ
cells ||| S:26957 E:26962 ||| NNS
,  ||| S:26962 E:26964 ||| ,
and  ||| S:26964 E:26968 ||| CC
it  ||| S:26968 E:26971 ||| PRP
did  ||| S:26971 E:26975 ||| VBD
so  ||| S:26975 E:26978 ||| RB
to  ||| S:26978 E:26981 ||| TO
a  ||| S:26981 E:26993 ||| DT
degree  ||| S:26993 E:27000 ||| NN
that  ||| S:27000 E:27005 ||| IN
approximated  ||| S:27005 E:27018 ||| NN
that  ||| S:27018 E:27023 ||| IN
to  ||| S:27023 E:27026 ||| TO
which  ||| S:27026 E:27032 ||| WDT
it  ||| S:27032 E:27035 ||| PRP
caused  ||| S:27035 E:27042 ||| VBD
a  ||| S:27042 E:27054 ||| DT
decrease  ||| S:27054 E:27063 ||| NN
in  ||| S:27063 E:27066 ||| IN
the  ||| S:27066 E:27070 ||| DT
frequency  ||| S:27070 E:27080 ||| NN
of  ||| S:27080 E:27083 ||| IN
localization  ||| S:27083 E:27096 ||| VBG
to  ||| S:27096 E:27099 ||| TO
the  ||| S:27099 E:27103 ||| DT
neck ||| S:27103 E:27107 ||| NN
:  ||| S:27107 E:27109 ||| :
in  ||| S:27109 E:27122 ||| IN
large-budded  ||| S:27122 E:27135 ||| JJ
cells ||| S:27135 E:27140 ||| NNS
,  ||| S:27140 E:27142 ||| ,
whereas  ||| S:27142 E:27150 ||| IN
wild-type  ||| S:27150 E:27160 ||| NNP
Boi1-GFP  ||| S:27160 E:27169 ||| NNP
was  ||| S:27169 E:27183 ||| VBD
localized  ||| S:27183 E:27193 ||| VBN
to  ||| S:27193 E:27196 ||| TO
the  ||| S:27196 E:27200 ||| DT
periphery  ||| S:27200 E:27210 ||| NN
of  ||| S:27210 E:27213 ||| IN
the  ||| S:27213 E:27217 ||| DT
mother  ||| S:27217 E:27224 ||| NN
part  ||| S:27224 E:27229 ||| NN
of  ||| S:27229 E:27232 ||| IN
the  ||| S:27232 E:27236 ||| DT
cell  ||| S:27236 E:27251 ||| NN
in  ||| S:27251 E:27254 ||| IN
only  ||| S:27254 E:27259 ||| RB
3 ||| S:27259 E:27260 ||| CD
%  ||| S:27260 E:27262 ||| NN
of  ||| S:27262 E:27265 ||| IN
the  ||| S:27265 E:27269 ||| DT
cells  ||| S:27269 E:27275 ||| NNS
and  ||| S:27275 E:27279 ||| CC
to  ||| S:27279 E:27282 ||| TO
the  ||| S:27282 E:27286 ||| DT
neck  ||| S:27286 E:27291 ||| NN
in  ||| S:27291 E:27294 ||| IN
31 ||| S:27294 E:27296 ||| CD
%  ||| S:27296 E:27298 ||| NN
of  ||| S:27298 E:27301 ||| IN
the  ||| S:27301 E:27315 ||| DT
cells ||| S:27315 E:27320 ||| NNS
,  ||| S:27320 E:27322 ||| ,
Boi1-S-GFP  ||| S:27322 E:27333 ||| NNP
was  ||| S:27333 E:27337 ||| VBD
localized  ||| S:27337 E:27347 ||| VBN
to  ||| S:27347 E:27350 ||| TO
the  ||| S:27350 E:27354 ||| DT
periphery  ||| S:27354 E:27364 ||| NN
of  ||| S:27364 E:27367 ||| IN
the  ||| S:27367 E:27381 ||| DT
mother  ||| S:27381 E:27388 ||| NN
in  ||| S:27388 E:27391 ||| IN
22 ||| S:27391 E:27393 ||| CD
%  ||| S:27393 E:27395 ||| NN
of  ||| S:27395 E:27398 ||| IN
the  ||| S:27398 E:27402 ||| DT
cells  ||| S:27402 E:27408 ||| NNS
( ||| S:27408 E:27409 ||| -LRB-
and  ||| S:27409 E:27413 ||| CC
was  ||| S:27413 E:27417 ||| VBD
never  ||| S:27417 E:27423 ||| RB
localized  ||| S:27423 E:27433 ||| VBN
to  ||| S:27433 E:27446 ||| TO
the  ||| S:27446 E:27450 ||| DT
neck ||| S:27450 E:27454 ||| NN
) ||| S:27454 E:27455 ||| -RRB-
.  ||| S:27455 E:27457 ||| .
These  ||| S:27457 E:27463 ||| DT
findings  ||| S:27463 E:27472 ||| NNS
raise  ||| S:27472 E:27478 ||| VBP
the  ||| S:27478 E:27482 ||| DT
possibility  ||| S:27482 E:27494 ||| NN
that  ||| S:27494 E:27509 ||| IN
failure  ||| S:27509 E:27517 ||| NN
to  ||| S:27517 E:27520 ||| TO
localize  ||| S:27520 E:27529 ||| VB
to  ||| S:27529 E:27532 ||| TO
the  ||| S:27532 E:27536 ||| DT
neck  ||| S:27536 E:27541 ||| NN
increases  ||| S:27541 E:27551 ||| VBZ
the  ||| S:27551 E:27555 ||| DT
likelihood  ||| S:27555 E:27576 ||| NN
that  ||| S:27576 E:27581 ||| IN
Boi1  ||| S:27581 E:27586 ||| NNP
will  ||| S:27586 E:27591 ||| MD
adopt  ||| S:27591 E:27597 ||| VB
or  ||| S:27597 E:27600 ||| CC
retain  ||| S:27600 E:27607 ||| VB
localization  ||| S:27607 E:27620 ||| VBN
at  ||| S:27620 E:27623 ||| IN
the  ||| S:27623 E:27637 ||| DT
periphery  ||| S:27637 E:27647 ||| NN
of  ||| S:27647 E:27650 ||| IN
the  ||| S:27650 E:27654 ||| DT
mother  ||| S:27654 E:27661 ||| NN
part  ||| S:27661 E:27666 ||| NN
of  ||| S:27666 E:27669 ||| IN
the  ||| S:27669 E:27673 ||| DT
cell ||| S:27673 E:27677 ||| NN
.  ||| S:27677 E:27689 ||| .
Another  ||| S:27689 E:27697 ||| DT
apparent  ||| S:27697 E:27706 ||| JJ
effect  ||| S:27706 E:27713 ||| NN
of  ||| S:27713 E:27716 ||| IN
the  ||| S:27716 E:27720 ||| DT
SH3-domain  ||| S:27720 E:27731 ||| JJ
mutation  ||| S:27731 E:27740 ||| NN
on  ||| S:27740 E:27753 ||| IN
the  ||| S:27753 E:27757 ||| DT
localization  ||| S:27757 E:27770 ||| NN
of  ||| S:27770 E:27773 ||| IN
Boi1-GFP  ||| S:27773 E:27782 ||| NNP
was  ||| S:27782 E:27786 ||| VBD
seen  ||| S:27786 E:27791 ||| VBN
in  ||| S:27791 E:27794 ||| IN
unbudded  ||| S:27794 E:27803 ||| JJ
cells ||| S:27803 E:27808 ||| NNS
,  ||| S:27808 E:27820 ||| ,
in  ||| S:27820 E:27823 ||| IN
which  ||| S:27823 E:27829 ||| WDT
the  ||| S:27829 E:27833 ||| DT
percentage  ||| S:27833 E:27844 ||| NN
of  ||| S:27844 E:27847 ||| IN
cells  ||| S:27847 E:27853 ||| NNS
that  ||| S:27853 E:27858 ||| WDT
showed  ||| S:27858 E:27865 ||| VBD
a  ||| S:27865 E:27867 ||| DT
polar  ||| S:27867 E:27883 ||| JJ
pattern  ||| S:27883 E:27891 ||| NN
of  ||| S:27891 E:27894 ||| IN
localization  ||| S:27894 E:27907 ||| NN
for  ||| S:27907 E:27911 ||| IN
Boi1-S-GFP  ||| S:27911 E:27922 ||| NNP
( ||| S:27922 E:27923 ||| -LRB-
24 ||| S:27923 E:27925 ||| CD
% ||| S:27925 E:27926 ||| NN
)  ||| S:27926 E:27928 ||| -RRB-
was  ||| S:27928 E:27932 ||| VBD
lower  ||| S:27932 E:27948 ||| JJR
than  ||| S:27948 E:27953 ||| IN
for  ||| S:27953 E:27957 ||| IN
wild-type  ||| S:27957 E:27967 ||| NNP
Boi1-GFP  ||| S:27967 E:27976 ||| NNP
( ||| S:27976 E:27977 ||| -LRB-
70 ||| S:27977 E:27979 ||| CD
% ||| S:27979 E:27980 ||| NN
) ||| S:27980 E:27981 ||| -RRB-
,  ||| S:27981 E:27983 ||| ,
and  ||| S:27983 E:27987 ||| CC
in  ||| S:27987 E:27990 ||| IN
which  ||| S:27990 E:28006 ||| WDT
Boi1-S-GFP  ||| S:28006 E:28017 ||| NNP
gave  ||| S:28017 E:28022 ||| VBD
a  ||| S:28022 E:28024 ||| DT
higher  ||| S:28024 E:28031 ||| JJR
percentage  ||| S:28031 E:28042 ||| NN
of  ||| S:28042 E:28045 ||| IN
cells  ||| S:28045 E:28051 ||| NNS
that  ||| S:28051 E:28056 ||| WDT
showed  ||| S:28056 E:28073 ||| VBD
the  ||| S:28073 E:28077 ||| DT
diffuse  ||| S:28077 E:28085 ||| JJ
pattern  ||| S:28085 E:28093 ||| NN
( ||| S:28093 E:28094 ||| -LRB-
62 ||| S:28094 E:28096 ||| CD
% ||| S:28096 E:28097 ||| NN
)  ||| S:28097 E:28099 ||| -RRB-
compared  ||| S:28099 E:28108 ||| VBN
to  ||| S:28108 E:28111 ||| TO
that  ||| S:28111 E:28116 ||| DT
given  ||| S:28116 E:28122 ||| VBN
by  ||| S:28122 E:28135 ||| IN
wild-type  ||| S:28135 E:28145 ||| NNP
Boi1-GFP  ||| S:28145 E:28154 ||| NNP
( ||| S:28154 E:28155 ||| -LRB-
24 ||| S:28155 E:28157 ||| CD
% ||| S:28157 E:28158 ||| NN
)  ||| S:28158 E:28160 ||| -RRB-
( ||| S:28160 E:28161 ||| -LRB-
Fig.  ||| S:28161 E:28166 ||| NNP
8A ||| S:28166 E:28168 ||| NNP
) ||| S:28168 E:28169 ||| -RRB-
.  ||| S:28169 E:28171 ||| .
These  ||| S:28171 E:28177 ||| DT
findings  ||| S:28177 E:28186 ||| NNS
raise  ||| S:28186 E:28202 ||| VBP
the  ||| S:28202 E:28206 ||| DT
possibility  ||| S:28206 E:28218 ||| NN
that  ||| S:28218 E:28223 ||| IN
one  ||| S:28223 E:28227 ||| CD
way  ||| S:28227 E:28231 ||| NN
in  ||| S:28231 E:28234 ||| IN
which  ||| S:28234 E:28240 ||| WDT
Boi1-GFP  ||| S:28240 E:28249 ||| NNP
acquires  ||| S:28249 E:28258 ||| VBZ
a  ||| S:28258 E:28270 ||| DT
polar  ||| S:28270 E:28276 ||| JJ
distribution  ||| S:28276 E:28289 ||| NN
in  ||| S:28289 E:28292 ||| IN
unbudded  ||| S:28292 E:28301 ||| JJ
cells  ||| S:28301 E:28307 ||| NNS
involves  ||| S:28307 E:28316 ||| VBZ
prior  ||| S:28316 E:28332 ||| RB
localization  ||| S:28332 E:28345 ||| VBN
to  ||| S:28345 E:28348 ||| TO
the  ||| S:28348 E:28352 ||| DT
neck ||| S:28352 E:28356 ||| NN
,  ||| S:28356 E:28358 ||| ,
via  ||| S:28358 E:28362 ||| IN
the  ||| S:28362 E:28366 ||| DT
SH3  ||| S:28366 E:28370 ||| JJ
domain ||| S:28370 E:28376 ||| NN
.  ||| S:28376 E:28388 ||| .
In  ||| S:28388 E:28391 ||| IN
all  ||| S:28391 E:28395 ||| DT
classes  ||| S:28395 E:28403 ||| NNS
of  ||| S:28403 E:28406 ||| IN
cells ||| S:28406 E:28411 ||| NNS
,  ||| S:28411 E:28413 ||| ,
the  ||| S:28413 E:28417 ||| DT
distributions  ||| S:28417 E:28431 ||| NNS
of  ||| S:28431 E:28444 ||| IN
localization  ||| S:28444 E:28457 ||| JJ
patterns  ||| S:28457 E:28466 ||| NNS
for  ||| S:28466 E:28470 ||| IN
Boi1-P-GFP  ||| S:28470 E:28481 ||| NNP
were  ||| S:28481 E:28486 ||| VBD
not  ||| S:28486 E:28490 ||| RB
notably  ||| S:28490 E:28508 ||| RB
different  ||| S:28508 E:28518 ||| JJ
from  ||| S:28518 E:28523 ||| IN
those  ||| S:28523 E:28529 ||| DT
for  ||| S:28529 E:28533 ||| IN
wild-type  ||| S:28533 E:28543 ||| NNP
Boi1-GFP ||| S:28543 E:28551 ||| NNP
,  ||| S:28551 E:28553 ||| ,
and  ||| S:28553 E:28557 ||| CC
the  ||| S:28557 E:28571 ||| DT
distributions  ||| S:28571 E:28585 ||| NNS
of  ||| S:28585 E:28588 ||| IN
localization  ||| S:28588 E:28601 ||| JJ
patterns  ||| S:28601 E:28610 ||| NNS
for  ||| S:28610 E:28614 ||| IN
Boi1-S-P-GFP  ||| S:28614 E:28637 ||| NNP
were  ||| S:28637 E:28642 ||| VBD
not  ||| S:28642 E:28646 ||| RB
notably  ||| S:28646 E:28654 ||| RB
different  ||| S:28654 E:28664 ||| JJ
from  ||| S:28664 E:28669 ||| IN
those  ||| S:28669 E:28675 ||| DT
for  ||| S:28675 E:28679 ||| IN
Boi1-S-GFP  ||| S:28679 E:28700 ||| NNP
( ||| S:28700 E:28701 ||| -LRB-
Figs.  ||| S:28701 E:28707 ||| NNP
8A ||| S:28707 E:28709 ||| NNP
, ||| S:28709 E:28710 ||| ,
8B ||| S:28710 E:28712 ||| NNP
, ||| S:28712 E:28713 ||| ,
8C ||| S:28713 E:28715 ||| CD
) ||| S:28715 E:28716 ||| -RRB-
,  ||| S:28716 E:28718 ||| ,
suggesting  ||| S:28718 E:28729 ||| VBG
that  ||| S:28729 E:28734 ||| IN
the  ||| S:28734 E:28738 ||| DT
proline-rich  ||| S:28738 E:28751 ||| JJ
region  ||| S:28751 E:28768 ||| NN
is  ||| S:28768 E:28771 ||| VBZ
not  ||| S:28771 E:28775 ||| RB
important  ||| S:28775 E:28785 ||| JJ
for  ||| S:28785 E:28789 ||| IN
any  ||| S:28789 E:28793 ||| DT
of  ||| S:28793 E:28796 ||| IN
the  ||| S:28796 E:28800 ||| DT
observed  ||| S:28800 E:28809 ||| JJ
patterns  ||| S:28809 E:28818 ||| NNS
of  ||| S:28818 E:28831 ||| IN
localization  ||| S:28831 E:28844 ||| NN
of  ||| S:28844 E:28847 ||| IN
Boi1-GFP ||| S:28847 E:28855 ||| CD
.  ||| S:28855 E:28888 ||| .
Discussion  ||| S:28888 E:28918 ||| NNP
Binding  ||| S:28918 E:28926 ||| NNP
to  ||| S:28926 E:28929 ||| TO
phospholipids  ||| S:28929 E:28953 ||| CD
Boi1-PH  ||| S:28953 E:28961 ||| CD
co-sediments  ||| S:28961 E:28974 ||| NN
with  ||| S:28974 E:28979 ||| IN
PS  ||| S:28979 E:28982 ||| NNP
vesicles ||| S:28982 E:28990 ||| NN
,  ||| S:28990 E:28992 ||| ,
suggesting  ||| S:28992 E:29003 ||| VBG
that  ||| S:29003 E:29018 ||| IN
Boi1 ||| S:29018 E:29022 ||| NNP
's  ||| S:29022 E:29025 ||| POS
PH  ||| S:29025 E:29028 ||| NNP
domain  ||| S:29028 E:29035 ||| NN
can  ||| S:29035 E:29039 ||| MD
bind  ||| S:29039 E:29044 ||| VB
PS ||| S:29044 E:29046 ||| NNP
.  ||| S:29046 E:29048 ||| .
Boi1-PH  ||| S:29048 E:29056 ||| NNP
co-sediments  ||| S:29056 E:29069 ||| NNP
more  ||| S:29069 E:29084 ||| RBR
readily  ||| S:29084 E:29092 ||| RB
when  ||| S:29092 E:29097 ||| WRB
such  ||| S:29097 E:29102 ||| JJ
vesicles  ||| S:29102 E:29111 ||| NNS
contain  ||| S:29111 E:29119 ||| VBP
a  ||| S:29119 E:29121 ||| DT
small  ||| S:29121 E:29127 ||| JJ
percentage  ||| S:29127 E:29148 ||| NN
( ||| S:29148 E:29149 ||| -LRB-
5 ||| S:29149 E:29150 ||| CD
% ||| S:29150 E:29151 ||| NN
)  ||| S:29151 E:29153 ||| -RRB-
of  ||| S:29153 E:29156 ||| IN
PIP  ||| S:29156 E:29171 ||| NNP
2  ||| S:29171 E:29173 ||| CD
,  ||| S:29173 E:29175 ||| ,
suggesting  ||| S:29175 E:29186 ||| VBG
that  ||| S:29186 E:29191 ||| IN
Boi1-PH  ||| S:29191 E:29199 ||| NNP
also  ||| S:29199 E:29204 ||| RB
binds  ||| S:29204 E:29220 ||| JJ
PIP  ||| S:29220 E:29235 ||| NNP
2  ||| S:29235 E:29237 ||| CD
and  ||| S:29237 E:29241 ||| CC
that  ||| S:29241 E:29246 ||| IN
it  ||| S:29246 E:29249 ||| PRP
does  ||| S:29249 E:29254 ||| VBZ
so  ||| S:29254 E:29257 ||| RB
with  ||| S:29257 E:29262 ||| IN
higher  ||| S:29262 E:29279 ||| JJR
affinity  ||| S:29279 E:29288 ||| NN
than  ||| S:29288 E:29293 ||| IN
it  ||| S:29293 E:29296 ||| PRP
binds  ||| S:29296 E:29302 ||| VBD
PS ||| S:29302 E:29304 ||| NNP
.  ||| S:29304 E:29306 ||| .
Given  ||| S:29306 E:29312 ||| VBN
that  ||| S:29312 E:29317 ||| IN
PIP  ||| S:29317 E:29332 ||| NNP
2  ||| S:29332 E:29334 ||| CD
and  ||| S:29334 E:29338 ||| CC
PS  ||| S:29338 E:29341 ||| NNP
are  ||| S:29341 E:29345 ||| VBP
negatively  ||| S:29345 E:29356 ||| RB
charged  ||| S:29356 E:29364 ||| VBN
( ||| S:29364 E:29365 ||| -LRB-
with  ||| S:29365 E:29380 ||| IN
PIP  ||| S:29380 E:29395 ||| NNP
2  ||| S:29395 E:29397 ||| CD
being  ||| S:29397 E:29403 ||| VBG
more  ||| S:29403 E:29408 ||| RBR
negatively  ||| S:29408 E:29419 ||| RB
charged  ||| S:29419 E:29427 ||| VBN
than  ||| S:29427 E:29442 ||| IN
PS ||| S:29442 E:29444 ||| NNP
) ||| S:29444 E:29445 ||| -RRB-
,  ||| S:29445 E:29447 ||| ,
a  ||| S:29447 E:29449 ||| DT
model  ||| S:29449 E:29455 ||| NN
to  ||| S:29455 E:29458 ||| TO
account  ||| S:29458 E:29466 ||| VB
for  ||| S:29466 E:29470 ||| IN
these  ||| S:29470 E:29476 ||| DT
binding  ||| S:29476 E:29484 ||| JJ
behaviors  ||| S:29484 E:29494 ||| NN
is  ||| S:29494 E:29507 ||| VBZ
that  ||| S:29507 E:29512 ||| IN
Boi1 ||| S:29512 E:29516 ||| NNP
's  ||| S:29516 E:29519 ||| POS
PH  ||| S:29519 E:29522 ||| NNP
domain  ||| S:29522 E:29529 ||| NN
binds  ||| S:29529 E:29535 ||| NN
in  ||| S:29535 E:29538 ||| IN
a  ||| S:29538 E:29540 ||| DT
non-specific  ||| S:29540 E:29553 ||| JJ
manner  ||| S:29553 E:29560 ||| NN
to  ||| S:29560 E:29573 ||| TO
negatively  ||| S:29573 E:29584 ||| VB
charged  ||| S:29584 E:29592 ||| VBN
surfaces ||| S:29592 E:29600 ||| NN
.  ||| S:29600 E:29602 ||| .
The  ||| S:29602 E:29606 ||| DT
ability  ||| S:29606 E:29614 ||| NN
to  ||| S:29614 E:29617 ||| TO
bind  ||| S:29617 E:29632 ||| VB
different  ||| S:29632 E:29642 ||| JJ
acidic  ||| S:29642 E:29649 ||| JJ
phospholipids  ||| S:29649 E:29663 ||| NN
appears  ||| S:29663 E:29671 ||| VBZ
to  ||| S:29671 E:29674 ||| TO
be  ||| S:29674 E:29677 ||| VB
a  ||| S:29677 E:29679 ||| DT
fairly  ||| S:29679 E:29696 ||| RB
common  ||| S:29696 E:29703 ||| JJ
attribute  ||| S:29703 E:29713 ||| NN
of  ||| S:29713 E:29716 ||| IN
PH  ||| S:29716 E:29719 ||| NNP
domains  ||| S:29719 E:29727 ||| NNS
[  ||| S:29727 E:29729 ||| -LRB-
11  ||| S:29729 E:29732 ||| CD
12  ||| S:29732 E:29735 ||| CD
]  ||| S:29735 E:29737 ||| -RRB-
.  ||| S:29737 E:29739 ||| .
For  ||| S:29739 E:29743 ||| IN
example ||| S:29743 E:29750 ||| NN
,  ||| S:29750 E:29762 ||| ,
five  ||| S:29762 E:29767 ||| CD
out  ||| S:29767 E:29771 ||| IN
of  ||| S:29771 E:29774 ||| IN
ten  ||| S:29774 E:29778 ||| JJ
PH  ||| S:29778 E:29781 ||| NNP
domains  ||| S:29781 E:29789 ||| NN
in  ||| S:29789 E:29792 ||| IN
one  ||| S:29792 E:29796 ||| CD
study  ||| S:29796 E:29802 ||| NN
were  ||| S:29802 E:29807 ||| VBD
judged  ||| S:29807 E:29814 ||| VBN
to  ||| S:29814 E:29827 ||| TO
bind  ||| S:29827 E:29832 ||| VB
to  ||| S:29832 E:29835 ||| TO
PS  ||| S:29835 E:29838 ||| NNP
with  ||| S:29838 E:29843 ||| IN
affinity  ||| S:29843 E:29852 ||| JJ
similar  ||| S:29852 E:29860 ||| JJ
to  ||| S:29860 E:29863 ||| TO
that  ||| S:29863 E:29868 ||| DT
for  ||| S:29868 E:29872 ||| IN
PIP  ||| S:29872 E:29887 ||| NNP
2  ||| S:29887 E:29889 ||| CD
and  ||| S:29889 E:29893 ||| CC
other  ||| S:29893 E:29899 ||| JJ
inositol-based  ||| S:29899 E:29924 ||| JJ
phospholipids ||| S:29924 E:29937 ||| NN
,  ||| S:29937 E:29939 ||| ,
suggesting  ||| S:29939 E:29950 ||| VBG
that  ||| S:29950 E:29955 ||| IN
many  ||| S:29955 E:29960 ||| JJ
PH  ||| S:29960 E:29963 ||| FW
domains  ||| S:29963 E:29971 ||| FW
bind  ||| S:29971 E:29986 ||| FW
promiscuously  ||| S:29986 E:30000 ||| FW
to  ||| S:30000 E:30003 ||| TO
negatively  ||| S:30003 E:30014 ||| VB
charged  ||| S:30014 E:30022 ||| VBN
phospholipids  ||| S:30022 E:30036 ||| NNS
[  ||| S:30036 E:30038 ||| -LRB-
11  ||| S:30038 E:30041 ||| CD
]  ||| S:30041 E:30053 ||| -RRB-
.  ||| S:30053 E:30065 ||| .
Findings  ||| S:30065 E:30074 ||| NNS
from  ||| S:30074 E:30079 ||| IN
protease-sensitivity  ||| S:30079 E:30100 ||| JJ
analyses  ||| S:30100 E:30109 ||| NNS
suggest  ||| S:30109 E:30127 ||| VBP
that  ||| S:30127 E:30132 ||| IN
Boi1-PH  ||| S:30132 E:30140 ||| CD
binds  ||| S:30140 E:30146 ||| NN
in  ||| S:30146 E:30149 ||| IN
a  ||| S:30149 E:30151 ||| DT
different  ||| S:30151 E:30161 ||| JJ
manner  ||| S:30161 E:30168 ||| NN
to  ||| S:30168 E:30171 ||| TO
PIP  ||| S:30171 E:30186 ||| NNP
2  ||| S:30186 E:30188 ||| CD
than  ||| S:30188 E:30193 ||| IN
to  ||| S:30193 E:30196 ||| TO
PS ||| S:30196 E:30198 ||| NNP
,  ||| S:30198 E:30200 ||| ,
however ||| S:30200 E:30207 ||| RB
.  ||| S:30207 E:30209 ||| .
Specifically ||| S:30209 E:30221 ||| RB
,  ||| S:30221 E:30233 ||| ,
proteolysis  ||| S:30233 E:30245 ||| VBG
of  ||| S:30245 E:30248 ||| IN
Boi1-PH  ||| S:30248 E:30256 ||| NNP
was  ||| S:30256 E:30260 ||| VBD
stimulated  ||| S:30260 E:30271 ||| VBN
by  ||| S:30271 E:30274 ||| IN
PIP  ||| S:30274 E:30289 ||| NNP
2  ||| S:30289 E:30291 ||| CD
/ ||| S:30291 E:30292 ||| CD
PS  ||| S:30292 E:30295 ||| NNP
mixed  ||| S:30295 E:30301 ||| JJ
vesicles  ||| S:30301 E:30310 ||| NN
but  ||| S:30310 E:30314 ||| CC
not  ||| S:30314 E:30318 ||| RB
by  ||| S:30318 E:30331 ||| IN
vesicles  ||| S:30331 E:30340 ||| NNS
that  ||| S:30340 E:30345 ||| WDT
contained  ||| S:30345 E:30355 ||| VBD
only  ||| S:30355 E:30360 ||| RB
PS ||| S:30360 E:30362 ||| NNP
.  ||| S:30362 E:30364 ||| .
For  ||| S:30364 E:30368 ||| IN
the  ||| S:30368 E:30372 ||| DT
following  ||| S:30372 E:30392 ||| JJ
reasons ||| S:30392 E:30399 ||| NNS
,  ||| S:30399 E:30401 ||| ,
we  ||| S:30401 E:30404 ||| PRP
think  ||| S:30404 E:30410 ||| VBP
that  ||| S:30410 E:30415 ||| IN
the  ||| S:30415 E:30419 ||| DT
inability  ||| S:30419 E:30429 ||| NN
of  ||| S:30429 E:30432 ||| IN
PS ||| S:30432 E:30434 ||| NNP
,  ||| S:30434 E:30436 ||| ,
by  ||| S:30436 E:30439 ||| IN
itself ||| S:30439 E:30445 ||| PRP
,  ||| S:30445 E:30447 ||| ,
to  ||| S:30447 E:30460 ||| TO
stimulate  ||| S:30460 E:30470 ||| VB
the  ||| S:30470 E:30474 ||| DT
proteolysis  ||| S:30474 E:30486 ||| NN
of  ||| S:30486 E:30489 ||| IN
PIP  ||| S:30489 E:30504 ||| NNP
2  ||| S:30504 E:30506 ||| CD
is  ||| S:30506 E:30509 ||| VBZ
not  ||| S:30509 E:30513 ||| RB
due  ||| S:30513 E:30517 ||| JJ
to  ||| S:30517 E:30520 ||| TO
an  ||| S:30520 E:30523 ||| DT
inability  ||| S:30523 E:30533 ||| NN
of  ||| S:30533 E:30536 ||| IN
PS  ||| S:30536 E:30539 ||| NNP
to  ||| S:30539 E:30552 ||| TO
bind  ||| S:30552 E:30557 ||| VB
to  ||| S:30557 E:30560 ||| TO
Boi1-PH ||| S:30560 E:30567 ||| CD
.  ||| S:30567 E:30569 ||| .
First ||| S:30569 E:30574 ||| NNP
,  ||| S:30574 E:30576 ||| ,
the  ||| S:30576 E:30580 ||| DT
ability  ||| S:30580 E:30588 ||| NN
of  ||| S:30588 E:30591 ||| IN
PIP  ||| S:30591 E:30606 ||| NNP
2  ||| S:30606 E:30608 ||| CD
to  ||| S:30608 E:30611 ||| TO
stimulate  ||| S:30611 E:30621 ||| VB
proteolysis  ||| S:30621 E:30633 ||| VBN
of  ||| S:30633 E:30636 ||| IN
Boi1-PH  ||| S:30636 E:30654 ||| NNP
was  ||| S:30654 E:30658 ||| VBD
greatly  ||| S:30658 E:30666 ||| RB
enhanced  ||| S:30666 E:30675 ||| VBN
when  ||| S:30675 E:30680 ||| WRB
using  ||| S:30680 E:30686 ||| VBG
PS  ||| S:30686 E:30689 ||| NNP
( ||| S:30689 E:30690 ||| -LRB-
rather  ||| S:30690 E:30697 ||| RB
than  ||| S:30697 E:30702 ||| IN
PC ||| S:30702 E:30704 ||| NN
)  ||| S:30704 E:30706 ||| -RRB-
as  ||| S:30706 E:30719 ||| IN
the  ||| S:30719 E:30723 ||| DT
bulk  ||| S:30723 E:30728 ||| JJ
lipid  ||| S:30728 E:30734 ||| NN
in  ||| S:30734 E:30737 ||| IN
the  ||| S:30737 E:30741 ||| DT
vesicles ||| S:30741 E:30749 ||| NN
,  ||| S:30749 E:30751 ||| ,
suggesting  ||| S:30751 E:30762 ||| VBG
that  ||| S:30762 E:30767 ||| IN
PS  ||| S:30767 E:30770 ||| NNP
binds  ||| S:30770 E:30786 ||| VBD
to  ||| S:30786 E:30789 ||| TO
Boi1-PH  ||| S:30789 E:30797 ||| CD
in  ||| S:30797 E:30800 ||| IN
this  ||| S:30800 E:30805 ||| DT
analysis ||| S:30805 E:30813 ||| NN
.  ||| S:30813 E:30815 ||| .
Second ||| S:30815 E:30821 ||| LS
,  ||| S:30821 E:30823 ||| ,
the  ||| S:30823 E:30827 ||| DT
proteolysis  ||| S:30827 E:30849 ||| JJ
analysis  ||| S:30849 E:30858 ||| NN
was  ||| S:30858 E:30862 ||| VBD
conducted  ||| S:30862 E:30872 ||| VBN
in  ||| S:30872 E:30875 ||| IN
conditions  ||| S:30875 E:30886 ||| NNS
that  ||| S:30886 E:30891 ||| WDT
were  ||| S:30891 E:30896 ||| VBD
very  ||| S:30896 E:30911 ||| RB
similar  ||| S:30911 E:30919 ||| JJ
to  ||| S:30919 E:30922 ||| TO
those  ||| S:30922 E:30928 ||| DT
used  ||| S:30928 E:30933 ||| VBN
in  ||| S:30933 E:30936 ||| IN
the  ||| S:30936 E:30940 ||| DT
vesicle  ||| S:30940 E:30948 ||| JJ
co-sedimentation  ||| S:30948 E:30975 ||| JJ
analysis ||| S:30975 E:30983 ||| NN
,  ||| S:30983 E:30985 ||| ,
in  ||| S:30985 E:30988 ||| IN
which  ||| S:30988 E:30994 ||| WDT
Boi1-PH  ||| S:30994 E:31002 ||| NNP
was  ||| S:31002 E:31006 ||| VBD
found  ||| S:31006 E:31012 ||| VBN
to  ||| S:31012 E:31015 ||| TO
bind  ||| S:31015 E:31020 ||| VB
readily  ||| S:31020 E:31028 ||| RB
to  ||| S:31028 E:31041 ||| TO
PS ||| S:31041 E:31043 ||| NNP
.  ||| S:31043 E:31045 ||| .
These  ||| S:31045 E:31051 ||| DT
findings  ||| S:31051 E:31060 ||| NNS
suggest  ||| S:31060 E:31068 ||| VBP
that ||| S:31068 E:31072 ||| RB
,  ||| S:31072 E:31074 ||| ,
in  ||| S:31074 E:31077 ||| IN
conditions  ||| S:31077 E:31088 ||| NNS
in  ||| S:31088 E:31091 ||| IN
which  ||| S:31091 E:31107 ||| WDT
both  ||| S:31107 E:31112 ||| DT
PS  ||| S:31112 E:31115 ||| NNP
and  ||| S:31115 E:31119 ||| CC
PIP  ||| S:31119 E:31134 ||| NNP
2  ||| S:31134 E:31136 ||| CD
bind  ||| S:31136 E:31141 ||| NN
to  ||| S:31141 E:31144 ||| TO
Boi1-PH ||| S:31144 E:31151 ||| CD
,  ||| S:31151 E:31153 ||| ,
only  ||| S:31153 E:31158 ||| RB
PIP  ||| S:31158 E:31173 ||| NNP
2  ||| S:31173 E:31175 ||| CD
binds  ||| S:31175 E:31181 ||| NN
in  ||| S:31181 E:31184 ||| IN
a  ||| S:31184 E:31186 ||| DT
manner  ||| S:31186 E:31193 ||| NN
that  ||| S:31193 E:31198 ||| WDT
triggers  ||| S:31198 E:31207 ||| VBZ
the  ||| S:31207 E:31221 ||| DT
exposure  ||| S:31221 E:31230 ||| NN
of  ||| S:31230 E:31233 ||| IN
a  ||| S:31233 E:31235 ||| DT
protease-sensitive  ||| S:31235 E:31254 ||| JJ
site ||| S:31254 E:31258 ||| NN
.  ||| S:31258 E:31270 ||| .
PIP  ||| S:31270 E:31285 ||| NNP
2  ||| S:31285 E:31287 ||| CD
was  ||| S:31287 E:31291 ||| VBD
not  ||| S:31291 E:31295 ||| RB
the  ||| S:31295 E:31299 ||| DT
only  ||| S:31299 E:31314 ||| JJ
phosphatidylinositide  ||| S:31314 E:31336 ||| NN
that  ||| S:31336 E:31341 ||| WDT
could  ||| S:31341 E:31347 ||| MD
stimulate  ||| S:31347 E:31357 ||| VB
proteolysis  ||| S:31357 E:31369 ||| VBN
of  ||| S:31369 E:31382 ||| IN
Boi1-PH ||| S:31382 E:31389 ||| CD
;  ||| S:31389 E:31391 ||| :
PI4P  ||| S:31391 E:31396 ||| CD
also  ||| S:31396 E:31401 ||| RB
did  ||| S:31401 E:31405 ||| VBD
so ||| S:31405 E:31407 ||| RB
,  ||| S:31407 E:31409 ||| ,
although  ||| S:31409 E:31418 ||| IN
less  ||| S:31418 E:31423 ||| RBR
effectively  ||| S:31423 E:31435 ||| RB
than  ||| S:31435 E:31450 ||| IN
did  ||| S:31450 E:31454 ||| VBD
PIP  ||| S:31454 E:31469 ||| NNP
2  ||| S:31469 E:31471 ||| CD
.  ||| S:31471 E:31473 ||| .
In  ||| S:31473 E:31476 ||| IN
contrast ||| S:31476 E:31484 ||| NN
,  ||| S:31484 E:31486 ||| ,
PI3P  ||| S:31486 E:31491 ||| NNP
and  ||| S:31491 E:31495 ||| CC
PI  ||| S:31495 E:31498 ||| NNP
were  ||| S:31498 E:31513 ||| VBD
comparatively  ||| S:31513 E:31527 ||| RB
ineffective  ||| S:31527 E:31539 ||| VBN
at  ||| S:31539 E:31542 ||| IN
stimulating  ||| S:31542 E:31554 ||| VBG
proteolysis ||| S:31554 E:31565 ||| NNS
.  ||| S:31565 E:31567 ||| .
The  ||| S:31567 E:31581 ||| DT
large  ||| S:31581 E:31587 ||| JJ
difference  ||| S:31587 E:31598 ||| NN
in  ||| S:31598 E:31601 ||| IN
the  ||| S:31601 E:31605 ||| DT
ability  ||| S:31605 E:31613 ||| NN
of  ||| S:31613 E:31616 ||| IN
PI4P  ||| S:31616 E:31621 ||| FW
versus  ||| S:31621 E:31628 ||| FW
PI3P  ||| S:31628 E:31633 ||| FW
to  ||| S:31633 E:31646 ||| TO
stimulate  ||| S:31646 E:31656 ||| VB
proteolysis  ||| S:31656 E:31668 ||| NN
supports  ||| S:31668 E:31677 ||| VBZ
the  ||| S:31677 E:31681 ||| DT
view  ||| S:31681 E:31686 ||| NN
that  ||| S:31686 E:31691 ||| IN
Boi1 ||| S:31691 E:31695 ||| NNP
's  ||| S:31695 E:31698 ||| POS
PH  ||| S:31698 E:31711 ||| NNP
domain  ||| S:31711 E:31718 ||| NN
can  ||| S:31718 E:31722 ||| MD
discriminate  ||| S:31722 E:31735 ||| VB
between  ||| S:31735 E:31743 ||| IN
different  ||| S:31743 E:31753 ||| JJ
phosphorylated  ||| S:31753 E:31778 ||| JJ
versions  ||| S:31778 E:31787 ||| NNS
of  ||| S:31787 E:31790 ||| IN
PI  ||| S:31790 E:31793 ||| NNP
in  ||| S:31793 E:31796 ||| IN
some  ||| S:31796 E:31801 ||| DT
manner  ||| S:31801 E:31808 ||| NN
that  ||| S:31808 E:31813 ||| WDT
involves  ||| S:31813 E:31822 ||| VBZ
more  ||| S:31822 E:31827 ||| JJR
than  ||| S:31827 E:31842 ||| IN
simply  ||| S:31842 E:31849 ||| RB
recognizing  ||| S:31849 E:31861 ||| VBG
net  ||| S:31861 E:31865 ||| JJ
charge ||| S:31865 E:31871 ||| NN
.  ||| S:31871 E:31901 ||| .
Residues  ||| S:31901 E:31910 ||| NNS
implicated  ||| S:31910 E:31921 ||| VBN
in  ||| S:31921 E:31924 ||| IN
binding  ||| S:31924 E:31932 ||| VBG
to  ||| S:31932 E:31945 ||| TO
phospholipid  ||| S:31945 E:31968 ||| VB
The  ||| S:31968 E:31972 ||| DT
KK ||| S:31972 E:31974 ||| NNP
,  ||| S:31974 E:31976 ||| ,
TK ||| S:31976 E:31978 ||| NNP
,  ||| S:31978 E:31980 ||| ,
and  ||| S:31980 E:31984 ||| CC
KKTK  ||| S:31984 E:31989 ||| NNP
mutant  ||| S:31989 E:31996 ||| JJ
versions  ||| S:31996 E:32005 ||| NNS
of  ||| S:32005 E:32008 ||| IN
Boi1-PH  ||| S:32008 E:32026 ||| NNP
contain  ||| S:32026 E:32034 ||| VBP
substitutions  ||| S:32034 E:32048 ||| VBN
at  ||| S:32048 E:32051 ||| IN
positions  ||| S:32051 E:32061 ||| NNS
in  ||| S:32061 E:32064 ||| IN
the  ||| S:32064 E:32068 ||| DT
PH  ||| S:32068 E:32071 ||| NNP
domain  ||| S:32071 E:32078 ||| NN
that  ||| S:32078 E:32093 ||| WDT
were  ||| S:32093 E:32098 ||| VBD
predicted  ||| S:32098 E:32108 ||| VBN
to  ||| S:32108 E:32111 ||| TO
be  ||| S:32111 E:32114 ||| VB
involved  ||| S:32114 E:32123 ||| VBN
in  ||| S:32123 E:32126 ||| IN
binding  ||| S:32126 E:32134 ||| JJ
PIP  ||| S:32134 E:32149 ||| NNP
2  ||| S:32149 E:32151 ||| CD
.  ||| S:32151 E:32153 ||| .
PIP  ||| S:32153 E:32168 ||| NNP
2  ||| S:32168 E:32170 ||| CD
/ ||| S:32170 E:32171 ||| CD
PS  ||| S:32171 E:32174 ||| NNP
vesicles  ||| S:32174 E:32183 ||| NN
did  ||| S:32183 E:32187 ||| VBD
not  ||| S:32187 E:32191 ||| RB
stimulate  ||| S:32191 E:32201 ||| VB
the  ||| S:32201 E:32215 ||| DT
proteolysis  ||| S:32215 E:32227 ||| NN
of  ||| S:32227 E:32230 ||| IN
any  ||| S:32230 E:32234 ||| DT
of  ||| S:32234 E:32237 ||| IN
these  ||| S:32237 E:32243 ||| DT
mutant  ||| S:32243 E:32250 ||| JJ
versions  ||| S:32250 E:32259 ||| NNS
of  ||| S:32259 E:32262 ||| IN
Boi1-PH ||| S:32262 E:32269 ||| NNP
,  ||| S:32269 E:32281 ||| ,
suggesting  ||| S:32281 E:32292 ||| VBG
that  ||| S:32292 E:32297 ||| IN
each  ||| S:32297 E:32302 ||| DT
mutant  ||| S:32302 E:32309 ||| NN
is  ||| S:32309 E:32312 ||| VBZ
indeed  ||| S:32312 E:32319 ||| RB
impaired  ||| S:32319 E:32328 ||| VBN
in  ||| S:32328 E:32331 ||| IN
the  ||| S:32331 E:32345 ||| DT
ability  ||| S:32345 E:32353 ||| NN
to  ||| S:32353 E:32356 ||| TO
associate  ||| S:32356 E:32366 ||| NN
with  ||| S:32366 E:32371 ||| IN
PIP  ||| S:32371 E:32386 ||| NNP
2  ||| S:32386 E:32388 ||| CD
and ||| S:32388 E:32391 ||| CC
/ ||| S:32391 E:32392 ||| NNP
or  ||| S:32392 E:32395 ||| CC
PS ||| S:32395 E:32397 ||| NNP
.  ||| S:32397 E:32409 ||| .
Vesicle  ||| S:32409 E:32417 ||| JJ
co-sedimentation  ||| S:32417 E:32434 ||| JJ
analyses  ||| S:32434 E:32443 ||| NNS
also  ||| S:32443 E:32448 ||| RB
suggest  ||| S:32448 E:32456 ||| VB
that  ||| S:32456 E:32471 ||| IN
each  ||| S:32471 E:32476 ||| DT
mutant  ||| S:32476 E:32483 ||| JJ
version  ||| S:32483 E:32491 ||| NN
of  ||| S:32491 E:32494 ||| IN
Boi1-PH  ||| S:32494 E:32502 ||| NNP
is  ||| S:32502 E:32505 ||| VBZ
impaired  ||| S:32505 E:32514 ||| VBN
in  ||| S:32514 E:32517 ||| IN
the  ||| S:32517 E:32521 ||| DT
ability  ||| S:32521 E:32539 ||| NN
to  ||| S:32539 E:32542 ||| TO
bind  ||| S:32542 E:32547 ||| VB
PIP  ||| S:32547 E:32562 ||| NNP
2  ||| S:32562 E:32564 ||| CD
/ ||| S:32564 E:32565 ||| CD
PS  ||| S:32565 E:32568 ||| NNP
vesicles ||| S:32568 E:32576 ||| NN
.  ||| S:32576 E:32578 ||| .
However ||| S:32578 E:32585 ||| RB
,  ||| S:32585 E:32587 ||| ,
these  ||| S:32587 E:32603 ||| DT
analyses  ||| S:32603 E:32612 ||| NNS
suggest  ||| S:32612 E:32620 ||| VBP
that  ||| S:32620 E:32625 ||| IN
the  ||| S:32625 E:32629 ||| DT
KK  ||| S:32629 E:32632 ||| NNP
substitutions  ||| S:32632 E:32646 ||| NN
may  ||| S:32646 E:32650 ||| MD
impair  ||| S:32650 E:32667 ||| VB
binding  ||| S:32667 E:32675 ||| VBN
in  ||| S:32675 E:32678 ||| IN
a  ||| S:32678 E:32680 ||| DT
different  ||| S:32680 E:32690 ||| JJ
manner  ||| S:32690 E:32697 ||| NN
than  ||| S:32697 E:32702 ||| IN
do  ||| S:32702 E:32705 ||| VBP
the  ||| S:32705 E:32709 ||| DT
TK  ||| S:32709 E:32722 ||| NNP
substitutions ||| S:32722 E:32735 ||| NN
.  ||| S:32735 E:32737 ||| .
In  ||| S:32737 E:32740 ||| IN
particular ||| S:32740 E:32750 ||| JJ
,  ||| S:32750 E:32752 ||| ,
the  ||| S:32752 E:32756 ||| DT
co-sedimentation  ||| S:32756 E:32783 ||| JJ
analyses  ||| S:32783 E:32792 ||| NNS
suggest  ||| S:32792 E:32800 ||| VBP
that  ||| S:32800 E:32805 ||| IN
the  ||| S:32805 E:32809 ||| DT
TK  ||| S:32809 E:32812 ||| NNP
mutant  ||| S:32812 E:32819 ||| NN
may  ||| S:32819 E:32823 ||| MD
be  ||| S:32823 E:32826 ||| VB
severely  ||| S:32826 E:32845 ||| RB
impaired  ||| S:32845 E:32854 ||| VBN
in  ||| S:32854 E:32857 ||| IN
the  ||| S:32857 E:32861 ||| DT
ability  ||| S:32861 E:32869 ||| NN
to  ||| S:32869 E:32872 ||| TO
bind  ||| S:32872 E:32877 ||| VB
acidic  ||| S:32877 E:32884 ||| JJ
phospholipids  ||| S:32884 E:32908 ||| NNS
generally ||| S:32908 E:32917 ||| RB
.  ||| S:32917 E:32919 ||| .
In  ||| S:32919 E:32922 ||| IN
contrast ||| S:32922 E:32930 ||| NN
,  ||| S:32930 E:32932 ||| ,
the  ||| S:32932 E:32936 ||| DT
KK  ||| S:32936 E:32939 ||| NNP
mutant  ||| S:32939 E:32946 ||| NN
appears  ||| S:32946 E:32954 ||| VBZ
to  ||| S:32954 E:32957 ||| TO
be  ||| S:32957 E:32970 ||| VB
impaired  ||| S:32970 E:32979 ||| VBN
more  ||| S:32979 E:32984 ||| JJR
in  ||| S:32984 E:32987 ||| IN
the  ||| S:32987 E:32991 ||| DT
ability  ||| S:32991 E:32999 ||| NN
to  ||| S:32999 E:33002 ||| TO
recognize  ||| S:33002 E:33012 ||| VB
specifically  ||| S:33012 E:33035 ||| RB
PIP  ||| S:33035 E:33050 ||| NNP
2  ||| S:33050 E:33052 ||| CD
than  ||| S:33052 E:33057 ||| IN
in  ||| S:33057 E:33060 ||| IN
the  ||| S:33060 E:33064 ||| DT
ability  ||| S:33064 E:33072 ||| NN
to  ||| S:33072 E:33075 ||| TO
bind  ||| S:33075 E:33090 ||| VB
non-specifically  ||| S:33090 E:33107 ||| JJ
to  ||| S:33107 E:33110 ||| TO
acidic  ||| S:33110 E:33117 ||| VB
phospholipids ||| S:33117 E:33130 ||| NNS
.  ||| S:33130 E:33160 ||| .
Significance  ||| S:33160 E:33173 ||| NN
of  ||| S:33173 E:33176 ||| IN
binding  ||| S:33176 E:33184 ||| VBG
to  ||| S:33184 E:33187 ||| TO
phospholipids  ||| S:33187 E:33211 ||| VB
Based  ||| S:33211 E:33217 ||| VBN
on  ||| S:33217 E:33220 ||| IN
colony-sectoring  ||| S:33220 E:33237 ||| JJ
analyses ||| S:33237 E:33245 ||| NNS
,  ||| S:33245 E:33247 ||| ,
the  ||| S:33247 E:33251 ||| DT
KK ||| S:33251 E:33253 ||| NNP
,  ||| S:33253 E:33255 ||| ,
TK ||| S:33255 E:33257 ||| NNP
,  ||| S:33257 E:33259 ||| ,
and  ||| S:33259 E:33273 ||| CC
KKTK  ||| S:33273 E:33278 ||| NNP
mutant  ||| S:33278 E:33285 ||| JJ
versions  ||| S:33285 E:33294 ||| NNS
of  ||| S:33294 E:33297 ||| IN
Boi1  ||| S:33297 E:33302 ||| NNP
are  ||| S:33302 E:33306 ||| VBP
all  ||| S:33306 E:33310 ||| RB
impaired  ||| S:33310 E:33319 ||| VBN
in  ||| S:33319 E:33332 ||| IN
function ||| S:33332 E:33340 ||| NN
.  ||| S:33340 E:33342 ||| .
The  ||| S:33342 E:33346 ||| DT
KK  ||| S:33346 E:33349 ||| NNP
( ||| S:33349 E:33350 ||| -LRB-
as  ||| S:33350 E:33353 ||| RB
well  ||| S:33353 E:33358 ||| RB
as  ||| S:33358 E:33361 ||| IN
the  ||| S:33361 E:33365 ||| DT
KKTK ||| S:33365 E:33369 ||| NNP
)  ||| S:33369 E:33371 ||| -RRB-
version  ||| S:33371 E:33379 ||| NN
of  ||| S:33379 E:33382 ||| IN
Boi1  ||| S:33382 E:33397 ||| NNP
appeared  ||| S:33397 E:33406 ||| VBD
to  ||| S:33406 E:33409 ||| TO
be  ||| S:33409 E:33412 ||| VB
completely  ||| S:33412 E:33423 ||| RB
non-functional ||| S:33423 E:33437 ||| JJ
,  ||| S:33437 E:33439 ||| ,
pointing  ||| S:33439 E:33448 ||| VBG
to  ||| S:33448 E:33451 ||| TO
the  ||| S:33451 E:33465 ||| DT
possibility  ||| S:33465 E:33477 ||| NN
that  ||| S:33477 E:33482 ||| IN
binding  ||| S:33482 E:33490 ||| VBG
specifically  ||| S:33490 E:33503 ||| RB
to  ||| S:33503 E:33506 ||| TO
PIP  ||| S:33506 E:33521 ||| NNP
2  ||| S:33521 E:33523 ||| CD
( ||| S:33523 E:33524 ||| -LRB-
as  ||| S:33524 E:33527 ||| RB
opposed  ||| S:33527 E:33535 ||| VBN
to  ||| S:33535 E:33538 ||| TO
binding  ||| S:33538 E:33546 ||| VB
to  ||| S:33546 E:33549 ||| TO
acidic  ||| S:33549 E:33566 ||| VB
phospholipids  ||| S:33566 E:33580 ||| VBN
generally ||| S:33580 E:33589 ||| RB
)  ||| S:33589 E:33591 ||| -RRB-
may  ||| S:33591 E:33595 ||| MD
be  ||| S:33595 E:33598 ||| VB
critical  ||| S:33598 E:33607 ||| JJ
for  ||| S:33607 E:33611 ||| IN
Boi1  ||| S:33611 E:33626 ||| CD
function ||| S:33626 E:33634 ||| NN
.  ||| S:33634 E:33646 ||| .
Fusion  ||| S:33646 E:33653 ||| NN
to  ||| S:33653 E:33656 ||| TO
a  ||| S:33656 E:33658 ||| DT
myristoyl  ||| S:33658 E:33668 ||| JJ
group-accepting  ||| S:33668 E:33684 ||| JJ
sequence  ||| S:33684 E:33703 ||| NN
appeared  ||| S:33703 E:33712 ||| VBD
to  ||| S:33712 E:33715 ||| TO
completely  ||| S:33715 E:33726 ||| RB
restore  ||| S:33726 E:33734 ||| VB
function  ||| S:33734 E:33743 ||| NN
to  ||| S:33743 E:33746 ||| TO
Boi1-PH ||| S:33746 E:33753 ||| CD
( ||| S:33753 E:33754 ||| -LRB-
TK ||| S:33754 E:33756 ||| NNP
) ||| S:33756 E:33757 ||| -RRB-
,  ||| S:33757 E:33769 ||| ,
consistent  ||| S:33769 E:33780 ||| JJ
with  ||| S:33780 E:33785 ||| IN
the  ||| S:33785 E:33789 ||| DT
possibility  ||| S:33789 E:33801 ||| NN
that  ||| S:33801 E:33806 ||| IN
the  ||| S:33806 E:33810 ||| DT
TK  ||| S:33810 E:33813 ||| NNP
substitutions  ||| S:33813 E:33837 ||| NN
may  ||| S:33837 E:33841 ||| MD
affect  ||| S:33841 E:33848 ||| VB
primarily  ||| S:33848 E:33858 ||| RB
association  ||| S:33858 E:33870 ||| NN
with  ||| S:33870 E:33875 ||| IN
membrane ||| S:33875 E:33883 ||| NN
.  ||| S:33883 E:33885 ||| .
The  ||| S:33885 E:33899 ||| DT
myristoyl  ||| S:33899 E:33909 ||| JJ
group-accepting  ||| S:33909 E:33925 ||| JJ
sequence  ||| S:33925 E:33934 ||| NN
did  ||| S:33934 E:33938 ||| VBD
not  ||| S:33938 E:33942 ||| RB
completely  ||| S:33942 E:33963 ||| RB
restore  ||| S:33963 E:33971 ||| VB
function  ||| S:33971 E:33980 ||| NN
to  ||| S:33980 E:33983 ||| TO
the  ||| S:33983 E:33987 ||| DT
KK  ||| S:33987 E:33990 ||| NNP
and  ||| S:33990 E:33994 ||| CC
KKTK  ||| S:33994 E:33999 ||| NNP
versions  ||| S:33999 E:34008 ||| NNS
of  ||| S:34008 E:34011 ||| IN
Boi1-PH ||| S:34011 E:34018 ||| NNP
,  ||| S:34018 E:34030 ||| ,
however ||| S:34030 E:34037 ||| RB
,  ||| S:34037 E:34039 ||| ,
raising  ||| S:34039 E:34047 ||| VBG
the  ||| S:34047 E:34051 ||| DT
possibility  ||| S:34051 E:34063 ||| NN
that ||| S:34063 E:34067 ||| IN
,  ||| S:34067 E:34069 ||| ,
rather  ||| S:34069 E:34076 ||| RB
than  ||| S:34076 E:34081 ||| IN
simply  ||| S:34081 E:34098 ||| RB
promoting  ||| S:34098 E:34108 ||| VBG
general  ||| S:34108 E:34116 ||| JJ
association  ||| S:34116 E:34128 ||| NN
with  ||| S:34128 E:34133 ||| IN
membrane ||| S:34133 E:34141 ||| NN
,  ||| S:34141 E:34143 ||| ,
one  ||| S:34143 E:34147 ||| CD
role  ||| S:34147 E:34152 ||| NN
of  ||| S:34152 E:34165 ||| IN
binding  ||| S:34165 E:34173 ||| VBG
to  ||| S:34173 E:34176 ||| TO
PIP  ||| S:34176 E:34191 ||| NNP
2  ||| S:34191 E:34193 ||| CD
may  ||| S:34193 E:34197 ||| MD
be  ||| S:34197 E:34200 ||| VB
to  ||| S:34200 E:34203 ||| TO
regulate  ||| S:34203 E:34212 ||| VB
some  ||| S:34212 E:34217 ||| DT
other  ||| S:34217 E:34233 ||| JJ
behavior  ||| S:34233 E:34242 ||| NN
of  ||| S:34242 E:34245 ||| IN
Boi1  ||| S:34245 E:34250 ||| NNP
( ||| S:34250 E:34251 ||| -LRB-
e.g. ||| S:34251 E:34255 ||| NNP
,  ||| S:34255 E:34257 ||| ,
the  ||| S:34257 E:34261 ||| DT
binding  ||| S:34261 E:34269 ||| NN
of  ||| S:34269 E:34272 ||| IN
Boi1  ||| S:34272 E:34277 ||| CD
to  ||| S:34277 E:34280 ||| TO
some  ||| S:34280 E:34285 ||| DT
other  ||| S:34285 E:34301 ||| JJ
protein  ||| S:34301 E:34309 ||| NN
at  ||| S:34309 E:34312 ||| IN
the  ||| S:34312 E:34316 ||| DT
plasma  ||| S:34316 E:34323 ||| JJ
membrane ||| S:34323 E:34331 ||| NN
) ||| S:34331 E:34332 ||| -RRB-
.  ||| S:34332 E:34344 ||| .
If  ||| S:34344 E:34347 ||| IN
specific  ||| S:34347 E:34356 ||| JJ
binding  ||| S:34356 E:34364 ||| NN
to  ||| S:34364 E:34367 ||| TO
PIP  ||| S:34367 E:34382 ||| NNP
2  ||| S:34382 E:34384 ||| CD
( ||| S:34384 E:34385 ||| -LRB-
and ||| S:34385 E:34388 ||| CC
/ ||| S:34388 E:34389 ||| NNP
or  ||| S:34389 E:34392 ||| CC
to  ||| S:34392 E:34395 ||| TO
some  ||| S:34395 E:34400 ||| DT
other  ||| S:34400 E:34416 ||| JJ
phosphatidylinositide ||| S:34416 E:34437 ||| NN
,  ||| S:34437 E:34439 ||| ,
such  ||| S:34439 E:34444 ||| JJ
as  ||| S:34444 E:34447 ||| IN
PI4P ||| S:34447 E:34451 ||| CD
)  ||| S:34451 E:34453 ||| -RRB-
is  ||| S:34453 E:34456 ||| VBZ
critical  ||| S:34456 E:34465 ||| JJ
for  ||| S:34465 E:34469 ||| IN
Boi1  ||| S:34469 E:34484 ||| CD
function ||| S:34484 E:34492 ||| NN
,  ||| S:34492 E:34494 ||| ,
then  ||| S:34494 E:34499 ||| RB
how  ||| S:34499 E:34503 ||| WRB
could  ||| S:34503 E:34509 ||| MD
fusion  ||| S:34509 E:34516 ||| VB
to  ||| S:34516 E:34519 ||| TO
a  ||| S:34519 E:34521 ||| DT
myristoyl  ||| S:34521 E:34541 ||| JJ
group-accepting  ||| S:34541 E:34557 ||| JJ
sequence  ||| S:34557 E:34566 ||| NN
( ||| S:34566 E:34567 ||| -LRB-
i.e. ||| S:34567 E:34571 ||| FW
,  ||| S:34571 E:34573 ||| ,
to  ||| S:34573 E:34576 ||| TO
a  ||| S:34576 E:34588 ||| DT
membrane-localization  ||| S:34588 E:34610 ||| JJ
tag ||| S:34610 E:34613 ||| NN
)  ||| S:34613 E:34615 ||| -RRB-
improve  ||| S:34615 E:34623 ||| VB
the  ||| S:34623 E:34627 ||| DT
function  ||| S:34627 E:34636 ||| NN
of  ||| S:34636 E:34639 ||| IN
mutant  ||| S:34639 E:34656 ||| JJ
versions  ||| S:34656 E:34665 ||| NNS
of  ||| S:34665 E:34668 ||| IN
Boi1-PH  ||| S:34668 E:34676 ||| NNP
that  ||| S:34676 E:34681 ||| WDT
are  ||| S:34681 E:34685 ||| VBP
impaired  ||| S:34685 E:34694 ||| VBN
in  ||| S:34694 E:34697 ||| IN
the  ||| S:34697 E:34701 ||| DT
ability  ||| S:34701 E:34709 ||| NN
to  ||| S:34709 E:34722 ||| TO
bind  ||| S:34722 E:34727 ||| VB
PIP  ||| S:34727 E:34742 ||| NNP
2  ||| S:34742 E:34744 ||| CD
?  ||| S:34744 E:34746 ||| .
One  ||| S:34746 E:34750 ||| CD
possibility  ||| S:34750 E:34762 ||| NN
is  ||| S:34762 E:34765 ||| VBZ
that  ||| S:34765 E:34770 ||| IN
each  ||| S:34770 E:34775 ||| DT
of  ||| S:34775 E:34788 ||| IN
these  ||| S:34788 E:34794 ||| DT
mutant  ||| S:34794 E:34801 ||| JJ
versions  ||| S:34801 E:34810 ||| NNS
of  ||| S:34810 E:34813 ||| IN
Boi1  ||| S:34813 E:34818 ||| NNP
retains  ||| S:34818 E:34826 ||| VBZ
at  ||| S:34826 E:34829 ||| IN
least  ||| S:34829 E:34835 ||| JJS
a  ||| S:34835 E:34837 ||| DT
slight  ||| S:34837 E:34854 ||| JJ
affinity  ||| S:34854 E:34863 ||| NN
for  ||| S:34863 E:34867 ||| IN
PIP  ||| S:34867 E:34882 ||| NNP
2  ||| S:34882 E:34884 ||| CD
and  ||| S:34884 E:34888 ||| CC
that  ||| S:34888 E:34893 ||| IN
the  ||| S:34893 E:34897 ||| DT
myristoyl  ||| S:34897 E:34907 ||| JJ
group  ||| S:34907 E:34913 ||| NN
causes  ||| S:34913 E:34930 ||| VBZ
these  ||| S:34930 E:34936 ||| DT
mutant  ||| S:34936 E:34943 ||| JJ
PH  ||| S:34943 E:34946 ||| NNP
domains  ||| S:34946 E:34954 ||| VBD
to  ||| S:34954 E:34957 ||| TO
be  ||| S:34957 E:34960 ||| VB
apposed  ||| S:34960 E:34968 ||| JJ
close  ||| S:34968 E:34974 ||| NN
enough  ||| S:34974 E:34981 ||| RB
to  ||| S:34981 E:34984 ||| TO
the  ||| S:34984 E:34998 ||| DT
lipid  ||| S:34998 E:35004 ||| JJ
bilayer  ||| S:35004 E:35012 ||| NN
to  ||| S:35012 E:35015 ||| TO
enable  ||| S:35015 E:35022 ||| VB
the  ||| S:35022 E:35026 ||| DT
residual  ||| S:35026 E:35035 ||| JJ
PIP  ||| S:35035 E:35050 ||| NNP
2  ||| S:35050 E:35052 ||| CD
-binding  ||| S:35052 E:35061 ||| JJ
activity  ||| S:35061 E:35070 ||| NN
to  ||| S:35070 E:35073 ||| TO
now  ||| S:35073 E:35077 ||| RB
be  ||| S:35077 E:35090 ||| VB
sufficient  ||| S:35090 E:35101 ||| JJ
for  ||| S:35101 E:35105 ||| IN
binding  ||| S:35105 E:35113 ||| VBG
to  ||| S:35113 E:35116 ||| TO
PIP  ||| S:35116 E:35131 ||| NNP
2  ||| S:35131 E:35133 ||| CD
.  ||| S:35133 E:35135 ||| .
We  ||| S:35135 E:35138 ||| PRP
speculate  ||| S:35138 E:35148 ||| VBP
that ||| S:35148 E:35152 ||| RB
,  ||| S:35152 E:35154 ||| ,
just  ||| S:35154 E:35159 ||| RB
as  ||| S:35159 E:35162 ||| IN
binding  ||| S:35162 E:35180 ||| VBG
to  ||| S:35180 E:35183 ||| TO
PS  ||| S:35183 E:35186 ||| NNP
may  ||| S:35186 E:35190 ||| MD
serve  ||| S:35190 E:35196 ||| VB
to  ||| S:35196 E:35199 ||| TO
position  ||| S:35199 E:35208 ||| VB
the  ||| S:35208 E:35212 ||| DT
PH  ||| S:35212 E:35215 ||| NNP
domain  ||| S:35215 E:35222 ||| NN
of  ||| S:35222 E:35225 ||| IN
wild-type  ||| S:35225 E:35245 ||| JJ
Boi1  ||| S:35245 E:35250 ||| NN
near  ||| S:35250 E:35255 ||| IN
the  ||| S:35255 E:35259 ||| DT
plasma  ||| S:35259 E:35266 ||| JJ
membrane  ||| S:35266 E:35275 ||| NN
in  ||| S:35275 E:35278 ||| IN
a  ||| S:35278 E:35280 ||| DT
manner  ||| S:35280 E:35287 ||| NN
that  ||| S:35287 E:35302 ||| WDT
facilitates  ||| S:35302 E:35314 ||| VBP
binding  ||| S:35314 E:35322 ||| VBG
to  ||| S:35322 E:35325 ||| TO
PIP  ||| S:35325 E:35340 ||| NNP
2  ||| S:35340 E:35342 ||| CD
,  ||| S:35342 E:35344 ||| ,
the  ||| S:35344 E:35348 ||| DT
myristoyl  ||| S:35348 E:35358 ||| JJ
group  ||| S:35358 E:35364 ||| NN
may  ||| S:35364 E:35368 ||| MD
help  ||| S:35368 E:35373 ||| VB
to  ||| S:35373 E:35386 ||| TO
situate  ||| S:35386 E:35394 ||| VB
the  ||| S:35394 E:35398 ||| DT
PH  ||| S:35398 E:35401 ||| NNP
domain  ||| S:35401 E:35408 ||| NN
of  ||| S:35408 E:35411 ||| IN
the  ||| S:35411 E:35415 ||| DT
mutant  ||| S:35415 E:35422 ||| JJ
versions  ||| S:35422 E:35431 ||| NNS
of  ||| S:35431 E:35434 ||| IN
Boi1-PH  ||| S:35434 E:35452 ||| CD
at  ||| S:35452 E:35455 ||| IN
the  ||| S:35455 E:35459 ||| DT
plasma  ||| S:35459 E:35466 ||| JJ
membrane  ||| S:35466 E:35475 ||| NN
in  ||| S:35475 E:35478 ||| IN
a  ||| S:35478 E:35480 ||| DT
manner  ||| S:35480 E:35487 ||| NN
that  ||| S:35487 E:35492 ||| WDT
facilitates  ||| S:35492 E:35514 ||| VBP
binding  ||| S:35514 E:35522 ||| VBG
to  ||| S:35522 E:35525 ||| TO
PIP  ||| S:35525 E:35540 ||| NNP
2  ||| S:35540 E:35542 ||| CD
.  ||| S:35542 E:35554 ||| .
Although  ||| S:35554 E:35563 ||| IN
the  ||| S:35563 E:35567 ||| DT
myristoyl  ||| S:35567 E:35577 ||| JJ
group-accepting  ||| S:35577 E:35593 ||| JJ
sequence  ||| S:35593 E:35612 ||| NN
improved  ||| S:35612 E:35621 ||| VBD
the  ||| S:35621 E:35625 ||| DT
ability  ||| S:35625 E:35633 ||| NN
of  ||| S:35633 E:35636 ||| IN
the  ||| S:35636 E:35640 ||| DT
KK  ||| S:35640 E:35643 ||| NNP
mutant  ||| S:35643 E:35650 ||| JJ
version  ||| S:35650 E:35658 ||| NN
of  ||| S:35658 E:35661 ||| IN
Boi1-PH  ||| S:35661 E:35679 ||| CD
to  ||| S:35679 E:35682 ||| TO
function ||| S:35682 E:35690 ||| VB
,  ||| S:35690 E:35692 ||| ,
it  ||| S:35692 E:35695 ||| PRP
failed  ||| S:35695 E:35702 ||| VBD
to  ||| S:35702 E:35705 ||| TO
improve  ||| S:35705 E:35713 ||| VB
the  ||| S:35713 E:35717 ||| DT
function  ||| S:35717 E:35726 ||| NN
of  ||| S:35726 E:35729 ||| IN
the  ||| S:35729 E:35743 ||| DT
corresponding  ||| S:35743 E:35757 ||| JJ
mutant  ||| S:35757 E:35764 ||| JJ
version  ||| S:35764 E:35772 ||| NN
( ||| S:35772 E:35773 ||| -LRB-
KK ||| S:35773 E:35775 ||| NNP
)  ||| S:35775 E:35777 ||| -RRB-
of  ||| S:35777 E:35780 ||| IN
full-length  ||| S:35780 E:35792 ||| JJ
Boi1 ||| S:35792 E:35796 ||| NN
.  ||| S:35796 E:35808 ||| .
This  ||| S:35808 E:35813 ||| DT
finding  ||| S:35813 E:35821 ||| NN
is  ||| S:35821 E:35824 ||| VBZ
consistent  ||| S:35824 E:35835 ||| JJ
with  ||| S:35835 E:35840 ||| IN
the  ||| S:35840 E:35844 ||| DT
possibility  ||| S:35844 E:35856 ||| NN
that  ||| S:35856 E:35861 ||| IN
the  ||| S:35861 E:35875 ||| DT
ability  ||| S:35875 E:35883 ||| NN
of  ||| S:35883 E:35886 ||| IN
the  ||| S:35886 E:35890 ||| DT
myristoyl  ||| S:35890 E:35900 ||| JJ
group  ||| S:35900 E:35906 ||| NN
to  ||| S:35906 E:35909 ||| TO
improve  ||| S:35909 E:35917 ||| VB
function  ||| S:35917 E:35926 ||| NN
to  ||| S:35926 E:35929 ||| TO
a  ||| S:35929 E:35941 ||| DT
version  ||| S:35941 E:35949 ||| NN
of  ||| S:35949 E:35952 ||| IN
Boi1  ||| S:35952 E:35957 ||| NNP
that  ||| S:35957 E:35962 ||| WDT
is  ||| S:35962 E:35965 ||| VBZ
impaired  ||| S:35965 E:35974 ||| VBN
in  ||| S:35974 E:35977 ||| IN
the  ||| S:35977 E:35981 ||| DT
ability  ||| S:35981 E:35989 ||| NN
to  ||| S:35989 E:35992 ||| TO
bind  ||| S:35992 E:36007 ||| VB
phospholipids  ||| S:36007 E:36021 ||| NNS
may  ||| S:36021 E:36025 ||| MD
depend  ||| S:36025 E:36032 ||| VB
on  ||| S:36032 E:36035 ||| IN
the  ||| S:36035 E:36039 ||| DT
myristoyl  ||| S:36039 E:36049 ||| JJ
group  ||| S:36049 E:36055 ||| NN
being  ||| S:36055 E:36071 ||| VBG
near  ||| S:36071 E:36076 ||| IN
enough  ||| S:36076 E:36083 ||| JJ
to  ||| S:36083 E:36086 ||| TO
the  ||| S:36086 E:36090 ||| DT
PH  ||| S:36090 E:36093 ||| NNP
domain  ||| S:36093 E:36100 ||| NN
to  ||| S:36100 E:36103 ||| TO
be  ||| S:36103 E:36106 ||| VB
able  ||| S:36106 E:36111 ||| JJ
to  ||| S:36111 E:36114 ||| TO
promote  ||| S:36114 E:36122 ||| VB
a  ||| S:36122 E:36134 ||| DT
close  ||| S:36134 E:36140 ||| JJ
association  ||| S:36140 E:36152 ||| NN
with  ||| S:36152 E:36157 ||| IN
membrane  ||| S:36157 E:36166 ||| NN
of  ||| S:36166 E:36169 ||| IN
specifically  ||| S:36169 E:36182 ||| RB
the  ||| S:36182 E:36186 ||| DT
PH  ||| S:36186 E:36199 ||| NNP
domain  ||| S:36199 E:36206 ||| NN
portion  ||| S:36206 E:36214 ||| NN
of  ||| S:36214 E:36217 ||| IN
the  ||| S:36217 E:36221 ||| DT
protein ||| S:36221 E:36228 ||| NN
.  ||| S:36228 E:36258 ||| .
Localization  ||| S:36258 E:36271 ||| NNP
of  ||| S:36271 E:36274 ||| IN
Boi1  ||| S:36274 E:36289 ||| CD
A  ||| S:36289 E:36291 ||| DT
behavior  ||| S:36291 E:36300 ||| NN
of  ||| S:36300 E:36303 ||| IN
Boi1  ||| S:36303 E:36308 ||| NNP
that  ||| S:36308 E:36313 ||| WDT
is  ||| S:36313 E:36316 ||| VBZ
affected  ||| S:36316 E:36325 ||| VBN
by  ||| S:36325 E:36328 ||| IN
mutations  ||| S:36328 E:36338 ||| NNS
that  ||| S:36338 E:36353 ||| WDT
impair  ||| S:36353 E:36360 ||| VBP
binding  ||| S:36360 E:36368 ||| VBG
to  ||| S:36368 E:36371 ||| TO
phospholipids  ||| S:36371 E:36385 ||| NN
is  ||| S:36385 E:36388 ||| VBZ
the  ||| S:36388 E:36392 ||| DT
localization  ||| S:36392 E:36405 ||| NN
of  ||| S:36405 E:36418 ||| IN
Boi1  ||| S:36418 E:36423 ||| CD
to  ||| S:36423 E:36426 ||| TO
buds ||| S:36426 E:36430 ||| VB
.  ||| S:36430 E:36432 ||| .
These  ||| S:36432 E:36438 ||| DT
mutant  ||| S:36438 E:36445 ||| JJ
versions  ||| S:36445 E:36454 ||| NNS
of  ||| S:36454 E:36457 ||| IN
Boi1  ||| S:36457 E:36462 ||| NNP
still  ||| S:36462 E:36478 ||| RB
localize  ||| S:36478 E:36487 ||| VBN
to  ||| S:36487 E:36490 ||| TO
mother ||| S:36490 E:36496 ||| CD
/ ||| S:36496 E:36497 ||| CD
bud  ||| S:36497 E:36501 ||| CD
necks ||| S:36501 E:36506 ||| NNS
,  ||| S:36506 E:36508 ||| ,
however ||| S:36508 E:36515 ||| RB
.  ||| S:36515 E:36517 ||| .
In  ||| S:36517 E:36520 ||| IN
contrast ||| S:36520 E:36528 ||| NN
,  ||| S:36528 E:36530 ||| ,
a  ||| S:36530 E:36542 ||| DT
mutation  ||| S:36542 E:36551 ||| NN
in  ||| S:36551 E:36554 ||| IN
the  ||| S:36554 E:36558 ||| DT
SH3  ||| S:36558 E:36562 ||| JJ
domain  ||| S:36562 E:36569 ||| NN
prevents  ||| S:36569 E:36578 ||| VBZ
Boi1  ||| S:36578 E:36583 ||| CD
from  ||| S:36583 E:36588 ||| IN
localizing  ||| S:36588 E:36609 ||| VBG
to  ||| S:36609 E:36612 ||| TO
necks ||| S:36612 E:36617 ||| NNS
,  ||| S:36617 E:36619 ||| ,
but  ||| S:36619 E:36623 ||| CC
it  ||| S:36623 E:36626 ||| PRP
does  ||| S:36626 E:36631 ||| VBZ
not  ||| S:36631 E:36635 ||| RB
diminish  ||| S:36635 E:36644 ||| VB
the  ||| S:36644 E:36648 ||| DT
ability  ||| S:36648 E:36656 ||| NN
of  ||| S:36656 E:36659 ||| IN
Boi1  ||| S:36659 E:36664 ||| CD
to  ||| S:36664 E:36677 ||| TO
localize  ||| S:36677 E:36686 ||| VB
to  ||| S:36686 E:36689 ||| TO
buds ||| S:36689 E:36693 ||| VB
.  ||| S:36693 E:36695 ||| .
These  ||| S:36695 E:36701 ||| DT
findings  ||| S:36701 E:36710 ||| NNS
suggest  ||| S:36710 E:36718 ||| VBP
that  ||| S:36718 E:36723 ||| IN
binding  ||| S:36723 E:36731 ||| VBG
to  ||| S:36731 E:36744 ||| TO
phospholipids  ||| S:36744 E:36758 ||| NNS
may  ||| S:36758 E:36762 ||| MD
promote  ||| S:36762 E:36770 ||| VB
the  ||| S:36770 E:36774 ||| DT
localization  ||| S:36774 E:36787 ||| NN
of  ||| S:36787 E:36790 ||| IN
Boi1  ||| S:36790 E:36795 ||| CD
to  ||| S:36795 E:36808 ||| TO
( ||| S:36808 E:36809 ||| -LRB-
and ||| S:36809 E:36812 ||| CC
/ ||| S:36812 E:36813 ||| NNP
or  ||| S:36813 E:36816 ||| CC
the  ||| S:36816 E:36820 ||| DT
retention  ||| S:36820 E:36830 ||| NN
of  ||| S:36830 E:36833 ||| IN
Boi1  ||| S:36833 E:36838 ||| CD
at ||| S:36838 E:36840 ||| IN
)  ||| S:36840 E:36842 ||| -RRB-
the  ||| S:36842 E:36846 ||| DT
bud ||| S:36846 E:36849 ||| NN
,  ||| S:36849 E:36851 ||| ,
but  ||| S:36851 E:36855 ||| CC
that  ||| S:36855 E:36860 ||| IN
this  ||| S:36860 E:36875 ||| DT
binding  ||| S:36875 E:36883 ||| NN
is  ||| S:36883 E:36886 ||| VBZ
not  ||| S:36886 E:36890 ||| RB
important  ||| S:36890 E:36900 ||| JJ
for  ||| S:36900 E:36904 ||| IN
the  ||| S:36904 E:36908 ||| DT
localization  ||| S:36908 E:36921 ||| NN
of  ||| S:36921 E:36924 ||| IN
Boi1  ||| S:36924 E:36929 ||| CD
to  ||| S:36929 E:36942 ||| TO
the  ||| S:36942 E:36946 ||| DT
neck ||| S:36946 E:36950 ||| NN
.  ||| S:36950 E:36962 ||| .
How  ||| S:36962 E:36966 ||| WRB
might  ||| S:36966 E:36972 ||| MD
binding  ||| S:36972 E:36980 ||| VB
to  ||| S:36980 E:36983 ||| TO
phospholipids  ||| S:36983 E:36997 ||| VB
promote  ||| S:36997 E:37015 ||| VB
localization  ||| S:37015 E:37028 ||| VBN
of  ||| S:37028 E:37031 ||| IN
Boi1  ||| S:37031 E:37036 ||| CD
to  ||| S:37036 E:37039 ||| TO
buds ||| S:37039 E:37043 ||| VB
?  ||| S:37043 E:37045 ||| .
One  ||| S:37045 E:37049 ||| CD
possibility  ||| S:37049 E:37061 ||| NN
is  ||| S:37061 E:37064 ||| VBZ
that  ||| S:37064 E:37069 ||| IN
the  ||| S:37069 E:37083 ||| DT
relevant  ||| S:37083 E:37092 ||| JJ
phospholipid ||| S:37092 E:37104 ||| NNS
( ||| S:37104 E:37105 ||| -LRB-
s ||| S:37105 E:37106 ||| LS
)  ||| S:37106 E:37108 ||| -RRB-
( ||| S:37108 E:37109 ||| -LRB-
e.g. ||| S:37109 E:37113 ||| NNP
,  ||| S:37113 E:37115 ||| ,
PIP  ||| S:37115 E:37130 ||| NNP
2  ||| S:37130 E:37132 ||| CD
)  ||| S:37132 E:37134 ||| -RRB-
is  ||| S:37134 E:37137 ||| VBZ
itself  ||| S:37137 E:37144 ||| PRP
concentrated  ||| S:37144 E:37157 ||| VBD
in  ||| S:37157 E:37160 ||| IN
buds ||| S:37160 E:37164 ||| NNS
.  ||| S:37164 E:37176 ||| .
Another  ||| S:37176 E:37184 ||| DT
possibility  ||| S:37184 E:37196 ||| NN
is  ||| S:37196 E:37199 ||| VBZ
that  ||| S:37199 E:37204 ||| IN
the  ||| S:37204 E:37208 ||| DT
binding  ||| S:37208 E:37216 ||| JJ
to  ||| S:37216 E:37219 ||| TO
phospholipid  ||| S:37219 E:37242 ||| NN
promotes  ||| S:37242 E:37251 ||| VBZ
the  ||| S:37251 E:37255 ||| DT
binding  ||| S:37255 E:37263 ||| NN
of  ||| S:37263 E:37266 ||| IN
Boi1  ||| S:37266 E:37271 ||| CD
to  ||| S:37271 E:37274 ||| TO
some  ||| S:37274 E:37279 ||| DT
other  ||| S:37279 E:37285 ||| JJ
protein  ||| S:37285 E:37293 ||| NN
that  ||| S:37293 E:37308 ||| WDT
is  ||| S:37308 E:37311 ||| VBZ
itself  ||| S:37311 E:37318 ||| PRP
localized  ||| S:37318 E:37328 ||| VBP
to  ||| S:37328 E:37331 ||| TO
buds ||| S:37331 E:37335 ||| VB
.  ||| S:37335 E:37337 ||| .
Other  ||| S:37337 E:37343 ||| JJ
than  ||| S:37343 E:37348 ||| IN
the  ||| S:37348 E:37352 ||| DT
unidentified  ||| S:37352 E:37375 ||| JJ
protease  ||| S:37375 E:37384 ||| NN
that  ||| S:37384 E:37389 ||| WDT
acts  ||| S:37389 E:37394 ||| VBZ
on  ||| S:37394 E:37397 ||| IN
Boi1  ||| S:37397 E:37402 ||| CD
in  ||| S:37402 E:37405 ||| IN
yeast  ||| S:37405 E:37411 ||| NN
extracts ||| S:37411 E:37419 ||| NN
,  ||| S:37419 E:37421 ||| ,
the  ||| S:37421 E:37425 ||| DT
only  ||| S:37425 E:37440 ||| JJ
proteins  ||| S:37440 E:37449 ||| NNS
that  ||| S:37449 E:37454 ||| IN
we  ||| S:37454 E:37457 ||| PRP
have  ||| S:37457 E:37462 ||| VBP
evidence  ||| S:37462 E:37471 ||| NN
for  ||| S:37471 E:37475 ||| IN
binding  ||| S:37475 E:37483 ||| VBG
to  ||| S:37483 E:37486 ||| TO
Boi1  ||| S:37486 E:37491 ||| CD
are  ||| S:37491 E:37505 ||| VBP
Bem1  ||| S:37505 E:37510 ||| NNP
and  ||| S:37510 E:37514 ||| CC
Cdc42 ||| S:37514 E:37519 ||| NNP
,  ||| S:37519 E:37521 ||| ,
both  ||| S:37521 E:37526 ||| DT
of  ||| S:37526 E:37529 ||| IN
which  ||| S:37529 E:37535 ||| WDT
show  ||| S:37535 E:37540 ||| VBP
localization  ||| S:37540 E:37553 ||| JJ
patterns  ||| S:37553 E:37572 ||| NNS
similar  ||| S:37572 E:37580 ||| JJ
to  ||| S:37580 E:37583 ||| TO
those  ||| S:37583 E:37589 ||| DT
for  ||| S:37589 E:37593 ||| IN
Boi1  ||| S:37593 E:37598 ||| NNP
(  ||| S:37598 E:37600 ||| -LRB-
[  ||| S:37600 E:37602 ||| CD
20  ||| S:37602 E:37605 ||| CD
21  ||| S:37605 E:37608 ||| CD
]  ||| S:37608 E:37610 ||| -RRB-
,  ||| S:37610 E:37612 ||| ,
and  ||| S:37612 E:37616 ||| CC
our  ||| S:37616 E:37630 ||| PRP$
unpublished  ||| S:37630 E:37642 ||| JJ
data ||| S:37642 E:37646 ||| NNS
) ||| S:37646 E:37647 ||| -RRB-
.  ||| S:37647 E:37649 ||| .
Amino-acid  ||| S:37649 E:37660 ||| JJ
substitutions  ||| S:37660 E:37674 ||| NN
in  ||| S:37674 E:37677 ||| IN
the  ||| S:37677 E:37691 ||| DT
proline-rich  ||| S:37691 E:37704 ||| JJ
stretch  ||| S:37704 E:37712 ||| NN
of  ||| S:37712 E:37715 ||| IN
Boi1  ||| S:37715 E:37720 ||| NNP
that  ||| S:37720 E:37725 ||| WDT
destroy  ||| S:37725 E:37733 ||| VBP
binding  ||| S:37733 E:37741 ||| VBG
to  ||| S:37741 E:37744 ||| TO
Bem1  ||| S:37744 E:37759 ||| CD
do  ||| S:37759 E:37762 ||| VBP
not  ||| S:37762 E:37766 ||| RB
affect  ||| S:37766 E:37773 ||| VB
the  ||| S:37773 E:37777 ||| DT
localization  ||| S:37777 E:37790 ||| NN
of  ||| S:37790 E:37793 ||| IN
Boi1 ||| S:37793 E:37797 ||| NNP
,  ||| S:37797 E:37799 ||| ,
suggesting  ||| S:37799 E:37810 ||| VBG
that  ||| S:37810 E:37825 ||| IN
binding  ||| S:37825 E:37833 ||| VBG
to  ||| S:37833 E:37836 ||| TO
Bem1  ||| S:37836 E:37841 ||| NNP
is  ||| S:37841 E:37844 ||| VBZ
not  ||| S:37844 E:37848 ||| RB
necessary  ||| S:37848 E:37858 ||| JJ
for  ||| S:37858 E:37862 ||| IN
any  ||| S:37862 E:37866 ||| DT
pattern  ||| S:37866 E:37874 ||| NN
of  ||| S:37874 E:37887 ||| IN
localization  ||| S:37887 E:37900 ||| NN
of  ||| S:37900 E:37903 ||| IN
Boi1 ||| S:37903 E:37907 ||| CD
.  ||| S:37907 E:37919 ||| .
The  ||| S:37919 E:37923 ||| DT
situation  ||| S:37923 E:37933 ||| NN
with  ||| S:37933 E:37938 ||| IN
respect  ||| S:37938 E:37946 ||| NN
to  ||| S:37946 E:37949 ||| TO
Cdc42  ||| S:37949 E:37955 ||| NNP
is  ||| S:37955 E:37958 ||| VBZ
less  ||| S:37958 E:37963 ||| RBR
clear ||| S:37963 E:37968 ||| JJ
.  ||| S:37968 E:37970 ||| .
We  ||| S:37970 E:37983 ||| PRP
have  ||| S:37983 E:37988 ||| VBP
not  ||| S:37988 E:37992 ||| RB
yet  ||| S:37992 E:37996 ||| RB
generated  ||| S:37996 E:38006 ||| VBD
mutations  ||| S:38006 E:38016 ||| VBN
in  ||| S:38016 E:38030 ||| IN
BOI1  ||| S:38030 E:38035 ||| NNP
that  ||| S:38035 E:38040 ||| WDT
would  ||| S:38040 E:38046 ||| MD
allow  ||| S:38046 E:38052 ||| VB
us  ||| S:38052 E:38055 ||| PRP
to  ||| S:38055 E:38058 ||| TO
probe  ||| S:38058 E:38074 ||| VB
the  ||| S:38074 E:38078 ||| DT
role  ||| S:38078 E:38083 ||| NN
of  ||| S:38083 E:38086 ||| IN
Boi1 ||| S:38086 E:38090 ||| NNP
's  ||| S:38090 E:38093 ||| POS
interaction  ||| S:38093 E:38105 ||| NN
specifically  ||| S:38105 E:38118 ||| RB
with  ||| S:38118 E:38123 ||| IN
Cdc42 ||| S:38123 E:38128 ||| CD
.  ||| S:38128 E:38140 ||| .
However ||| S:38140 E:38147 ||| RB
,  ||| S:38147 E:38149 ||| ,
we  ||| S:38149 E:38152 ||| PRP
have  ||| S:38152 E:38157 ||| VBP
observed  ||| S:38157 E:38166 ||| VBN
that  ||| S:38166 E:38171 ||| IN
the  ||| S:38171 E:38175 ||| DT
two-hybrid  ||| S:38175 E:38186 ||| JJ
interaction  ||| S:38186 E:38208 ||| NN
between  ||| S:38208 E:38216 ||| IN
Boi1-PH  ||| S:38216 E:38224 ||| NNP
and  ||| S:38224 E:38228 ||| CC
Cdc42  ||| S:38228 E:38234 ||| NNP
is  ||| S:38234 E:38237 ||| VBZ
not  ||| S:38237 E:38241 ||| RB
reduced  ||| S:38241 E:38249 ||| VBN
by  ||| S:38249 E:38252 ||| IN
substitutions  ||| S:38252 E:38276 ||| NNS
( ||| S:38276 E:38277 ||| -LRB-
i.e. ||| S:38277 E:38281 ||| FW
,  ||| S:38281 E:38283 ||| ,
KK ||| S:38283 E:38285 ||| NNP
,  ||| S:38285 E:38287 ||| ,
TK ||| S:38287 E:38289 ||| NNP
,  ||| S:38289 E:38291 ||| ,
and  ||| S:38291 E:38295 ||| CC
KKTK ||| S:38295 E:38299 ||| NNP
)  ||| S:38299 E:38301 ||| -RRB-
that  ||| S:38301 E:38306 ||| WDT
impair  ||| S:38306 E:38313 ||| VBP
binding  ||| S:38313 E:38321 ||| VBG
to  ||| S:38321 E:38334 ||| TO
phospholipids ||| S:38334 E:38347 ||| VB
.  ||| S:38347 E:38349 ||| .
These  ||| S:38349 E:38355 ||| DT
findings  ||| S:38355 E:38364 ||| NNS
suggest  ||| S:38364 E:38372 ||| VBP
that  ||| S:38372 E:38377 ||| IN
binding  ||| S:38377 E:38385 ||| VBG
to  ||| S:38385 E:38398 ||| TO
phospholipid  ||| S:38398 E:38411 ||| NN
is  ||| S:38411 E:38414 ||| VBZ
not  ||| S:38414 E:38418 ||| RB
necessary  ||| S:38418 E:38428 ||| JJ
for  ||| S:38428 E:38432 ||| IN
the  ||| S:38432 E:38436 ||| DT
interaction  ||| S:38436 E:38448 ||| NN
between  ||| S:38448 E:38466 ||| IN
Boi1  ||| S:38466 E:38471 ||| NNP
and  ||| S:38471 E:38475 ||| CC
Cdc42 ||| S:38475 E:38480 ||| NNP
,  ||| S:38480 E:38482 ||| ,
and  ||| S:38482 E:38486 ||| CC
so  ||| S:38486 E:38489 ||| RB
place  ||| S:38489 E:38495 ||| VB
in  ||| S:38495 E:38498 ||| IN
doubt  ||| S:38498 E:38504 ||| NN
the  ||| S:38504 E:38508 ||| DT
possibility  ||| S:38508 E:38530 ||| NN
that  ||| S:38530 E:38535 ||| IN
the  ||| S:38535 E:38539 ||| DT
mechanism  ||| S:38539 E:38549 ||| NN
by  ||| S:38549 E:38552 ||| IN
which  ||| S:38552 E:38558 ||| WDT
binding  ||| S:38558 E:38566 ||| VBZ
to  ||| S:38566 E:38569 ||| TO
phospholipid  ||| S:38569 E:38592 ||| VB
promotes  ||| S:38592 E:38601 ||| JJ
localization  ||| S:38601 E:38614 ||| NN
of  ||| S:38614 E:38617 ||| IN
Boi1  ||| S:38617 E:38622 ||| CD
to  ||| S:38622 E:38625 ||| TO
buds  ||| S:38625 E:38630 ||| NN
is  ||| S:38630 E:38633 ||| VBZ
by  ||| S:38633 E:38636 ||| IN
positively  ||| S:38636 E:38657 ||| RB
regulating  ||| S:38657 E:38668 ||| VBG
the  ||| S:38668 E:38672 ||| DT
binding  ||| S:38672 E:38680 ||| NN
of  ||| S:38680 E:38683 ||| IN
Boi1  ||| S:38683 E:38688 ||| CD
to  ||| S:38688 E:38691 ||| TO
Cdc42 ||| S:38691 E:38696 ||| CD
.  ||| S:38696 E:38698 ||| .
We  ||| S:38698 E:38701 ||| PRP
note ||| S:38701 E:38705 ||| VBP
,  ||| S:38705 E:38717 ||| ,
however ||| S:38717 E:38724 ||| RB
,  ||| S:38724 E:38726 ||| ,
that  ||| S:38726 E:38731 ||| IN
these  ||| S:38731 E:38737 ||| DT
two-hybrid  ||| S:38737 E:38748 ||| JJ
analyses  ||| S:38748 E:38757 ||| NNS
may  ||| S:38757 E:38761 ||| MD
be  ||| S:38761 E:38764 ||| VB
quite  ||| S:38764 E:38780 ||| RB
limited  ||| S:38780 E:38788 ||| VBN
in  ||| S:38788 E:38791 ||| IN
terms  ||| S:38791 E:38797 ||| NNS
of  ||| S:38797 E:38800 ||| IN
what  ||| S:38800 E:38805 ||| WP
they  ||| S:38805 E:38810 ||| PRP
can  ||| S:38810 E:38814 ||| MD
reveal  ||| S:38814 E:38821 ||| VB
about  ||| S:38821 E:38837 ||| IN
interactions  ||| S:38837 E:38850 ||| NNS
between  ||| S:38850 E:38858 ||| IN
Boi1  ||| S:38858 E:38863 ||| NNP
and  ||| S:38863 E:38867 ||| CC
Cdc42  ||| S:38867 E:38873 ||| NNP
that  ||| S:38873 E:38878 ||| WDT
might  ||| S:38878 E:38884 ||| MD
normally  ||| S:38884 E:38903 ||| RB
occur  ||| S:38903 E:38909 ||| VB
at  ||| S:38909 E:38912 ||| IN
the  ||| S:38912 E:38916 ||| DT
plasma  ||| S:38916 E:38923 ||| JJ
membrane  ||| S:38923 E:38932 ||| NNS
( ||| S:38932 E:38933 ||| -LRB-
or  ||| S:38933 E:38936 ||| CC
at  ||| S:38936 E:38939 ||| IN
other  ||| S:38939 E:38945 ||| JJ
membranes ||| S:38945 E:38954 ||| NN
) ||| S:38954 E:38955 ||| -RRB-
,  ||| S:38955 E:38967 ||| ,
because  ||| S:38967 E:38975 ||| IN
1 ||| S:38975 E:38976 ||| CD
)  ||| S:38976 E:38978 ||| -RRB-
the  ||| S:38978 E:38982 ||| DT
two-hybrid  ||| S:38982 E:38993 ||| JJ
assay  ||| S:38993 E:38999 ||| NN
monitors  ||| S:38999 E:39008 ||| VBZ
only  ||| S:39008 E:39013 ||| RB
those  ||| S:39013 E:39029 ||| DT
interactions  ||| S:39029 E:39042 ||| NN
that  ||| S:39042 E:39047 ||| WDT
are  ||| S:39047 E:39051 ||| VBP
occurring  ||| S:39051 E:39061 ||| VBG
in  ||| S:39061 E:39064 ||| IN
the  ||| S:39064 E:39068 ||| DT
nucleus  ||| S:39068 E:39076 ||| NN
and  ||| S:39076 E:39080 ||| CC
2 ||| S:39080 E:39081 ||| LS
)  ||| S:39081 E:39083 ||| -RRB-
in  ||| S:39083 E:39096 ||| IN
these  ||| S:39096 E:39102 ||| DT
two-hybrid  ||| S:39102 E:39113 ||| JJ
analyses ||| S:39113 E:39121 ||| NNS
,  ||| S:39121 E:39123 ||| ,
we  ||| S:39123 E:39126 ||| PRP
used  ||| S:39126 E:39131 ||| VBD
only  ||| S:39131 E:39136 ||| JJ
versions  ||| S:39136 E:39145 ||| NNS
of  ||| S:39145 E:39148 ||| IN
Cdc42  ||| S:39148 E:39164 ||| NNP
that  ||| S:39164 E:39169 ||| WDT
lack  ||| S:39169 E:39174 ||| VBP
a  ||| S:39174 E:39176 ||| DT
site  ||| S:39176 E:39181 ||| NN
of  ||| S:39181 E:39184 ||| IN
isoprenylation  ||| S:39184 E:39199 ||| NNS
( ||| S:39199 E:39200 ||| -LRB-
because  ||| S:39200 E:39208 ||| IN
we  ||| S:39208 E:39211 ||| PRP
were  ||| S:39211 E:39226 ||| VBD
unable  ||| S:39226 E:39233 ||| JJ
to  ||| S:39233 E:39236 ||| TO
detect  ||| S:39236 E:39243 ||| VB
two-hybrid  ||| S:39243 E:39254 ||| JJ
interactions  ||| S:39254 E:39267 ||| NNS
between  ||| S:39267 E:39275 ||| IN
Boi1  ||| S:39275 E:39280 ||| NNP
and  ||| S:39280 E:39294 ||| CC
versions  ||| S:39294 E:39303 ||| NNS
of  ||| S:39303 E:39306 ||| IN
Cdc42  ||| S:39306 E:39312 ||| NNP
that  ||| S:39312 E:39317 ||| WDT
retain  ||| S:39317 E:39324 ||| VBP
that  ||| S:39324 E:39329 ||| DT
site ||| S:39329 E:39333 ||| NN
) ||| S:39333 E:39334 ||| -RRB-
.  ||| S:39334 E:39336 ||| .
Thus ||| S:39336 E:39340 ||| RB
,  ||| S:39340 E:39342 ||| ,
it  ||| S:39342 E:39345 ||| PRP
is  ||| S:39345 E:39358 ||| VBZ
still  ||| S:39358 E:39364 ||| RB
possible  ||| S:39364 E:39373 ||| JJ
that  ||| S:39373 E:39378 ||| IN
at  ||| S:39378 E:39381 ||| IN
the  ||| S:39381 E:39385 ||| DT
plasma  ||| S:39385 E:39392 ||| JJ
membrane ||| S:39392 E:39400 ||| NN
,  ||| S:39400 E:39402 ||| ,
binding  ||| S:39402 E:39410 ||| VBG
to  ||| S:39410 E:39423 ||| TO
one  ||| S:39423 E:39427 ||| CD
or  ||| S:39427 E:39430 ||| CC
more  ||| S:39430 E:39435 ||| JJR
types  ||| S:39435 E:39441 ||| NNS
of  ||| S:39441 E:39444 ||| IN
phospholipid  ||| S:39444 E:39457 ||| NN
influences  ||| S:39457 E:39468 ||| VBZ
Boi1 ||| S:39468 E:39472 ||| NNP
's  ||| S:39472 E:39485 ||| POS
ability  ||| S:39485 E:39493 ||| NN
to  ||| S:39493 E:39496 ||| TO
associate  ||| S:39496 E:39506 ||| NN
with  ||| S:39506 E:39511 ||| IN
Cdc42 ||| S:39511 E:39516 ||| CD
.  ||| S:39516 E:39518 ||| .
Alternatively ||| S:39518 E:39531 ||| RB
,  ||| S:39531 E:39543 ||| ,
phospholipids  ||| S:39543 E:39557 ||| NNS
might  ||| S:39557 E:39563 ||| MD
regulate  ||| S:39563 E:39572 ||| VB
the  ||| S:39572 E:39576 ||| DT
binding  ||| S:39576 E:39584 ||| NN
of  ||| S:39584 E:39587 ||| IN
Boi1  ||| S:39587 E:39592 ||| CD
to  ||| S:39592 E:39595 ||| TO
some  ||| S:39595 E:39610 ||| DT
other ||| S:39610 E:39615 ||| JJ
,  ||| S:39615 E:39617 ||| ,
as-yet  ||| S:39617 E:39624 ||| RB
unidentified  ||| S:39624 E:39637 ||| JJ
binding  ||| S:39637 E:39645 ||| JJ
partner  ||| S:39645 E:39653 ||| NN
of  ||| S:39653 E:39656 ||| IN
Boi1 ||| S:39656 E:39660 ||| CD
.  ||| S:39660 E:39662 ||| .
To  ||| S:39662 E:39675 ||| TO
us ||| S:39675 E:39677 ||| PRP
,  ||| S:39677 E:39679 ||| ,
an  ||| S:39679 E:39682 ||| DT
important  ||| S:39682 E:39692 ||| JJ
breakthrough  ||| S:39692 E:39705 ||| NN
toward  ||| S:39705 E:39712 ||| IN
elucidating  ||| S:39712 E:39724 ||| VBG
the  ||| S:39724 E:39728 ||| DT
role  ||| S:39728 E:39743 ||| NN
of  ||| S:39743 E:39746 ||| IN
the  ||| S:39746 E:39750 ||| DT
binding  ||| S:39750 E:39758 ||| NN
of  ||| S:39758 E:39761 ||| IN
any  ||| S:39761 E:39765 ||| DT
phospholipid  ||| S:39765 E:39778 ||| NN
to  ||| S:39778 E:39781 ||| TO
Boi1  ||| S:39781 E:39786 ||| NNP
would  ||| S:39786 E:39792 ||| MD
be  ||| S:39792 E:39795 ||| VB
the  ||| S:39795 E:39809 ||| DT
identification  ||| S:39809 E:39824 ||| NN
of  ||| S:39824 E:39827 ||| IN
a  ||| S:39827 E:39829 ||| DT
protein  ||| S:39829 E:39837 ||| NN
whose  ||| S:39837 E:39843 ||| WP$
binding  ||| S:39843 E:39851 ||| JJ
to  ||| S:39851 E:39854 ||| TO
Boi1  ||| S:39854 E:39859 ||| NNP
is  ||| S:39859 E:39872 ||| VBZ
regulated  ||| S:39872 E:39882 ||| VBN
by  ||| S:39882 E:39885 ||| IN
that  ||| S:39885 E:39890 ||| DT
phospholipid ||| S:39890 E:39902 ||| NN
.  ||| S:39902 E:39935 ||| .
Conclusions  ||| S:39935 E:39955 ||| NNS
From  ||| S:39955 E:39960 ||| IN
vesicle  ||| S:39960 E:39968 ||| JJ
co-sedimentation  ||| S:39968 E:39985 ||| JJ
and  ||| S:39985 E:39997 ||| CC
proteolysis-stimulation  ||| S:39997 E:40021 ||| JJ
analyses ||| S:40021 E:40029 ||| NNS
,  ||| S:40029 E:40031 ||| ,
we  ||| S:40031 E:40034 ||| PRP
gained  ||| S:40034 E:40041 ||| VBD
evidence  ||| S:40041 E:40050 ||| NN
that  ||| S:40050 E:40063 ||| IN
the  ||| S:40063 E:40067 ||| DT
PH  ||| S:40067 E:40070 ||| NNP
domain  ||| S:40070 E:40077 ||| NN
of  ||| S:40077 E:40080 ||| IN
Boi1  ||| S:40080 E:40085 ||| CD
binds  ||| S:40085 E:40091 ||| NN
with  ||| S:40091 E:40096 ||| IN
higher  ||| S:40096 E:40103 ||| JJR
affinity  ||| S:40103 E:40112 ||| NN
to  ||| S:40112 E:40115 ||| TO
PIP  ||| S:40115 E:40128 ||| NNP
2  ||| S:40128 E:40130 ||| CD
than  ||| S:40130 E:40135 ||| IN
to  ||| S:40135 E:40138 ||| TO
PS  ||| S:40138 E:40141 ||| NNP
and  ||| S:40141 E:40145 ||| CC
that  ||| S:40145 E:40150 ||| IN
binding  ||| S:40150 E:40158 ||| VBG
to  ||| S:40158 E:40161 ||| TO
PIP  ||| S:40161 E:40174 ||| NNP
2  ||| S:40174 E:40176 ||| CD
is  ||| S:40176 E:40179 ||| VBZ
facilitated  ||| S:40179 E:40191 ||| VBN
by  ||| S:40191 E:40194 ||| IN
PS  ||| S:40194 E:40197 ||| NNP
and  ||| S:40197 E:40201 ||| CC
promotes  ||| S:40201 E:40210 ||| VBZ
a  ||| S:40210 E:40220 ||| DT
conformational  ||| S:40220 E:40235 ||| JJ
change  ||| S:40235 E:40242 ||| NN
in  ||| S:40242 E:40245 ||| IN
Boi1 ||| S:40245 E:40249 ||| CD
.  ||| S:40249 E:40251 ||| .
Amino-acid  ||| S:40251 E:40262 ||| JJ
substitutions  ||| S:40262 E:40284 ||| NN
that  ||| S:40284 E:40289 ||| WDT
diminish  ||| S:40289 E:40298 ||| VBP
binding  ||| S:40298 E:40306 ||| VBG
to  ||| S:40306 E:40309 ||| TO
PS  ||| S:40309 E:40312 ||| NNP
and  ||| S:40312 E:40316 ||| CC
PIP  ||| S:40316 E:40329 ||| NNP
2  ||| S:40329 E:40331 ||| CD
impair  ||| S:40331 E:40338 ||| CD
Boi1  ||| S:40338 E:40343 ||| CD
function ||| S:40343 E:40351 ||| NN
,  ||| S:40351 E:40353 ||| ,
and  ||| S:40353 E:40357 ||| CC
fusion  ||| S:40357 E:40364 ||| NN
to  ||| S:40364 E:40367 ||| TO
a  ||| S:40367 E:40377 ||| DT
myristoyl  ||| S:40377 E:40387 ||| JJ
group-accepting  ||| S:40387 E:40403 ||| JJ
sequence  ||| S:40403 E:40412 ||| NN
improves  ||| S:40412 E:40421 ||| VBZ
the  ||| S:40421 E:40425 ||| DT
ability  ||| S:40425 E:40433 ||| NN
of  ||| S:40433 E:40444 ||| IN
these  ||| S:40444 E:40450 ||| DT
mutant  ||| S:40450 E:40457 ||| JJ
versions  ||| S:40457 E:40466 ||| NNS
of  ||| S:40466 E:40469 ||| IN
Boi1-PH  ||| S:40469 E:40477 ||| CD
to  ||| S:40477 E:40480 ||| TO
function ||| S:40480 E:40488 ||| VB
,  ||| S:40488 E:40490 ||| ,
suggesting  ||| S:40490 E:40509 ||| VBG
that  ||| S:40509 E:40514 ||| IN
binding  ||| S:40514 E:40522 ||| VBG
to  ||| S:40522 E:40525 ||| TO
phospholipids  ||| S:40525 E:40539 ||| NN
is  ||| S:40539 E:40542 ||| VBZ
important  ||| S:40542 E:40552 ||| JJ
for  ||| S:40552 E:40556 ||| IN
Boi1  ||| S:40556 E:40561 ||| CD
action ||| S:40561 E:40567 ||| NN
.  ||| S:40567 E:40577 ||| .
Based  ||| S:40577 E:40583 ||| VBN
on  ||| S:40583 E:40586 ||| IN
the  ||| S:40586 E:40590 ||| DT
differing  ||| S:40590 E:40600 ||| JJ
extents  ||| S:40600 E:40608 ||| NN
to  ||| S:40608 E:40611 ||| TO
which  ||| S:40611 E:40617 ||| WDT
the  ||| S:40617 E:40621 ||| DT
myristoyl  ||| S:40621 E:40639 ||| JJ
group-accepting  ||| S:40639 E:40655 ||| JJ
sequence  ||| S:40655 E:40664 ||| NN
improved  ||| S:40664 E:40673 ||| VBD
the  ||| S:40673 E:40677 ||| DT
ability  ||| S:40677 E:40685 ||| NN
of  ||| S:40685 E:40688 ||| IN
the  ||| S:40688 E:40700 ||| DT
different  ||| S:40700 E:40710 ||| JJ
mutant  ||| S:40710 E:40717 ||| JJ
versions  ||| S:40717 E:40726 ||| NNS
of  ||| S:40726 E:40729 ||| IN
Boi1-PH  ||| S:40729 E:40737 ||| CD
to  ||| S:40737 E:40740 ||| TO
function ||| S:40740 E:40748 ||| VB
,  ||| S:40748 E:40750 ||| ,
we  ||| S:40750 E:40761 ||| PRP
propose  ||| S:40761 E:40769 ||| VBP
that  ||| S:40769 E:40774 ||| IN
the  ||| S:40774 E:40778 ||| DT
main  ||| S:40778 E:40783 ||| JJ
role  ||| S:40783 E:40788 ||| NN
of  ||| S:40788 E:40791 ||| IN
binding  ||| S:40791 E:40799 ||| VBG
to  ||| S:40799 E:40802 ||| TO
PS  ||| S:40802 E:40805 ||| NNP
is  ||| S:40805 E:40808 ||| VBZ
to  ||| S:40808 E:40811 ||| TO
promote  ||| S:40811 E:40827 ||| VB
association  ||| S:40827 E:40839 ||| NN
with  ||| S:40839 E:40844 ||| IN
membrane  ||| S:40844 E:40853 ||| NN
and  ||| S:40853 E:40857 ||| CC
that  ||| S:40857 E:40862 ||| IN
binding  ||| S:40862 E:40870 ||| VBG
to  ||| S:40870 E:40873 ||| TO
PIP  ||| S:40873 E:40886 ||| NNP
2  ||| S:40886 E:40888 ||| CD
plays  ||| S:40888 E:40894 ||| VBZ
some  ||| S:40894 E:40899 ||| DT
additional  ||| S:40899 E:40910 ||| JJ
important  ||| S:40910 E:40920 ||| JJ
role ||| S:40920 E:40924 ||| NN
.  ||| S:40924 E:40934 ||| .
Boi1  ||| S:40934 E:40939 ||| NNP
and  ||| S:40939 E:40943 ||| CC
Boi2  ||| S:40943 E:40948 ||| NNP
are  ||| S:40948 E:40952 ||| VBP
localized  ||| S:40952 E:40962 ||| VBN
to  ||| S:40962 E:40965 ||| TO
sites  ||| S:40965 E:40971 ||| NNS
of  ||| S:40971 E:40974 ||| IN
polarized  ||| S:40974 E:40984 ||| JJ
growth ||| S:40984 E:40990 ||| NN
,  ||| S:40990 E:41000 ||| ,
consistent  ||| S:41000 E:41011 ||| JJ
with  ||| S:41011 E:41016 ||| IN
the  ||| S:41016 E:41020 ||| DT
view  ||| S:41020 E:41025 ||| NN
that  ||| S:41025 E:41030 ||| IN
they  ||| S:41030 E:41035 ||| PRP
are  ||| S:41035 E:41039 ||| VBP
involved  ||| S:41039 E:41048 ||| VBN
in  ||| S:41048 E:41059 ||| IN
polarized  ||| S:41059 E:41069 ||| JJ
growth ||| S:41069 E:41075 ||| NN
.  ||| S:41075 E:41077 ||| .
Whereas  ||| S:41077 E:41085 ||| IN
the  ||| S:41085 E:41089 ||| DT
SH3  ||| S:41089 E:41093 ||| JJ
domain  ||| S:41093 E:41100 ||| NN
is  ||| S:41100 E:41103 ||| VBZ
needed  ||| S:41103 E:41110 ||| VBN
for  ||| S:41110 E:41122 ||| IN
localization  ||| S:41122 E:41135 ||| NN
of  ||| S:41135 E:41138 ||| IN
Boi1  ||| S:41138 E:41143 ||| CD
to  ||| S:41143 E:41146 ||| TO
the  ||| S:41146 E:41150 ||| DT
neck ||| S:41150 E:41154 ||| NN
,  ||| S:41154 E:41156 ||| ,
the  ||| S:41156 E:41160 ||| DT
phospholipid-binding  ||| S:41160 E:41189 ||| JJ
portion  ||| S:41189 E:41197 ||| NN
of  ||| S:41197 E:41200 ||| IN
the  ||| S:41200 E:41204 ||| DT
PH  ||| S:41204 E:41207 ||| NNP
domain  ||| S:41207 E:41214 ||| NN
is  ||| S:41214 E:41217 ||| VBZ
important  ||| S:41217 E:41227 ||| JJ
for  ||| S:41227 E:41231 ||| IN
localization  ||| S:41231 E:41244 ||| VBG
to  ||| S:41244 E:41255 ||| TO
the  ||| S:41255 E:41259 ||| DT
bud ||| S:41259 E:41262 ||| NN
.  ||| S:41262 E:41286 ||| .
Materials  ||| S:41286 E:41296 ||| NNS
and  ||| S:41296 E:41300 ||| CC
Methods  ||| S:41300 E:41327 ||| NNP
Materials  ||| S:41327 E:41347 ||| NNPS
The  ||| S:41347 E:41351 ||| DT
plasmids  ||| S:41351 E:41360 ||| NN
used  ||| S:41360 E:41365 ||| VBN
in  ||| S:41365 E:41368 ||| IN
this  ||| S:41368 E:41373 ||| DT
study  ||| S:41373 E:41379 ||| NN
are  ||| S:41379 E:41383 ||| VBP
described  ||| S:41383 E:41393 ||| VBN
in  ||| S:41393 E:41406 ||| IN
Additional  ||| S:41406 E:41417 ||| JJ
file  ||| S:41417 E:41422 ||| NN
1 ||| S:41422 E:41423 ||| CD
:  ||| S:41423 E:41425 ||| :
Plasmids  ||| S:41425 E:41434 ||| NNP
and  ||| S:41434 E:41438 ||| CC
phage ||| S:41438 E:41443 ||| NN
.  ||| S:41443 E:41445 ||| .
The  ||| S:41445 E:41449 ||| DT
yeast  ||| S:41449 E:41455 ||| NN
strains  ||| S:41455 E:41473 ||| NNS
used  ||| S:41473 E:41478 ||| VBN
are  ||| S:41478 E:41482 ||| VBP
Y312  ||| S:41482 E:41487 ||| NNP
(  ||| S:41487 E:41500 ||| -LRB-
MATα  ||| S:41500 E:41505 ||| NNP
ura3  ||| S:41505 E:41510 ||| NNP
leu2  ||| S:41510 E:41515 ||| NNP
his3  ||| S:41515 E:41520 ||| NNP
Gal  ||| S:41520 E:41524 ||| NNP
+ ||| S:41524 E:41525 ||| NNP
) ||| S:41525 E:41526 ||| -RRB-
,  ||| S:41526 E:41528 ||| ,
Y1284  ||| S:41528 E:41534 ||| NNP
(  ||| S:41534 E:41557 ||| -LRB-
MAT  ||| S:41557 E:41585 ||| NNP
a  ||| S:41585 E:41610 ||| DT
boi1 ||| S:41610 E:41614 ||| NNP
: ||| S:41614 E:41615 ||| :
: ||| S:41615 E:41616 ||| :
LEU2  ||| S:41616 E:41621 ||| FW
ura3  ||| S:41621 E:41626 ||| FW
leu2  ||| S:41626 E:41631 ||| FW
his3  ||| S:41631 E:41636 ||| FW
trp1  ||| S:41636 E:41651 ||| FW
met14  ||| S:41651 E:41657 ||| FW
Gal  ||| S:41657 E:41661 ||| FW
+ ||| S:41661 E:41662 ||| FW
) ||| S:41662 E:41663 ||| -RRB-
,  ||| S:41663 E:41665 ||| ,
Y1300  ||| S:41665 E:41671 ||| NNP
(  ||| S:41671 E:41684 ||| -LRB-
MAT  ||| S:41684 E:41712 ||| FW
a  ||| S:41712 E:41726 ||| FW
/  ||| S:41726 E:41739 ||| FW
MATα  ||| S:41739 E:41744 ||| FW
ura3 ||| S:41744 E:41748 ||| FW
/ ||| S:41748 E:41749 ||| FW
ura3  ||| S:41749 E:41754 ||| FW
leu2 ||| S:41754 E:41758 ||| FW
/ ||| S:41758 E:41759 ||| FW
leu2  ||| S:41759 E:41764 ||| FW
his3 ||| S:41764 E:41768 ||| FW
/ ||| S:41768 E:41769 ||| FW
his3  ||| S:41769 E:41784 ||| FW
trp1 ||| S:41784 E:41788 ||| FW
/ ||| S:41788 E:41789 ||| FW
trp1  ||| S:41789 E:41794 ||| FW
met14 ||| S:41794 E:41799 ||| FW
/ ||| S:41799 E:41800 ||| FW
met14  ||| S:41800 E:41806 ||| FW
Gal  ||| S:41806 E:41810 ||| FW
+ ||| S:41810 E:41811 ||| FW
) ||| S:41811 E:41812 ||| -RRB-
,  ||| S:41812 E:41814 ||| ,
and  ||| S:41814 E:41818 ||| CC
PY967  ||| S:41818 E:41824 ||| NNP
(  ||| S:41824 E:41837 ||| -LRB-
MAT  ||| S:41837 E:41865 ||| FW
a  ||| S:41865 E:41879 ||| FW
/  ||| S:41879 E:41892 ||| FW
Matα  ||| S:41892 E:41897 ||| FW
boi1 ||| S:41897 E:41901 ||| FW
: ||| S:41901 E:41902 ||| :
: ||| S:41902 E:41903 ||| :
LEU2 ||| S:41903 E:41907 ||| CD
/ ||| S:41907 E:41908 ||| CD
boi1 ||| S:41908 E:41912 ||| CD
: ||| S:41912 E:41913 ||| :
: ||| S:41913 E:41914 ||| :
LEU2  ||| S:41914 E:41929 ||| CD
boi2 ||| S:41929 E:41933 ||| CD
: ||| S:41933 E:41934 ||| :
: ||| S:41934 E:41935 ||| :
LEU2 ||| S:41935 E:41939 ||| CD
/ ||| S:41939 E:41940 ||| CD
boi2 ||| S:41940 E:41944 ||| CD
: ||| S:41944 E:41945 ||| :
: ||| S:41945 E:41946 ||| :
LEU2  ||| S:41946 E:41951 ||| FW
ura3 ||| S:41951 E:41955 ||| FW
/ ||| S:41955 E:41956 ||| FW
ura3  ||| S:41956 E:41961 ||| FW
leu2 ||| S:41961 E:41965 ||| FW
/ ||| S:41965 E:41966 ||| FW
leu2  ||| S:41966 E:41971 ||| FW
trp1 ||| S:41971 E:41975 ||| FW
/ ||| S:41975 E:41976 ||| FW
trp1  ||| S:41976 E:41991 ||| FW
ade2 ||| S:41991 E:41995 ||| FW
/ ||| S:41995 E:41996 ||| FW
ade2  ||| S:41996 E:42001 ||| FW
ade3 ||| S:42001 E:42005 ||| FW
/ ||| S:42005 E:42006 ||| FW
ade3  ||| S:42006 E:42011 ||| FW
bearing  ||| S:42011 E:42019 ||| FW
plasmid  ||| S:42019 E:42027 ||| FW
pPB799 ||| S:42027 E:42033 ||| FW
) ||| S:42033 E:42034 ||| -RRB-
.  ||| S:42034 E:42046 ||| .
SC  ||| S:42046 E:42049 ||| NNP
medium  ||| S:42049 E:42056 ||| NN
is  ||| S:42056 E:42059 ||| VBZ
1.7  ||| S:42059 E:42063 ||| CD
g ||| S:42063 E:42064 ||| CD
/ ||| S:42064 E:42065 ||| CD
l  ||| S:42065 E:42067 ||| JJ
yeast  ||| S:42067 E:42073 ||| NN
nitrogen  ||| S:42073 E:42082 ||| NN
base  ||| S:42082 E:42087 ||| NN
without  ||| S:42087 E:42095 ||| IN
amino  ||| S:42095 E:42111 ||| JJ
acids  ||| S:42111 E:42117 ||| NNS
and  ||| S:42117 E:42121 ||| CC
ammonium  ||| S:42121 E:42130 ||| JJ
sulfate ||| S:42130 E:42137 ||| NN
,  ||| S:42137 E:42139 ||| ,
5  ||| S:42139 E:42141 ||| CD
g ||| S:42141 E:42142 ||| FW
/ ||| S:42142 E:42143 ||| FW
l  ||| S:42143 E:42145 ||| FW
ammonium  ||| S:42145 E:42154 ||| FW
sulfate ||| S:42154 E:42161 ||| FW
,  ||| S:42161 E:42163 ||| ,
20  ||| S:42163 E:42176 ||| CD
g ||| S:42176 E:42177 ||| CD
/ ||| S:42177 E:42178 ||| CD
l  ||| S:42178 E:42180 ||| JJ
glucose ||| S:42180 E:42187 ||| NN
,  ||| S:42187 E:42189 ||| ,
20  ||| S:42189 E:42192 ||| CD
mg ||| S:42192 E:42194 ||| CD
/ ||| S:42194 E:42195 ||| CD
l  ||| S:42195 E:42197 ||| JJ
uracil ||| S:42197 E:42203 ||| NN
,  ||| S:42203 E:42205 ||| ,
20  ||| S:42205 E:42208 ||| CD
mg ||| S:42208 E:42210 ||| CD
/ ||| S:42210 E:42211 ||| CD
l  ||| S:42211 E:42213 ||| JJ
adenine ||| S:42213 E:42220 ||| NN
,  ||| S:42220 E:42222 ||| ,
80  ||| S:42222 E:42225 ||| CD
mg ||| S:42225 E:42227 ||| CD
/ ||| S:42227 E:42228 ||| CD
l  ||| S:42228 E:42240 ||| JJ
L-leucine ||| S:42240 E:42249 ||| NN
,  ||| S:42249 E:42251 ||| ,
20  ||| S:42251 E:42254 ||| CD
mg ||| S:42254 E:42256 ||| CD
/ ||| S:42256 E:42257 ||| CD
l  ||| S:42257 E:42259 ||| JJ
L-histidine ||| S:42259 E:42270 ||| NN
,  ||| S:42270 E:42272 ||| ,
40  ||| S:42272 E:42275 ||| CD
mg ||| S:42275 E:42277 ||| CD
/ ||| S:42277 E:42278 ||| CD
l  ||| S:42278 E:42280 ||| JJ
L-tryptophan ||| S:42280 E:42292 ||| NN
,  ||| S:42292 E:42294 ||| ,
20  ||| S:42294 E:42307 ||| CD
mg ||| S:42307 E:42309 ||| CD
/ ||| S:42309 E:42310 ||| CD
l  ||| S:42310 E:42312 ||| JJ
L-methionine ||| S:42312 E:42324 ||| NN
,  ||| S:42324 E:42326 ||| ,
and  ||| S:42326 E:42330 ||| CC
30  ||| S:42330 E:42333 ||| CD
mg ||| S:42333 E:42335 ||| CD
/ ||| S:42335 E:42336 ||| CD
l  ||| S:42336 E:42338 ||| JJ
L-lysine ||| S:42338 E:42346 ||| NN
.  ||| S:42346 E:42348 ||| .
SC-Leu ||| S:42348 E:42354 ||| NNP
,  ||| S:42354 E:42356 ||| ,
SC-Ura ||| S:42356 E:42362 ||| NNP
,  ||| S:42362 E:42374 ||| ,
and  ||| S:42374 E:42378 ||| CC
SC-Ura-Leu  ||| S:42378 E:42389 ||| NNS
are  ||| S:42389 E:42393 ||| VBP
SC  ||| S:42393 E:42396 ||| NNP
without  ||| S:42396 E:42404 ||| IN
leucine ||| S:42404 E:42411 ||| NN
,  ||| S:42411 E:42413 ||| ,
uracil ||| S:42413 E:42419 ||| NN
,  ||| S:42419 E:42421 ||| ,
and  ||| S:42421 E:42425 ||| CC
both  ||| S:42425 E:42440 ||| DT
leucine  ||| S:42440 E:42448 ||| NN
and  ||| S:42448 E:42452 ||| CC
uracil ||| S:42452 E:42458 ||| NN
,  ||| S:42458 E:42460 ||| ,
respectively ||| S:42460 E:42472 ||| RB
.  ||| S:42472 E:42474 ||| .
Sgal-Leu  ||| S:42474 E:42483 ||| NNP
is  ||| S:42483 E:42486 ||| VBZ
SC-Leu  ||| S:42486 E:42493 ||| JJ
with  ||| S:42493 E:42508 ||| IN
20  ||| S:42508 E:42511 ||| CD
g ||| S:42511 E:42512 ||| CD
/ ||| S:42512 E:42513 ||| CD
l  ||| S:42513 E:42515 ||| CD
galactose  ||| S:42515 E:42525 ||| NNS
plus  ||| S:42525 E:42530 ||| CC
20  ||| S:42530 E:42533 ||| CD
g ||| S:42533 E:42534 ||| CD
/ ||| S:42534 E:42535 ||| CD
l  ||| S:42535 E:42537 ||| NNS
raffinose  ||| S:42537 E:42547 ||| VBP
instead  ||| S:42547 E:42555 ||| RB
of  ||| S:42555 E:42568 ||| IN
glucose ||| S:42568 E:42575 ||| NN
.  ||| S:42575 E:42587 ||| .
PBS  ||| S:42587 E:42591 ||| NNP
( ||| S:42591 E:42592 ||| -LRB-
phosphate-buffered  ||| S:42592 E:42611 ||| JJ
saline ||| S:42611 E:42617 ||| NN
,  ||| S:42617 E:42619 ||| ,
pH  ||| S:42619 E:42622 ||| JJ
7.0 ||| S:42622 E:42625 ||| CD
)  ||| S:42625 E:42627 ||| -RRB-
is  ||| S:42627 E:42630 ||| VBZ
1.42  ||| S:42630 E:42635 ||| CD
g ||| S:42635 E:42636 ||| CD
/ ||| S:42636 E:42637 ||| CD
l  ||| S:42637 E:42639 ||| CD
Na  ||| S:42639 E:42663 ||| CD
2  ||| S:42663 E:42665 ||| CD
PO  ||| S:42665 E:42679 ||| CD
4  ||| S:42679 E:42681 ||| CD
,  ||| S:42681 E:42683 ||| ,
245  ||| S:42683 E:42687 ||| CD
mg ||| S:42687 E:42689 ||| CD
/ ||| S:42689 E:42690 ||| CD
l  ||| S:42690 E:42692 ||| JJ
KH  ||| S:42692 E:42706 ||| NNP
2  ||| S:42706 E:42708 ||| CD
PO  ||| S:42708 E:42722 ||| CD
4  ||| S:42722 E:42724 ||| CD
,  ||| S:42724 E:42726 ||| ,
8  ||| S:42726 E:42728 ||| CD
g ||| S:42728 E:42729 ||| CD
/ ||| S:42729 E:42730 ||| CD
l  ||| S:42730 E:42732 ||| JJ
NaCl ||| S:42732 E:42736 ||| NN
,  ||| S:42736 E:42738 ||| ,
and  ||| S:42738 E:42742 ||| CC
0.2  ||| S:42742 E:42746 ||| CD
g ||| S:42746 E:42747 ||| CD
/ ||| S:42747 E:42748 ||| CD
l  ||| S:42748 E:42750 ||| JJ
KCl ||| S:42750 E:42753 ||| NN
.  ||| S:42753 E:42765 ||| .
Protease  ||| S:42765 E:42774 ||| JJ
inhibitors  ||| S:42774 E:42785 ||| NNS
are  ||| S:42785 E:42789 ||| VBP
40  ||| S:42789 E:42792 ||| CD
μg ||| S:42792 E:42794 ||| CD
/ ||| S:42794 E:42795 ||| CD
ml  ||| S:42795 E:42798 ||| JJ
bestatin ||| S:42798 E:42806 ||| NN
,  ||| S:42806 E:42808 ||| ,
0.7  ||| S:42808 E:42812 ||| FW
μg ||| S:42812 E:42814 ||| FW
/ ||| S:42814 E:42815 ||| FW
ml  ||| S:42815 E:42828 ||| FW
pepstatin  ||| S:42828 E:42838 ||| FW
A ||| S:42838 E:42839 ||| NNP
,  ||| S:42839 E:42841 ||| ,
1  ||| S:42841 E:42843 ||| CD
mM  ||| S:42843 E:42846 ||| JJ
PMSF ||| S:42846 E:42850 ||| NNP
,  ||| S:42850 E:42852 ||| ,
50  ||| S:42852 E:42855 ||| CD
μM  ||| S:42855 E:42858 ||| JJ
leupeptin ||| S:42858 E:42867 ||| NN
,  ||| S:42867 E:42869 ||| ,
1  ||| S:42869 E:42871 ||| CD
mM  ||| S:42871 E:42884 ||| JJ
benzamidine ||| S:42884 E:42895 ||| NN
,  ||| S:42895 E:42897 ||| ,
and  ||| S:42897 E:42901 ||| CC
1  ||| S:42901 E:42903 ||| CD
mM  ||| S:42903 E:42906 ||| JJ
EGTA.  ||| S:42906 E:42912 ||| NNP
2×  ||| S:42912 E:42915 ||| NNP
SDS  ||| S:42915 E:42919 ||| NNP
sample  ||| S:42919 E:42926 ||| NN
buffer  ||| S:42926 E:42933 ||| NN
is  ||| S:42933 E:42936 ||| VBZ
2 ||| S:42936 E:42937 ||| CD
%  ||| S:42937 E:42949 ||| NN
sodium  ||| S:42949 E:42956 ||| FW
dodecyl  ||| S:42956 E:42964 ||| FW
sulfate ||| S:42964 E:42971 ||| FW
,  ||| S:42971 E:42973 ||| ,
50  ||| S:42973 E:42976 ||| CD
mM  ||| S:42976 E:42979 ||| JJ
Tris  ||| S:42979 E:42984 ||| NNP
( ||| S:42984 E:42985 ||| -LRB-
pH6.8 ||| S:42985 E:42990 ||| NNP
) ||| S:42990 E:42991 ||| -RRB-
,  ||| S:42991 E:42993 ||| ,
6  ||| S:42993 E:42995 ||| CD
M  ||| S:42995 E:42997 ||| NNP
urea ||| S:42997 E:43001 ||| NN
,  ||| S:43001 E:43003 ||| ,
and  ||| S:43003 E:43017 ||| CC
bromophenol  ||| S:43017 E:43029 ||| JJ
blue ||| S:43029 E:43033 ||| NN
.  ||| S:43033 E:43045 ||| .
Phosphatidylcholine ||| S:43045 E:43064 ||| NNP
,  ||| S:43064 E:43066 ||| ,
phosphatidylinositol ||| S:43066 E:43086 ||| NN
,  ||| S:43086 E:43088 ||| ,
and  ||| S:43088 E:43102 ||| CC
phosphatidylserine  ||| S:43102 E:43121 ||| NNS
were  ||| S:43121 E:43126 ||| VBD
from  ||| S:43126 E:43131 ||| IN
Avanti  ||| S:43131 E:43138 ||| NNP
Polar  ||| S:43138 E:43144 ||| NNP
Lipids  ||| S:43144 E:43161 ||| NNP
( ||| S:43161 E:43162 ||| -LRB-
Alabaster ||| S:43162 E:43171 ||| NNP
,  ||| S:43171 E:43173 ||| ,
AL ||| S:43173 E:43175 ||| NNP
) ||| S:43175 E:43176 ||| -RRB-
;  ||| S:43176 E:43178 ||| :
phosphatidylinositol-4,5-bisphosphate  ||| S:43178 E:43226 ||| CD
and  ||| S:43226 E:43230 ||| CC
phosphatidylinositol-4-phosphate  ||| S:43230 E:43263 ||| NNP
were  ||| S:43263 E:43268 ||| VBD
from  ||| S:43268 E:43273 ||| IN
Calbiochem  ||| S:43273 E:43294 ||| NNP
( ||| S:43294 E:43295 ||| -LRB-
San  ||| S:43295 E:43299 ||| NNP
Diego ||| S:43299 E:43304 ||| NNP
,  ||| S:43304 E:43306 ||| ,
CA ||| S:43306 E:43308 ||| NNP
) ||| S:43308 E:43309 ||| -RRB-
;  ||| S:43309 E:43311 ||| :
and  ||| S:43311 E:43315 ||| CC
phosphatidylinositol-3-phosphate  ||| S:43315 E:43348 ||| NNP
was  ||| S:43348 E:43362 ||| VBD
from  ||| S:43362 E:43367 ||| IN
Matreya ||| S:43367 E:43374 ||| NNP
,  ||| S:43374 E:43376 ||| ,
Inc ||| S:43376 E:43379 ||| NNP
.  ||| S:43379 E:43381 ||| .
( ||| S:43381 E:43382 ||| -LRB-
Pleasant  ||| S:43382 E:43391 ||| NNP
Gap ||| S:43391 E:43394 ||| NNP
,  ||| S:43394 E:43396 ||| ,
PA ||| S:43396 E:43398 ||| NNP
) ||| S:43398 E:43399 ||| -RRB-
.  ||| S:43399 E:43411 ||| .
AP-PH  ||| S:43411 E:43417 ||| NNP
is  ||| S:43417 E:43420 ||| VBZ
affinity-purified  ||| S:43420 E:43438 ||| JJ
anti-Boi1  ||| S:43438 E:43448 ||| CD
antibody  ||| S:43448 E:43457 ||| NN
[  ||| S:43457 E:43459 ||| -LRB-
1  ||| S:43459 E:43461 ||| LS
]  ||| S:43461 E:43463 ||| -RRB-
.  ||| S:43463 E:43475 ||| .
AP-101  ||| S:43475 E:43482 ||| NNP
is  ||| S:43482 E:43485 ||| VBZ
affinity-purified  ||| S:43485 E:43503 ||| JJ
anti-Boi1  ||| S:43503 E:43513 ||| CD
antibody  ||| S:43513 E:43522 ||| NN
that  ||| S:43522 E:43527 ||| WDT
was  ||| S:43527 E:43541 ||| VBD
generated  ||| S:43541 E:43551 ||| VBN
in  ||| S:43551 E:43554 ||| IN
the  ||| S:43554 E:43558 ||| DT
same  ||| S:43558 E:43563 ||| JJ
manner  ||| S:43563 E:43570 ||| NN
as  ||| S:43570 E:43573 ||| IN
AP-PH ||| S:43573 E:43578 ||| NNP
,  ||| S:43578 E:43580 ||| ,
except  ||| S:43580 E:43587 ||| IN
that  ||| S:43587 E:43592 ||| WDT
it  ||| S:43592 E:43605 ||| PRP
came  ||| S:43605 E:43610 ||| VBD
from  ||| S:43610 E:43615 ||| IN
the  ||| S:43615 E:43619 ||| DT
serum  ||| S:43619 E:43625 ||| NN
of  ||| S:43625 E:43628 ||| IN
a  ||| S:43628 E:43630 ||| DT
different  ||| S:43630 E:43640 ||| JJ
rabbit ||| S:43640 E:43646 ||| NN
.  ||| S:43646 E:43648 ||| .
Both  ||| S:43648 E:43653 ||| DT
types  ||| S:43653 E:43659 ||| NNS
of  ||| S:43659 E:43672 ||| IN
antibody  ||| S:43672 E:43681 ||| NN
were  ||| S:43681 E:43686 ||| VBD
affinity  ||| S:43686 E:43695 ||| JJ
purified  ||| S:43695 E:43704 ||| NNS
[  ||| S:43704 E:43706 ||| -LRB-
22  ||| S:43706 E:43709 ||| CD
]  ||| S:43709 E:43711 ||| -RRB-
using  ||| S:43711 E:43717 ||| VBG
a  ||| S:43717 E:43719 ||| DT
6×His  ||| S:43719 E:43735 ||| JJ
fusion  ||| S:43735 E:43742 ||| NN
to  ||| S:43742 E:43745 ||| TO
the  ||| S:43745 E:43749 ||| DT
C-terminal  ||| S:43749 E:43760 ||| JJ
194  ||| S:43760 E:43764 ||| CD
amino  ||| S:43764 E:43770 ||| CD
acids  ||| S:43770 E:43776 ||| NNS
of  ||| S:43776 E:43779 ||| IN
Boi1  ||| S:43779 E:43784 ||| NNP
( ||| S:43784 E:43785 ||| -LRB-
the  ||| S:43785 E:43799 ||| DT
same  ||| S:43799 E:43804 ||| JJ
fusion  ||| S:43804 E:43811 ||| NN
that  ||| S:43811 E:43816 ||| WDT
was  ||| S:43816 E:43820 ||| VBD
used  ||| S:43820 E:43825 ||| VBN
as  ||| S:43825 E:43828 ||| IN
immunogen ||| S:43828 E:43837 ||| CD
)  ||| S:43837 E:43839 ||| -RRB-
[  ||| S:43839 E:43841 ||| -LRB-
1  ||| S:43841 E:43843 ||| LS
]  ||| S:43843 E:43845 ||| -RRB-
.  ||| S:43845 E:43847 ||| .
Immobilon  ||| S:43847 E:43867 ||| JJ
P  ||| S:43867 E:43869 ||| NN
membrane  ||| S:43869 E:43878 ||| NNS
was  ||| S:43878 E:43882 ||| VBD
from  ||| S:43882 E:43887 ||| IN
Millipore ||| S:43887 E:43896 ||| NNP
,  ||| S:43896 E:43898 ||| ,
Inc ||| S:43898 E:43901 ||| NNP
.  ||| S:43901 E:43903 ||| .
( ||| S:43903 E:43904 ||| -LRB-
Bedford ||| S:43904 E:43911 ||| NNP
,  ||| S:43911 E:43913 ||| ,
MA ||| S:43913 E:43915 ||| NNP
) ||| S:43915 E:43916 ||| -RRB-
.  ||| S:43916 E:43918 ||| .
ECL  ||| S:43918 E:43932 ||| NNP
reagents  ||| S:43932 E:43941 ||| NN
were  ||| S:43941 E:43946 ||| VBD
from  ||| S:43946 E:43951 ||| IN
Amersham  ||| S:43951 E:43960 ||| NNP
Pharmacia  ||| S:43960 E:43970 ||| NNP
Biotech ||| S:43970 E:43977 ||| NNP
,  ||| S:43977 E:43979 ||| ,
Inc ||| S:43979 E:43982 ||| NNP
.  ||| S:43982 E:43994 ||| .
( ||| S:43994 E:43995 ||| -LRB-
Piscataway ||| S:43995 E:44005 ||| NNP
,  ||| S:44005 E:44007 ||| ,
NJ ||| S:44007 E:44009 ||| NNP
) ||| S:44009 E:44010 ||| -RRB-
.  ||| S:44010 E:44022 ||| .
Additional  ||| S:44022 E:44033 ||| JJ
file  ||| S:44033 E:44038 ||| NN
1  ||| S:44038 E:44050 ||| CD
This  ||| S:44050 E:44055 ||| DT
table  ||| S:44055 E:44061 ||| NN
describes  ||| S:44061 E:44071 ||| VBZ
the  ||| S:44071 E:44075 ||| DT
plasmids  ||| S:44075 E:44084 ||| NN
and  ||| S:44084 E:44088 ||| CC
phage  ||| S:44088 E:44094 ||| VB
used  ||| S:44094 E:44099 ||| VBN
in  ||| S:44099 E:44112 ||| IN
this  ||| S:44112 E:44117 ||| DT
study  ||| S:44117 E:44133 ||| NN
Click  ||| S:44133 E:44139 ||| NNP
here  ||| S:44139 E:44144 ||| RB
for  ||| S:44144 E:44148 ||| IN
file  ||| S:44148 E:44181 ||| NN
Generation  ||| S:44181 E:44192 ||| NNP
of  ||| S:44192 E:44195 ||| IN
lipid  ||| S:44195 E:44201 ||| JJ
vesicles  ||| S:44201 E:44220 ||| JJ
PC  ||| S:44220 E:44223 ||| NN
and  ||| S:44223 E:44227 ||| CC
PS  ||| S:44227 E:44230 ||| NNP
were  ||| S:44230 E:44235 ||| VBD
stored  ||| S:44235 E:44242 ||| VBN
dissolved  ||| S:44242 E:44252 ||| VBN
in  ||| S:44252 E:44255 ||| IN
chloroform  ||| S:44255 E:44266 ||| NN
at  ||| S:44266 E:44279 ||| IN
concentrations  ||| S:44279 E:44294 ||| NNS
of  ||| S:44294 E:44297 ||| IN
20  ||| S:44297 E:44300 ||| CD
and  ||| S:44300 E:44304 ||| CC
10  ||| S:44304 E:44307 ||| CD
mg ||| S:44307 E:44309 ||| CD
/ ||| S:44309 E:44310 ||| CD
ml ||| S:44310 E:44312 ||| NN
,  ||| S:44312 E:44314 ||| ,
respectively ||| S:44314 E:44326 ||| RB
.  ||| S:44326 E:44338 ||| .
Inositol-based  ||| S:44338 E:44353 ||| JJ
phospholipids  ||| S:44353 E:44367 ||| NN
were  ||| S:44367 E:44372 ||| VBD
stored  ||| S:44372 E:44379 ||| VBN
at  ||| S:44379 E:44382 ||| IN
1  ||| S:44382 E:44384 ||| CD
mg ||| S:44384 E:44386 ||| CD
/ ||| S:44386 E:44387 ||| CD
ml  ||| S:44387 E:44400 ||| NNS
dissolved  ||| S:44400 E:44410 ||| VBN
in  ||| S:44410 E:44413 ||| IN
a  ||| S:44413 E:44415 ||| DT
1 ||| S:44415 E:44416 ||| CD
: ||| S:44416 E:44417 ||| :
1  ||| S:44417 E:44419 ||| CD
mixture  ||| S:44419 E:44427 ||| NN
of  ||| S:44427 E:44430 ||| IN
chloroform ||| S:44430 E:44440 ||| NNS
: ||| S:44440 E:44441 ||| :
methanol ||| S:44441 E:44449 ||| NN
.  ||| S:44449 E:44451 ||| .
Lipids  ||| S:44451 E:44468 ||| NNP
( ||| S:44468 E:44469 ||| -LRB-
pure  ||| S:44469 E:44474 ||| JJ
or  ||| S:44474 E:44477 ||| CC
mixtures ||| S:44477 E:44485 ||| NNS
)  ||| S:44485 E:44487 ||| -RRB-
were  ||| S:44487 E:44492 ||| VBD
dried  ||| S:44492 E:44498 ||| VBN
down  ||| S:44498 E:44503 ||| RP
from  ||| S:44503 E:44508 ||| IN
these  ||| S:44508 E:44514 ||| DT
solutions  ||| S:44514 E:44534 ||| NNS
under  ||| S:44534 E:44540 ||| IN
a  ||| S:44540 E:44542 ||| DT
stream  ||| S:44542 E:44549 ||| NN
of  ||| S:44549 E:44552 ||| IN
nitrogen  ||| S:44552 E:44561 ||| JJ
gas ||| S:44561 E:44564 ||| NN
.  ||| S:44564 E:44566 ||| .
Bath-type  ||| S:44566 E:44576 ||| JJ
sonication  ||| S:44576 E:44587 ||| NN
was  ||| S:44587 E:44601 ||| VBD
then  ||| S:44601 E:44606 ||| RB
used  ||| S:44606 E:44611 ||| VBN
to  ||| S:44611 E:44614 ||| TO
generate  ||| S:44614 E:44623 ||| VB
suspensions  ||| S:44623 E:44635 ||| NNS
of  ||| S:44635 E:44638 ||| IN
vesicles  ||| S:44638 E:44647 ||| NN
of  ||| S:44647 E:44650 ||| IN
these  ||| S:44650 E:44666 ||| DT
lipids  ||| S:44666 E:44673 ||| NN
in  ||| S:44673 E:44676 ||| IN
PBS ||| S:44676 E:44679 ||| NNP
.  ||| S:44679 E:44709 ||| .
Proteolysis  ||| S:44709 E:44721 ||| NNP
assay  ||| S:44721 E:44737 ||| VBD
The  ||| S:44737 E:44741 ||| DT
wild-type ||| S:44741 E:44750 ||| JJ
,  ||| S:44750 E:44752 ||| ,
KK ||| S:44752 E:44754 ||| NNP
,  ||| S:44754 E:44756 ||| ,
TK ||| S:44756 E:44758 ||| NNP
,  ||| S:44758 E:44760 ||| ,
and  ||| S:44760 E:44764 ||| CC
KKTK  ||| S:44764 E:44769 ||| NNP
versions  ||| S:44769 E:44778 ||| NNS
of  ||| S:44778 E:44781 ||| IN
Boi1-PH  ||| S:44781 E:44800 ||| NNP
were  ||| S:44800 E:44805 ||| VBD
expressed  ||| S:44805 E:44815 ||| VBN
in  ||| S:44815 E:44818 ||| IN
yeast  ||| S:44818 E:44824 ||| NN
strain  ||| S:44824 E:44831 ||| NN
Y312  ||| S:44831 E:44836 ||| NN
under  ||| S:44836 E:44842 ||| IN
the  ||| S:44842 E:44846 ||| DT
control  ||| S:44846 E:44854 ||| NN
of  ||| S:44854 E:44867 ||| IN
the  ||| S:44867 E:44882 ||| DT
GAL10  ||| S:44882 E:44888 ||| JJ
promoter  ||| S:44888 E:44897 ||| NN
from  ||| S:44897 E:44902 ||| IN
plasmids  ||| S:44902 E:44921 ||| CD
pPB900 ||| S:44921 E:44927 ||| CD
,  ||| S:44927 E:44929 ||| ,
pPB1308 ||| S:44929 E:44936 ||| NNP
,  ||| S:44936 E:44938 ||| ,
pPB1699 ||| S:44938 E:44945 ||| NNP
,  ||| S:44945 E:44947 ||| ,
and  ||| S:44947 E:44951 ||| CC
pPB1755 ||| S:44951 E:44958 ||| NNP
,  ||| S:44958 E:44960 ||| ,
respectively ||| S:44960 E:44972 ||| RB
.  ||| S:44972 E:44984 ||| .
Cultures  ||| S:44984 E:44993 ||| NNS
were  ||| S:44993 E:44998 ||| VBD
grown  ||| S:44998 E:45004 ||| VBN
to  ||| S:45004 E:45007 ||| TO
an  ||| S:45007 E:45010 ||| DT
O.D.  ||| S:45010 E:45026 ||| CD
600  ||| S:45026 E:45030 ||| CD
of  ||| S:45030 E:45033 ||| IN
0.8  ||| S:45033 E:45037 ||| CD
in  ||| S:45037 E:45040 ||| IN
250  ||| S:45040 E:45044 ||| CD
mls  ||| S:45044 E:45048 ||| NN
of  ||| S:45048 E:45051 ||| IN
SC-Leu ||| S:45051 E:45057 ||| NNP
,  ||| S:45057 E:45069 ||| ,
pelleted ||| S:45069 E:45077 ||| NN
,  ||| S:45077 E:45079 ||| ,
suspended  ||| S:45079 E:45089 ||| VBN
in  ||| S:45089 E:45092 ||| IN
250  ||| S:45092 E:45096 ||| CD
mls  ||| S:45096 E:45100 ||| NN
of  ||| S:45100 E:45103 ||| IN
Sgal-Leu ||| S:45103 E:45111 ||| NNP
,  ||| S:45111 E:45113 ||| ,
and  ||| S:45113 E:45117 ||| CC
incubated  ||| S:45117 E:45137 ||| NN
at  ||| S:45137 E:45140 ||| IN
30°C  ||| S:45140 E:45145 ||| CD
for  ||| S:45145 E:45149 ||| IN
16  ||| S:45149 E:45152 ||| CD
hours ||| S:45152 E:45157 ||| NNS
.  ||| S:45157 E:45159 ||| .
The  ||| S:45159 E:45163 ||| DT
following  ||| S:45163 E:45173 ||| JJ
procedures  ||| S:45173 E:45184 ||| NNS
were  ||| S:45184 E:45189 ||| VBD
then  ||| S:45189 E:45204 ||| RB
performed  ||| S:45204 E:45214 ||| VBN
at  ||| S:45214 E:45217 ||| IN
4°C ||| S:45217 E:45220 ||| CD
.  ||| S:45220 E:45222 ||| .
Cells  ||| S:45222 E:45228 ||| NNS
were  ||| S:45228 E:45233 ||| VBD
pelleted ||| S:45233 E:45241 ||| CD
,  ||| S:45241 E:45243 ||| ,
and  ||| S:45243 E:45247 ||| CC
the  ||| S:45247 E:45251 ||| DT
pellets  ||| S:45251 E:45269 ||| NN
were  ||| S:45269 E:45274 ||| VBD
rinsed  ||| S:45274 E:45281 ||| VBN
with  ||| S:45281 E:45286 ||| IN
PBS  ||| S:45286 E:45290 ||| NNP
containing  ||| S:45290 E:45301 ||| VBG
all  ||| S:45301 E:45305 ||| DT
of  ||| S:45305 E:45308 ||| IN
the  ||| S:45308 E:45312 ||| DT
protease  ||| S:45312 E:45331 ||| JJ
inhibitors  ||| S:45331 E:45342 ||| NN
except  ||| S:45342 E:45349 ||| IN
leupeptin ||| S:45349 E:45358 ||| NN
,  ||| S:45358 E:45360 ||| ,
benzamidine ||| S:45360 E:45371 ||| NN
,  ||| S:45371 E:45373 ||| ,
and  ||| S:45373 E:45377 ||| CC
EGTA ||| S:45377 E:45381 ||| NNP
.  ||| S:45381 E:45383 ||| .
Cells  ||| S:45383 E:45399 ||| NNS
were  ||| S:45399 E:45404 ||| VBD
suspended  ||| S:45404 E:45414 ||| VBN
in  ||| S:45414 E:45417 ||| IN
PBS  ||| S:45417 E:45421 ||| NNP
containing  ||| S:45421 E:45432 ||| VBG
the  ||| S:45432 E:45436 ||| DT
same  ||| S:45436 E:45441 ||| JJ
protease  ||| S:45441 E:45460 ||| JJ
inhibitors  ||| S:45460 E:45471 ||| NN
and  ||| S:45471 E:45475 ||| CC
were  ||| S:45475 E:45480 ||| VBD
then  ||| S:45480 E:45485 ||| RB
lysed  ||| S:45485 E:45491 ||| VBP
using  ||| S:45491 E:45497 ||| VBG
a  ||| S:45497 E:45499 ||| DT
French  ||| S:45499 E:45506 ||| JJ
press ||| S:45506 E:45511 ||| NN
.  ||| S:45511 E:45523 ||| .
Large  ||| S:45523 E:45529 ||| JJ
pieces  ||| S:45529 E:45536 ||| NNS
of  ||| S:45536 E:45539 ||| IN
cellular  ||| S:45539 E:45548 ||| JJ
debris  ||| S:45548 E:45555 ||| NN
were  ||| S:45555 E:45560 ||| VBD
removed  ||| S:45560 E:45568 ||| VBN
by  ||| S:45568 E:45581 ||| IN
centrifugation  ||| S:45581 E:45596 ||| NN
at  ||| S:45596 E:45599 ||| IN
12,000  ||| S:45599 E:45606 ||| CD
×  ||| S:45606 E:45608 ||| CD
g  ||| S:45608 E:45610 ||| NN
for  ||| S:45610 E:45614 ||| IN
10  ||| S:45614 E:45617 ||| CD
min  ||| S:45617 E:45621 ||| NN
in  ||| S:45621 E:45624 ||| IN
a  ||| S:45624 E:45626 ||| DT
Sorval  ||| S:45626 E:45633 ||| NNP
SS34  ||| S:45633 E:45648 ||| NNP
rotor ||| S:45648 E:45653 ||| NN
.  ||| S:45653 E:45655 ||| .
Soluble  ||| S:45655 E:45663 ||| JJ
fractions  ||| S:45663 E:45673 ||| NNS
were  ||| S:45673 E:45678 ||| VBD
then  ||| S:45678 E:45683 ||| RB
generated  ||| S:45683 E:45693 ||| VBN
by  ||| S:45693 E:45706 ||| IN
centrifugation  ||| S:45706 E:45721 ||| NN
of  ||| S:45721 E:45724 ||| IN
lysates  ||| S:45724 E:45732 ||| NN
at  ||| S:45732 E:45735 ||| IN
541,000  ||| S:45735 E:45743 ||| CD
×  ||| S:45743 E:45745 ||| CD
g  ||| S:45745 E:45747 ||| NN
for  ||| S:45747 E:45751 ||| IN
1  ||| S:45751 E:45753 ||| CD
hr  ||| S:45753 E:45756 ||| NN
in  ||| S:45756 E:45759 ||| IN
a  ||| S:45759 E:45771 ||| DT
TLA  ||| S:45771 E:45775 ||| NNP
100.4  ||| S:45775 E:45781 ||| CD
rotor  ||| S:45781 E:45787 ||| NN
in  ||| S:45787 E:45790 ||| IN
an  ||| S:45790 E:45793 ||| DT
Optima  ||| S:45793 E:45800 ||| NNP
TLX  ||| S:45800 E:45804 ||| NNP
ultracentrifuge  ||| S:45804 E:45830 ||| NNS
( ||| S:45830 E:45831 ||| -LRB-
Beckman ||| S:45831 E:45838 ||| NNP
,  ||| S:45838 E:45840 ||| ,
Palo  ||| S:45840 E:45845 ||| NNP
Alto ||| S:45845 E:45849 ||| NNP
,  ||| S:45849 E:45851 ||| ,
CA ||| S:45851 E:45853 ||| NNP
) ||| S:45853 E:45854 ||| -RRB-
.  ||| S:45854 E:45856 ||| .
To  ||| S:45856 E:45859 ||| TO
the  ||| S:45859 E:45863 ||| DT
cytosolic  ||| S:45863 E:45873 ||| JJ
fractions  ||| S:45873 E:45893 ||| NNS
( ||| S:45893 E:45894 ||| -LRB-
supernatants ||| S:45894 E:45906 ||| LS
) ||| S:45906 E:45907 ||| -RRB-
,  ||| S:45907 E:45909 ||| ,
glycerol  ||| S:45909 E:45918 ||| NN
was  ||| S:45918 E:45922 ||| VBD
added  ||| S:45922 E:45928 ||| VBN
to  ||| S:45928 E:45931 ||| TO
a  ||| S:45931 E:45933 ||| DT
final  ||| S:45933 E:45949 ||| JJ
concentration  ||| S:45949 E:45963 ||| NN
of  ||| S:45963 E:45966 ||| IN
40 ||| S:45966 E:45968 ||| CD
% ||| S:45968 E:45969 ||| NN
.  ||| S:45969 E:45971 ||| .
These  ||| S:45971 E:45977 ||| DT
fractions  ||| S:45977 E:45987 ||| NN
were  ||| S:45987 E:45992 ||| VBD
stored  ||| S:45992 E:45999 ||| VBN
at  ||| S:45999 E:46012 ||| IN
-20°C  ||| S:46012 E:46018 ||| NNP
and  ||| S:46018 E:46022 ||| CC
used  ||| S:46022 E:46027 ||| VBN
within  ||| S:46027 E:46034 ||| IN
one  ||| S:46034 E:46038 ||| CD
month.  ||| S:46038 E:46045 ||| CD
15  ||| S:46045 E:46048 ||| CD
μl  ||| S:46048 E:46051 ||| NN
of  ||| S:46051 E:46054 ||| IN
1  ||| S:46054 E:46056 ||| CD
mg ||| S:46056 E:46058 ||| FW
/ ||| S:46058 E:46059 ||| FW
ml  ||| S:46059 E:46062 ||| FW
lipid  ||| S:46062 E:46078 ||| FW
vesicle ||| S:46078 E:46085 ||| FW
/ ||| S:46085 E:46086 ||| FW
PBS  ||| S:46086 E:46090 ||| NNP
suspension  ||| S:46090 E:46101 ||| NN
was  ||| S:46101 E:46105 ||| VBD
mixed  ||| S:46105 E:46111 ||| VBN
with  ||| S:46111 E:46116 ||| IN
15  ||| S:46116 E:46119 ||| CD
μl  ||| S:46119 E:46122 ||| NN
of  ||| S:46122 E:46125 ||| IN
cytosol.  ||| S:46125 E:46134 ||| CD
5  ||| S:46134 E:46146 ||| CD
mM  ||| S:46146 E:46149 ||| JJ
DTT  ||| S:46149 E:46153 ||| NNP
was  ||| S:46153 E:46157 ||| VBD
included  ||| S:46157 E:46166 ||| VBN
to  ||| S:46166 E:46169 ||| TO
inactivate  ||| S:46169 E:46180 ||| VB
any  ||| S:46180 E:46184 ||| DT
residual  ||| S:46184 E:46193 ||| JJ
PMSF ||| S:46193 E:46197 ||| NNP
,  ||| S:46197 E:46199 ||| ,
and  ||| S:46199 E:46213 ||| CC
then  ||| S:46213 E:46218 ||| RB
2  ||| S:46218 E:46220 ||| CD
mM  ||| S:46220 E:46223 ||| JJ
CaCl  ||| S:46223 E:46239 ||| JJ
2  ||| S:46239 E:46241 ||| CD
was  ||| S:46241 E:46245 ||| VBD
added  ||| S:46245 E:46251 ||| VBN
to  ||| S:46251 E:46254 ||| TO
allow  ||| S:46254 E:46260 ||| VB
proteolysis  ||| S:46260 E:46272 ||| VBN
of  ||| S:46272 E:46285 ||| IN
Boi1-PH ||| S:46285 E:46292 ||| CD
.  ||| S:46292 E:46294 ||| .
Reaction  ||| S:46294 E:46303 ||| NN
mixtures  ||| S:46303 E:46312 ||| NNS
were  ||| S:46312 E:46317 ||| VBD
then  ||| S:46317 E:46322 ||| RB
transferred  ||| S:46322 E:46344 ||| VBN
immediately  ||| S:46344 E:46356 ||| RB
to  ||| S:46356 E:46359 ||| TO
a  ||| S:46359 E:46361 ||| DT
30°C  ||| S:46361 E:46366 ||| JJ
water  ||| S:46366 E:46372 ||| NN
bath ||| S:46372 E:46376 ||| NN
,  ||| S:46376 E:46378 ||| ,
and  ||| S:46378 E:46382 ||| CC
proteolysis  ||| S:46382 E:46394 ||| NNS
was  ||| S:46394 E:46408 ||| VBD
inhibited  ||| S:46408 E:46418 ||| CD
5  ||| S:46418 E:46420 ||| CD
min  ||| S:46420 E:46424 ||| NNS
later  ||| S:46424 E:46430 ||| RB
by  ||| S:46430 E:46433 ||| IN
addition  ||| S:46433 E:46442 ||| NN
of  ||| S:46442 E:46445 ||| IN
an  ||| S:46445 E:46448 ||| DT
equal  ||| S:46448 E:46454 ||| JJ
volume  ||| S:46454 E:46461 ||| NN
of  ||| S:46461 E:46474 ||| IN
2×  ||| S:46474 E:46477 ||| NNP
SDS  ||| S:46477 E:46481 ||| NNP
sample  ||| S:46481 E:46488 ||| NN
buffer  ||| S:46488 E:46495 ||| NN
containing  ||| S:46495 E:46506 ||| VBG
2  ||| S:46506 E:46508 ||| CD
mM  ||| S:46508 E:46511 ||| JJ
EGTA ||| S:46511 E:46515 ||| NNP
.  ||| S:46515 E:46517 ||| .
Proteins  ||| S:46517 E:46526 ||| NNS
were  ||| S:46526 E:46541 ||| VBD
separated  ||| S:46541 E:46551 ||| VBN
by  ||| S:46551 E:46554 ||| IN
SDS-PAGE  ||| S:46554 E:46563 ||| JJ
through  ||| S:46563 E:46571 ||| IN
a  ||| S:46571 E:46573 ||| DT
12 ||| S:46573 E:46575 ||| CD
%  ||| S:46575 E:46577 ||| NN
gel ||| S:46577 E:46580 ||| NN
,  ||| S:46580 E:46582 ||| ,
and  ||| S:46582 E:46586 ||| CC
then  ||| S:46586 E:46601 ||| RB
proteins  ||| S:46601 E:46610 ||| NNS
were  ||| S:46610 E:46615 ||| VBD
transferred  ||| S:46615 E:46627 ||| VBN
electrophoretically  ||| S:46627 E:46647 ||| VBN
to  ||| S:46647 E:46660 ||| TO
Immobilon  ||| S:46660 E:46670 ||| NNP
P  ||| S:46670 E:46672 ||| NN
membrane ||| S:46672 E:46680 ||| NN
.  ||| S:46680 E:46682 ||| .
Blots  ||| S:46682 E:46688 ||| NNP
were  ||| S:46688 E:46693 ||| VBD
probed  ||| S:46693 E:46700 ||| VBN
with  ||| S:46700 E:46705 ||| IN
anti-Boi1  ||| S:46705 E:46725 ||| CD
antibody  ||| S:46725 E:46734 ||| NN
AP-PH ||| S:46734 E:46739 ||| NN
.  ||| S:46739 E:46741 ||| .
Antibody-bound  ||| S:46741 E:46756 ||| JJ
protein  ||| S:46756 E:46764 ||| NN
bands  ||| S:46764 E:46770 ||| NNS
were  ||| S:46770 E:46785 ||| VBD
detected  ||| S:46785 E:46794 ||| VBN
on  ||| S:46794 E:46797 ||| IN
X-ray  ||| S:46797 E:46803 ||| NN
film  ||| S:46803 E:46808 ||| NN
using  ||| S:46808 E:46814 ||| VBG
ECL ||| S:46814 E:46817 ||| NNP
.  ||| S:46817 E:46819 ||| .
Each  ||| S:46819 E:46824 ||| DT
of  ||| S:46824 E:46827 ||| IN
the  ||| S:46827 E:46831 ||| DT
proteolysis  ||| S:46831 E:46853 ||| JJ
experiments  ||| S:46853 E:46865 ||| NNS
was  ||| S:46865 E:46869 ||| VBD
performed  ||| S:46869 E:46879 ||| VBN
at  ||| S:46879 E:46882 ||| IN
least  ||| S:46882 E:46888 ||| JJS
three  ||| S:46888 E:46894 ||| CD
times ||| S:46894 E:46899 ||| NNS
,  ||| S:46899 E:46901 ||| ,
with  ||| S:46901 E:46916 ||| IN
similar  ||| S:46916 E:46924 ||| JJ
results ||| S:46924 E:46931 ||| NNS
.  ||| S:46931 E:46961 ||| .
Vesicle  ||| S:46961 E:46969 ||| FW
co-sedimentation  ||| S:46969 E:46986 ||| FW
assay  ||| S:46986 E:47002 ||| FW
Yeast  ||| S:47002 E:47008 ||| FW
cytosol  ||| S:47008 E:47016 ||| FW
( ||| S:47016 E:47017 ||| -LRB-
from  ||| S:47017 E:47022 ||| IN
541,000  ||| S:47022 E:47030 ||| FW
×  ||| S:47030 E:47032 ||| FW
g  ||| S:47032 E:47034 ||| FW
spins ||| S:47034 E:47039 ||| FW
)  ||| S:47039 E:47041 ||| -RRB-
containing  ||| S:47041 E:47062 ||| VBG
wild-type  ||| S:47062 E:47072 ||| JJ
and  ||| S:47072 E:47076 ||| CC
mutant  ||| S:47076 E:47083 ||| JJ
versions  ||| S:47083 E:47092 ||| NNS
of  ||| S:47092 E:47095 ||| IN
Boi1-PH  ||| S:47095 E:47103 ||| NNP
were  ||| S:47103 E:47108 ||| VBD
prepared  ||| S:47108 E:47127 ||| VBN
and  ||| S:47127 E:47131 ||| CC
stored  ||| S:47131 E:47138 ||| VBD
as  ||| S:47138 E:47141 ||| RB
described  ||| S:47141 E:47151 ||| VBN
for  ||| S:47151 E:47155 ||| IN
the  ||| S:47155 E:47159 ||| DT
proteolysis  ||| S:47159 E:47171 ||| JJ
assay ||| S:47171 E:47176 ||| NN
,  ||| S:47176 E:47178 ||| ,
except  ||| S:47178 E:47195 ||| IN
that  ||| S:47195 E:47200 ||| IN
the  ||| S:47200 E:47204 ||| DT
protease  ||| S:47204 E:47213 ||| JJ
inhibitors  ||| S:47213 E:47224 ||| JJ
leupeptin ||| S:47224 E:47233 ||| NN
,  ||| S:47233 E:47235 ||| ,
benzamidine ||| S:47235 E:47246 ||| NN
,  ||| S:47246 E:47248 ||| ,
and  ||| S:47248 E:47262 ||| CC
EGTA  ||| S:47262 E:47267 ||| NNP
were  ||| S:47267 E:47272 ||| VBD
included.  ||| S:47272 E:47282 ||| CD
15  ||| S:47282 E:47285 ||| CD
μl  ||| S:47285 E:47288 ||| NN
of  ||| S:47288 E:47291 ||| IN
1  ||| S:47291 E:47293 ||| CD
mg ||| S:47293 E:47295 ||| FW
/ ||| S:47295 E:47296 ||| FW
ml  ||| S:47296 E:47299 ||| FW
lipid  ||| S:47299 E:47305 ||| FW
vesicle ||| S:47305 E:47312 ||| FW
/ ||| S:47312 E:47313 ||| FW
PBS  ||| S:47313 E:47327 ||| NNP
suspensions  ||| S:47327 E:47339 ||| NNS
were  ||| S:47339 E:47344 ||| VBD
mixed  ||| S:47344 E:47350 ||| VBN
with  ||| S:47350 E:47355 ||| IN
15  ||| S:47355 E:47358 ||| CD
μl  ||| S:47358 E:47361 ||| NN
of  ||| S:47361 E:47364 ||| IN
cytosol.  ||| S:47364 E:47373 ||| CD
30  ||| S:47373 E:47376 ||| CD
μl  ||| S:47376 E:47379 ||| NN
of  ||| S:47379 E:47392 ||| IN
PBS ||| S:47392 E:47395 ||| NNP
,  ||| S:47395 E:47397 ||| ,
with  ||| S:47397 E:47402 ||| IN
or  ||| S:47402 E:47405 ||| CC
without  ||| S:47405 E:47413 ||| IN
additional  ||| S:47413 E:47424 ||| JJ
KCl ||| S:47424 E:47427 ||| NN
,  ||| S:47427 E:47429 ||| ,
was  ||| S:47429 E:47433 ||| VBD
then  ||| S:47433 E:47438 ||| RB
added  ||| S:47438 E:47444 ||| VBD
to  ||| S:47444 E:47457 ||| TO
each  ||| S:47457 E:47462 ||| DT
mixture  ||| S:47462 E:47470 ||| NN
to  ||| S:47470 E:47473 ||| TO
reduce  ||| S:47473 E:47480 ||| VB
the  ||| S:47480 E:47484 ||| DT
concentration  ||| S:47484 E:47498 ||| NN
of  ||| S:47498 E:47501 ||| IN
glycerol  ||| S:47501 E:47510 ||| VBG
to  ||| S:47510 E:47523 ||| TO
approximately  ||| S:47523 E:47537 ||| RB
10 ||| S:47537 E:47539 ||| CD
% ||| S:47539 E:47540 ||| NN
.  ||| S:47540 E:47542 ||| .
For  ||| S:47542 E:47546 ||| IN
the  ||| S:47546 E:47550 ||| DT
experiment  ||| S:47550 E:47561 ||| NN
shown  ||| S:47561 E:47567 ||| VBN
in  ||| S:47567 E:47570 ||| IN
Fig.  ||| S:47570 E:47575 ||| CD
3 ||| S:47575 E:47576 ||| CD
,  ||| S:47576 E:47588 ||| ,
the  ||| S:47588 E:47592 ||| DT
concentrations  ||| S:47592 E:47607 ||| NNS
of  ||| S:47607 E:47610 ||| IN
additional  ||| S:47610 E:47621 ||| JJ
KCl  ||| S:47621 E:47625 ||| NN
in  ||| S:47625 E:47628 ||| IN
the  ||| S:47628 E:47632 ||| DT
final  ||| S:47632 E:47648 ||| JJ
reaction  ||| S:47648 E:47657 ||| NN
mixture  ||| S:47657 E:47665 ||| NNS
are  ||| S:47665 E:47669 ||| VBP
indicated ||| S:47669 E:47678 ||| VBN
.  ||| S:47678 E:47680 ||| .
For  ||| S:47680 E:47684 ||| IN
the  ||| S:47684 E:47688 ||| DT
experiment  ||| S:47688 E:47699 ||| NN
shown  ||| S:47699 E:47715 ||| VBN
in  ||| S:47715 E:47718 ||| IN
Fig.  ||| S:47718 E:47723 ||| CD
5B ||| S:47723 E:47725 ||| CD
,  ||| S:47725 E:47727 ||| ,
no  ||| S:47727 E:47730 ||| DT
additional  ||| S:47730 E:47741 ||| JJ
KCl  ||| S:47741 E:47745 ||| NN
was  ||| S:47745 E:47749 ||| VBD
present ||| S:47749 E:47756 ||| JJ
.  ||| S:47756 E:47758 ||| .
Mixtures  ||| S:47758 E:47767 ||| NNP
were  ||| S:47767 E:47782 ||| VBD
then  ||| S:47782 E:47787 ||| RB
centrifuged  ||| S:47787 E:47799 ||| VBN
immediately  ||| S:47799 E:47811 ||| RB
at  ||| S:47811 E:47814 ||| IN
436,000  ||| S:47814 E:47822 ||| CD
×  ||| S:47822 E:47824 ||| CD
g  ||| S:47824 E:47826 ||| NN
for  ||| S:47826 E:47830 ||| IN
1  ||| S:47830 E:47832 ||| CD
hr  ||| S:47832 E:47835 ||| NN
in  ||| S:47835 E:47838 ||| IN
a  ||| S:47838 E:47850 ||| DT
TLA100  ||| S:47850 E:47857 ||| JJ
rotor ||| S:47857 E:47862 ||| NN
.  ||| S:47862 E:47864 ||| .
Supernatants  ||| S:47864 E:47877 ||| NNP
were  ||| S:47877 E:47882 ||| VBD
combined  ||| S:47882 E:47891 ||| VBN
1 ||| S:47891 E:47892 ||| CD
: ||| S:47892 E:47893 ||| :
1  ||| S:47893 E:47895 ||| CD
with  ||| S:47895 E:47900 ||| IN
2×  ||| S:47900 E:47903 ||| NNP
SDS  ||| S:47903 E:47917 ||| NNP
sample  ||| S:47917 E:47924 ||| NN
buffer ||| S:47924 E:47930 ||| NN
,  ||| S:47930 E:47932 ||| ,
and  ||| S:47932 E:47936 ||| CC
pellets  ||| S:47936 E:47944 ||| NNS
were  ||| S:47944 E:47949 ||| VBD
dissolved  ||| S:47949 E:47959 ||| VBN
in  ||| S:47959 E:47962 ||| IN
2×  ||| S:47962 E:47965 ||| NNP
SDS  ||| S:47965 E:47979 ||| NNP
sample  ||| S:47979 E:47986 ||| NN
buffer ||| S:47986 E:47992 ||| NN
.  ||| S:47992 E:47994 ||| .
Equal  ||| S:47994 E:48000 ||| JJ
proportions  ||| S:48000 E:48012 ||| NNS
of  ||| S:48012 E:48015 ||| IN
each  ||| S:48015 E:48020 ||| DT
fraction  ||| S:48020 E:48029 ||| NN
were  ||| S:48029 E:48044 ||| VBD
subjected  ||| S:48044 E:48054 ||| VBN
to  ||| S:48054 E:48057 ||| TO
SDS-PAGE  ||| S:48057 E:48066 ||| JJ
through  ||| S:48066 E:48074 ||| IN
a  ||| S:48074 E:48076 ||| DT
12 ||| S:48076 E:48078 ||| CD
%  ||| S:48078 E:48080 ||| NN
gel ||| S:48080 E:48083 ||| NN
,  ||| S:48083 E:48085 ||| ,
proteins  ||| S:48085 E:48094 ||| NNS
were  ||| S:48094 E:48109 ||| VBD
transblotted  ||| S:48109 E:48122 ||| JJ
Immobilon  ||| S:48122 E:48132 ||| JJ
P  ||| S:48132 E:48134 ||| NN
membrane ||| S:48134 E:48142 ||| NN
,  ||| S:48142 E:48144 ||| ,
blots  ||| S:48144 E:48150 ||| NN
were  ||| S:48150 E:48155 ||| VBD
probed  ||| S:48155 E:48162 ||| VBN
with  ||| S:48162 E:48177 ||| IN
antibody  ||| S:48177 E:48186 ||| NN
AP-PH ||| S:48186 E:48191 ||| NN
,  ||| S:48191 E:48193 ||| ,
and  ||| S:48193 E:48197 ||| CC
bound  ||| S:48197 E:48203 ||| JJ
antibodies  ||| S:48203 E:48214 ||| NNS
were  ||| S:48214 E:48219 ||| VBD
detected  ||| S:48219 E:48228 ||| VBN
by  ||| S:48228 E:48241 ||| IN
ECL ||| S:48241 E:48244 ||| NNP
.  ||| S:48244 E:48246 ||| .
Each  ||| S:48246 E:48251 ||| DT
of  ||| S:48251 E:48254 ||| IN
the  ||| S:48254 E:48258 ||| DT
vesicle  ||| S:48258 E:48266 ||| JJ
co-sedimentation  ||| S:48266 E:48283 ||| JJ
experiments  ||| S:48283 E:48295 ||| NNS
was  ||| S:48295 E:48309 ||| VBD
performed  ||| S:48309 E:48319 ||| VBN
at  ||| S:48319 E:48322 ||| IN
least  ||| S:48322 E:48328 ||| JJS
three  ||| S:48328 E:48334 ||| CD
times ||| S:48334 E:48339 ||| NNS
,  ||| S:48339 E:48341 ||| ,
with  ||| S:48341 E:48346 ||| IN
similar  ||| S:48346 E:48354 ||| JJ
results ||| S:48354 E:48361 ||| NNS
.  ||| S:48361 E:48391 ||| .
Colony-sectoring  ||| S:48391 E:48408 ||| JJ
assay  ||| S:48408 E:48424 ||| JJ
Plasmids  ||| S:48424 E:48433 ||| NNP
were  ||| S:48433 E:48438 ||| VBD
introduced  ||| S:48438 E:48449 ||| VBN
into  ||| S:48449 E:48454 ||| IN
strain  ||| S:48454 E:48461 ||| NN
PY967  ||| S:48461 E:48467 ||| VBZ
using  ||| S:48467 E:48473 ||| VBG
the  ||| S:48473 E:48487 ||| DT
lithium  ||| S:48487 E:48495 ||| JJ
thiocyanate  ||| S:48495 E:48507 ||| JJ
procedure  ||| S:48507 E:48517 ||| NN
[  ||| S:48517 E:48519 ||| -LRB-
23  ||| S:48519 E:48522 ||| CD
]  ||| S:48522 E:48524 ||| -RRB-
,  ||| S:48524 E:48526 ||| ,
and  ||| S:48526 E:48530 ||| CC
transformants  ||| S:48530 E:48554 ||| NNS
were  ||| S:48554 E:48559 ||| VBD
selected  ||| S:48559 E:48568 ||| VBN
on  ||| S:48568 E:48571 ||| IN
SC-Ura ||| S:48571 E:48577 ||| JJ
.  ||| S:48577 E:48579 ||| .
Concentrations  ||| S:48579 E:48594 ||| NNS
of  ||| S:48594 E:48597 ||| IN
plasmid  ||| S:48597 E:48605 ||| JJ
DNAs  ||| S:48605 E:48620 ||| NN
were  ||| S:48620 E:48625 ||| VBD
adjusted  ||| S:48625 E:48634 ||| VBN
so  ||| S:48634 E:48637 ||| RB
that  ||| S:48637 E:48642 ||| IN
they  ||| S:48642 E:48647 ||| PRP
would  ||| S:48647 E:48653 ||| MD
give  ||| S:48653 E:48658 ||| VB
approximately  ||| S:48658 E:48672 ||| RB
400  ||| S:48672 E:48686 ||| CD
colonies  ||| S:48686 E:48695 ||| NNS
per  ||| S:48695 E:48699 ||| IN
petri  ||| S:48699 E:48705 ||| JJ
plate ||| S:48705 E:48710 ||| NN
.  ||| S:48710 E:48712 ||| .
Transformation  ||| S:48712 E:48727 ||| JJ
plates  ||| S:48727 E:48734 ||| NN
were  ||| S:48734 E:48749 ||| VBD
incubated  ||| S:48749 E:48759 ||| VBN
at  ||| S:48759 E:48762 ||| IN
either  ||| S:48762 E:48769 ||| DT
23  ||| S:48769 E:48772 ||| CD
or  ||| S:48772 E:48775 ||| CC
30°C  ||| S:48775 E:48780 ||| CD
for  ||| S:48780 E:48784 ||| IN
4-5  ||| S:48784 E:48788 ||| CD
days  ||| S:48788 E:48793 ||| NNS
and  ||| S:48793 E:48797 ||| CC
then  ||| S:48797 E:48812 ||| RB
stored  ||| S:48812 E:48819 ||| VBN
at  ||| S:48819 E:48822 ||| IN
4°C  ||| S:48822 E:48826 ||| CD
for  ||| S:48826 E:48830 ||| IN
one  ||| S:48830 E:48834 ||| CD
week  ||| S:48834 E:48839 ||| NN
to  ||| S:48839 E:48842 ||| TO
allow  ||| S:48842 E:48848 ||| VB
further  ||| S:48848 E:48856 ||| JJ
development  ||| S:48856 E:48878 ||| NN
of  ||| S:48878 E:48881 ||| IN
the  ||| S:48881 E:48885 ||| DT
red  ||| S:48885 E:48889 ||| JJ
color ||| S:48889 E:48894 ||| NN
.  ||| S:48894 E:48896 ||| .
To  ||| S:48896 E:48899 ||| TO
assay  ||| S:48899 E:48905 ||| VB
sectoring ||| S:48905 E:48914 ||| NNS
,  ||| S:48914 E:48916 ||| ,
colonies  ||| S:48916 E:48925 ||| NNS
were  ||| S:48925 E:48940 ||| VBD
viewed  ||| S:48940 E:48947 ||| VBN
using  ||| S:48947 E:48953 ||| VBG
a  ||| S:48953 E:48955 ||| DT
low-power  ||| S:48955 E:48965 ||| JJ
dissecting  ||| S:48965 E:48976 ||| JJ
microscope ||| S:48976 E:48986 ||| NN
.  ||| S:48986 E:48988 ||| .
A  ||| S:48988 E:48990 ||| DT
minimum  ||| S:48990 E:49008 ||| NN
of  ||| S:49008 E:49011 ||| IN
200  ||| S:49011 E:49015 ||| CD
colonies  ||| S:49015 E:49024 ||| NNS
were  ||| S:49024 E:49029 ||| VBD
analyzed  ||| S:49029 E:49038 ||| VBN
for  ||| S:49038 E:49042 ||| IN
each  ||| S:49042 E:49047 ||| DT
plasmid  ||| S:49047 E:49055 ||| NN
tested  ||| S:49055 E:49062 ||| VBN
at  ||| S:49062 E:49075 ||| IN
each  ||| S:49075 E:49080 ||| DT
temperature ||| S:49080 E:49091 ||| NN
.  ||| S:49091 E:49121 ||| .
Analysis  ||| S:49121 E:49130 ||| NN
of  ||| S:49130 E:49133 ||| IN
relative  ||| S:49133 E:49142 ||| JJ
protein  ||| S:49142 E:49150 ||| NN
concentrations  ||| S:49150 E:49175 ||| NNS
To  ||| S:49175 E:49178 ||| TO
analyze  ||| S:49178 E:49186 ||| VB
versions  ||| S:49186 E:49195 ||| NNS
of  ||| S:49195 E:49198 ||| IN
full-length  ||| S:49198 E:49210 ||| JJ
Boi1 ||| S:49210 E:49214 ||| NN
,  ||| S:49214 E:49227 ||| ,
boi1  ||| S:49227 E:49232 ||| CD
strain  ||| S:49232 E:49239 ||| NN
Y1284  ||| S:49239 E:49245 ||| NN
was  ||| S:49245 E:49249 ||| VBD
used ||| S:49249 E:49253 ||| VBN
,  ||| S:49253 E:49265 ||| ,
selecting  ||| S:49265 E:49275 ||| VBG
for  ||| S:49275 E:49279 ||| IN
plasmids  ||| S:49279 E:49288 ||| NN
in  ||| S:49288 E:49291 ||| IN
SC-Ura ||| S:49291 E:49297 ||| JJ
.  ||| S:49297 E:49299 ||| .
To  ||| S:49299 E:49302 ||| TO
analyze  ||| S:49302 E:49310 ||| VB
versions  ||| S:49310 E:49319 ||| NNS
of  ||| S:49319 E:49332 ||| IN
Boi1-PH ||| S:49332 E:49339 ||| NNP
,  ||| S:49339 E:49341 ||| ,
strain  ||| S:49341 E:49348 ||| NN
PY967  ||| S:49348 E:49354 ||| NN
was  ||| S:49354 E:49358 ||| VBD
used ||| S:49358 E:49362 ||| VBN
,  ||| S:49362 E:49364 ||| ,
selecting  ||| S:49364 E:49374 ||| VBG
for  ||| S:49374 E:49378 ||| IN
plasmids  ||| S:49378 E:49387 ||| NN
in  ||| S:49387 E:49400 ||| IN
SC-Ura-Leu ||| S:49400 E:49410 ||| JJ
.  ||| S:49410 E:49412 ||| .
Cultures  ||| S:49412 E:49421 ||| NNS
were  ||| S:49421 E:49426 ||| VBD
grown  ||| S:49426 E:49432 ||| VBN
to  ||| S:49432 E:49435 ||| TO
an  ||| S:49435 E:49438 ||| DT
O.D.  ||| S:49438 E:49454 ||| CD
600  ||| S:49454 E:49458 ||| CD
of  ||| S:49458 E:49461 ||| IN
0.8  ||| S:49461 E:49465 ||| CD
at  ||| S:49465 E:49468 ||| IN
23°C  ||| S:49468 E:49473 ||| NNP
and  ||| S:49473 E:49477 ||| CC
then  ||| S:49477 E:49482 ||| RB
diluted  ||| S:49482 E:49500 ||| VBN
1 ||| S:49500 E:49501 ||| CD
: ||| S:49501 E:49502 ||| :
1  ||| S:49502 E:49504 ||| CD
with  ||| S:49504 E:49509 ||| IN
0.4  ||| S:49509 E:49513 ||| CD
M  ||| S:49513 E:49515 ||| NNP
NaOH  ||| S:49515 E:49520 ||| NNP
+  ||| S:49520 E:49522 ||| CD
1.7 ||| S:49522 E:49525 ||| CD
%  ||| S:49525 E:49527 ||| NN
2-mercaptoethanol ||| S:49527 E:49544 ||| NN
.  ||| S:49544 E:49546 ||| .
The  ||| S:49546 E:49560 ||| DT
resulting  ||| S:49560 E:49570 ||| VBG
lysed-cell  ||| S:49570 E:49581 ||| JJ
suspensions  ||| S:49581 E:49593 ||| NNS
were  ||| S:49593 E:49598 ||| VBD
then  ||| S:49598 E:49603 ||| RB
incubated  ||| S:49603 E:49613 ||| VBN
on  ||| S:49613 E:49626 ||| IN
ice  ||| S:49626 E:49630 ||| NN
for  ||| S:49630 E:49634 ||| IN
10  ||| S:49634 E:49637 ||| CD
min ||| S:49637 E:49640 ||| NN
,  ||| S:49640 E:49642 ||| ,
and  ||| S:49642 E:49646 ||| CC
protein  ||| S:49646 E:49654 ||| NN
was  ||| S:49654 E:49658 ||| VBD
made  ||| S:49658 E:49663 ||| VBN
to  ||| S:49663 E:49666 ||| TO
precipitate  ||| S:49666 E:49678 ||| VB
using  ||| S:49678 E:49694 ||| VBG
10 ||| S:49694 E:49696 ||| CD
%  ||| S:49696 E:49698 ||| NN
trichloroacetic  ||| S:49698 E:49714 ||| NN
acid ||| S:49714 E:49718 ||| NN
.  ||| S:49718 E:49720 ||| .
Pellets  ||| S:49720 E:49728 ||| NNP
were  ||| S:49728 E:49733 ||| VBD
rinsed  ||| S:49733 E:49740 ||| JJ
first  ||| S:49740 E:49746 ||| JJ
with  ||| S:49746 E:49761 ||| IN
70 ||| S:49761 E:49763 ||| CD
%  ||| S:49763 E:49765 ||| NN
ethanol  ||| S:49765 E:49773 ||| NN
and  ||| S:49773 E:49777 ||| CC
then  ||| S:49777 E:49782 ||| RB
with  ||| S:49782 E:49787 ||| IN
acetone ||| S:49787 E:49794 ||| NN
,  ||| S:49794 E:49796 ||| ,
and  ||| S:49796 E:49800 ||| CC
they  ||| S:49800 E:49805 ||| PRP
were  ||| S:49805 E:49810 ||| VBD
then  ||| S:49810 E:49825 ||| RB
suspended  ||| S:49825 E:49835 ||| VBN
in  ||| S:49835 E:49838 ||| IN
1 ||| S:49838 E:49839 ||| CD
%  ||| S:49839 E:49841 ||| NN
SDS  ||| S:49841 E:49845 ||| NNP
+  ||| S:49845 E:49847 ||| CD
3  ||| S:49847 E:49849 ||| CD
M  ||| S:49849 E:49851 ||| NNP
urea ||| S:49851 E:49855 ||| NN
.  ||| S:49855 E:49857 ||| .
Protein  ||| S:49857 E:49865 ||| NN
concentrations  ||| S:49865 E:49890 ||| NNS
were  ||| S:49890 E:49895 ||| VBD
determined  ||| S:49895 E:49906 ||| VBN
using  ||| S:49906 E:49912 ||| VBG
the  ||| S:49912 E:49916 ||| DT
BCA  ||| S:49916 E:49920 ||| NNP
Protein  ||| S:49920 E:49928 ||| NNP
Assay  ||| S:49928 E:49934 ||| NNP
( ||| S:49934 E:49935 ||| -LRB-
Pierce ||| S:49935 E:49941 ||| NNP
,  ||| S:49941 E:49953 ||| ,
Rockford ||| S:49953 E:49961 ||| NNP
,  ||| S:49961 E:49963 ||| ,
IL ||| S:49963 E:49965 ||| NNP
) ||| S:49965 E:49966 ||| -RRB-
.  ||| S:49966 E:49968 ||| .
10  ||| S:49968 E:49971 ||| CD
μg  ||| S:49971 E:49974 ||| NN
of  ||| S:49974 E:49977 ||| IN
total  ||| S:49977 E:49983 ||| JJ
protein  ||| S:49983 E:49991 ||| NN
from  ||| S:49991 E:49996 ||| IN
each  ||| S:49996 E:50001 ||| DT
sample  ||| S:50001 E:50018 ||| NN
was  ||| S:50018 E:50022 ||| VBD
subjected  ||| S:50022 E:50032 ||| VBN
to  ||| S:50032 E:50035 ||| TO
SDS-PAGE  ||| S:50035 E:50044 ||| JJ
through  ||| S:50044 E:50052 ||| IN
a  ||| S:50052 E:50054 ||| DT
12 ||| S:50054 E:50056 ||| CD
%  ||| S:50056 E:50058 ||| NN
gel ||| S:50058 E:50061 ||| NN
.  ||| S:50061 E:50063 ||| .
Proteins  ||| S:50063 E:50082 ||| NNS
were  ||| S:50082 E:50087 ||| VBD
transblotted  ||| S:50087 E:50100 ||| VBN
to  ||| S:50100 E:50103 ||| TO
Immobilon  ||| S:50103 E:50113 ||| NNP
P  ||| S:50113 E:50115 ||| NN
membrane ||| S:50115 E:50123 ||| NN
,  ||| S:50123 E:50125 ||| ,
blots  ||| S:50125 E:50131 ||| NN
were  ||| S:50131 E:50146 ||| VBD
probed  ||| S:50146 E:50153 ||| VBN
with  ||| S:50153 E:50158 ||| IN
antibody  ||| S:50158 E:50167 ||| CD
AP-101 ||| S:50167 E:50173 ||| CD
,  ||| S:50173 E:50175 ||| ,
and  ||| S:50175 E:50179 ||| CC
bound  ||| S:50179 E:50185 ||| JJ
antibodies  ||| S:50185 E:50196 ||| NNS
were  ||| S:50196 E:50211 ||| VBD
detected  ||| S:50211 E:50220 ||| VBN
by  ||| S:50220 E:50223 ||| IN
ECL ||| S:50223 E:50226 ||| NNP
.  ||| S:50226 E:50228 ||| .
Each  ||| S:50228 E:50233 ||| DT
of  ||| S:50233 E:50236 ||| IN
the  ||| S:50236 E:50240 ||| DT
analyses  ||| S:50240 E:50249 ||| NN
of  ||| S:50249 E:50252 ||| IN
protein  ||| S:50252 E:50270 ||| NN
concentration  ||| S:50270 E:50284 ||| NN
was  ||| S:50284 E:50288 ||| VBD
performed  ||| S:50288 E:50298 ||| VBN
three  ||| S:50298 E:50304 ||| CD
times ||| S:50304 E:50309 ||| NNS
,  ||| S:50309 E:50311 ||| ,
with  ||| S:50311 E:50316 ||| IN
similar  ||| S:50316 E:50334 ||| JJ
results ||| S:50334 E:50341 ||| NNS
.  ||| S:50341 E:50371 ||| .
Localization  ||| S:50371 E:50384 ||| JJ
studies  ||| S:50384 E:50402 ||| NNS
Yeast  ||| S:50402 E:50408 ||| NN
strain  ||| S:50408 E:50415 ||| NN
Y1300  ||| S:50415 E:50421 ||| NN
was  ||| S:50421 E:50425 ||| VBD
used  ||| S:50425 E:50430 ||| VBN
for  ||| S:50430 E:50434 ||| IN
localization  ||| S:50434 E:50447 ||| JJ
studies ||| S:50447 E:50454 ||| NNS
.  ||| S:50454 E:50466 ||| .
Cells  ||| S:50466 E:50472 ||| NNS
were  ||| S:50472 E:50477 ||| VBD
grown  ||| S:50477 E:50483 ||| VBN
in  ||| S:50483 E:50486 ||| IN
SC-Ura  ||| S:50486 E:50493 ||| JJ
to  ||| S:50493 E:50496 ||| TO
select  ||| S:50496 E:50503 ||| VB
for  ||| S:50503 E:50507 ||| IN
plasmids  ||| S:50507 E:50516 ||| NNS
that  ||| S:50516 E:50531 ||| WDT
encode  ||| S:50531 E:50538 ||| VBZ
the  ||| S:50538 E:50542 ||| DT
GFP  ||| S:50542 E:50546 ||| NNP
fusions ||| S:50546 E:50553 ||| NN
.  ||| S:50553 E:50555 ||| .
Aliquots  ||| S:50555 E:50564 ||| NNP
of  ||| S:50564 E:50567 ||| IN
cells  ||| S:50567 E:50573 ||| NNS
from  ||| S:50573 E:50588 ||| IN
exponentially  ||| S:50588 E:50602 ||| NNS
growing  ||| S:50602 E:50610 ||| VBG
cultures  ||| S:50610 E:50619 ||| NNS
were  ||| S:50619 E:50624 ||| VBD
placed  ||| S:50624 E:50631 ||| VBN
directly  ||| S:50631 E:50650 ||| RB
( ||| S:50650 E:50651 ||| -LRB-
without  ||| S:50651 E:50659 ||| IN
centrifugation ||| S:50659 E:50673 ||| CD
)  ||| S:50673 E:50675 ||| -RRB-
onto  ||| S:50675 E:50680 ||| IN
glass  ||| S:50680 E:50686 ||| NN
slides  ||| S:50686 E:50693 ||| NNS
for  ||| S:50693 E:50697 ||| IN
analysis  ||| S:50697 E:50716 ||| NN
using  ||| S:50716 E:50722 ||| VBG
a  ||| S:50722 E:50724 ||| DT
Zeiss  ||| S:50724 E:50730 ||| NNP
Axioplan  ||| S:50730 E:50739 ||| NNP
epifluorescence  ||| S:50739 E:50755 ||| JJ
microscope ||| S:50755 E:50765 ||| NN
.  ||| S:50765 E:50767 ||| .
No  ||| S:50767 E:50780 ||| DT
slide  ||| S:50780 E:50786 ||| NN
sample  ||| S:50786 E:50793 ||| NN
was  ||| S:50793 E:50797 ||| VBD
analyzed  ||| S:50797 E:50806 ||| VBN
for  ||| S:50806 E:50810 ||| IN
longer  ||| S:50810 E:50817 ||| JJR
than  ||| S:50817 E:50822 ||| IN
5  ||| S:50822 E:50824 ||| CD
min ||| S:50824 E:50827 ||| NN
,  ||| S:50827 E:50829 ||| ,
to  ||| S:50829 E:50832 ||| TO
avoid  ||| S:50832 E:50848 ||| VB
stressing  ||| S:50848 E:50858 ||| VBG
the  ||| S:50858 E:50862 ||| DT
cells ||| S:50862 E:50867 ||| NNS
.  ||| S:50867 E:50869 ||| .
Quantification  ||| S:50869 E:50884 ||| NNP
of  ||| S:50884 E:50887 ||| IN
the  ||| S:50887 E:50891 ||| DT
different  ||| S:50891 E:50911 ||| JJ
localization  ||| S:50911 E:50924 ||| JJ
patterns  ||| S:50924 E:50933 ||| NNS
was  ||| S:50933 E:50937 ||| VBD
done  ||| S:50937 E:50942 ||| VBN
separately  ||| S:50942 E:50953 ||| RB
for  ||| S:50953 E:50957 ||| IN
each  ||| S:50957 E:50972 ||| DT
morphological  ||| S:50972 E:50986 ||| JJ
category  ||| S:50986 E:50995 ||| NN
( ||| S:50995 E:50996 ||| -LRB-
i.e. ||| S:50996 E:51000 ||| FW
,  ||| S:51000 E:51002 ||| ,
analyzing  ||| S:51002 E:51012 ||| VBG
first  ||| S:51012 E:51018 ||| RB
only  ||| S:51018 E:51033 ||| RB
unbudded  ||| S:51033 E:51042 ||| JJ
cells ||| S:51042 E:51047 ||| NNS
,  ||| S:51047 E:51049 ||| ,
then  ||| S:51049 E:51054 ||| RB
only  ||| S:51054 E:51059 ||| RB
small-budded  ||| S:51059 E:51072 ||| JJ
cells ||| S:51072 E:51077 ||| NNS
,  ||| S:51077 E:51079 ||| ,
and  ||| S:51079 E:51083 ||| CC
then  ||| S:51083 E:51098 ||| RB
only  ||| S:51098 E:51103 ||| RB
large-budded  ||| S:51103 E:51116 ||| JJ
cells ||| S:51116 E:51121 ||| NNS
) ||| S:51121 E:51122 ||| -RRB-
.  ||| S:51122 E:51124 ||| .
Cells  ||| S:51124 E:51130 ||| NNS
in  ||| S:51130 E:51133 ||| IN
which  ||| S:51133 E:51139 ||| WDT
the  ||| S:51139 E:51143 ||| DT
diameter  ||| S:51143 E:51152 ||| NN
of  ||| S:51152 E:51165 ||| IN
the  ||| S:51165 E:51169 ||| DT
bud  ||| S:51169 E:51173 ||| NN
was  ||| S:51173 E:51177 ||| VBD
less  ||| S:51177 E:51182 ||| JJR
than  ||| S:51182 E:51187 ||| IN
1 ||| S:51187 E:51188 ||| CD
/ ||| S:51188 E:51189 ||| CD
4  ||| S:51189 E:51191 ||| CD
of  ||| S:51191 E:51194 ||| IN
the  ||| S:51194 E:51198 ||| DT
diameter  ||| S:51198 E:51207 ||| NN
of  ||| S:51207 E:51210 ||| IN
the  ||| S:51210 E:51214 ||| DT
mother  ||| S:51214 E:51231 ||| NN
part  ||| S:51231 E:51236 ||| NN
of  ||| S:51236 E:51239 ||| IN
the  ||| S:51239 E:51243 ||| DT
cell  ||| S:51243 E:51248 ||| NN
were  ||| S:51248 E:51253 ||| VBD
classified  ||| S:51253 E:51264 ||| VBN
as  ||| S:51264 E:51267 ||| IN
small-budded  ||| S:51267 E:51280 ||| JJ
cells ||| S:51280 E:51285 ||| NNS
.  ||| S:51285 E:51297 ||| .
For  ||| S:51297 E:51301 ||| IN
each  ||| S:51301 E:51306 ||| DT
experiment ||| S:51306 E:51316 ||| NN
,  ||| S:51316 E:51318 ||| ,
we  ||| S:51318 E:51321 ||| PRP
analyzed  ||| S:51321 E:51330 ||| VBD
at  ||| S:51330 E:51333 ||| IN
least  ||| S:51333 E:51339 ||| JJS
100  ||| S:51339 E:51343 ||| CD
cells  ||| S:51343 E:51349 ||| NNS
in  ||| S:51349 E:51362 ||| IN
each  ||| S:51362 E:51367 ||| DT
morphological  ||| S:51367 E:51381 ||| JJ
category ||| S:51381 E:51389 ||| NN
,  ||| S:51389 E:51391 ||| ,
scoring  ||| S:51391 E:51399 ||| VBG
only  ||| S:51399 E:51404 ||| JJ
cells  ||| S:51404 E:51410 ||| NNS
that  ||| S:51410 E:51415 ||| WDT
gave  ||| S:51415 E:51430 ||| VBD
detectable  ||| S:51430 E:51441 ||| JJ
green  ||| S:51441 E:51447 ||| JJ
fluorescence ||| S:51447 E:51459 ||| NN
.  ||| S:51459 E:51461 ||| .
Figure  ||| S:51461 E:51468 ||| NN
8shows  ||| S:51468 E:51475 ||| VBZ
the  ||| S:51475 E:51479 ||| DT
average  ||| S:51479 E:51497 ||| JJ
values  ||| S:51497 E:51504 ||| NNS
from  ||| S:51504 E:51509 ||| IN
the  ||| S:51509 E:51513 ||| DT
results  ||| S:51513 E:51521 ||| NNS
of  ||| S:51521 E:51524 ||| IN
three  ||| S:51524 E:51530 ||| CD
such  ||| S:51530 E:51535 ||| JJ
experiments ||| S:51535 E:51546 ||| NNS
.  ||| S:51546 E:51548 ||| .
In  ||| S:51548 E:51561 ||| IN
some  ||| S:51561 E:51566 ||| DT
large-budded  ||| S:51566 E:51579 ||| JJ
cells ||| S:51579 E:51584 ||| NNS
,  ||| S:51584 E:51586 ||| ,
but  ||| S:51586 E:51590 ||| CC
in  ||| S:51590 E:51593 ||| IN
no  ||| S:51593 E:51596 ||| DT
case  ||| S:51596 E:51601 ||| NN
more  ||| S:51601 E:51606 ||| RBR
than  ||| S:51606 E:51611 ||| IN
in  ||| S:51611 E:51614 ||| IN
3 ||| S:51614 E:51615 ||| CD
%  ||| S:51615 E:51627 ||| NN
of  ||| S:51627 E:51630 ||| IN
such  ||| S:51630 E:51635 ||| JJ
cells ||| S:51635 E:51640 ||| NNS
,  ||| S:51640 E:51642 ||| ,
green  ||| S:51642 E:51648 ||| JJ
fluorescence  ||| S:51648 E:51661 ||| NN
was  ||| S:51661 E:51665 ||| VBD
seen  ||| S:51665 E:51670 ||| VBN
both  ||| S:51670 E:51675 ||| DT
at  ||| S:51675 E:51678 ||| IN
the  ||| S:51678 E:51692 ||| DT
neck  ||| S:51692 E:51697 ||| NN
and  ||| S:51697 E:51701 ||| CC
at  ||| S:51701 E:51704 ||| IN
the  ||| S:51704 E:51708 ||| DT
mother  ||| S:51708 E:51715 ||| NN
periphery ||| S:51715 E:51724 ||| NN
.  ||| S:51724 E:51726 ||| .
Such  ||| S:51726 E:51731 ||| JJ
cells  ||| S:51731 E:51737 ||| NNS
were  ||| S:51737 E:51742 ||| VBD
placed  ||| S:51742 E:51759 ||| VBN
in  ||| S:51759 E:51762 ||| IN
the  ||| S:51762 E:51766 ||| DT
"neck ||| S:51766 E:51771 ||| NN
"  ||| S:51771 E:51773 ||| ''
rather  ||| S:51773 E:51780 ||| RB
than  ||| S:51780 E:51785 ||| IN
in  ||| S:51785 E:51788 ||| IN
the  ||| S:51788 E:51792 ||| DT
"peripheral ||| S:51792 E:51803 ||| NN
"  ||| S:51803 E:51805 ||| ''
category ||| S:51805 E:51813 ||| NN
.  ||| S:51813 E:51825 ||| .
Images  ||| S:51825 E:51832 ||| NNS
were  ||| S:51832 E:51837 ||| VBD
captured  ||| S:51837 E:51846 ||| VBN
using  ||| S:51846 E:51852 ||| VBG
a  ||| S:51852 E:51854 ||| DT
MicroMAX  ||| S:51854 E:51863 ||| JJ
digital  ||| S:51863 E:51871 ||| JJ
camera  ||| S:51871 E:51888 ||| NN
system  ||| S:51888 E:51895 ||| NN
and  ||| S:51895 E:51899 ||| CC
WinView ||| S:51899 E:51906 ||| JJ
/ ||| S:51906 E:51907 ||| CD
32  ||| S:51907 E:51910 ||| CD
software  ||| S:51910 E:51919 ||| NN
( ||| S:51919 E:51920 ||| -LRB-
Princeton  ||| S:51920 E:51930 ||| NNP
Instruments  ||| S:51930 E:51952 ||| NNP
Inc. ||| S:51952 E:51956 ||| NNP
,  ||| S:51956 E:51958 ||| ,
Trenton ||| S:51958 E:51965 ||| NNP
,  ||| S:51965 E:51967 ||| ,
N.J. ||| S:51967 E:51971 ||| NNP
) ||| S:51971 E:51972 ||| -RRB-
.  ||| S:51972 E:51974 ||| .
Images  ||| S:51974 E:51981 ||| NNS
were  ||| S:51981 E:51986 ||| VBD
processed  ||| S:51986 E:51996 ||| VBN
using  ||| S:51996 E:52012 ||| VBG
Photoshop  ||| S:52012 E:52022 ||| NNP
5  ||| S:52022 E:52024 ||| CD
software  ||| S:52024 E:52033 ||| NN
( ||| S:52033 E:52034 ||| -LRB-
Adobe  ||| S:52034 E:52040 ||| NNP
Systems  ||| S:52040 E:52048 ||| NNPS
Inc. ||| S:52048 E:52052 ||| NNP
,  ||| S:52052 E:52054 ||| ,
San  ||| S:52054 E:52058 ||| NNP
Jose ||| S:52058 E:52062 ||| NNP
,  ||| S:52062 E:52074 ||| ,
CA ||| S:52074 E:52076 ||| NNP
) ||| S:52076 E:52077 ||| -RRB-
.  ||| S:52077 E:52110 ||| .
Authors ||| S:52110 E:52117 ||| NNP
'  ||| S:52117 E:52119 ||| POS
contributions  ||| S:52119 E:52141 ||| NNS
M.A.H.  ||| S:52141 E:52148 ||| VBP
performed  ||| S:52148 E:52158 ||| VBN
the  ||| S:52158 E:52162 ||| DT
lipid-binding  ||| S:52162 E:52176 ||| JJ
analyses ||| S:52176 E:52184 ||| NNS
,  ||| S:52184 E:52186 ||| ,
assisted  ||| S:52186 E:52195 ||| VBN
in  ||| S:52195 E:52206 ||| IN
the  ||| S:52206 E:52210 ||| DT
localization  ||| S:52210 E:52223 ||| NN
and  ||| S:52223 E:52227 ||| CC
colony-sectoring  ||| S:52227 E:52244 ||| JJ
studies ||| S:52244 E:52251 ||| NNS
,  ||| S:52251 E:52253 ||| ,
and  ||| S:52253 E:52257 ||| CC
prepared  ||| S:52257 E:52274 ||| VBN
the  ||| S:52274 E:52278 ||| DT
figures ||| S:52278 E:52285 ||| NNS
.  ||| S:52285 E:52287 ||| .
H.S.L.  ||| S:52287 E:52294 ||| NNP
conducted  ||| S:52294 E:52304 ||| VBD
localization  ||| S:52304 E:52317 ||| JJ
and  ||| S:52317 E:52329 ||| CC
colony-sectoring  ||| S:52329 E:52346 ||| JJ
analyses  ||| S:52346 E:52355 ||| NNS
and  ||| S:52355 E:52359 ||| CC
constructed  ||| S:52359 E:52371 ||| VBN
most  ||| S:52371 E:52376 ||| RBS
of  ||| S:52376 E:52379 ||| IN
the  ||| S:52379 E:52391 ||| DT
plasmids  ||| S:52391 E:52400 ||| NN
and  ||| S:52400 E:52404 ||| CC
phage ||| S:52404 E:52409 ||| NN
.  ||| S:52409 E:52411 ||| .
A.B.  ||| S:52411 E:52416 ||| RB
constructed  ||| S:52416 E:52428 ||| VBN
some  ||| S:52428 E:52433 ||| DT
of  ||| S:52433 E:52436 ||| IN
the  ||| S:52436 E:52440 ||| DT
plasmids  ||| S:52440 E:52457 ||| NN
and  ||| S:52457 E:52461 ||| CC
phage  ||| S:52461 E:52467 ||| NNS
and  ||| S:52467 E:52471 ||| CC
assisted  ||| S:52471 E:52480 ||| VBN
in  ||| S:52480 E:52483 ||| IN
the  ||| S:52483 E:52487 ||| DT
colony-sectoring  ||| S:52487 E:52512 ||| JJ
analyses ||| S:52512 E:52520 ||| NNS
.  ||| S:52520 E:52530 ||| .
All  ||| S:52530 E:52534 ||| DT
authors  ||| S:52534 E:52542 ||| NNS
read  ||| S:52542 E:52547 ||| VBP
and  ||| S:52547 E:52551 ||| CC
approved  ||| S:52551 E:52560 ||| VBD
the  ||| S:52560 E:52564 ||| DT
final  ||| S:52564 E:52570 ||| JJ
manuscript ||| S:52570 E:52580 ||| NN
.  ||| S:52580 E:52597 ||| .
